[go: up one dir, main page]

TWI904243B - Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device - Google Patents

Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device

Info

Publication number
TWI904243B
TWI904243B TW110134956A TW110134956A TWI904243B TW I904243 B TWI904243 B TW I904243B TW 110134956 A TW110134956 A TW 110134956A TW 110134956 A TW110134956 A TW 110134956A TW I904243 B TWI904243 B TW I904243B
Authority
TW
Taiwan
Prior art keywords
group
groups
preferred
acid
formula
Prior art date
Application number
TW110134956A
Other languages
Chinese (zh)
Other versions
TW202219161A (en
Inventor
青島俊栄
Original Assignee
日商富士軟片股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商富士軟片股份有限公司 filed Critical 日商富士軟片股份有限公司
Publication of TW202219161A publication Critical patent/TW202219161A/en
Application granted granted Critical
Publication of TWI904243B publication Critical patent/TWI904243B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F283/00Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
    • C08F283/04Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polycarbonamides, polyesteramides or polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/032Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders
    • G03F7/037Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders the binders being polyamides or polyimides
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/20Exposure; Apparatus therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Materials For Photolithography (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

本發明提供一種樹脂組成物、硬化上述樹脂組成物而成之硬化物、含有上述硬化物之積層體、上述硬化物的製造方法及包含上述硬化物或上述積層體之半導體元件,前述樹脂組成物含有:化合物A,其具有經由具有直接鍵結2個以上的酯鍵之結構之連接基鍵結而成之複數個聚合性基並且分子量小於1000;以及選自包括環化樹脂及其前驅物之群組中之至少1種樹脂。The present invention provides a resin composition, a cured product formed by curing the resin composition, a laminate containing the cured product, a method for manufacturing the cured product, and a semiconductor device comprising the cured product or the laminate, wherein the resin composition comprises: compound A, having a plurality of polymerizable groups bonded by linkers having a structure having two or more directly bonded ester bonds and having a molecular weight of less than 1000; and at least one resin selected from the group consisting of cyclized resins and their precursors.

Description

樹脂組成物、硬化物、積層體、硬化物的製造方法及半導體元件Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device

本發明係關於一種樹脂組成物、硬化物、積層體、硬化物的製造方法及半導體元件。This invention relates to a resin composition, a cured material, a laminate, a method for manufacturing the cured material, and a semiconductor device.

聚醯亞胺等環化樹脂的耐熱性及絕緣性等優異,因此適用於各種用途。作為上述用途並無特別限定,但是若以實際安裝用半導體元件為例而舉出,則可舉出絕緣膜或密封材料的材料或作為保護膜的利用。又,亦可以用作可撓性基板的基底膜或覆蓋膜等。Cyclic resins such as polyimide possess excellent heat resistance and insulation properties, making them suitable for a wide range of applications. While there are no particular limitations on these applications, examples include their use as insulating films or sealing materials, or as protective films, in the practical installation of semiconductor components. Furthermore, they can also be used as base films or cover films for flexible substrates.

例如在上述之用途中,聚醯亞胺等環化樹脂以含有環化樹脂之樹脂組成物或含有聚醯亞胺前驅物等環化樹脂的前驅物之樹脂組成物的形態使用。 將該等樹脂組成物例如藉由塗佈等適用於基材來形成感光膜,之後依據需要進行曝光、顯影、加熱等,藉此能夠在基材上形成硬化物。 上述聚醯亞胺前驅物等環化樹脂的前驅物例如藉由加熱而環化,並在硬化物中成為聚醯亞胺等環化樹脂。 硬化性樹脂組成物能夠藉由公知的塗佈方法等而適用,因此可以說製造上的適應性優異,例如所適用之樹脂組成物在適用時的形狀、大小、適用位置等設計的自由度高等。從除了聚醯亞胺等環化樹脂所具有之高性能以外這種製造上的適應性優異之觀點考慮,愈來愈期待上述樹脂組成物在產業上的應用開發。 For example, in the above-described applications, cyclic resins such as polyimide are used in the form of resin compositions containing cyclic resins or resin compositions containing precursors of cyclic resins such as polyimide precursors. These resin compositions are applied to a substrate, for example, by coating, to form a photosensitive film. Then, exposure, development, heating, etc., are performed as needed, thereby forming a cured material on the substrate. The aforementioned cyclic resin precursors, such as polyimide precursors, are cyclized, for example, by heating, and become cyclic resins such as polyimide in the cured material. Curing resin compositions are adaptable to various applications using well-known coating methods, thus offering excellent manufacturing flexibility. For example, they allow for a high degree of design freedom in terms of shape, size, and application location. Considering this excellent manufacturing flexibility, in addition to the high performance of cyclic resins such as polyimide, there is growing anticipation for the industrial application development of these resin compositions.

例如,在專利文獻1中記載有一種感光性樹脂組成物,其特徵為,在將聚醯胺及具有光聚合性不飽和鍵之三聚異氰酸衍生物作為必要成分之感光性樹脂組成物中,(A)上述聚醯胺為具有特定的結構單元之聚醯胺,(B)上述具有光聚合性不飽和鍵之三聚異氰酸衍生物為特定的三聚異氰酸衍生物,相對於(A)100質量份之(B)的含量為15~70質量份。 在專利文獻2中記載有一種能夠鹼性顯影之感光性樹脂組成物,其特徵為,作為必要成分含有特定的聚矽氧烷化合物(A)、選自包括具有含乙烯性不飽和鍵之基團(x)之鄰苯二甲酸酯、偏苯三酸酯及均苯四酸酯之群組中之至少1種酯化合物(B)、多官能(甲基)丙烯酸酯單體(C)及光自由基聚合起始劑(D)。 For example, Patent Document 1 describes a photosensitive resin composition characterized in that, in a photosensitive resin composition in which polyamide and a triisocyanate derivative having photopolymerizable unsaturated bonds are essential components, (A) the polyamide is a polyamide having a specific structural unit, and (B) the triisocyanate derivative having a photopolymerizable unsaturated bond is a specific triisocyanate derivative, and the content of (B) relative to 100 parts by weight of (A) is 15 to 70 parts by weight. Patent document 2 describes a photosensitive resin composition capable of alkaline development, characterized by comprising, as essential components, a specific polysiloxane compound (A), at least one ester compound (B) selected from the group consisting of phthalates, trimellites, and pyromellitic esters having ethylene-containing unsaturated groups (x), a polyfunctional (meth)acrylate monomer (C), and a photoradical polymerization initiator (D).

[專利文獻1]日本特開2007-241195號公報 [專利文獻2]日本特開2013-76791號公報 [Patent Document 1] Japanese Patent Application Publication No. 2007-241195 [Patent Document 2] Japanese Patent Application Publication No. 2013-76791

在由樹脂組成物構成之硬化物中,要求提高所獲得之圖案的解析性。In hardened materials composed of resins, it is desirable to improve the resolution of the obtained patterns.

本發明的目的在於提供一種所獲得之圖案的解析性優異之樹脂組成物、硬化上述樹脂組成物而成之硬化物、含有上述硬化物之積層體、上述硬化物的製造方法及含有上述硬化物或上述積層體之半導體元件。The purpose of this invention is to provide a resin composition with excellent resolution of the obtained pattern, a cured product formed by curing the resin composition, a laminate containing the cured product, a method for manufacturing the cured product, and a semiconductor device containing the cured product or the laminate.

將本發明的代表性實施態樣的例子示於以下。 <1>一種樹脂組成物,其含有: 化合物A,其具有經由連接基鍵結之複數個聚合性基並且分子量小於1000,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構;以及 選自包括環化樹脂及其前驅物之群組中之至少1種樹脂。 <2>如<1>所述之樹脂組成物,其中 上述化合物A中的聚合性基為具有乙烯性不飽和鍵之基團。 <3>如<1>或<2>所述之樹脂組成物,其中 上述化合物A為由下述通式(1-1)表示之化合物。 [化學式1] 式(1-1)中,R 1、R 2及R 3分別獨立地表示具有聚合性基之1價的有機基。 <4>如<1>至<3>之任一項所述之樹脂組成物,其進一步含有自由基聚合起始劑。 <5>如<1>至<4>之任一項所述之樹脂組成物,其中 作為上述樹脂,含有聚醯亞胺前驅物。 <6>如<5>所述之樹脂組成物,其中 上述聚醯亞胺前驅物具有由下述式(2)表示之重複單元, [化學式2] 式(2)中,A 1及A 2分別獨立地表示氧原子或-NH-,R 111表示2價的有機基,R 115表示4價的有機基,R 113及R 114分別獨立地表示氫原子或1價的有機基。 <7>如<6>所述之樹脂組成物,其中 上述式(2)中的R 113及R 114中的至少一者含有自由基聚合性基。 <8>如<1>至<7>之任一項所述之硬化性樹脂組成物,其用於形成再配線層用層間絕緣膜。 <9>一種硬化物,其為硬化<1>至<8>之任一項所述之樹脂組成物而成。 <10>一種積層體,其包含2層以上的由<9>所述之硬化物構成之層,在上述硬化物層之間的任一層之間包含金屬層。 <11>一種硬化物的製造方法,其包括將<1>至<8>之任一項所述之樹脂組成物適用於基材上來形成膜之膜形成步驟。 <12>如<11>所述之硬化物的製造方法,其包括選擇性地曝光上述膜之曝光步驟及使用顯影液顯影上述膜來形成圖案之顯影步驟。 <13>如<11>或<12>所述之硬化物的製造方法,其包括在50~450℃下加熱上述膜之加熱步驟。 <14>一種半導體元件,其含有<9>所述之硬化物或<10>所述之積層體。 [發明效果] Examples of representative embodiments of the present invention are shown below. <1> A resin composition comprising: compound A having a plurality of polymerizable groups bonded by linkers and having a molecular weight less than 1000, wherein the linkers have a structure in which two or more ester bonds are directly bonded to an aromatic ring; and at least one resin selected from the group consisting of cyclized resins and their precursors. <2> The resin composition as described in <1>, wherein the polymerizable groups in compound A are groups having ethylene unsaturated bonds. <3> The resin composition as described in <1> or <2>, wherein compound A is a compound represented by the following general formula (1-1). [Formula 1] In formula (1-1), R1 , R2 , and R3 each independently represent a monovalent organic group having a polymerizable group. <4> The resin composition described in any of <1> to <3> further contains a free radical polymerization initiator. <5> The resin composition described in any of <1> to <4>, wherein the resin contains a polyimide precursor. <6> The resin composition described in <5>, wherein the polyimide precursor has a repeating unit represented by the following formula (2), [Formula 2] In formula (2), A1 and A2 independently represent an oxygen atom or -NH-, R111 represents a divalent organic group, R115 represents a tetravalent organic group, and R113 and R114 independently represent a hydrogen atom or a monovalent organic group. <7> A resin composition as described in <6>, wherein at least one of R113 and R114 in formula (2) contains a free radical polymerizable group. <8> A curable resin composition as described in any one of <1> to <7>, used to form an interlayer insulating film for a redistribution layer. <9> A curable material formed by curing any one of the resin compositions described in <1> to <8>. <10> A laminate comprising two or more layers composed of the curing agent described in <9>, wherein a metal layer is included between any of the curing agent layers. <11> A method of manufacturing a curing agent, comprising a film forming step of adapting a resin composition described in any one of <1> to <8> onto a substrate to form a film. <12> A method of manufacturing a curing agent as described in <11>, comprising an exposure step of selectively exposing the film and a developing step of developing the film using a developing solution to form a pattern. <13> A method of manufacturing a curing agent as described in <11> or <12>, comprising a heating step of heating the film at a temperature of 50 to 450°C. <14> A semiconductor device comprising the curing agent described in <9> or the laminate described in <10>. [Invention Effect]

依據本發明可提供一種所獲得之圖案的解析性優異之樹脂組成物、硬化上述樹脂組成物而成之硬化物、含有上述硬化物之積層體、上述硬化物的製造方法及含有上述硬化物或上述積層體之半導體元件。According to the present invention, a resin composition with excellent resolution of the obtained pattern can be provided, a cured product formed by curing the resin composition, a laminate containing the cured product, a method for manufacturing the cured product, and a semiconductor device containing the cured product or the laminate.

以下,對本發明的主要實施形態進行說明。然而,本發明並不限於所明示之實施形態。 在本說明書中,用“~”記號表示之數值範圍表示將記載於“~”的前後之數值分別作為下限值及上限值包括之範圍。 在本說明書中,“步驟”這一用語不僅表示獨立之步驟,只要能夠實現該步驟所預期之作用,則亦表示包括無法與其他步驟明確區分之步驟。 關於本說明書中之基團(原子團)的表述,未標註經取代及未經取代的表述同時包括不具有取代基的基團(原子團)和具有取代基之基團(原子團)。例如,“烷基”不僅包括不具有取代基的烷基(未經取代的烷基),而且還包括具有取代基之烷基(取代烷基)。 在本說明書中,除非另有說明,則“曝光”不僅包括利用光之曝光,而且還包括利用電子束、離子束等粒子束之曝光。又,作為用於曝光之光,可舉出水銀燈的明線光譜、以準分子雷射為代表之遠紫外線、極紫外線(EUV光)、X射線、電子束等光化射線或放射線。 在本說明書中,“(甲基)丙烯酸酯”表示“丙烯酸酯”及“甲基丙烯酸酯”這兩者或其中任一者,“(甲基)丙烯酸”表示“丙烯酸”及“甲基丙烯酸”這兩者或其中任一者,“(甲基)丙烯醯基”表示“丙烯醯基”及“甲基丙烯醯基”這兩者或其中任一者。 在本說明書中,結構式中的Me表示甲基,Et表示乙基,Bu表示丁基,Ph表示苯基。 在本說明書中,總固體成分係指組成物的所有成分中除了溶劑以外之成分的總質量。又,在本說明書中,固體成分濃度為除了溶劑以外之其他成分相對於組成物的總質量之質量百分率。 在本說明書中,除非另有說明,則重量平均分子量(Mw)及數量平均分子量(Mn)為使用凝膠滲透層析(GPC)法進行測定之值,並且被定義為聚苯乙烯換算值。在本說明書中,關於重量平均分子量(Mw)及數量平均分子量(Mn),例如能夠藉由使用HLC-8220GPC(TOSOH CORPORATION製),並將保護管柱HZ-L、TSKgel Super HZM-M、TSKgel Super HZ4000、TSKgel Super HZ3000及TSKgel Super HZ2000(以上為TOSOH CORPORATION製)串聯連接而用作管柱來求出。除非另有說明,則該等分子量為使用THF(四氫呋喃)作為洗滌液進行測定者。其中,在溶解性低的情況等THF不適合作為洗滌液的情況下,亦能夠使用NMP(N-甲基-2-吡咯啶酮)。又,除非另有說明,則GPC測定中之檢測為使用UV線(紫外線)的波長254nm檢測器者。 在本說明書中,關於構成積層體之各層的位置關係,記載為“上”或“下”時,只要在所關注之複數層中成為標準之層的上側或下側存在其他層即可。亦即,亦可以在成為標準之層與上述其他層之間進一步夾有第3層或第3要素,並且成為標準之層與上述其他層無需接觸。又,除非另有說明,則將對於基材逐漸堆疊層之方向稱為“上”,或者,在具有樹脂組成物層之情況下,將從基材朝向樹脂組成物層之方向稱為“上”,將其相反方向稱為“下”。再者,這種上下方向的設定係為了便於說明本說明書,在實際態樣中,本說明書中之“上”方向亦可以與鉛直朝上不同。 在本說明書中,除非另有說明,則作為組成物中所包含之各成分,組成物亦可以包含與該成分對應之2種以上的化合物。又,除非另有說明,則組成物中之各成分的含量表示與該成分對應之所有化合物的總含量。 在本說明書中,除非另有說明,則溫度為23℃,氣壓為101,325Pa(1氣壓),相對濕度為50%RH。 在本說明書中,較佳態樣的組合為更佳的態樣。 The main embodiments of the present invention are described below. However, the present invention is not limited to the embodiments shown. In this specification, the numerical range indicated by the symbol “~” represents the range including the lower and upper limits of the numerical values recorded before and after the “~”, respectively. In this specification, the term “step” not only refers to an independent step, but also includes steps that cannot be clearly distinguished from other steps, as long as the expected effect of the step can be achieved. Regarding the description of group (atomic group) in this specification, the descriptions without indication of substitution and non-substitution include both unsubstituent group (atomic group) and substituent group (atomic group). For example, "alkyl" includes not only unsubstituted alkyl groups (unsubstituted alkyl groups) but also substituted alkyl groups (substituted alkyl groups). In this specification, unless otherwise stated, "exposure" includes not only exposure using light but also exposure using particle beams such as electron beams and ion beams. Furthermore, examples of light used for exposure include brightline spectra from mercury lamps, far-ultraviolet light (represented by excimer lasers), extreme ultraviolet light (EUV light), X-rays, electron beams, and other photochemical rays or radiation. In this specification, "(meth)acrylate" means either or both "acrylate" and "methacrylate," "(meth)acrylic acid" means either or both "acrylic acid" and "methacrylic acid," and "(meth)acrylyl" means either or both "acrylyl" and "methacrylyl." In this specification, Me represents methyl, Et represents ethyl, Bu represents butyl, and Ph represents phenyl in the structural formula. In this specification, total solids content refers to the total mass of all components of the composition, excluding the solvent. Furthermore, in this specification, solids concentration is the mass percentage of components other than the solvent relative to the total mass of the composition. In this specification, unless otherwise stated, the weight-average molecular weight (Mw) and number-average molecular weight (Mn) are values determined using gel osmosis chromatography (GPC) and are defined as polystyrene equivalents. In this instruction manual, the weight average molecular weight (Mw) and number average molecular weight (Mn) can be determined, for example, by using an HLC-8220GPC (manufactured by TOSOH CORPORATION) with guard columns HZ-L, TSKgel Super HZM-M, TSKgel Super HZ4000, TSKgel Super HZ3000, and TSKgel Super HZ2000 (all manufactured by TOSOH CORPORATION) connected in series. Unless otherwise stated, these molecular weights are determined using THF (tetrahydrofuran) as the washing solution. In cases where THF is unsuitable as a washing solution due to low solubility, NMP (N-methyl-2-pyrrolidone) can also be used. Furthermore, unless otherwise stated, the detection in GPC measurements uses a UV (ultraviolet) detector with a wavelength of 254 nm. In this specification, when describing the positional relationship of the layers constituting the laminate as "upper" or "lower," it is sufficient that there are other layers above or below the standard layer among the layers of interest. That is, a third layer or third element may be sandwiched between the standard layer and the other layers mentioned above, and the standard layer does not need to be in contact with the other layers. Furthermore, unless otherwise stated, the direction of gradual layering of the substrate is referred to as "up," or, in the case of a resin composition layer, the direction from the substrate towards the resin composition layer is referred to as "up," and the opposite direction is referred to as "down." Moreover, this up-down direction designation is for ease of explanation of this specification; in actual samples, the "up" direction in this specification may differ from "vertically upward." In this specification, unless otherwise stated, as components included in the composition, the composition may contain two or more compounds corresponding to that component. Furthermore, unless otherwise stated, the content of each component in the composition represents the total content of all compounds corresponding to that component. Unless otherwise specified, the temperature in this specification is 23°C, the pressure is 101,325 Pa (1 atmosphere), and the relative humidity is 50% RH. In this specification, the combination of preferred samples is considered a better sample.

(樹脂組成物) 本發明的樹脂組成物,其含有:化合物A(以下,亦簡稱為“化合物A”。),其具有經由連接基鍵結之複數個聚合性基並且分子量小於1000,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構;以及選自包括環化樹脂及其前驅物之群組中之至少1種樹脂(以下,亦稱為“特定樹脂”。)。 (Resin Composition) The resin composition of the present invention comprises: compound A (hereinafter also referred to as "Compound A"), having a plurality of polymerizable groups bonded by linkers and having a molecular weight of less than 1000, wherein the linkers have a structure in which two or more ester bonds are directly bonded to an aromatic ring; and at least one resin selected from the group consisting of cyclized resins and their precursors (hereinafter also referred to as "specific resin").

本發明的樹脂組成物用於形成提供於曝光及顯影之感光膜為較佳,用於形成提供於曝光及使用了包含有機溶劑之顯影液之顯影之膜為較佳。 又,本發明的樹脂組成物用於形成提供於負型顯影之感光膜為較佳。 在本發明中,負型顯影係指在曝光及顯影中,藉由顯影而去除非曝光部之顯影,正型顯影係指藉由顯影而去除曝光部之顯影。 作為上述曝光的方法、上述顯影液及上述顯影的方法,例如使用在後述硬化物的製造方法的說明中之曝光步驟中所說明之曝光方法、在顯影步驟中所說明之顯影液及顯影方法。 The resin composition of this invention is preferably used to form a photosensitive film for exposure and development, and preferably to form a developing film for exposure and development using a developing solution containing an organic solvent. Furthermore, the resin composition of this invention is preferably used to form a photosensitive film for negative development. In this invention, negative development refers to development in which the non-exposed areas are removed by development during exposure and development, and positive development refers to development in which the exposed areas are removed by development. As the above-described exposure method, the above-described developing solution, and the above-described developing method, for example, the exposure method described in the exposure step of the description of the method for manufacturing a cured material described later, and the developing solution and developing method described in the developing step are used.

本發明的樹脂組成物的所獲得之圖案的解析性優異。 可以獲得上述效果之機制雖尚不明確,但是推測為如下。 The resin composition of this invention produces patterns with excellent resolution. While the mechanism by which this effect is achieved is not yet clear, it is hypothesized as follows:

以往進行了在含有環化樹脂的前驅物及聚合性化合物之樹脂組成物中藉由曝光及顯影來形成圖案之步驟。 化合物A具有連接基,因此認為與特定樹脂的相溶性優異,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構。 因此,認為化合物A和樹脂容易在感光膜中以幾乎均勻的狀態分散,藉由顯影液容易去除非圖像部。 又,在所獲得之硬化物中,以幾乎均勻的狀態分散之化合物A形成交聯,因此認為可抑制溶劑等的滲透,並且耐藥品性亦優異。 Previous methods have involved forming patterns in resin compositions containing cyclized resin precursors and polymeric compounds through exposure and development. Compound A possesses a linker group, thus exhibiting excellent compatibility with certain resins. This linker group has a structure in which two or more ester bonds are directly bonded to an aromatic ring. Therefore, it is believed that compound A and the resin are easily dispersed in a nearly uniform state in the photosensitive film, and non-image areas are easily removed by the developing solution. Furthermore, in the obtained cured product, compound A, dispersed in a nearly uniform state, forms crosslinks, thus inhibiting the penetration of solvents, etc., and exhibiting excellent chemical resistance.

在此,在專利文獻1~2中未記載有含有化合物A及環化樹脂的前驅物之樹脂組成物。Here, patent documents 1 and 2 do not describe resin compositions containing compound A and cyclized resin precursors.

以下,對本發明的樹脂組成物中所含有之成分進行詳細說明。The following is a detailed description of the components contained in the resin composition of the present invention.

<化合物A> 本發明的樹脂組成物含有化合物A,上述化合物A具有經由連接基鍵結之複數個聚合性基,並且分子量小於1000,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構。 化合物A的分子量小於1000,900以下為較佳,800以下為更佳。上述分子量的下限並無特別限定,例如為200以上為較佳。 <Compound A> The resin composition of this invention contains compound A, which has a plurality of polymerizable groups linked by linkers and has a molecular weight of less than 1000. The linkers have a structure in which two or more ester bonds are directly bonded to an aromatic ring. The molecular weight of compound A is preferably less than 1000, less than 900, and more preferably less than 800. There is no particular limitation on the lower limit of the above molecular weight; for example, it is preferred to be 200 or more.

〔聚合性基〕 作為化合物A中所含有之聚合性基為能夠藉由熱、自由基等的作用而進行交聯反應的基團,自由基聚合性基為較佳。作為聚合性基的具體例,可舉出具有乙烯性不飽和鍵之基團、烷氧基甲基、羥甲基、醯氧基甲基、環氧基、氧雜環丁基、苯并噁唑基、嵌段異氰酸酯基、胺基,具有乙烯性不飽和鍵之基團為較佳。 作為具有乙烯性不飽和鍵之基團,可舉出(甲基)丙烯醯氧基、(甲基)丙烯醯胺基、乙烯基苯基等在芳香環上直接鍵結乙烯基而成之基團、烯丙基、乙烯基等,從反應性的觀點考慮,(甲基)丙烯醯氧基為較佳。 [Polymerizable Group] The polymerizable group contained in compound A is a group capable of cross-linking reactions through the action of heat, free radicals, etc., and a free radical polymerizable group is preferred. Specific examples of polymerizable groups include groups having ethylene unsaturated bonds, alkoxymethyl, hydroxymethyl, acetoxymethyl, epoxy, oxacyclobutyl, benzoxazolyl, block isocyanate, and amino groups, with groups having ethylene unsaturated bonds being preferred. As groups possessing vinyl unsaturated bonds, examples include (meth)acryloxy, (meth)acrylamine, vinylphenyl, etc., which are groups formed by direct bonding of vinyl groups to an aromatic ring, allyl, vinyl, etc. From a reactivity perspective, (meth)acryloxy is preferred.

化合物A含有複數個聚合性基。 化合物A例如,如包含1個環氧基及1個(甲基)丙烯醯氧基那樣可以包含2種以上的聚合性基,以使其合計成為複數個,但含有複數個環氧基或具有乙烯性不飽和鍵之基團為較佳,含有複數個具有乙烯性不飽和鍵之基團為更佳。 Compound A contains a plurality of polymerizable groups. Compound A may contain, for example, one epoxy group and one (meth)acrylic acid group, so that the total number of polymerizable groups is plurality. However, it is preferable to contain a plurality of epoxy groups or groups having ethylene unsaturated bonds, and even more preferable to contain a plurality of groups having ethylene unsaturated bonds.

化合物A中的聚合性基的數量為2以上即可,2~15為較佳,2~10為更佳,2~4為進一步較佳,2為特佳。 1g化合物A中所含有之聚合性基的莫耳量為2.0mmol/g以上為較佳,2.5mmol/g以上為更佳,3.0mmol/g以上為進一步較佳。上述莫耳量的上限並無特別限定,8.0mmol/g以下為較佳。 The number of polymerizable groups in compound A should be 2 or more, preferably 2–15, more preferably 2–10, further preferably 2–4, and very preferably 2. The molar amount of polymerizable groups contained in 1g of compound A is preferably 2.0 mmol/g or more, more preferably 2.5 mmol/g or more, and further preferably 3.0 mmol/g or more. There is no particular upper limit to the above molar amounts, but 8.0 mmol/g or less is preferred.

〔連接基〕 化合物A具有經由連接基鍵結之複數個聚合性基,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構。亦即,在化合物A中,複數個聚合性基經由連接基鍵結,上述連接基具有在芳香環上直接鍵結2個以上的酯鍵之結構。 [Linking Group] Compound A has a plurality of polymerizable groups linked by linking groups, wherein each linking group has a structure in which two or more ester bonds are directly bonded to an aromatic ring. That is, in compound A, a plurality of polymerizable groups are linked by linking groups, wherein each linking group has a structure in which two or more ester bonds are directly bonded to an aromatic ring.

上述連接基可以僅含有1個芳香環,亦可以含有複數個,含有1~4個為較佳,含有1或2個為更佳。 作為上述芳香環,可以為芳香族烴環亦可以為芳香族雜環,芳香族烴環為較佳,苯環為特佳。 上述酯鍵為羧酸酯結構為較佳。 又,當上述酯鍵為羧酸酯結構之情況下,羧酸酯結構中的碳原子側(羧酸酯結構中所含有之羰基側)直接鍵結於芳香環上為較佳。 上述酯結構存在於芳香環中的相鄰位置為較佳。相鄰位置係指芳香環中的相鄰之環員的位置,芳香環為苯環,則為鄰位。 聚合性基可以鍵結於連接基中的任一位置,含有聚合性基之結構經由上述酯鍵與上述芳香環鍵結為較佳。 亦即,上述連接基含有由下述式(L-1)表示之結構為較佳。 【化學式3】 式(L-1)中,Ar表示芳香環,n表示2以上的整數,m表示0以上的整數,n+m為Ar的最大取代基數以下的數,*及#分別表示與其他結構的鍵結部位。 The aforementioned linker may contain only one aromatic ring or multiple aromatic rings, with one to four being preferred, and one or two being even more preferred. The aromatic ring may be an aromatic hydrocarbon ring or an aromatic heterocyclic ring, with an aromatic hydrocarbon ring being preferred and a benzene ring being particularly preferred. The aforementioned ester bond is preferably a carboxylic acid ester structure. Furthermore, when the aforementioned ester bond is a carboxylic acid ester structure, it is preferable that the carbon atom side of the carboxylic acid ester structure (the carbonyl side contained in the carboxylic acid ester structure) is directly bonded to the aromatic ring. It is preferable that the aforementioned ester structure is located in an adjacent position within the aromatic ring. An adjacent position refers to the position of an adjacent ring member within the aromatic ring; if the aromatic ring is a benzene ring, then it is an adjacent position. The polymerizable group can be bonded to any position in the linker, and the structure containing the polymerizable group is preferably formed by the above-mentioned ester bond and the above-mentioned aromatic ring bond. That is, it is preferable that the linker group contains a structure represented by the following formula (L-1). [Chemical Formula 3] In formula (L-1), Ar represents an aromatic ring, n represents an integer greater than 2, m represents an integer greater than 0, n+m is a number below the maximum substituent number of Ar, and * and # represent the bonding sites with other structures, respectively.

式(L-1)中,Ar的較佳的態樣與上述芳香環的較佳的態樣相同。 式(L-1)中,n表示2以上的整數,2~4為較佳,2為特佳。 式(L-1)中,m表示0以上的整數,0~4為較佳,0~2為更佳。 式(L-1)中,Ar的最大取代基數為將Ar設為不具有取代基之芳香環時的氫原子的數,例如Ar為苯環時為6。 式(L-1)中,*及#分別為與其他結構的鍵結部位,*為與聚合性基的鍵結部位為較佳。 In Formula (L-1), the preferred state of Ar is the same as the preferred state of the aromatic ring described above. In Formula (L-1), n represents an integer greater than or equal to 2, with 2 to 4 being preferred and 2 being particularly preferred. In Formula (L-1), m represents an integer greater than or equal to 0, with 0 to 4 being preferred and 0 to 2 being even more preferred. In Formula (L-1), the maximum number of substituents for Ar is the number of hydrogen atoms when Ar is set as an aromatic ring without substituents, for example, 6 when Ar is a benzene ring. In Formula (L-1), * and # represent bonding sites with other structures, respectively, with * representing a preferred bonding site with a polymerizable group.

上述連接基為藉由在上述芳香環上直接鍵結2個以上的酯鍵之結構與選自包括可以經取代的烴基、(聚)伸烷氧基、-O-、-S-、-SO 2-、-CO-及-NHCO-之群組中之至少1種基團的組合形成之基團為較佳,藉由在上述芳香環上直接鍵結2個以上的酯鍵之結構與可以經取代的烴基的組合形成之基團為更佳。 作為上述烴基,可舉出飽和脂肪族烴基、不飽和脂肪族烴基、芳香族烴基或由該等組合表示之基團,飽和脂肪族烴基、芳香族烴基或由該等的組合表示之基團為更佳,飽和脂肪族烴基為特佳。 又,作為上述烴基中的取代基,可舉出氟原子等鹵素原子。 作為上述(聚)伸烷氧基中的伸烷基,可舉出伸乙基、伸丙基、三亞甲基、伸丁基等,伸乙基或伸丙基為較佳。 上述連接基為2價以上的連接基即可,2~6價的連接基為較佳,2~4價的連接基為進一步較佳。 The aforementioned linker is preferably a group formed by a combination of a structure having two or more ester bonds directly bonded to the aromatic ring and a group selected from at least one group selected from the group consisting of substituted hydrocarbons, (poly)alkoxy groups, -O-, -S-, -SO₂- , -CO-, and -NHCO-. It is even more preferred that the linker is a group formed by a combination of a structure having two or more ester bonds directly bonded to the aromatic ring and a substituted hydrocarbon. Examples of the aforementioned hydrocarbons include saturated aliphatic hydrocarbons, unsaturated aliphatic hydrocarbons, aromatic hydrocarbons, or groups represented by combinations thereof. Saturated aliphatic hydrocarbons, aromatic hydrocarbons, or groups represented by combinations thereof are more preferred, and saturated aliphatic hydrocarbons are particularly preferred. Furthermore, halogen atoms, such as fluorine atoms, can be cited as substituents in the aforementioned hydrocarbon groups. Alkyl groups, such as ethyl, propyl, trimethylene, and butyl, can be cited as alkyl groups, with ethyl or propyl being preferred. The linking group can be divalent or higher; divalent to hexavalent links are preferred, and divalent to tetravalent links are even more preferred.

該等之中,化合物A為由下述式(1-1)表示之化合物為較佳。 【化學式4】 式(1-1)中,R 1、R 2及R 3分別獨立地表示具有聚合性基之1價的有機基。 Of these, compound A is preferably represented by the following formula (1-1). [Chemical Formula 4] In equation (1-1), R1 , R2 and R3 each independently represent an organic group with a monovalent polymericity.

式(1-1)中,R 1、R 2及R 3分別獨立地為由下述式(P-1)表示之基團為較佳。 【化學式5】 式(P-1)中,L 1表示n+1價的連接基,P 1表示聚合性基,n表示1以上的整數,*表示與式(1-1)中的氧原子的鍵結部位。 式(P-1)中,作為L 1,可舉出在上述連接基中說明之基團,較佳的態樣亦相同。 式(P-1)中,作為P 1,可舉出在上述聚合性基中說明之基團,較佳的態樣亦相同。 式(P-1)中,n為1~10的整數為較佳,1~5的整數為更佳,1或2為進一步較佳,1為特佳。 In formula (1-1), it is preferable that R1 , R2 , and R3 are each independently represented by the following formula (P-1). [Chemical Formula 5] In formula (P-1), L1 represents a linker with an n+1 valence, P1 represents a polymerizable group, n represents an integer greater than or equal to 1, and * represents a bonding site with the oxygen atom in formula (1-1). In formula (P-1), L1 can be any group described in the linker above, and the preferred state is the same. In formula (P-1), P1 can be any group described in the polymerizable group above, and the preferred state is the same. In formula (P-1), n is preferably an integer from 1 to 10, more preferably an integer from 1 to 5, 1 or 2 is further preferred, and 1 is especially preferred.

又,由式(1-1)表示之化合物為由式(1-2)表示之化合物亦較佳。 【化學式6】 式(1-2)中,L 2表示單鍵或2價的連接基,R 11~R 14分別獨立地表示具有聚合性基之基團。 Furthermore, it is preferable that the compound represented by formula (1-1) is also represented by formula (1-2). [Chemical Formula 6] In equation (1-2), L2 represents a single bond or a divalent linker, and R11 to R14 represent groups with polymerizable properties, respectively.

式(1-2)中,作為L 2,可舉出單鍵或在上述連接基中說明之基團,單鍵、-CH 2-、-O-、-S-、-SO 2-、-CO-、-NHCO-、-C(CF 32-或-C(CH 32-為較佳。 式(1-2)中,R 11~R 14的含義分別獨立地與式(1-1)中的R 1的含義相同,較佳的態樣亦相同。 In equation (1-2), L2 can be a single bond or a group described in the above-mentioned connecting base, with single bond, -CH2- , -O-, -S-, -SO2-, -CO-, -NHCO-, -C( CF3 ) 2- or -C( CH3 ) 2- being preferred. In equation (1-2), the meanings of R11 to R14 are independently the same as the meaning of R1 in equation (1-1), and the preferred states are also the same.

作為化合物A的具體例,可舉出下述化合物,但是並不限定於此。 【化學式7】 【化學式8】 Specific examples of compound A include, but are not limited to, the following compounds. [Chemical Formula 7] 【Chemical Formula 8】

化合物A的含量相對於本發明的樹脂組成物的總固體成分超過0質量%且60質量%以下為較佳。下限為5質量%以上為更佳。上限為50質量%以下為更佳,30質量%以下為進一步較佳。The content of compound A relative to the total solid content of the resin composition of the present invention is preferably more than 0% by mass and less than 60% by mass. The lower limit is more preferably 5% by mass or more. The upper limit is more preferably 50% by mass or less, and less than 30% by mass or less is even more preferred.

<特定樹脂> 本發明的樹脂組成物含有選自包括環化樹脂及其前驅物之群組中之至少1種樹脂(特定樹脂)。 環化樹脂為在主鏈結構中含有醯亞胺環結構或噁唑環結構之樹脂為較佳。 在本發明中,主鏈表示在樹脂分子中相對最長的鍵結鏈。 作為環化樹脂,可舉出聚醯亞胺、聚苯并噁唑、聚醯胺醯亞胺等。 環化樹脂的前驅物係指藉由外部刺激產生化學結構的變化而成為環化樹脂之樹脂,藉由熱產生化學結構的變化而成為環化樹脂之樹脂為較佳,藉由熱產生閉環反應而形成環結構來成為環化樹脂之樹脂為更佳。 作為環化樹脂的前驅物,可舉出聚醯亞胺前驅物、聚苯并噁唑前驅物、聚醯胺醯亞胺前驅物等。 亦即,本發明的樹脂組成物作為特定樹脂含有選自包括聚醯亞胺、聚醯亞胺前驅物、聚苯并噁唑、聚苯并噁唑前驅物、聚醯胺醯亞胺及聚醯胺醯亞胺前驅物之群組中之至少1種樹脂(特定樹脂)為較佳。 本發明的樹脂組成物作為特定樹脂含有聚醯亞胺或聚醯亞胺前驅物為較佳,含有聚醯亞胺前驅物為更佳。 又,特定樹脂具有聚合性基為較佳,含有自由基聚合性基為更佳。 當特定樹脂具有自由基聚合性基之情況下,本發明的樹脂組成物含有後述自由基聚合起始劑為較佳,含有後述自由基聚合起始劑並且含有後述自由基交聯劑為更佳。此外,依據需要,能夠含有後述增感劑。由這種本發明的樹脂組成物例如可形成負型感光膜。 又,特定樹脂可以具有酸分解性基等極性反轉基。 當特定樹脂具有酸分解性基之情況下,本發明的樹脂組成物含有後述光酸產生劑為較佳。由這種本發明的樹脂組成物例如可形成化學增幅型的正型感光膜或負型感光膜。 又,特定樹脂含有與化合物A中所含有之聚合性基進行反應而能夠共價鍵結之基團為較佳。 例如,當化合物A含有具有乙烯性不飽和鍵之基團之情況下,特定樹脂亦含有具有乙烯性不飽和鍵之基團為較佳。 又,當化合物A含有環氧基之情況下,特定樹脂亦含有環氧基為較佳。 依據上述態樣,認為化合物A與特定樹脂之間亦形成交聯,並且更提高所獲得之硬化物的耐藥品性。 <Specific Resin> The resin composition of this invention contains at least one resin (specific resin) selected from the group consisting of cyclized resins and their precursors. Preferably, the cyclized resin is a resin containing an imine ring structure or an oxazole ring structure in its backbone structure. In this invention, the backbone refers to the relatively longest bond chain in the resin molecule. Examples of cyclized resins include polyimide, polybenzoxazole, and polyamide-imide. Cyclomeric resin precursors refer to resins that undergo chemical structural changes through external stimuli to become cyclized resins. Resins that undergo chemical structural changes through heat to become cyclized resins are preferred, and those that form a ring structure through a heat-induced ring-closing reaction are even better. Examples of cyclized resin precursors include polyimide precursors, polybenzoxazole precursors, and polyamide-imide precursors. That is, the resin composition of the present invention, as a specific resin, preferably contains at least one resin (the specific resin) selected from the group consisting of polyimide, polyimide precursor, polybenzoxazole, polybenzoxazole precursor, polyamideimide, and polyamideimide precursor. The resin composition of the present invention, as a specific resin, preferably contains polyimide or a polyimide precursor, and more preferably contains a polyimide precursor. Furthermore, the specific resin preferably has polymerizable groups, and more preferably contains free radical polymerizable groups. When a particular resin possesses free radical polymerizable groups, it is preferable that the resin composition of the present invention contains the free radical polymerization initiator described later, and it is even more preferable that it contains both the free radical polymerization initiator and the free radical crosslinking agent described later. Furthermore, depending on need, it can contain the sensitizer described later. Such a resin composition of the present invention can, for example, form a negative photosensitive film. Furthermore, a particular resin may possess polar reversible groups such as acid-decomposing groups. When a particular resin possesses acid-decomposing groups, it is preferable that the resin composition of the present invention contains the photoacid generator described later. Such a resin composition of the present invention can, for example, form a chemically amplified positive or negative photosensitive film. Furthermore, it is preferable that the specific resin contains groups that can covalently bond with the polymerizable groups contained in compound A. For example, if compound A contains groups with ethylene unsaturated bonds, it is preferable that the specific resin also contains groups with ethylene unsaturated bonds. Furthermore, if compound A contains epoxy groups, it is preferable that the specific resin also contains epoxy groups. Based on the above, it is believed that cross-linking also occurs between compound A and the specific resin, further improving the chemical resistance of the obtained cured product.

〔聚醯亞胺前驅物〕 本發明中所使用之聚醯亞胺前驅物的其種類等並沒有特別規定,但包含由下述式(2)表示之重複單元為較佳。 【化學式9】 式(2)中,A 1及A 2分別獨立地表示氧原子或-NH-,R 111表示2價的有機基,R 115表示4價的有機基,R 113及R 114分別獨立地表示氫原子或1價的有機基。 [Polyimide Precursor] The type of polyimide precursor used in this invention is not specifically specified, but it is preferable to include repeating units represented by the following formula (2). [Chemical Formula 9] In formula (2), A1 and A2 represent oxygen atoms or -NH- respectively, R111 represents a divalent organic group, R115 represents a tetravalent organic group, and R113 and R114 represent hydrogen atoms or monovalent organic groups respectively.

式(2)中之A 1及A 2分別獨立地表示氧原子或-NH-,氧原子為較佳。 式(2)中之R 111表示2價的有機基。作為2價的有機基,可例示包含直鏈或支鏈的脂肪族基、環狀脂肪族基及芳香族基之基團,包括碳數2~20的直鏈或支鏈的脂肪族基、碳數3~20的環狀脂肪族基、碳數3~20的芳香族基或該等的組合之基團為較佳,包含碳數6~20的芳香族基之基團為更佳。上述直鏈或支鏈的脂肪族基可以經鏈中的烴基包含雜原子之基團取代,並且上述環狀的脂肪族基及芳香族基可以經環員的烴基包含雜原子之基團取代。作為本發明的較佳的實施形態,可例示由-Ar-及-Ar-L-Ar-表示之基團,特佳為由-Ar-L-Ar-表示之基團。其中,Ar分別獨立地為芳香族基,L為包括單鍵、可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-CO-、-S-、-SO 2-或-NHCO-或者上述中的兩個以上的組合之基團。該等較佳的範圍如上所述。 In formula (2), A1 and A2 respectively represent oxygen atoms or -NH-, with oxygen atoms being preferred. In formula (2), R111 represents a divalent organic group. Examples of divalent organic groups include aliphatic groups, cyclic aliphatic groups, and aromatic groups that are linear or branched, preferably linear or branched aliphatic groups with 2 to 20 carbon atoms, cyclic aliphatic groups with 3 to 20 carbon atoms, aromatic groups with 3 to 20 carbon atoms, or combinations thereof, and more preferably groups that include aromatic groups with 6 to 20 carbon atoms. The aforementioned linear or branched aliphatic groups can be substituted via groups containing heteroatoms in the hydrocarbon chain, and the aforementioned cyclic aliphatic and aromatic groups can be substituted via groups containing heteroatoms in the hydrocarbon chain. As a preferred embodiment of the invention, groups represented by -Ar- and -Ar-L-Ar- are exemplified, with a particular preference for groups represented by -Ar-L-Ar-. Wherein, Ar is independently an aromatic group, and L is a group comprising a single bond, an aliphatic hydrocarbon of 1 to 10 carbon atoms that can be substituted with a fluorine atom, -O-, -CO-, -S-, -SO₂- , or -NHCO-, or a combination of two or more of the above. These preferred ranges are as described above.

R 111衍生自二胺為較佳。作為聚醯亞胺前驅物的製造中所使用之二胺,可舉出直鏈或支鏈的脂肪族、環狀脂肪族或芳香族二胺等。二胺可以僅使用1種,亦可以使用2種以上。 具體而言,包含包括碳數2~20的直鏈或支鏈的脂肪族基、碳數3~20的環狀脂肪族基、碳數3~20的芳香族基或該等的組合之基團之二胺為較佳,包含碳數6~20的芳香族基之二胺為更佳。上述直鏈或支鏈的脂肪族基可以經鏈中的烴基包含雜原子之基團取代,並且上述環狀的脂肪族基及芳香族基可以經環員的烴基包含雜原子之基團取代。作為包含芳香族基之基團的例子,可舉出下述。 R 111 is preferably derived from a diamine. Examples of diamines used in the manufacture of polyimide precursors include linear or branched aliphatic, cyclic aliphatic, or aromatic diamines. Only one type of diamine may be used, or two or more types may be used. Specifically, diamines containing aliphatic groups (2-20 carbon atoms), cyclic aliphatic groups (3-20 carbon atoms), aromatic groups (3-20 carbon atoms), or combinations thereof are preferred, and diamines containing aromatic groups (6-20 carbon atoms) are even more preferred. The linear or branched aliphatic groups can be substituted with groups containing heteroatoms in the hydrocarbon group of the chain, and the cyclic aliphatic and aromatic groups can be substituted with groups containing heteroatoms in the hydrocarbon group of the ring member. Examples of groups containing aromatic groups include the following.

【化學式10】 式中,A表示單鍵或2價的連接基,單鍵或選自可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-C(=O)-、-S-、-SO 2-、-NHCO-或該等的組合中之基團為較佳,單鍵、選自可以經氟原子取代的碳數1~3的伸烷基、-O-、-C(=O)-、-S-或-SO 2-中之基團為更佳,-CH 2-、-O-、-S-、-SO 2-、-C(CF 32-或-C(CH 32-為進一步較佳。 式中,*表示與其他結構的鍵結部位。 【Chemical Formula 10】 In the formula, A represents a single bond or a divalent linker. A single bond or a group selected from aliphatic hydrocarbons of 1 to 10 carbon atoms that can be substituted with fluorine atoms, -O-, -C(=O)-, -S-, -SO₂- , -NHCO-, or combinations thereof is preferred. A single bond, a group selected from alkyl groups of 1 to 3 carbon atoms that can be substituted with fluorine atoms, -O-, -C(=O)-, -S-, or -SO₂- is more preferred. -CH₂- , -O-, -S-, -SO₂-, -C( CF₃ ) ₂- , or -C( CH₃ ) ₂- are even more preferred. * indicates a bonding site with other structures.

作為二胺,具體而言,可舉出選自1,2-二胺基乙烷、1,2-二胺基丙烷、1,3-二胺基丙烷、1,4-二胺基丁烷及1,6-二胺基己烷;1,2-二胺基環戊烷或1,3-二胺基環戊烷、1,2-二胺基環己烷、1,3-二胺基環己烷或1,4-二胺基環己烷、1,2-雙(胺甲基)環己烷、1,3-雙(胺甲基)環己烷或1,4-雙(胺甲基)環己烷、雙-(4-胺基環己基)甲烷、雙-(3-胺基環己基)甲烷、4,4’-二胺基-3,3’-二甲基環己基甲烷及異佛爾酮二胺;間苯二胺或對苯二胺、二胺基甲苯、4,4’-二胺基聯苯或3,3’-二胺基聯苯、4,4’-二胺基二苯醚、3,3’-二胺基二苯醚、4,4’-二胺基二苯基甲烷及3,3’-二胺基二苯基甲烷、4,4’-二胺基二苯碸及3,3-二胺基二苯碸、4,4’-二胺基二苯醚及3,3’-二胺基二苯醚、4,4’-二胺基二苯甲酮或3,3’-二胺基二苯甲酮、3,3’-二甲基-4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2-雙(4-胺基苯基)丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙(3-羥基-4-胺基苯基)丙烷、2,2-雙(3-羥基-4-胺基苯基)六氟丙烷、2,2-雙(3-胺基-4-羥基苯基)丙烷、2,2-雙(3-胺基-4-羥基苯基)六氟丙烷、雙(3-胺基-4-羥基苯基)碸、雙(4-胺基-3-羥基苯基)碸、4,4’-二胺基對聯三苯、4,4’-雙(4-胺基苯氧基)聯苯、雙[4-(4-胺基苯氧基)苯基]碸、雙[4-(3-胺基苯氧基)苯基]碸、雙[4-(2-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、9,10-雙(4-胺基苯基)蒽、3,3’-二甲基-4,4’-二胺基二苯碸、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、1,3-雙(4-胺基苯基)苯、3,3’-二乙基-4,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷、4,4’-二胺基八氟聯苯、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、9,9-雙(4-胺基苯基)-10-氫蒽、3,3’,4,4’-四胺基聯苯、3,3’,4,4’-四胺基二苯醚、1,4-二胺基蒽醌、1,5-二胺基蒽醌、3,3-二羥基-4,4’-二胺基聯苯、9,9’-雙(4-胺基苯基)茀、4,4’-二甲基-3,3’-二胺基二苯碸、3,3’,5,5’-四甲基-4,4’-二胺基二苯基甲烷、2,4-二胺基枯烯及2,5-二胺基枯烯、2,5-二甲基-對苯二胺、乙醯胍胺、2,3,5,6-四甲基-對苯二胺、2,4,6-三甲基-間苯二胺、雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷、2,7-二胺基茀、2,5-二胺基吡啶、1,2-雙(4-胺基苯基)乙烷、二胺基苯甲醯苯胺、二胺苯甲酸的酯、1,5-二胺基萘、二胺基三氟甲苯、1,3-雙(4-胺基苯基)六氟丙烷、1,4-雙(4-胺基苯基)八氟丁烷、1,5-雙(4-胺基苯基)十氟戊烷、1,7-雙(4-胺基苯基)十四氟庚烷、2,2-雙[4-(3-胺基苯氧基)苯基]六氟丙烷、2,2-雙[4-(2-胺基苯氧基)苯基]六氟丙烷、2,2-雙[4-(4-胺基苯氧基)-3,5-二甲基苯基]六氟丙烷、2,2-雙[4-(4-胺基苯氧基)-3,5-雙(三氟甲基)苯基]六氟丙烷、對雙(4-胺基-2-三氟甲基苯氧基)苯、4,4’-雙(4-胺基-2-三氟甲基苯氧基)聯苯、4,4’-雙(4-胺基-3-三氟甲基苯氧基)聯苯、4,4’-雙(4-胺基-2-三氟甲基苯氧基)二苯碸、4,4’-雙(3-胺基-5-三氟甲基苯氧基)二苯碸、2,2-雙[4-(4-胺基-3-三氟甲基苯氧基)苯基]六氟丙烷、3,3’,5,5’-四甲基-4,4’-二胺基聯苯、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、2,2’,5,5’,6,6’-六氟聯甲苯胺及4,4’-二胺基四聯苯中的至少一種二胺。As a diamine, specifically, examples include those selected from 1,2-diaminoethane, 1,2-diaminopropane, 1,3-diaminopropane, 1,4-diaminobutane, and 1,6-diaminohexane; 1,2-diaminocyclopentane or 1,3-diaminocyclopentane, 1,2-diaminocyclohexane, 1,3-diaminocyclohexane or 1,4-diaminocyclohexane, 1,2-bis(aminomethyl)cyclohexane, 1,3-bis(aminomethyl)cyclohexane or 1,4-bis(aminomethyl)cyclohexane, bis-(4-aminocyclohexyl)methane, bis-(3-aminocyclohexyl)methane, and 4,4'-diamino-3,3'-dimethyl Cyclohexylmethane and isophorone diamine; m-phenylenediamine or p-phenylenediamine, diaminotoluene, 4,4'-diaminobiphenyl or 3,3'-diaminobiphenyl, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane and 3,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfone and 3,3'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl ether and 3,3'-diaminodiphenyl ether, 4,4'-diaminodibenzophenone or 3,3'-diaminodibenzophenone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl-4, 4’-Diaminobiphenyl, 3,3’-Dimethoxy-4,4’-Diaminobiphenyl, 2,2-bis(4-aminophenyl)propane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis(3-hydroxy-4-aminophenyl)propane, 2,2-bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, bis(3-amino-4-hydroxyphenyl) phosphate, bis(4-amino-3-hydroxyphenyl) phosphate, 4,4’-diaminobiphenyl, 4,4’-bis(4-amino-3-hydroxyphenyl) Bis[4-(4-aminophenoxy)phenyl] benzox, bis[4-(3-aminophenoxy)phenyl] benzox, bis[4-(2-aminophenoxy)phenyl] benzox, 1,4-bis(4-aminophenoxy)benzene, 9,10-bis(4-aminophenyl)anthracene, 3,3’-dimethyl-4,4’-diaminodiphenyl benzox, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 3,3’-diethyl-4,4’-diaminodiphenylmethane, 3,3’-dimethyl-4,4’-diaminodiphenylmethane 4,4'-Diaminooctafluorobiphenyl, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 3,3',4,4'-tetraaminobiphenyl, 3,3',4,4'-tetraaminodiphenyl ether, 1,4-diaminoanthraquinone, 1,5-diaminoanthraquinone, 3,3-dihydroxy-4,4'-diaminobiphenyl, 9,9'-bis(4-aminophenyl)furan, 4,4'-dimethyl-3,3'-diaminodiphenyl ether, 3,3',5,5'-tetramethyl-4, 4'-Diaminodiphenylmethane, 2,4-Diaminocumene and 2,5-Diaminocumene, 2,5-Dimethyl-p-phenylenediamine, acetoguanidine, 2,3,5,6-Tetramethyl-p-phenylenediamine, 2,4,6-Trimethyl-m-phenylenediamine, bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, 2,7-Diaminopyridine, 2,5-Diaminopyridine, 1,2-bis(4-aminophenyl)ethane, diaminobenzoniline, esters of diaminobenzoic acid, 1,5-Diaminonaphthalene, diaminotrifluorotoluene, 1,3-bis(4-aminophenyl)hexafluoropropane, 1,4-bis... (4-aminophenyl)octafluorobutane, 1,5-bis(4-aminophenyl)decafluoropentane, 1,7-bis(4-aminophenyl)tetrafluoroheptane, 2,2-bis[4-(3-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(2-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-dimethylphenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-bis(trifluoromethyl)phenyl]hexafluoropropane, p-bis(4-amino-2-trifluoromethylphenoxy)benzene, 4,4'-bis(4-amino-2-trifluoromethyl)phenyl The diamine selected from at least one of the following: 4,4'-bis(4-amino-3-trifluoromethylphenoxy)biphenyl, 4,4'-bis(4-amino-2-trifluoromethylphenoxy)diphenyl sulfonium, 4,4'-bis(3-amino-5-trifluoromethylphenoxy)diphenyl sulfonium, 2,2-bis[4-(4-amino-3-trifluoromethylphenoxy)phenyl]hexafluoropropane, 3,3',5,5'-tetramethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,2',5,5',6,6'-hexafluorobitoluidine, and 4,4'-diaminotetraphenyl.

又,國際公開第2017/038598號的0030~0031段中所記載之二胺(DA-1)~(DA-18)亦較佳。Furthermore, the diamines (DA-1) to (DA-18) described in paragraphs 0030 to 0031 of International Publication No. 2017/038598 are also preferred.

又,亦可較佳地使用在主鏈上具有國際公開第2017/038598號的0032~0034段中所記載之兩個以上的伸烷基二醇單元之二胺。Alternatively, a diamine having two or more alkyl diol units as described in paragraphs 0032 to 0034 of International Publication No. 2017/038598 on the main chain may also be preferred.

從所獲得之有機膜的柔軟性的觀點考慮,R 111由-Ar-L-Ar-表示為較佳。其中,Ar分別獨立地為芳香族基,L為包括可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-CO-、-S-、-SO 2-或-NHCO-或者上述中的兩個以上的組合之基團。Ar為伸苯基為較佳,L為可以經氟原子取代的碳數1或2的脂肪族烴基、-O-、-CO-、-S-或-SO 2-為較佳。此處的脂肪族烴基為伸烷基為較佳。 From the viewpoint of the flexibility of the obtained organic membrane, R 111 is preferably represented by -Ar-L-Ar-. Here, Ar is independently an aromatic group, and L is a group including an aliphatic hydrocarbon of 1 to 10 carbon atoms that can be substituted with a fluorine atom, -O-, -CO-, -S-, -SO₂- , or -NHCO-, or a combination of two or more of the above. Ar is preferably phenyl, and L is preferably an aliphatic hydrocarbon of 1 or 2 carbon atoms that can be substituted with a fluorine atom, -O-, -CO-, -S-, or -SO₂- . Here, the aliphatic hydrocarbon is preferably alkyl.

又,從i射線透射率的觀點考慮,R 111為由下述式(51)或式(61)表示之2價的有機基為較佳。尤其,從i射線透射率、易獲得性的觀點考慮,由式(61)表示之2價的有機基為更佳。 式(51) 【化學式11】 式(51)中,R 50~R 57分別獨立地為氫原子、氟原子或1價的有機基,R 50~R 57中的至少1個為氟原子、甲基或三氟甲基,*分別獨立地表示式(2)中的與氮原子的鍵結部位。 作為R 50~R 57的1價的有機基,可舉出碳數1~10(較佳為碳數1~6)的未經取代的烷基、碳數1~10(較佳為碳數1~6)的氟化烷基等。 【化學式12】 式(61)中,R 58及R 59分別獨立地為氟原子、甲基或三氟甲基,*分別獨立地表示式(2)中的與氮原子的鍵結部位。 作為提供式(51)或式(61)的結構之二胺,可舉出2,2’-二甲基聯苯胺、2,2’-雙(三氟甲基)-4,4’-二胺基聯苯、2,2’-雙(氟)-4,4’-二胺基聯苯、4,4’-二胺基八氟聯苯等。該等可以使用1種或組合使用2種以上。 Furthermore, from the viewpoint of i-ray transmittance, R 111 is preferably a divalent organic group represented by formula (51) or formula (61) below. In particular, from the viewpoints of i-ray transmittance and availability, the divalent organic group represented by formula (61) is more preferred. Formula (51) [Chemical Formula 11] In formula (51), R50 to R57 are each independently a hydrogen atom, a fluorine atom, or a monovalent organic group, and at least one of R50 to R57 is a fluorine atom, a methyl group, or a trifluoromethyl group. *Each independently represents a bonding site with a nitrogen atom in formula (2). Examples of monovalent organic groups of R50 to R57 include unsubstituted alkyl groups with 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms) and fluorinated alkyl groups with 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms). [Chemical Formula 12] In formula (61), R 58 and R 59 are independently fluorine atoms, methyl groups, or trifluoromethyl groups, respectively, and * independently represent the bonding sites with nitrogen atoms in formula (2). Examples of diamines providing the structure of formula (51) or formula (61) include 2,2'-dimethylbenzidine, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(fluoro)-4,4'-diaminobiphenyl, and 4,4'-diaminooctafluorobiphenyl. One or more of these may be used.

式(2)中之R 115表示4價的有機基。作為4價的有機基,包含芳香環之4價的有機基為較佳,由下述式(5)或式(6)表示之基團為更佳。 式(5)或式(6)中,*分別獨立地表示與其他結構的鍵結部位。 【化學式13】 式(5)中,R 112為單鍵或2價的連接基,單鍵或選自可以經氟原子取代的碳數1~10的脂肪族烴基、-O-、-CO-、-S-、-SO 2-及-NHCO-以及該等的組合中之基團為較佳,單鍵、選自可以經氟原子取代的碳數1~3的伸烷基、-O-、-CO-、-S-及SO 2-中之基團為更佳,選自包括-CH 2-、-C(CF 32-、-C(CH 32-、-O-、-CO-、-S-及-SO 2-之群組中之2價的基團為進一步較佳。 In formula (2), R 115 represents a tetravalent organic group. As a tetravalent organic group, a tetravalent organic group containing an aromatic ring is preferred, and a group represented by formula (5) or formula (6) below is even more preferred. In formula (5) or formula (6), * independently represents the bonding site with other structures. [Chemical Formula 13] In formula (5), R 112 is a single bond or a divalent linker. It is preferred to have a single bond or a group selected from aliphatic hydrocarbons with 1 to 10 carbon atoms that can be substituted by fluorine atoms, -O-, -CO-, -S-, -SO 2- and -NHCO-, and combinations thereof. It is even more preferred to have a single bond, a group selected from alkyl groups with 1 to 3 carbon atoms that can be substituted by fluorine atoms, -O-, -CO-, -S- and SO 2- , and a divalent group selected from the group including -CH 2- , -C(CF 3 ) 2- , -C(CH 3 ) 2- , -O-, -CO-, -S- and -SO 2- .

關於R 115,具體而言,可舉出從四羧酸二酐去除酐基之後所殘存之四羧酸殘基等。聚醯亞胺前驅物作為相當於R 115之結構可以僅含有1種四羧酸二酐殘基,亦可以含有2種以上四羧酸二酐殘基。 四羧酸二酐由下述式(O)表示為較佳。 【化學式14】 式(O)中,R 115表示4價的有機基。R 115的較佳的範圍的含義與式(2)中之R 115的含義相同,較佳的範圍亦相同。 Regarding R 115 , specifically, examples include the tetracarboxylic acid residue remaining after removing the anhydride group from a tetracarboxylic dianhydride. Polyimide precursors, as equivalent to R 115 , may contain only one type of tetracarboxylic acid dianhydride residue, or they may contain two or more types of tetracarboxylic acid dianhydride residues. It is preferred that the tetracarboxylic acid dianhydride be represented by the following formula (O). [Chemical Formula 14] In equation (O), R 115 represents a tetravalent organic group. The meaning of the preferred range of R 115 is the same as that of R 115 in equation (2), and the preferred range is also the same.

作為四羧酸二酐的具體例,可舉出均苯四甲酸二酐(PMDA)、3,3’,4,4’-聯苯四羧酸二酐、3,3’,4,4’-二苯硫醚四羧酸二酐、3,3’,4,4’-二苯基碸四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-二苯基甲烷四羧酸二酐、2,2’,3,3’-二苯基甲烷四羧酸二酐、2,3,3’,4’-聯苯四羧酸二酐、2,3,3’,4’-二苯甲酮四羧酸二酐、4,4’-氧基二鄰苯二甲酸二酐、2,3,6,7-萘四羧酸二酐、1,4,5,7-萘四羧酸二酐、2,2-雙(3,4-二羧基苯基)丙烷二酐、2,2-雙(2,3-二羧基苯基)丙烷二酐、2,2-雙(3,4-二羧基苯基)六氟丙烷二酐、1,3-二苯基六氟丙烷-3,3,4,4-四羧酸二酐、1,4,5,6-萘四羧酸二酐、2,2’,3,3’-二苯基四羧酸二酐、3,4,9,10-苝四羧酸二酐、1,2,4,5-萘四羧酸二酐、1,4,5,8-萘四羧酸二酐、1,8,9,10-菲四羧酸二酐、1,1-雙(2,3-二羧基苯基)乙烷二酐、1,1-雙(3,4-二羧基苯基)乙烷二酐、1,2,3,4-苯四羧酸二酐及該等碳數1~6的烷基及碳數1~6的烷氧基衍生物。Specific examples of tetracarboxylic dianhydrides include pyromellitic dianhydride (PMDA), 3,3’,4,4’-biphenyltetracarboxylic dianhydride, 3,3’,4,4’-diphenyl sulfide tetracarboxylic dianhydride, 3,3’,4,4’-diphenyl sulfide tetracarboxylic dianhydride, 3,3’,4,4’-benzophenone tetracarboxylic dianhydride, 3,3’,4,4’-diphenylmethane tetracarboxylic dianhydride, 2,2’,3,3’-diphenylmethane tetracarboxylic dianhydride, 2,3,3’,4’-biphenyltetracarboxylic dianhydride, 2,3,3’,4’-benzophenone tetracarboxylic dianhydride, 4,4’-oxydiphthalic acid dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,4,5,7-naphthalenetetracarboxylic dianhydride, and 2,2-bis(3,4-dicarboxyphenyl)propane. Alkane dianhydrides, 2,2-bis(2,3-dicarboxyphenyl)propane dianhydrides, 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydrides, 1,3-diphenylhexafluoropropane-3,3,4,4-tetracarboxylic acid dianhydrides, 1,4,5,6-naphthalenetetracarboxylic acid dianhydrides, 2,2',3,3'-diphenyltetracarboxylic acid dianhydrides, 3,4,9,10-perylenetetracarboxylic acid dianhydrides, 1,2,4,5-naphthalenetetracarboxylic acid dianhydrides, 1,4,5,8-naphthalenetetracarboxylic acid dianhydrides, 1,8,9,10-phenanthrenetetracarboxylic acid dianhydrides, 1,1-bis(2,3-dicarboxyphenyl)ethane dianhydrides, 1,1-bis(3,4-dicarboxyphenyl)ethane dianhydrides, 1,2,3,4-benzenetetracarboxylic acid dianhydrides, and such alkyl and alkoxy derivatives having 1 to 6 carbon atoms.

又,亦可舉出國際公開第2017/038598號的0038段中所記載之四羧酸二酐(DAA-1)~(DAA-5)作為較佳例。Alternatively, the tetracarboxylic acid dianhydrides (DAA-1) to (DAA-5) described in paragraph 0038 of International Publication No. 2017/038598 can be cited as a better example.

式(2)中,R 111和R 115中的至少一者亦可以具有OH基。更具體而言,作為R 111,可舉出雙胺基苯酚衍生物的殘基。 In formula (2), at least one of R 111 and R 115 may also have an OH group. More specifically, as R 111 , the residual group of a diaminophenol derivative can be cited.

式(2)中的R 113及R 114分別獨立地表示氫原子或1價的有機基。作為1價的有機基,含有直鏈或支鏈的烷基、環狀烷基、芳香族基或聚伸烷氧基為較佳。又,R 113及R 114中的至少一者含有聚合性基為較佳,兩者含有聚合性基為更佳。R 113及R 114中的至少一者含有2以上的聚合性基亦較佳。作為聚合性基為能夠藉由熱、自由基等的作用而進行交聯反應的基團,自由基聚合性基為較佳。作為聚合性基的具體例,可舉出具有乙烯性不飽和鍵之基團、烷氧基甲基、羥甲基、醯氧基甲基、環氧基、氧雜環丁基、苯并噁唑基、嵌段異氰酸酯基、胺基。作為聚醯亞胺前驅物所具有之自由基聚合性基,具有乙烯性不飽和鍵之基團為較佳。 作為具有乙烯性不飽和鍵之基團,可舉出乙烯基、烯丙基、異烯丙基、2-甲基烯丙基、具有直接與乙烯基鍵結之芳香環之基團(例如乙烯基苯基等)、(甲基)丙烯醯胺基、(甲基)丙烯醯氧基、由下述式(III)表示之基團等,由下述式(III)表示之基團為較佳。 In formula (2), R113 and R114 independently represent a hydrogen atom or a monovalent organic group. As a monovalent organic group, it is preferable to contain a straight-chain or branched alkyl, cyclic alkyl, aromatic, or polyalkylene alkoxy group. Furthermore, it is preferable that at least one of R113 and R114 contains a polymerizable group, and even more preferable that both contain polymerizable groups. It is also preferable that at least one of R113 and R114 contains two or more polymerizable groups. As a polymerizable group, it is a group capable of cross-linking reactions through the action of heat, free radicals, etc., and a free radical polymerizable group is preferred. Specific examples of polymerizable groups include groups having vinyl unsaturated bonds, alkoxymethyl, hydroxymethyl, acetoxymethyl, epoxy, oxacyclobutyl, benzoxazolyl, block isocyanate, and amino groups. As a free radical polymerizable group in a polyimide precursor, a group having vinyl unsaturated bonds is preferred. Examples of groups having vinyl unsaturated bonds include vinyl, allyl, isoallyl, 2-methylallyl, groups having an aromatic ring directly bonded to a vinyl group (e.g., vinylphenyl), (meth)acrylamide, (meth)acryloxy, and groups represented by formula (III) below, with groups represented by formula (III) below being preferred.

【化學式15】 【Chemical Formula 15】

式(III)中,R 200表示氫原子、甲基、乙基或羥甲基,氫原子或甲基為較佳。 式(III)中,*表示與其他結構的鍵結部位。 式(III)中,R 201表示碳數2~12的伸烷基、-CH 2CH(OH)CH 2-、伸環烷基或聚伸烷氧基。 較佳的R 201的例可舉出伸乙基、伸丙基、三亞甲基、四亞甲基、五亞甲基、六亞甲基、八亞甲基、十二亞甲基等的伸烷基、1,2-丁二基、1,3-丁二基、-CH 2CH(OH)CH 2-、聚伸烷氧基,伸乙基、伸丙基等的伸烷基、-CH 2CH(OH)CH 2-、環己基、聚伸烷氧基為更佳,伸乙基、伸丙基等的伸烷基或聚伸烷氧基為進一步較佳。 在本發明中,聚伸烷氧基係指直接鍵結兩個以上的伸烷氧基而獲得之基團。聚伸烷氧基中所包含之複數個伸烷氧基中之伸烷基可以分別相同,亦可以不同。 在聚伸烷氧基包含伸烷基不同之複數種伸烷氧基之情況下,聚伸烷氧基中之伸烷氧基的排列可以為無規排列,亦可以為具有嵌段之排列,還可以為具有交替等圖案之排列。 上述伸烷基的碳數(在伸烷基具有取代基之情況下,包含取代基的碳數)為2以上為較佳,2~10為更佳,2~6為更佳,2~5為進一步較佳,2~4為更進一步較佳,2或3為特佳,2為最佳。 又,上述伸烷基可以具有取代基。作為較佳的取代基,可舉出烷基、芳基、鹵素原子等。 又,聚伸烷氧基中所包含之伸烷氧基的數量(聚伸烷氧基的重複數)為2~20為較佳,2~10為更佳,2~6為進一步較佳。 作為聚伸烷氧基,從溶劑溶解性及耐溶劑性的觀點考慮,聚乙烯氧基、聚丙烯氧基、聚三亞甲氧基、聚四亞甲氧基或複數個乙烯氧基與複數個丙烯氧基鍵結而獲得之基團為較佳,聚乙烯氧基或聚丙烯氧基為更佳,聚乙烯氧基為進一步較佳。在上述複數個乙烯氧基與複數個丙烯氧基鍵結而獲得之基團中,乙烯氧基與丙烯氧基可以無規排列,亦可以形成嵌段而排列,還可以排列成交替等圖案狀。該等基團中之乙烯氧基等重複數較佳態樣如上所述。 In formula (III), R 200 represents a hydrogen atom, methyl, ethyl, or hydroxymethyl, with a hydrogen atom or methyl being preferred. In formula (III), * indicates a bonding site with other structures. In formula (III), R 201 represents an alkyl group having 2 to 12 carbon atoms, -CH 2 CH(OH)CH 2 -, cycloalkyl group, or polyalkylene group. Examples of preferred R 201 include alkyl groups such as ethyl, propyl, trimethylene, tetramethylene, pentamethylene, hexamethylene, octamethylene, and dodecamethylene; 1,2-butadiyl, 1,3-butadiyl; -CH₂CH (OH) CH₂- ; polyalkyleneoxy; alkyl groups such as ethyl and propyl; -CH₂CH (OH) CH₂- ; cyclohexyl; and polyalkyleneoxy, alkyl groups such as ethyl and propyl, or polyalkyleneoxy, are even more preferred. In this invention, polyalkyleneoxy refers to a group obtained by directly bonding two or more alkyleneoxy groups. The alkyl groups in the plurality of alkyleneoxy groups contained in the polyalkyleneoxy group may be the same or different. When the polyalkylene group contains a plurality of different penecoloxy groups, the arrangement of the penecoloxy groups in the polyalkylene group can be random, block, or alternating. It is preferable that the number of carbon atoms in the aforementioned penecoloxy group (the number of carbon atoms including the substituent when the penecoloxy group has substituents) is 2 or more, more preferably 2 to 10, more preferably 2 to 6, further preferably 2 to 5, even more preferably 2 to 4, particularly preferably 2 or 3, and most preferably 2. Furthermore, the aforementioned penecoloxy group can have substituents. Examples of preferred substituents include alkyl, aryl, and halogen atoms. Furthermore, it is preferable that the number of penecoloxy groups contained in the polyalkylene group (the repetition number of the polyalkylene group) is 2 to 20, more preferably 2 to 10, and even more preferably 2 to 6. From the viewpoint of solvent solubility and solvent resistance, polyvinyloxy, polypropyleneoxy, polytrimethyleneoxy, polytetramethoxy, or groups obtained by bonding a plurality of ethyleneoxy groups with a plurality of propyleneoxy groups are preferred as polyvinyloxy or polypropyleneoxy groups, with polyvinyloxy being even more preferred. Among the groups obtained by bonding a plurality of ethyleneoxy groups with a plurality of propyleneoxy groups, the ethyleneoxy and propyleneoxy groups can be arranged randomly, can form blocks, or can be arranged in alternating patterns. The preferred states of the repetition of ethyleneoxy groups in these groups are as described above.

式(2)中,在R 113為氫原子之情況或在R 114為氫原子之情況下,聚醯亞胺前驅物可以與具有乙烯性不飽和鍵之三級胺化合物形成共軛鹼。作為這種具有乙烯性不飽和鍵之三級胺化合物的例子,可舉出甲基丙烯酸N,N-二甲胺基丙酯。 In formula (2), when R 113 is a hydrogen atom or when R 114 is a hydrogen atom, the polyimide precursor can form a conjugated base with a tertiary amine compound having vinyl unsaturated bonds. N,N-dimethylaminopropyl methacrylate is an example of such a tertiary amine compound having vinyl unsaturated bonds.

式(2)中,R 113及R 114中的至少一者可以為酸分解性基等極性反轉基。作為酸分解性基,只要為在酸的作用下分解而產生酚性羥基、羧基等鹼可溶性基者,則並無特別限定,但是縮醛基、縮酮基、甲矽烷基、甲矽烷基醚基、三級烷基酯基等為較佳,從曝光靈敏度的觀點考慮,縮醛基或縮酮基為更佳。 作為酸分解性基的具體例,可舉出三級丁氧基羰基、異丙氧基羰基、四氫吡喃基、四氫呋喃基、乙氧基乙基、甲氧基乙基、乙氧基甲基、三甲基甲矽烷基、三級丁氧基羰基甲基、三甲基甲矽烷基醚基等。從曝光靈敏度的觀點考慮,乙氧基乙基或四氫呋喃基為較佳。 In formula (2), at least one of R 113 and R 114 can be a polar reversible group such as an acid-degradable group. As an acid-degradable group, there is no particular limitation as long as it decomposes under the action of acid to produce an alkaline soluble group such as a phenolic hydroxyl group or a carboxyl group, but acetal, ketal, silyl alkyl, silyl ether, and tertiary alkyl ester are preferred. From the perspective of exposure sensitivity, acetal or ketal is more preferred. Specific examples of acid-degradable groups include tertiary butoxycarbonyl, isopropoxycarbonyl, tetrahydropyranyl, tetrahydrofuranyl, ethoxyethyl, methoxyethyl, ethoxymethyl, trimethylsilyl, tertiary butoxycarbonylmethyl, and trimethylsilyl ether. From the perspective of exposure sensitivity, ethoxyethyl or tetrahydrofuranyl are preferred.

又,聚醯亞胺前驅物在結構中具有氟原子亦較佳。聚醯亞胺前驅物中的氟原子含量為10質量%以上為較佳,又20質量%以下為較佳。Furthermore, it is preferable for polyimide precursors to have fluorine atoms in their structure. A fluorine atom content of 10% by mass or more in the polyimide precursor is preferred, while a fluorine atom content of less than 20% by mass is also preferred.

又,以提高與基板的密接性為目的,聚醯亞胺前驅物可以與具有矽氧烷結構之脂肪族基共聚。具體而言,作為二胺,可舉出使用雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷等之態樣。Furthermore, to improve adhesion to the substrate, polyimide precursors can be copolymerized with aliphatic groups having a silicate structure. Specifically, examples of diamines include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.

由式(2)表示之重複單元為由式(2-A)表示之重複單元為較佳。亦即,本發明中所使用之聚醯亞胺前驅物中的至少一種為具有由式(2-A)表示之重複單元之前驅物為較佳。藉由聚醯亞胺前驅物含有由式(2-A)表示之重複單元,能夠更加寬曝光寬容度的寬度。 式(2-A) 【化學式16】 式(2-A)中,A 1及A 2表示氧原子,R 111及R 112分別獨立地表示2價的有機基,R 113及R 114分別獨立地表示氫原子或1價的有機基,R 113及R 114中的至少一者為包含聚合性基之基團,兩者含有聚合性基為較佳。 It is preferable that the repeating unit represented by formula (2) is a repeating unit represented by formula (2-A). That is, it is preferable that at least one of the polyimide precursors used in this invention is a precursor having a repeating unit represented by formula (2-A). By having the polyimide precursor contain a repeating unit represented by formula (2-A), the exposure tolerance can be widened. Formula (2-A) [Chemical Formula 16] In formula (2-A), A1 and A2 represent oxygen atoms, R111 and R112 represent divalent organic groups independently, R113 and R114 represent hydrogen atoms or monovalent organic groups independently, and at least one of R113 and R114 is a group containing polymerizable groups, preferably both of which contain polymerizable groups.

A 1、A 2、R 111、R 113及R 114的含義分別獨立地與式(2)中之A 1、A 2、R 111、R 113及R 114的含義相同,較佳的範圍亦相同。 R 112的含義與式(5)中之R 112的含義相同,較佳的範圍亦相同。 The meanings of A1 , A2 , R111 , R113 , and R114 are independently the same as those of A1 , A2 , R111 , R113 , and R114 in equation (2), and the preferred ranges are also the same. The meaning of R112 is the same as that of R112 in equation (5), and the preferred range is also the same.

聚醯亞胺前驅物可以包含1種由式(2)表示之重複單元,亦可以包含2種以上。又,亦可以包含由式(2)表示之重複單元的結構異構物。又,聚醯亞胺前驅物除了上述式(2)的重複單元以外,亦可以包含其他種類的重複單元,這是不言而喻的。Polyimide precursors may contain one or more repeating units represented by formula (2). They may also contain structural isomers of the repeating units represented by formula (2). Furthermore, it is self-evident that polyimide precursors may contain other types of repeating units besides the repeating units of formula (2) mentioned above.

作為本發明中的聚醯亞胺前驅物的一實施形態,可舉出由式(2)表示之重複單元的含量為所有重複單元的50莫耳%以上之態樣。上述總含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述總含量的上限並無特別限定,除了末端之聚醯亞胺前驅物中的所有重複單元可以為由式(2)表示之重複單元。As one embodiment of the polyimide precursor in this invention, an example is that the content of the repeating unit represented by formula (2) is 50 mol% or more of all repeating units. It is more preferable that the total content is 70 mol% or more, even more preferable that it is 90 mol% or more, and even more preferable that it exceeds 90 mol%. There is no particular limitation on the upper limit of the total content, except that all repeating units in the terminal polyimide precursor can be repeating units represented by formula (2).

聚醯亞胺前驅物的重量平均分子量(Mw)較佳為5,000~100,000,更佳為10,000~50,000,進一步較佳為15,000~40,000。又,數量平均分子量(Mn)較佳為2,000~40,000,更佳為3,000~30,000,進一步較佳為4,000~20,000。 上述聚醯亞胺前驅物的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯亞胺前驅物的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。 在本說明書中,分子量的分散度為利用重量平均分子量/數量平均分子量計算出之值。 又,當樹脂組成物作為特定樹脂包含複數種聚醯亞胺前驅物之情況下,至少1種聚醯亞胺前驅物的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯亞胺前驅物作為1個樹脂而計算之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of the polyimide precursor is preferably 5,000 to 100,000, more preferably 10,000 to 50,000, and even more preferably 15,000 to 40,000. Furthermore, the number-average molecular weight (Mn) is preferably 2,000 to 40,000, more preferably 3,000 to 30,000, and even more preferably 4,000 to 20,000. The molecular weight dispersion of the above-mentioned polyimide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and even more preferably 2.0 or higher. There is no specific upper limit to the molecular weight dispersion of the polyimide precursor, but for example, 7.0 or below is preferred, 6.5 or below is more preferred, and 6.0 or below is even more preferred. In this specification, the molecular weight dispersion is a value calculated using weight average molecular weight/number average molecular weight. Furthermore, when the resin composition, as a specific resin, contains multiple polyimide precursors, it is preferred that the weight average molecular weight, number average molecular weight, and dispersion of at least one polyimide precursor are within the above-mentioned ranges. Moreover, it is also preferred that the weight average molecular weight, number average molecular weight, and dispersion calculated when considering the multiple polyimide precursors as a single resin are each within the above-mentioned ranges.

〔聚醯亞胺〕 本發明中所使用之聚醯亞胺可以為鹼可溶性聚醯亞胺,亦可以為可溶於以有機溶劑為主成分之顯影液之聚醯亞胺。 在本說明書中,鹼可溶性聚醯亞胺係指相對於100g的2.38質量%四甲基銨水溶液在23℃下溶解0.1g以上之聚醯亞胺,從圖案形成性的觀點考慮,溶解0.5g以上之聚醯亞胺為較佳,溶解1.0g以上之聚醯亞胺為進一步較佳。上述溶解量的上限並無特別限定,但100g以下為較佳。 又,從所得到之有機膜的膜強度及絕緣性的觀點考慮,聚醯亞胺係在主鏈中具有複數個醯亞胺結構之聚醯亞胺為較佳。 在本說明書中,“主鏈”係指在構成樹脂之高分子化合物的分子中相對最長的鍵結鏈,“側鏈”係指除此以外的鍵結鏈。 [Polyimide] The polyimide used in this invention can be an alkaline-soluble polyimide or a polyimide soluble in a developing solution primarily composed of an organic solvent. In this specification, alkaline-soluble polyimide refers to polyimide that dissolves at least 0.1 g in 100 g of a 2.38% (w/w) tetramethylammonium aqueous solution at 23°C. From a pattern-forming point of view, dissolving at least 0.5 g of polyimide is preferred, and dissolving at least 1.0 g of polyimide is further preferred. There is no particular upper limit to the above dissolution amount, but less than 100 g is preferred. Furthermore, considering the strength and insulation properties of the resulting organic membrane, polyimides with a plurality of amide structures in the backbone are preferred. In this specification, "backbone" refers to the longest bond in the polymer molecule constituting the resin, and "side chain" refers to all other bond chains.

-氟原子- 從所得到之有機膜的膜強度的觀點考慮,聚醯亞胺具有氟原子亦較佳。 氟原子例如包含於由後述之式(4)表示之重複單元中之R 132或由後述之式(4)表示之重複單元中之R 131中為較佳,作為氟化烷基而包含於由後述之式(4)表示之重複單元中之R 132或由後述之式(4)表示之重複單元中之R 131中為更佳。 氟原子相對於聚醯亞胺的總質量之量為5質量%以上為較佳,又20質量%以下為較佳。 -Fluorine Atom- From the viewpoint of the membrane strength of the obtained organic membrane, it is preferable that the polyimide has fluorine atoms. It is preferable that the fluorine atom is contained, for example, in R 132 or R 131 of the repeating unit represented by formula (4) described later, and even more preferably as a fluorinated alkyl group in R 132 or R 131 of the repeating unit represented by formula (4) described later. It is preferable that the amount of fluorine atoms relative to the total mass of the polyimide is 5% by mass or more, and preferably 20% by mass or less.

-矽原子- 從所得到之有機膜的膜強度的觀點考慮,聚醯亞胺具有矽原子亦較佳。 矽原子例如包含於由後述之式(4)表示之重複單元中之R 131中為較佳,作為後述之有機改質(聚)矽氧烷結構而包含於由後述之式(4)表示之重複單元中之R 131中為更佳。 又,上述矽原子或上述有機改質(聚)矽氧烷結構亦可以包含於聚醯亞胺的側鏈中,但包含於聚醯亞胺的主鏈中為較佳。 矽原子相對於聚醯亞胺的總質量之量為1質量%以上為較佳,20質量%以下為更佳。 -Silicon Atoms- From the viewpoint of the strength of the obtained organic film, it is preferable that polyimide contains silicon atoms. It is preferable that the silicon atoms are included, for example, in R 131 of the repeating unit represented by the formula (4) described later, and even more preferably in R 131 of the repeating unit represented by the formula (4) described later as an organically modified (poly)siloxane structure. Furthermore, the aforementioned silicon atoms or the aforementioned organically modified (poly)siloxane structure may also be included in the side chain of polyimide, but it is preferable that they are included in the main chain of polyimide. It is preferable that the amount of silicon atoms relative to the total mass of polyimide is 1% by mass or more, and even more preferably 20% by mass or less.

-乙烯性不飽和鍵- 從所得到之有機膜的膜強度的觀點考慮,聚醯亞胺具有乙烯性不飽和鍵為較佳。 聚醯亞胺可以在主鏈末端具有乙烯性不飽和鍵,亦可以在側鏈中具有乙烯性不飽和鍵,但在側鏈中具有乙烯性不飽和鍵為較佳。 上述乙烯性不飽和鍵具有自由基聚合性為較佳。 乙烯性不飽和鍵包含於由後述之式(4)表示之重複單元中之R 132或由後述之式(4)表示之重複單元中之R 131中為較佳,作為具有乙烯性不飽和鍵之基團而包含於由後述之式(4)表示之重複單元中之R 132或由後述之式(4)表示之重複單元中之R 131中為更佳。 在該等之中,乙烯性不飽和鍵包含於由後述之式(4)表示之重複單元中之R 131中為較佳,作為具有乙烯性不飽和鍵之基團而包含於由後述之式(4)表示之重複單元中之R 131中為更佳。 作為具有乙烯性不飽和鍵之基團,可舉出乙烯基、烯丙基、乙烯基苯基等直接鍵結於芳香環且可以經取代之具有乙烯基之基團、(甲基)丙烯醯基、(甲基)丙烯醯氧基、由下述式(IV)表示之基團等。 -Ethylene Unsaturated Bonds- From the perspective of the film strength of the obtained organic film, it is preferable that polyimide has ethylene unsaturated bonds. Polyimide can have ethylene unsaturated bonds at the main chain end or in the side chain, but it is preferable that it has ethylene unsaturated bonds in the side chain. The aforementioned ethylene unsaturated bonds are preferably free radical polymerizable. It is preferable that the ethylene unsaturated bond is contained in R 132 or R 131 of the repeating unit represented by equation (4) described later, and even more preferable that it is contained in R 132 or R 131 of the repeating unit represented by equation (4) described later as a group having an ethylene unsaturated bond. Among these, it is preferable that the ethylene unsaturated bond is contained in R 131 of the repeating unit represented by equation (4) described later, and even more preferable that it is contained in R 131 of the repeating unit represented by equation (4) described later as a group having an ethylene unsaturated bond. Examples of vinyl groups with vinyl unsaturated bonds include vinyl, allyl, vinylphenyl, vinyl groups that are directly bonded to an aromatic ring and can be substituted, (meth)acrylyl, (meth)acryloxy, and groups represented by the following formula (IV).

【化學式17】 【Chemical Formula 17】

式(IV)中,R 20表示氫原子、甲基、乙基或羥甲基,氫原子或甲基為較佳。 In formula (IV), R 20 represents a hydrogen atom, methyl, ethyl or hydroxymethyl, with hydrogen atom or methyl being preferred.

式(IV)中,R 21表示碳數2~12的伸烷基、-O-CH 2CH(OH)CH 2-、-C(=O)O-、-O(C=O)NH-、碳數2~30的(聚)伸烷氧基(伸烷基的碳數係2~12為較佳,2~6為更佳,2或3為特佳;重複數係1~12為較佳,1~6為更佳,1~3為特佳)或將該等中的2個以上組合而成之基團。 又,作為上述碳數2~12的伸烷基,可以為直鏈狀、支鏈狀、環狀或由該等的組合表示之伸烷基中的任一種。 作為上述碳數2~12的伸烷基,碳數2~8的伸烷基為較佳,碳數2~4的伸烷基為更佳。 In formula (IV), R 21 represents an alkyl group having 2 to 12 carbon atoms, -O-CH 2 CH(OH)CH 2 -, -C(=O)O-, -O(C=O)NH-, a (poly)alkylene group having 2 to 30 carbon atoms (preferably 2 to 12 carbon atoms, more preferably 2 to 6, and especially preferably 2 or 3; a repetition number of 1 to 12 is preferred, 1 to 6 is more preferred, and 1 to 3 is especially preferred), or a group formed by combining two or more of these. Furthermore, the alkyl group having 2 to 12 carbon atoms can be any of linear, branched, cyclic, or a combination thereof. Among the alkyl groups having 2 to 12 carbon atoms, alkyl groups having 2 to 8 carbon atoms are preferred, and alkyl groups having 2 to 4 carbon atoms are even more preferred.

在該等之中,R 21為由下述式(R1)~式(R3)中的任一個表示之基團為較佳,由式(R1)表示之基團為更佳。 【化學式18】 式(R1)~(R3)中,L表示單鍵或碳數2~12的伸烷基、碳數2~30的(聚)伸烷氧基或將該等中的2個以上鍵結而成之基團,X表示氧原子或硫原子,*表示與其他結構的鍵結部位,●表示與式(IV)中的R 21所鍵結之氧原子的鍵結部位。 式(R1)~(R3)中,L中之碳數2~12的伸烷基或碳數2~30的(聚)伸烷氧基的較佳態樣與上述的R 21中之碳數2~12的伸烷基或碳數2~30的(聚)伸烷氧基的較佳態樣相同。 式(R1)中,X為氧原子為較佳。 式(R1)~(R3)中,*的含義與式(IV)中的*含義相同,較佳態樣亦相同。 由式(R1)表示之結構例如藉由使具有酚性羥基等羥基之聚醯亞胺與具有異氰酸酯基及乙烯性不飽和鍵之化合物(例如,甲基丙烯酸2-異氰酸酯基乙酯等)進行反應而得到。 由式(R2)表示之結構例如藉由使具有羧基之聚醯亞胺與具有羥基及乙烯性不飽和鍵之化合物(例如,甲基丙烯酸2-羥乙酯等)進行反應而得到。 由式(R3)表示之結構例如藉由使具有酚性羥基等羥基之聚醯亞胺與具有縮水甘油基及乙烯性不飽和鍵之化合物(例如,甲基丙烯酸縮水甘油酯等)進行反應而得到。 Of these, it is preferable that R21 is a group represented by any of the following formulas (R1) to (R3), with the group represented by formula (R1) being more preferred. [Chemical Formula 18] In formulas (R1) to (R3), L represents a single bond or a group consisting of an alkyl group having 2 to 12 carbon atoms, a (poly)alkylene group having 2 to 30 carbon atoms, or two or more of these bonded together; X represents an oxygen atom or a sulfur atom; * represents a bonding site with other structures; and ● represents a bonding site with the oxygen atom bonded to R 21 in formula (IV). In formulas (R1) to (R3), the preferred state of the alkyl group having 2 to 12 carbon atoms or the (poly)alkylene group having 2 to 30 carbon atoms in L is the same as the preferred state of the alkyl group having 2 to 12 carbon atoms or the (poly)alkylene group having 2 to 30 carbon atoms in R 21 described above. In formula (R1), it is preferred that X is an oxygen atom. In formulas (R1) to (R3), the asterisk (*) has the same meaning as in formula (IV), and the preferred state is also the same. The structure represented by formula (R1) is obtained, for example, by reacting a polyimide having hydroxyl groups such as phenolic hydroxyl groups with a compound having isocyanate groups and vinyl unsaturated bonds (e.g., ethyl 2-isocyanate methacrylate). The structure represented by formula (R2) is obtained, for example, by reacting a polyimide having carboxyl groups with a compound having hydroxyl groups and vinyl unsaturated bonds (e.g., ethyl 2-hydroxymethacrylate). The structure represented by formula (R3) can be obtained, for example, by reacting a polyimide having hydroxyl groups such as phenolic hydroxyl groups with a compound having glycidyl groups and vinyl unsaturated bonds (e.g., glycidyl methacrylate).

式(IV)中,*表示與其他結構的鍵結部位,與聚醯亞胺的主鏈的鍵結部位為較佳。In formula (IV), * indicates the bonding site with other structures, and the bonding site with the polyimide backbone is preferred.

乙烯性不飽和鍵相對於聚醯亞胺的總質量之量為0.0001~0.1mol/g為較佳,0.0005~0.05mol/g為更佳。The preferred content of ethylene unsaturated bonds relative to the total mass of polyimide is 0.0001–0.1 mol/g, and even more preferred content is 0.0005–0.05 mol/g.

-除了具有乙烯性不飽和鍵之基團以外的聚合性基- 聚醯亞胺可以具有除了具有乙烯性不飽和鍵之基團以外的聚合性基。 作為除了具有乙烯性不飽和鍵之基團以外的聚合性基,可舉出環氧基、氧環丁基等環狀醚基、甲氧基甲基等烷氧基甲基、羥甲基等。 除了具有乙烯性不飽和鍵之基團以外的聚合性基例如包含於由後述之式(4)表示之重複單元中之R 131中為較佳。 除了具有乙烯性不飽和鍵之基團以外的聚合性基相對於聚醯亞胺的總質量之量為0.0001~0.1mol/g為較佳,0.001~0.05mol/g為更佳。 - Polymerizable groups other than those with ethylene unsaturated bonds- Polyimide may have polymerizable groups other than those with ethylene unsaturated bonds. Examples of polymerizable groups other than those with ethylene unsaturated bonds include cyclic ether groups such as epoxy and oxycyclobutyl, alkoxymethyl groups such as methoxymethyl, hydroxymethyl, etc. It is preferable that the polymerizable groups other than those with ethylene unsaturated bonds are included, for example, in R 131 of the repeating unit represented by formula (4) described later. It is preferable that the amount of polymerizable groups other than those with ethylene unsaturated bonds relative to the total mass of polyimide is 0.0001 to 0.1 mol/g, and more preferably 0.001 to 0.05 mol/g.

-極性反轉基- 聚醯亞胺可以具有酸分解性基等極性反轉基。聚醯亞胺中之酸分解性基與在上述式(2)中之R 113及R 114中所說明之酸分解性基相同,較佳態樣亦相同。 極性反轉基例如包含於由後述之式(4)表示之重複單元中的R 131、R 132、聚醯亞胺的末端等中。 -Polar Reversible Group- Polyimides can have polar reversible groups such as acid-degrading groups. The acid-degrading groups in polyimides are the same as those described in R 113 and R 114 in the above formula (2), and the preferred forms are also the same. Polar reversible groups are included, for example, in R 131 , R 132 in the repeating unit represented by the following formula (4), the end of the polyimide, etc.

-酸值- 當將聚醯亞胺提供於鹼顯影時,從提高顯影性之觀點考慮,聚醯亞胺的酸值係30mgKOH/g以上為較佳,50mgKOH/g以上為更佳,70mgKOH/g以上為進一步較佳。 又,上述酸值係500mgKOH/g以下為較佳,400mgKOH/g以下為更佳,200mgKOH/g以下為進一步較佳。 又,當將聚醯亞胺提供於使用了以有機溶劑為主成分之顯影液之顯影(例如,後述之“溶劑顯影”)時,聚醯亞胺的酸值為1~35mgKOH/g為較佳,2~30mgKOH/g為更佳,5~20mgKOH/g為進一步較佳。 上述酸值藉由公知的方法測定,例如,藉由記載於JIS K 0070:1992中的方法測定。 又,作為聚醯亞胺中所包含之酸基,從兼顧保存穩定性及顯影性之觀點考慮,pKa為0~10的酸基為較佳,3~8的酸基為更佳。 pKa係考慮到從酸中釋放氫離子之解離反應而將其平衡常數Ka用其負的常用對數pKa表示者。本說明書中只要沒有特別說明,pKa設為基於ACD/ChemSketch(註冊商標)之計算值。或者,亦可以參閱日本化學會編“修訂5版 化學便覽 基礎編”中公佈的值。 又,當酸基例如為磷酸等多元酸之情況下,上述pKa為第一解離常數。 作為這種酸基,聚醯亞胺包含選自包括羧基及酚性羥基之群組中之至少一種為較佳,包含酚性羥基為更佳。 -Acid Value- When polyimide is provided in alkaline developing solutions, from the viewpoint of improving developing properties, an acid value of 30 mg KOH/g or higher is preferred, 50 mg KOH/g or higher is more preferred, and 70 mg KOH/g or higher is even more preferred. Furthermore, an acid value of 500 mg KOH/g or lower is preferred, 400 mg KOH/g or lower is even more preferred, and 200 mg KOH/g or lower is even more preferred. Furthermore, when polyimide is provided in developing solutions using organic solvents as the main component (e.g., "solvent developing" as described below), an acid value of 1–35 mg KOH/g is preferred, 2–30 mg KOH/g is more preferred, and 5–20 mg KOH/g is even more preferred. The acid values mentioned above are determined by well-known methods, such as those described in JIS K 0070:1992. Furthermore, considering both stability and development, acid groups containing acid groups in polyimide with pKa values of 0–10 are preferred, while those with pKa values of 3–8 are even better. pKa is the negative logarithm of the equilibrium constant Ka, expressed in terms of the dissociation reaction that releases hydrogen ions from the acid. Unless otherwise specified in this specification, pKa is assumed to be a calculated value based on ACD/ChemSketch (registered trademark). Alternatively, the values published in the 5th revised edition of the Chemical Handbook of Japan, Basic Chemicals, can be consulted. Furthermore, when the acid group is a polybasic acid such as phosphoric acid, the above-mentioned pKa is the first dissociation constant. As such an acid group, it is preferable that the polyimide contains at least one group selected from the group consisting of carboxyl and phenolic hydroxyl groups, and more preferably a phenolic hydroxyl group.

-酚性羥基- 從使基於鹼顯影液之顯影速度成為適當者之觀點考慮,聚醯亞胺具有酚性羥基為較佳。 聚醯亞胺可以在主鏈末端中具有酚性羥基,亦可以在側鏈中具有酚性羥基。 酚性羥基例如包含於由後述之式(4)表示之重複單元中之R 132或由後述之式(4)表示之重複單元中之R 131中為較佳。 酚性羥基相對於聚醯亞胺的總質量之量為0.1~30mol/g為較佳,1~20mol/g為更佳。 -Phenolic hydroxyl group- From the viewpoint of making the developing speed of alkaline developing solution suitable, it is preferable that polyimide has a phenolic hydroxyl group. Polyimide may have a phenolic hydroxyl group at the end of the main chain or in the side chain. It is preferable that the phenolic hydroxyl group is included, for example, in R 132 or R 131 in the repeating unit represented by formula (4) described later. It is preferable that the amount of phenolic hydroxyl group relative to the total mass of polyimide is 0.1 to 30 mol/g, and more preferably 1 to 20 mol/g.

作為本發明中所使用之聚醯亞胺,只要為具有醯亞胺結構之高分子化合物,則並無特別限定,含有由下述式(4)表示之重複單元為較佳。 【化學式19】 式(4)中,R 131表示2價的有機基,R 132表示4價的有機基。 當具有聚合性基之情況下,聚合性基可以位於R 131及R 132中的至少一者上,如下述式(4-1)或式(4-2)所示,亦可以位於聚醯亞胺的末端。 式(4-1) 【化學式20】 式(4-1)中,R 133為聚合性基,其他基團的含義與式(4)的含義相同。 式(4-2) 【化學式21】 R 134及R 135中的至少一者為聚合性基,當不是聚合性基時為有機基,其他基團的含義與式(4)的含義相同。 The polyimide used in this invention is not particularly limited as long as it is a polymer compound having an imide structure, but it is preferable to contain a repeating unit represented by the following formula (4). [Chemical Formula 19] In formula (4), R 131 represents a divalent organic group, and R 132 represents a tetravalent organic group. When a polymerizable group is present, the polymerizable group can be located on at least one of R 131 and R 132 , as shown in formula (4-1) or formula (4-2) below, or it can be located at the end of the polyimide. Formula (4-1) [Chemical Formula 20] In formula (4-1), R 133 is a polymerizable group, and the meanings of the other groups are the same as in formula (4). Formula (4-2) [Chemical Formula 21] At least one of R 134 and R 135 is a polymerizable group, and when it is not a polymerizable group, it is an organic group. The meanings of the other groups are the same as those in equation (4).

作為聚合性基,可舉出上述含有乙烯性不飽和鍵之基團或除了上述具有乙烯性不飽和鍵之基團以外的交聯性基。 R 131表示2價的有機基。作為2價的有機基,可例示與式(2)中之R 111相同者,較佳的範圍亦相同。 又,作為R 131,可舉出去除二胺的胺基之後殘存之二胺殘基。作為二胺,可舉出脂肪族、環式脂肪族或芳香族二胺等。作為具體例,可舉出聚醯亞胺前驅物的式(2)中的R 111的例子。 As a polymerizable group, examples include the groups containing ethylene unsaturated bonds or crosslinking groups other than those containing ethylene unsaturated bonds. R 131 represents a divalent organic group. As a divalent organic group, examples can be the same as R 111 in formula (2), and the preferred range is also the same. Furthermore, as R 131 , examples can be the diamine residue remaining after removing the amino group of a diamine. As a diamine, examples can be aliphatic, cyclic aliphatic, or aromatic diamines. As a specific example, examples can be given for R 111 in formula (2) of polyimide precursors.

在更有效地抑制煆燒時產生翹曲之觀點上,R 131為在主鏈中具有至少2個伸烷基二醇單元之二胺殘基為較佳。更佳為在1個分子中合計包含2個以上的乙二醇鏈、丙二醇鏈中的任一者或兩者之二胺殘基,進一步較佳為上述二胺且不包含芳香環之二胺殘基。 From the viewpoint of more effectively suppressing warping during burning, R 131 is preferably a diamine residue having at least two alkyl diol units in the main chain. More preferably, it is a diamine residue containing a total of two or more ethylene glycol chains or propylene glycol chains in one molecule, and even more preferably, it is a diamine without an aromatic ring.

作為在1個分子中合計包含2個以上的乙二醇鏈、丙二醇鏈中的任一者或兩者之二胺,可舉出JEFFAMINE(註冊商標)KH-511、ED-600、ED-900、ED-2003、EDR-148、EDR-176、D-200、D-400、D-2000、D-4000(以上為商品名,HUNTSMAN公司製)、1-(2-(2-(2-胺基丙氧基)乙氧基)丙氧基)丙烷-2-胺、1-(1-(1-(2-胺基丙氧基)丙烷-2-基)氧基)丙烷-2-胺等,但並不限定於該等。Examples of diamines comprising two or more ethylene glycol chains or propylene glycol chains in a single molecule include JEFFAMINE (registered trademark) KH-511, ED-600, ED-900, ED-2003, EDR-148, EDR-176, D-200, D-400, D-2000, D-4000 (trade names, manufactured by HUNTSMAN), 1-(2-(2-(2-aminopropoxy)ethoxy)propoxy)propane-2-amine, 1-(1-(1-(1-(2-aminopropoxy)propane-2-yl)oxy)propane-2-amine, etc., but are not limited to these.

R 132表示4價的有機基。作為4價的有機基,可例示與式(2)中之R 115相同者,較佳的範圍亦相同。 例如,作為R 115而例示之4價的有機基的4個鍵結子與上述式(4)中的4個-C(=O)-部分鍵結而形成縮合環。 R 132 represents a tetravalent organic group. As a tetravalent organic group, it can be exemplified as the same as R 115 in equation (2), and the preferred range is also the same. For example, the four bonded elements of the tetravalent organic group exemplified as R 115 bond with the four -C (=O)- parts in the above equation (4) to form a condensation ring.

又,R 132可舉出從四羧酸二酐中去除酐基之後殘存之四羧酸殘基等。作為具體例,可舉出聚醯亞胺前驅物的式(2)中的R 115的例子。從有機膜的強度的觀點考慮,R 132係具有1~4個芳香環之芳香族二胺殘基為較佳。 Furthermore, R 132 can be exemplified by the tetracarboxylic acid residue remaining after the anhydride group is removed from the tetracarboxylic acid dianhydride. As a specific example, R 115 in formula (2) of polyimide precursors can be cited. From the viewpoint of the strength of organic membranes, R 132 is preferably an aromatic diamine residue having 1 to 4 aromatic rings.

在R 131和R 132中的至少一者上具有OH基亦較佳。更具體而言,作為R 131,作為較佳例可舉出2,2-雙(3-羥基-4-胺基苯基)丙烷、2,2-雙(3-羥基-4-胺基苯基)六氟丙烷、2,2-雙(3-胺基-4-羥基苯基)丙烷、2,2-雙(3-胺基-4-羥基苯基)六氟丙烷、上述(DA-1)~(DA-18),作為R 132,作為更佳例可舉出上述(DAA-1)~(DAA-5)。 It is also preferable that at least one of R 131 and R 132 has an OH group. More specifically, as R 131 , preferred examples include 2,2-bis(3-hydroxy-4-aminophenyl)propane, 2,2-bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, and the above (DA-1) to (DA-18), and as R 132 , more preferred examples include the above (DAA-1) to (DAA-5).

又,聚醯亞胺在結構中具有氟原子亦較佳。聚醯亞胺中的氟原子的含量係10質量%以上為較佳,又20質量%以下為較佳。Furthermore, it is preferable for polyimide to have fluorine atoms in its structure. The fluorine atom content in polyimide is preferably 10% by mass or more, and preferably less than 20% by mass.

又,以提高與基板的密接性為目的,聚醯亞胺可以與具有矽氧烷結構之脂肪族基共聚。具體而言,作為二胺成分,可舉出雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷等。Furthermore, to improve adhesion to the substrate, polyimide can be copolymerized with aliphatic groups having a silicate structure. Specifically, examples of diamine components include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.

又,為了提高樹脂組成物的保存穩定性,聚醯亞胺的主鏈末端藉由單胺、酸酐、單羧酸、單醯氯化合物、單活性酯化合物等封端劑被密封為較佳。在該等之中,使用單胺為更佳,作為單胺的較佳的化合物,可舉出苯胺、2-乙炔基苯胺、3-乙炔基苯胺、4-乙炔基苯胺、5-胺基-8-羥基喹啉、1-羥基-7-胺基萘、1-羥基-6-胺基萘、1-羥基-5-胺基萘、1-羥基-4-胺基萘、2-羥基-7-胺基萘、2-羥基-6-胺基萘、2-羥基-5-胺基萘、1-羧基-7-胺基萘、1-羧基-6-胺基萘、1-羧基-5-胺基萘、2-羧基-7-胺基萘、2-羧基-6-胺基萘、2-羧基-5-胺基萘、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯磺酸、3-胺基苯磺酸、4-胺基苯磺酸、3-胺基-4,6-二羥基嘧啶、2-胺基酚、3-胺基酚、4-胺基酚、2-胺基苯硫酚、3-胺基苯硫酚、4-胺基苯硫酚、等。該等可以使用2種以上,亦可以藉由使複數種封端劑反應而導入複數種不同的末端基。Furthermore, in order to improve the storage stability of resin components, it is preferable to seal the main chain ends of polyimide with end-capping agents such as monoamines, acid anhydrides, monocarboxylic acids, monochlorodimethylamine compounds, and monoactive ester compounds. Among these, monoamines are preferred. Examples of preferred monoamine compounds include aniline, 2-ethynylaniline, 3-ethynylaniline, 4-ethynylaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxyl-7-aminonaphthalene, 1-carboxyl-6-aminonaphthalene, and 1-carboxyl... -5-aminonaphthalene, 2-carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminobenzenethiophenol, 3-aminobenzenethiophenol, 4-aminobenzenethiophenol, etc. Two or more of these can be used, or multiple different terminal groups can be introduced by reacting multiple end-capping agents.

-醯亞胺化率(閉環率)- 從所得到之有機膜的膜強度、絕緣性等觀點考慮,聚醯亞胺的醯亞胺化率(亦稱為“閉環率”)為70%以上為較佳,80%以上為更佳,90%以上為更佳。 上述醯亞胺化率的上限並無特別限定,只要為100%以下即可。 上述醯亞胺化率例如藉由下述方法來進行測定。 測定聚醯亞胺的紅外吸收光譜,求出作為來自於醯亞胺結構之吸收峰值之1377cm -1附近的峰值強度P1。接著,將該聚醯亞胺在350℃下熱處理1小時之後,再次測定紅外吸收光譜,求出1377cm -1附近的峰值強度P2。使用所得到之峰值強度P1、P2,依據下述式能夠求出聚醯亞胺的醯亞胺化率。 醯亞胺化率(%)=(峰值強度P1/峰值強度P2)×100 -Lipidification Rate (Ring-Closing Rate)- From the perspective of the obtained organic membrane's strength and insulation, a lipimization rate (also known as "ring-closing rate") of 70% or higher for polyimide is preferred, 80% or higher is even better, and 90% or higher is still preferable. There is no particular upper limit to the above lipimization rate; it only needs to be below 100%. The above lipimization rate can be determined, for example, by the following method: Measure the infrared absorption spectrum of the polyimide and determine the peak intensity P1 near 1377 cm⁻¹ , which represents the absorption peak originating from the lipimide structure. Next, after heat-treating the polyimide at 350°C for 1 hour, the infrared absorption spectrum was measured again, and the peak intensity P2 near 1377 cm⁻¹ was determined. Using the obtained peak intensities P1 and P2, the amide ratio of the polyimide can be calculated according to the following formula: Imidization ratio (%) = (Peak intensity P1 / Peak intensity P2) × 100

聚醯亞胺可以全部都含有包含1種R 131或R 132之由上述式(4)表示之重複單元,亦可以含有包含2個以上的不同種類的R 131或R 132之由上述式(4)表示之重複單元。又,聚醯亞胺除了由上述式(4)表示之重複單元以外,還可以包含其他種類的重複單元。作為其他種類的重複單元,可舉出由下述式(2)表示之重複單元等。 Polyimide may contain only one type of repeating unit represented by formula (4) above, which includes one type of R 131 or R 132 , or it may contain two or more different types of repeating units represented by formula (4) above. In addition to the repeating units represented by formula (4) above, polyimide may also contain other types of repeating units. Examples of other types of repeating units include repeating units represented by formula (2) below.

聚醯亞胺例如能夠利用如下方法來進行合成:在低溫下使四羧酸二酐與二胺(將一部分置換為單胺封端劑)進行反應之方法;在低溫下使四羧酸二酐(將一部分置換為酸酐或單醯氯化合物或單活性酯化合物封端劑)與二胺物進行反應之方法;藉由四羧酸二酐和醇來得到二酯,然後使其與二胺(將一部分置換為單胺封端劑)在縮合劑的存在下進行反應之方法;利用藉由四羧酸二酐和醇得到二酯,然後使其餘的二羧酸進行醯氯化,並使其與二胺(將一部分置換為單胺封端劑)進行反應之方法等方法得到聚醯亞胺前驅物,並且使用已知的醯亞胺化反應法使其完全醯亞胺化之方法;或者,在中途停止醯亞胺化反應,導入一部分醯亞胺結構之方法;以及藉由混合完全醯亞胺化之聚合物和該聚醯亞胺前驅物而導入一部分醯亞胺結構之方法。又,亦能夠適用其他公知的聚醯亞胺的合成方法。Polyimides can be synthesized, for example, by reacting tetracarboxylic dianhydride with a diamine (with a portion replaced by a monoamine end-capping agent) at low temperature; by reacting tetracarboxylic dianhydride (with a portion replaced by an anhydride, a monochloro compound, or a monoactive ester compound end-capping agent) with a diamine at low temperature; by obtaining a diester from tetracarboxylic dianhydride and an alcohol, and then reacting it with a diamine (with a portion replaced by a monoamine end-capping agent) in the presence of a condensing agent; using... A polyimide precursor is obtained by methods such as reacting a tetracarboxylic acid dianhydride with an alcohol to form a diester, then oxychlorinating the remaining dicarboxylic acid and reacting it with a diamine (with a portion replaced by a monoamine end-capping agent), and then completely oxyimidizing it using a known oxyimidation reaction; or, stopping the oxyimidation reaction midway to introduce a partial oxyimide structure; and introducing a partial oxyimide structure by mixing a fully oxyimidized polymer with the polyimide precursor. Other known methods for synthesizing polyimides are also applicable.

聚醯亞胺的重量平均分子量(Mw)較佳為5,000~100,000,更佳為10,000~50,000,進一步較佳為15,000~40,000。藉由將重量平均分子量設為5,000以上,能夠提高硬化後的膜的耐折性。為了得到機械特性(例如,斷裂伸長率)優異之有機膜,重量平均分子量為15,000以上為特佳。 又,聚醯亞胺的數量平均分子量(Mn)較佳為2,000~40,000,更佳為3,000~30,000,進一步較佳為4,000~20,000。 上述聚醯亞胺的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯亞胺的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。 又,當樹脂組成物作為特定樹脂包含複數種聚醯亞胺之情況下,至少1種聚醯亞胺的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯亞胺作為一個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of polyimide is preferably 5,000 to 100,000, more preferably 10,000 to 50,000, and even more preferably 15,000 to 40,000. Setting the weight-average molecular weight to 5,000 or higher improves the folding resistance of the cured film. For obtaining organic films with excellent mechanical properties (e.g., elongation at break), a weight-average molecular weight of 15,000 or higher is particularly preferred. Furthermore, the number-average molecular weight (Mn) of polyimide is preferably 2,000 to 40,000, more preferably 3,000 to 30,000, and even more preferably 4,000 to 20,000. The molecular weight dispersion of the aforementioned polyimide is preferably 1.5 or higher, more preferably 1.8 or higher, and further preferably 2.0 or higher. There is no particular upper limit specified for the molecular weight dispersion of the polyimide; for example, 7.0 or lower is preferred, 6.5 or lower is more preferred, and 6.0 or lower is further preferred. Furthermore, when the resin composition comprises multiple polyimides as a specific resin, it is preferable that the weight average molecular weight, number average molecular weight, and dispersion of at least one polyimide are within the aforementioned ranges. It is also preferable that the weight average molecular weight, number average molecular weight, and dispersion calculated when the multiple polyimides are treated as a single resin are each within the aforementioned ranges.

〔聚苯并噁唑前驅物〕 關於本發明中所使用之聚苯并噁唑前驅物的其結構等並沒有特別規定,但較佳為包含由下述式(3)表示之重複單元。 【化學式22】 式(3)中,R 121表示2價的有機基,R 122表示4價的有機基,R 123及R 124分別獨立地表示氫原子或1價的有機基。 [Polybenzoxazole precursor] There are no particular provisions regarding the structure of the polybenzoxazole precursor used in this invention, but it is preferred that it contains repeating units represented by the following formula (3). [Chemical Formula 22] In equation (3), R 121 represents a divalent organic group, R 122 represents a tetravalent organic group, and R 123 and R 124 represent hydrogen atoms or monovalent organic groups, respectively.

式(3)中,R 123及R 124的含義分別與式(2)中之R 113的含義相同,較佳的範圍亦相同。亦即,至少一者係聚合性基為較佳。 式(3)中,R 121表示2價的有機基。作為2價的有機基,包含脂肪族基及芳香族基中的至少一者之基團為較佳。作為脂肪族基,直鏈脂肪族基為較佳。R 121係二羧酸殘基為較佳。二羧酸殘基可以僅使用1種,亦可以使用2種以上。 In formula (3), the meanings of R 123 and R 124 are the same as those of R 113 in formula (2), and the preferred ranges are also the same. That is, it is preferred that at least one of them is a polymerizable group. In formula (3), R 121 represents a divalent organic group. As a divalent organic group, it is preferred that the group includes at least one of aliphatic and aromatic groups. As an aliphatic group, a linear aliphatic group is preferred. It is preferred that R 121 is a dicarboxylic acid residue. Only one type of dicarboxylic acid residue may be used, or two or more types may be used.

作為二羧酸殘基,包含脂肪族基之二羧酸及包含芳香族基之二羧酸殘基為較佳,包含芳香族基之二羧酸殘基為更佳。 作為包含脂肪族基之二羧酸,包含直鏈或支鏈(較佳為直鏈)脂肪族基之二羧酸為較佳,由直鏈或支鏈(較佳為直鏈)脂肪族基和2個-COOH構成之二羧酸為更佳。直鏈或支鏈(較佳為直鏈)脂肪族基的碳數係2~30為較佳,2~25為更佳,3~20為進一步較佳,4~15為進一步較佳,5~10為特佳。直鏈脂肪族基係伸烷基為較佳。 作為包含直鏈脂肪族基之二羧酸,可舉出丙二酸、二甲基丙二酸、乙基丙二酸、異丙基丙二酸、二正丁基丙二酸、丁二酸、四氟丁二酸、甲基丁二酸、2,2-二甲基丁二酸、2,3-二甲基丁二酸、二甲基甲基丁二酸、戊二酸、六氟戊二酸、2-甲基戊二酸、3-甲基戊二酸、2,2-二甲基戊二酸、3,3-二甲基戊二酸、3-乙基-3-甲基戊二酸、己二酸、八氟己二酸、3-甲基己二酸、庚二酸、2,2,6,6-四甲基庚二酸、辛二酸、十二氟辛二酸、壬二酸、癸二酸、十六氟癸二酸、1,9-壬二酸、十二烷二酸、十三烷二酸、十四烷二酸、十五烷二酸、十六烷二酸、十七烷二酸、十八烷二酸、十九烷二酸、二十烷二酸、二十一烷二酸、二十二烷二酸、二十三烷二酸、二十四烷二酸、二十五烷二酸、二十六烷二酸、二十七烷二酸、二十八烷二酸、二十九烷二酸、三十烷二酸、三十一烷二酸、三十二烷二酸、二乙醇酸(diglycolic acid)以及下述式所表示之二羧酸等。 As a dicarboxylic acid residue, dicarboxylic acids containing aliphatic groups and dicarboxylic acid residues containing aromatic groups are preferred, with dicarboxylic acid residues containing aromatic groups being more preferred. As a dicarboxylic acid containing an aliphatic group, dicarboxylic acids containing straight-chain or branched (preferably straight-chain) aliphatic groups are preferred, and dicarboxylic acids composed of a straight-chain or branched (preferably straight-chain) aliphatic group and two -COOH groups are more preferred. The carbon number of the straight-chain or branched (preferably straight-chain) aliphatic group is preferably 2-30, more preferably 2-25, further preferably 3-20, further preferably 4-15, and especially preferably 5-10. The straight-chain aliphatic group is preferably an alkyl group. Examples of dicarboxylic acids containing a linear aliphatic group include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, and 2,2,6,6-tetramethyl Pimelic acid, suberic acid, dodecanedioic acid, azelaic acid, sebacic acid, hexafluorosebacic acid, 1,9-azelaic acid, dodecanedioic acid, tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, eicosanedioic acid, eicosanedioic acid Monoacanedioic acid, docosanedioic acid, tricosanedioic acid, tetracosanedioic acid, pentacosanedioic acid, hexacosanedioic acid, heptacosanedioic acid, octacanedioic acid, nonacosanedioic acid, triacontanedioic acid, triacontanedioic acid, docosanedioic acid, diglycolic acid acid) and the dicarboxylic acid represented by the following formula, etc.

【化學式23】 (式中,Z為碳數1~6的烴基,n為1~6的整數。) 【Chemical Formula 23】 (In the formula, Z is a hydrocarbon with 1 to 6 carbon atoms, and n is an integer from 1 to 6.)

作為包含芳香族基之二羧酸,以下的具有芳香族基之二羧酸為較佳,以下的僅由具有芳香族基之基團和2個-COOH構成之二羧酸為更佳。As a dicarboxylic acid containing an aromatic group, the following dicarboxylic acids having an aromatic group are preferred, and the following dicarboxylic acids consisting only of an aromatic group and two -COOH groups are even more preferred.

【化學式24】 式中,A表示選自包括-CH 2-、-O-、-S-、-SO 2-、-CO-、-NHCO-、-C(CF 32-及-C(CH 32-之群組中之2價的基團,*分別獨立地表示與其他結構的鍵結部位。 【Chemical Formula 24】 In the formula, A represents a divalent group selected from the group including -CH2- , -O-, -S-, -SO2- , -CO-, -NHCO-, -C( CF3 ) 2- and -C( CH3 ) 2- , and * represents the bonding site with other structures independently.

作為包含芳香族基之二羧酸的具體例,可舉出4,4’-羰基二苯甲酸及4,4’-二羧基二苯醚、鄰苯二甲酸。Specific examples of dicarboxylic acids containing aromatic groups include 4,4'-carbonyl dibenzoic acid and 4,4'-dicarboxylic diphenyl ether and phthalic acid.

式(3)中,R 122表示4價的有機基。作為4價的有機基,其含義與上述式(2)中之R 115的含義相同,較佳的範圍亦相同。 R 122係來自於雙胺基苯酚衍生物之基團亦較佳,作為來自於雙胺基苯酚衍生物之基團,例如可舉出3,3’-二胺基-4,4’-二羥基聯苯、4,4’-二胺基-3,3’-二羥基聯苯、3,3’-二胺基-4,4’-二羥基二苯碸、4,4’-二胺基-3,3’-二羥基二苯碸、雙-(3-胺基-4-羥基苯基)甲烷、2,2-雙(3-胺基-4-羥基苯基)丙烷、2,2-雙-(3-胺基-4-羥基苯基)六氟丙烷、2,2-雙-(4-胺基-3-羥基苯基)六氟丙烷、雙-(4-胺基-3-羥基苯基)甲烷、2,2-雙-(4-胺基-3-羥基苯基)丙烷、4,4’-二胺基-3,3’-二羥基二苯甲酮、3,3’-二胺基-4,4’-二羥基二苯甲酮、4,4’-二胺基-3,3’-二羥基二苯醚、3,3’-二胺基-4,4’-二羥基二苯醚、1,4-二胺基-2,5-二羥基苯、1,3-二胺基-2,4-二羥基苯、1,3-二胺基-4,6-二羥基苯等。該等雙胺基苯酚可以單獨使用或者混合使用。 In equation (3), R 122 represents a tetravalent organic group. As a tetravalent organic group, its meaning is the same as that of R 115 in equation (2) above, and the preferred range is also the same. Groups derived from diaminophenol derivatives are also preferred, such as 3,3' -diamino-4,4'-dihydroxybiphenyl, 4,4'-diamino-3,3'-dihydroxybiphenyl, 3,3'-diamino-4,4'-dihydroxydiphenyl tin, 4,4'-diamino-3,3'-dihydroxydiphenyl tin, bis-(3-amino-4-hydroxyphenyl)methane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis-(3-amino-4-hydroxyphenyl)hexafluoropropane, 2,2-bis- (4-amino-3-hydroxyphenyl)hexafluoropropane, bis-(4-amino-3-hydroxyphenyl)methane, 2,2-bis-(4-amino-3-hydroxyphenyl)propane, 4,4'-diamino-3,3'-dihydroxybenzophenone, 3,3'-diamino-4,4'-dihydroxybenzophenone, 4,4'-diamino-3,3'-dihydroxydiphenyl ether, 3,3'-diamino-4,4'-dihydroxydiphenyl ether, 1,4-diamino-2,5-dihydroxybenzene, 1,3-diamino-2,4-dihydroxybenzene, 1,3-diamino-4,6-dihydroxybenzene, etc. These diaminophenols can be used alone or in combination.

在雙胺基苯酚衍生物之中,下述具有芳香族基之雙胺基苯酚衍生物為較佳。Among diaminophenol derivatives, the following diaminophenol derivatives having aromatic groups are preferred.

【化學式25】 式中,X 1表示-O-、-S-、-C(CF 32-、-CH 2-、-SO 2-、-NHCO-,*及#分別表示與其他結構的鍵結部位。R表示氫原子或1價的取代基,氫原子或烴基為較佳,氫原子或烷基為更佳。又,R 122係由上述式表示之結構亦較佳。當R 122為由上述式表示之結構時,在共計4個*及#中,任意2個為與式(3)中的R 122所鍵結之氮原子的鍵結部位且其他2個為與式(3)中的R 122所鍵結之氧原子的鍵結部位為較佳,2個*為與式(3)中的R 122所鍵結之氧原子的鍵結部位且2個#為與式(3)中的R 122所鍵結之氮原子的鍵結部位,或者2個*為與式(3)中的R 122所鍵結之氮原子的鍵結部位且2個#為與式(3)中的R 122所鍵結之氧原子的鍵結部位為更佳,2個*為與式(3)中的R 122所鍵結之氧原子的鍵結部位且2個#為與式(3)中的R 122所鍵結之氮原子的鍵結部位為進一步較佳。 【Chemical Formula 25】 In the formula, X1 represents -O-, -S-, -C( CF3 ) 2- , -CH2- , -SO2- , and -NHCO-, and * and # represent the bonding sites with other structures, respectively. R represents a hydrogen atom or a monovalent substituent, with hydrogen atom or alkyl group being preferred, and hydrogen atom or alkyl group being even more preferred. Furthermore, R122 is also preferred as the structure represented by the above formula. When R 122 has the structure represented by the above formula, it is preferable that any two of the four asterisks and # are bonded to nitrogen atoms in R 122 in formula (3) and the other two are bonded to oxygen atoms in R 122 in formula (3). It is even better that two asterisks are bonded to oxygen atoms in R 122 in formula (3) and two # are bonded to nitrogen atoms in R 122 in formula (3), or two asterisks are bonded to nitrogen atoms in R 122 in formula (3) and two # are bonded to oxygen atoms in R 122 in formula (3). The bonding sites of the oxygen atoms bonded by 122 and the two # are more preferably the bonding sites of the nitrogen atoms bonded by R in equation (3).

雙胺基苯酚衍生物為由式(A-s)表示之化合物亦較佳。 【化學式26】 Diaminophenol derivatives represented by formula (As) are also preferred. [Chemical Formula 26]

式(A-s)中,R 1為氫原子、伸烷基、取代伸烷基、-O-、-S-、-SO 2-、-CO-、-NHCO-、單鍵或選自下述式(A-sc)的群組中之有機基。R 2為氫原子、烷基、烷氧基、醯氧基、環狀烷基中的任一個,其可以相同亦可以不同。R 3為氫原子、直鏈或支鏈烷基、烷氧基、醯氧基、環狀烷基中的任一個,其可以相同亦可以不同。 In formula (As), R1 is a hydrogen atom, an alkyl group, a substituted alkyl group, -O-, -S-, -SO₂- , -CO-, -NHCO-, a single bond, or an organic group selected from the group of formulas (A-sc) below. R2 is any one of a hydrogen atom, an alkyl group, an alkoxy group, an acetoxy group, or a cyclic alkyl group, which may be the same or different. R3 is any one of a hydrogen atom, a straight-chain or branched alkyl group, an alkoxy group, an acetoxy group, or a cyclic alkyl group, which may be the same or different.

【化學式27】 (式(A-sc)中,*表示鍵結於由上述式(A-s)表示之雙胺基苯酚衍生物的胺基苯酚基的芳香環。) 【Chemical Formula 27】 (In formula (A-sc), * indicates an aromatic ring bonded to the aminophenol group of the diaminophenol derivative represented by formula (As) above.)

上述式(A-s)中,認為在酚性羥基的鄰位亦即R 3上亦具有取代基會使醯胺鍵的羰基碳與羥基的距離更靠近,在低溫下硬化時成為高環化率之效果進一步得到提高之觀點上為特佳。 In the above formula (As), it is considered that the presence of substituents at the position adjacent to the phenolic hydroxyl group, i.e. R3 , would bring the carbonyl carbon of the amide bond closer to the hydroxyl group, thereby further enhancing the effect of achieving a high cyclization rate during hardening at low temperatures.

又,上述式(A-s)中,R 2為烷基且R 3為烷基時能夠維持對i射線的高透明性和在低溫下硬化時為高環化率這樣的效果,因此為較佳。 Furthermore, in the above formula (As), when R2 is an alkyl group and R3 is an alkyl group, it can maintain the effect of high transparency to i-rays and high cyclization rate when hardened at low temperature, which is therefore better.

又,上述式(A-s)中,R 1為伸烷基或取代伸烷基為進一步較佳。作為R 1之伸烷基及取代伸烷基的具體例,可舉出碳數1~8的直鏈狀或支鏈狀烷基等,其中,在維持對i射線的高透明性和在低溫下硬化時為高環化率這樣的效果,並且能夠得到對溶劑具有充分的溶解性之平衡優異之聚苯并噁唑前驅物之方面而言,-CH 2-、-CH(CH 3)-、-C(CH 32-為更佳。 Furthermore, in the above formula (As), it is even more preferable that R1 is an alkylene group or a substituted alkylene group. Specific examples of alkylene groups and substituted alkylene groups of 1 to 8 carbon atoms can be given, such as linear or branched alkyl groups. Among them, -CH2-, -CH(CH3)-, and -C( CH3 ) 2- are more preferred in terms of maintaining high transparency to i-rays and high cyclization rate when curing at low temperatures, and in order to obtain a polybenzoxazole precursor with a good balance of sufficient solubility in solvents.

作為由上述式(A-s)表示之雙胺基苯酚衍生物的製造方法,例如能夠參閱日本特開2013-256506號公報的段落號0085~0094及實施例1(段落號0189~0190),該等內容被編入本說明書中。As for the method of manufacturing the diaminophenol derivative represented by the above formula (A-s), for example, you can refer to paragraphs 0085 to 0094 and Example 1 (paragraphs 0189 to 0190) of Japanese Patent Application Publication No. 2013-256506, the contents of which are incorporated in this specification.

作為由上述式(A-s)表示之雙胺基苯酚衍生物的結構的具體例,可舉出日本特開2013-256506號公報的段落號0070~0080中所記載者,該等內容被編入本說明書中。當然並不限定於該等。Specific examples of the structure of a diaminophenol derivative represented by the above formula (A-s) can be found in paragraphs 0070 to 0080 of Japanese Patent Application Publication No. 2013-256506, the contents of which are incorporated herein by reference. However, it is not limited to these examples.

除了上述式(3)的重複單元以外,聚苯并噁唑前驅物亦可以包含其他種類的重複單元。 在能夠抑制伴隨閉環之翹曲的產生之方面而言,聚苯并噁唑前驅物作為其他種類的重複單元含有由下述式(SL)表示之二胺殘基為較佳。 In addition to the repeating unit of formula (3) above, polybenzoxazole precursors may also contain other types of repeating units. In terms of suppressing the formation of curl-up associated with ring closure, it is preferable that the polybenzoxazole precursor, as another type of repeating unit, contains a diamine residue represented by formula (SL).

【化學式28】 式(SL)中,Z具有a結構和b結構,R 1s為氫原子或碳數1~10的烴基,R 2s為碳數1~10的烴基,R 3s、R 4s、R 5s、R 6s中的至少1個為芳香族基,其餘為氫原子或碳數1~30的有機基,其分別可以相同亦可以不同。a結構及b結構的聚合可以為嵌段聚合或隨機聚合。關於Z部分的莫耳%,a結構為5~95莫耳%、b結構為95~5莫耳%,a+b為100莫耳%。 【Chemical Formula 28】 In formula (SL), Z has an a-structure and a b-structure. R1s is a hydrogen atom or an hydrocarbon with 1 to 10 carbon atoms, R2s is an hydrocarbon with 1 to 10 carbon atoms, at least one of R3s , R4s , R5s , and R6s is an aromatic group, and the rest are hydrogen atoms or organic groups with 1 to 30 carbon atoms. These groups can be the same or different. The polymerization of the a-structure and the b-structure can be block polymerization or random polymerization. Regarding the molar percentage of the Z part, the a-structure is 5 to 95 molars, the b-structure is 95 to 5 molars, and a+b is 100 molars.

式(SL)中,作為較佳的Z,可舉出b結構中的R 5s及R 6s為苯基者。又,由式(SL)表示之結構的分子量為400~4,000為較佳,500~3,000為更佳。藉由將上述分子量設在上述範圍內,能夠更有效地減小聚苯并噁唑前驅物的脫水閉環後的彈性模數,能夠兼顧可抑制翹曲之效果和提高溶劑溶解性之效果。 In formula (SL), Z is preferably represented by R5s and R6s in structure b being phenyl. Furthermore, the molecular weight of the structure represented by formula (SL) is preferably 400–4,000, and more preferably 500–3,000. By setting the molecular weight within the above range, the elastic modulus after dehydration and ring closure of the polybenzoxazole precursor can be reduced more effectively, thus achieving both the effect of suppressing warping and improving solvent solubility.

當包含式(SL)所表示之二胺殘基作為其他種類的重複單元之情況下,進一步包含從四羧酸二酐中去除酐基之後殘存之四羧酸殘基作為重複結構單元亦為較佳。作為這種四羧酸殘基的例子,可舉出式(2)中的R 115的例子。 When the diamine residue represented by formula (SL) is used as another type of repeating unit, it is also preferable to further include the tetracarboxylic acid residue remaining after the anhydride group is removed from the tetracarboxylic acid dianhydride as a repeating structural unit. As an example of such a tetracarboxylic acid residue, R 115 in formula (2) can be cited.

聚苯并噁唑前驅物的重量平均分子量(Mw)例如較佳為18,000~30,000,更佳為20,000~29,000,進一步較佳為22,000~28,000。又,數量平均分子量(Mn)較佳為7,200~14,000,更佳為8,000~12,000,進一步較佳為9,200~11,200。 上述聚苯并噁唑前驅物的分子量的分散度為1.4以上為較佳,1.5以上為更佳,1.6以上為進一步較佳。聚苯并噁唑前驅物的分子量的分散度的上限值並沒有特別規定,例如2.6以下為較佳,2.5以下為更佳,2.4以下為進一步較佳,2.3以下為進一步較佳,2.2以下為更進一步較佳。 又,當樹脂組成物作為特定樹脂含有複數種聚苯并噁唑前驅物之情況下,至少1種聚苯并噁唑前驅物的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚苯并噁唑前驅物作為1個樹脂而算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of the polybenzoxazole precursor is preferably 18,000 to 30,000, more preferably 20,000 to 29,000, and even more preferably 22,000 to 28,000. Furthermore, the number-average molecular weight (Mn) is preferably 7,200 to 14,000, more preferably 8,000 to 12,000, and even more preferably 9,200 to 11,200. The molecular weight dispersion of the above-mentioned polybenzoxazole precursor is preferably 1.4 or higher, more preferably 1.5 or higher, and even more preferably 1.6 or higher. There is no specific upper limit for the molecular weight dispersity of the polybenzoxazole precursor. For example, 2.6 or less is preferred, 2.5 or less is more preferred, 2.4 or less is further preferred, 2.3 or less is even more preferred, and 2.2 or less is still more preferred. Furthermore, when the resin composition contains multiple polybenzoxazole precursors as a specific resin, it is preferred that the weight average molecular weight, number average molecular weight, and dispersity of at least one polybenzoxazole precursor are within the above-mentioned ranges. Also, it is preferred that the weight average molecular weight, number average molecular weight, and dispersity calculated when considering the multiple polybenzoxazole precursors as a single resin are each within the above-mentioned ranges.

〔聚苯并噁唑〕 作為聚苯并噁唑,只要係具有苯并噁唑環之高分子化合物,則沒有特別限定,但由下述式(X)表示之化合物為較佳,由下述式(X)表示且具有聚合性基之化合物為更佳。作為上述聚合性基,自由基聚合性基為較佳。又,亦可以為由下述式(X)表示且具有酸分解性基等極性反轉基之化合物。 【化學式29】 式(X)中,R 133表示2價的有機基,R 134表示4價的有機基。 當具有聚合性基或酸分解性基等極性反轉基之情況下,聚合性基或酸分解性基等極性反轉基可以位於R 133及R 134中的至少一者上,如下述式(X-1)或式(X-2)所示,亦可以位於聚苯并噁唑的末端。 式(X-1) 【化學式30】 式(X-1)中,R 135及R 136中的至少一者為聚合性基或酸分解性基等極性反轉基,當不是聚合性基或酸分解性基等極性反轉基時為有機基,其他基團的含義與式(X)的含義相同。 式(X-2) 【化學式31】 式(X-2)中,R 137為聚合性基或酸分解性基等極性反轉基,其他為取代基,其他基團的含義與式(X)的含義相同。 [Polybenzoxazole] There are no particular limitations on the polybenzoxazole as long as it is a polymeric compound having a benzoxazole ring, but compounds represented by formula (X) are preferred, and compounds represented by formula (X) and having a polymerizable group are even more preferred. As the polymerizable group, a free radical polymerizable group is preferred. Furthermore, compounds represented by formula (X) and having a polar reversible group such as an acid-decomposing group can also be used. [Chemical Formula 29] In formula (X), R 133 represents a divalent organic group, and R 134 represents a tetravalent organic group. When a polar inversion group, such as a polymerizable or acid-degradable group, is present, the polymerizable or acid-degradable group can be located on at least one of R 133 and R 134 , as shown in formula (X-1) or formula (X-2) below, or it can be located at the end of the polybenzoxazole. Formula (X-1) [Chemical Formula 30] In formula (X-1), at least one of R 135 and R 136 is a polar reversal group, such as a polymerizable group or an acid-decomposable group. When it is not a polymerizable group or an acid-decomposable group, it is an organic group. The meanings of the other groups are the same as those in formula (X). Formula (X-2) [Chemical Formula 31] In formula (X-2), R 137 is a polar reversal group such as a polymerizable group or an acid-degradable group, and the others are substituents. The meanings of the other groups are the same as those in formula (X).

聚合性基或酸分解性基等極性反轉基的含義與在上述聚醯亞胺前驅物所具有之聚合性基中敘述之聚合性基的含義相同。The meaning of polar reverse groups, such as polymerizable groups or acid-degradable groups, is the same as the meaning of polymerizable groups described in the above-mentioned polyimide precursors.

R 133表示2價的有機基。作為2價的有機基,可舉出脂肪族基或芳香族基。作為具體例,可舉出聚苯并噁唑前驅物的式(3)中的R 121的例子。又,其較佳例與R 121相同。 R 133 represents a divalent organic group. Examples of divalent organic groups include aliphatic or aromatic groups. As a specific example, R 121 in formula (3) of polybenzoxazole precursors can be cited. Furthermore, a preferred example is the same as R 121 .

R 134表示4價的有機基。作為4價的有機基,可舉出聚苯并噁唑前驅物的式(3)中的R 122的例子。又,其較佳例與R 122相同。 例如,作為R 122而例示之4價的有機基的4個鍵結子與上述式(X)中的氮原子、氧原子鍵結而形成縮合環。例如,當R 134為下述有機基之情況下,形成下述結構。下述結構中,*分別表示與式(X)中的氮原子或氧原子的鍵結部位。 【化學式32】 R 134 represents a tetravalent organic group. An example of a tetravalent organic group is R 122 in formula (3) of a polybenzoxazole precursor. A preferred example is also R 122. For example, the four bond atoms of the tetravalent organic group exemplified as R 122 bond with the nitrogen and oxygen atoms in formula (X) above to form a condensed ring. For example, when R 134 is an organic group as described below, the following structure is formed. In the following structure, * respectively indicates the bonding site with the nitrogen or oxygen atom in formula (X). [Chemical Formula 32]

聚苯并噁唑的噁唑化率為85%以上為較佳,90%以上為更佳。上限並沒有特別限定,可以為100%。藉由噁唑化率為85%以上,由藉由加熱而噁唑化時所產生之閉環所引起之膜收縮減少,能夠更有效地抑制產生翹曲。 上述噁唑化率例如藉由下述方法來進行測量。 測量聚苯并噁唑的紅外吸收光譜,求出作為來自於前驅物的醯胺結構之吸收峰值之1650cm -1附近的峰值強度Q1。接著,以在1490cm -1附近發現之芳香環的吸收強度進行標準化。在350℃下對其聚苯并噁唑進行了1小的熱處理之後,再次測量紅外吸收光譜,求出1650cm -1附近的峰值強度Q2,並且以在1490cm -1附近發現之芳香環的吸收強度進行標準化。使用所獲得之峰值強度Q1、Q2的標準值,依據下述式,能夠求出聚苯并噁唑的噁唑化率。 噁唑化率(%)=(峰值強度Q1的標準值/峰值強度Q2的標準值)×100 An oxazolization rate of 85% or higher for polybenzoxazole is preferred, and 90% or higher is even better. There is no specific upper limit; it can be 100%. With an oxazolization rate of 85% or higher, the film shrinkage caused by ring closure during heating-induced oxazolization is reduced, thus more effectively suppressing warping. The aforementioned oxazolization rate is measured, for example, by the following method: The infrared absorption spectrum of polybenzoxazole is measured, and the peak intensity Q1 near 1650 cm⁻¹, representing the absorption peak of the amide structure from the precursor, is determined. Then, it is standardized using the absorption intensity of the aromatic ring found near 1490 cm⁻¹ . After heat-treating the polybenzoxazole at 350°C for one hour, the infrared absorption spectrum was measured again to determine the peak intensity Q2 near 1650 cm⁻¹ , which was then standardized using the absorption intensity of the aromatic ring found near 1490 cm⁻¹ . Using the obtained standard values of peak intensities Q1 and Q2, the oxazolization rate of the polybenzoxazole can be calculated according to the following formula: Oxazolization rate (%) = (Standard value of peak intensity Q1 / Standard value of peak intensity Q2) × 100

聚苯并噁唑可以全部都含有包含一種R 131或R 132之上述式(X)的重複單元,亦可以含有包含2個以上的不同種類的R 131或R 132之上述式(X)的重複單元。又,聚苯并噁唑除了上述式(X)的重複單元以外,還可以包含其他種類的重複單元。 Polybenzoxazole may contain only repeating units of formula (X) of the above form, which include one type of R 131 or R 132 , or it may contain repeating units of formula (X) of the above form, which include two or more different types of R 131 or R 132. In addition to repeating units of formula (X) above, polybenzoxazole may also contain repeating units of other types.

聚苯并噁唑例如藉由使雙胺基苯酚衍生物與包含R 133之二羧酸或選自上述二羧酸的二羧酸二醯氯(dicarboxylic acid dichloride)及二羧酸衍生物等中之化合物進行反應而得到聚苯并噁唑前驅物,並利用已知的噁唑化反應法使其噁唑化而得到。 另外,當二羧酸的情況下,為了提高反應產率等,可以使用使1-羥基-1,2,3-苯并三唑等預先反應而得到之活性酯型二羧酸衍生物。 Polybenzoxazole precursors are obtained, for example, by reacting a diaminophenol derivative with a dicarboxylic acid containing R133 , or a dicarboxylic acid dichloride selected from the aforementioned dicarboxylic acids, and dicarboxylic acid derivatives, and then oxazolizing it using a known oxazolization reaction. Alternatively, in the case of a dicarboxylic acid, to improve the reaction yield, an active ester-type dicarboxylic acid derivative obtained by pre-reaction of 1-hydroxy-1,2,3-benzotriazole can be used.

聚苯并噁唑的重量平均分子量(Mw)為5,000~70,000為較佳,8,000~50,000為更佳,10,000~30,000為進一步較佳。藉由將重量平均分子量設為5,000以上,能夠提高硬化後的膜的耐折性。為了得到機械特性優異之有機膜,重量平均分子量係20,000以上為特佳。又,當含有兩種以上的聚苯并噁唑之情況下,至少一種聚苯并噁唑的重量平均分子量在上述範圍內為較佳。 又,聚苯并噁唑的數量平均分子量(Mn)較佳為7,200~14,000,更佳為8,000~12,000,進一步較佳為9,200~11,200。 上述聚苯并噁唑的分子量的分散度為1.4以上為較佳,1.5以上為更佳,1.6以上為進一步較佳。聚苯并噁唑的分子量的分散度的上限值並沒有特別規定,例如2.6以下為較佳,2.5以下為更佳,2.4以下為進一步較佳,2.3以下為進一步較佳,2.2以下為更進一步較佳。 又,當樹脂組成物作為特定樹脂含有複數種聚苯并噁唑之情況下,至少1種聚苯并噁唑的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚苯并噁唑作為1個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of polybenzoxazole is preferably 5,000–70,000, more preferably 8,000–50,000, and even more preferably 10,000–30,000. Setting the weight-average molecular weight to 5,000 or higher improves the folding resistance of the cured film. For organic films with excellent mechanical properties, a weight-average molecular weight of 20,000 or higher is particularly preferred. Furthermore, when two or more polybenzoxazoles are contained, it is preferable that at least one polybenzoxazole has a weight-average molecular weight within the above range. Furthermore, the number average molecular weight (Mn) of polybenzoxazole is preferably 7,200–14,000, more preferably 8,000–12,000, and even more preferably 9,200–11,200. The molecular weight dispersion of the above-mentioned polybenzoxazole is preferably 1.4 or higher, more preferably 1.5 or higher, and even more preferably 1.6 or higher. There is no specific upper limit for the molecular weight dispersion of polybenzoxazole; for example, 2.6 or lower is preferred, 2.5 or lower is more preferred, 2.4 or lower is even more preferred, 2.3 or lower is even more preferred, and 2.2 or lower is even more preferred. Furthermore, when the resin composition contains multiple polybenzoxazoles as a specific resin, it is preferable that the weight-average molecular weight, number-average molecular weight, and dispersibility of at least one polybenzoxazole are within the aforementioned ranges. It is also preferable that the weight-average molecular weight, number-average molecular weight, and dispersibility calculated when considering the multiple polybenzoxazoles as a single resin are each within the aforementioned ranges.

〔聚醯胺醯亞胺前驅物〕 聚醯胺醯亞胺前驅物含有由下述式(PAI-2)表示之重複單元為較佳。 【化學式33】 式(PAI-2)中,R 117表示3價的有機基,R 111表示2價的有機基,A 2表示氧原子或-NH-,R 113表示氫原子或1價的有機基。 [Polyamide-imide precursor] It is preferable that the polyamide-imide precursor contains a repeating unit represented by the following formula (PAI-2). [Chemical Formula 33] In formula (PAI-2), R 117 represents a trivalent organic group, R 111 represents a divalent organic group, A 2 represents an oxygen atom or -NH-, and R 113 represents a hydrogen atom or a monovalent organic group.

式(PAI-2)中,R 117可例示直鏈狀或支鏈狀的脂肪族基、環狀的脂肪族基及芳香族基、雜芳族基團或者單鍵或藉由連接基將該等連接兩個以上而獲得之基團,碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合兩個以上而獲得之基團為較佳,碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合兩個以上而獲得之基團為更佳。 作為上述連接基,-O-、-S-、-C(=O)-、-S(=O) 2-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結兩個以上而形成之連接基為較佳,-O-、-S-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結兩個以上而形成之連接基為更佳。 作為上述伸烷基,碳數1~20的伸烷基為較佳,碳數1~10的伸烷基為更佳,碳數1~4的伸烷基為進一步較佳。 作為上述鹵化伸烷基,碳數1~20的鹵化伸烷基為較佳,碳數1~10的鹵化伸烷基為更佳,碳數1~4的鹵化伸烷基為更佳。又,作為上述鹵化伸烷基中之鹵素原子,可舉出氟原子、氯原子、溴原子、碘原子等,氟原子為較佳。上述鹵化伸烷基可以具有氫原子,亦可以使所有氫原子經鹵素原子取代,但是所有氫原子經鹵素原子取代為較佳。作為較佳的鹵化伸烷基的例子,可舉出(二三氟甲基)亞甲基等。 作為上述伸芳基,伸苯基或伸萘基為較佳,伸苯基為更佳,1,3-伸苯基或1,4-伸苯基為進一步較佳。 In formula (PAI-2), R 117 can exemplify a linear or branched aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaryl group, or a group obtained by connecting two or more of these groups with a single bond or by linking groups. It is preferred to have a linear aliphatic group with 2 to 20 carbons, a branched aliphatic group with 3 to 20 carbons, a cyclic aliphatic group with 3 to 20 carbons, an aromatic group with 6 to 20 carbons, or a group obtained by combining two or more of these groups with a single bond or by linking groups. It is even more preferred to have an aromatic group with 6 to 20 carbons, or a group obtained by combining two or more aromatic groups with 6 to 20 carbons with a single bond or by linking groups. As the linking group mentioned above, -O-, -S-, -C(=O)-, -S(=O) 2- , alkylene, halogenated alkylene, arylene, or a linking group formed by two or more of these bonds is preferred; -O-, -S-, alkylene, halogenated alkylene, arylene, or a linking group formed by two or more of these bonds is even more preferred. As the alkylene group mentioned above, alkylene having 1 to 20 carbon atoms is preferred, alkylene having 1 to 10 carbon atoms is more preferred, and alkylene having 1 to 4 carbon atoms is even more preferred. As the halogenated alkylene group mentioned above, halogenated alkylene having 1 to 20 carbon atoms is preferred, halogenated alkylene having 1 to 10 carbon atoms is even more preferred, and halogenated alkylene having 1 to 4 carbon atoms is even more preferred. Furthermore, examples of halogen atoms in the aforementioned halogenated alkyl groups include fluorine, chlorine, bromine, and iodine atoms, with fluorine atoms being preferred. The aforementioned halogenated alkyl groups may contain hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but substitution with halogen atoms is preferred. Examples of preferred halogenated alkyl groups include (di-trifluoromethyl)methylene. As for the aforementioned aryl groups, phenyl or naphthyl groups are preferred, with phenyl groups being more preferred, and 1,3-phenyl or 1,4-phenyl groups being even more preferred.

又,R 117從至少一個羧基可以被鹵化的三羧酸化合物衍生為較佳。作為上述鹵化,氯化為較佳。 在本發明中,將具有三個羧基之化合物稱為三羧酸化合物。 上述三羧酸化合物的三個羧基中的兩個羧基可以被酸酐化。 作為用於聚醯胺醯亞胺前驅物的製造中之可以被鹵化的三羧酸化合物,可舉出支鏈狀的脂肪族、環狀的脂肪族或芳香族的三羧酸化合物等。 該等三羧酸化合物可以僅使用1種,亦可以使用2種以上。 Furthermore, R 117 is preferably derived from a tricarboxylic acid compound in which at least one carboxyl group can be halogenated. Chlorination is preferred as the halogenation method. In this invention, a compound having three carboxyl groups is referred to as a tricarboxylic acid compound. Two of the three carboxyl groups in the aforementioned tricarboxylic acid compound can be anhydride-substituted. Examples of halogenable tricarboxylic acid compounds used in the manufacture of polyamide-imide precursors include branched aliphatic, cyclic aliphatic, or aromatic tricarboxylic acid compounds. Only one type of such tricarboxylic acid compound may be used, or two or more types may be used.

具體而言,作為三羧酸化合物,包含碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合兩個以上而獲得之基團之三羧酸化合物為較佳,包含碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合兩個以上而獲得之基團之三羧酸化合物為更佳。Specifically, as a tricarboxylic acid compound, a tricarboxylic acid compound comprising a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more of these groups via a linker is preferred. A tricarboxylic acid compound comprising an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more aromatic groups having 6 to 20 carbon atoms via a linker is even more preferred.

又,作為三羧酸化合物的具體例,可舉出藉由單鍵、-O-、-CH 2-、-C(CH 32-、-C(CF 32-、-SO 2-或伸苯基連接1,2,3-丙烷三羧酸、1,3,5-戊烷三羧酸、檸檬酸、偏苯三甲酸、2,3,6-萘三羧酸、鄰苯二甲酸(或者,鄰苯二甲酸酐)與苯甲酸之化合物等。 該等化合物可以為兩個羧基被酐化之化合物(例如,偏苯三甲酸酐),亦可以為至少一個羧基被鹵化之化合物(例如,偏苯三酸酐醯氯)。 Furthermore, specific examples of tricarboxylic acid compounds include compounds in which 1,2,3-propanetricarboxylic acid, 1,3,5 - pentanetricarboxylic acid, citric acid, trimellitic acid, 2,3,6-naphthalenetricarboxylic acid, phthalic acid (or phthalic anhydride), and benzoic acid are linked by single bonds, -O-, -CH2-, -C( CH3 ) 2- , -C( CF3 )2-, -SO2- , or extended phenyl groups. These compounds can be compounds in which two carboxyl groups are anhydridated (e.g., trimellitic anhydride) or compounds in which at least one carboxyl group is halogenated (e.g., trimellitic anhydride chlorohydride).

式(PAI-2)中,R 111、A 2、R 113的含義分別與上述式(2)中之R 111、A 2、R 113的含義相同,較佳態樣亦相同。 In formula (PAI-2), the meanings of R111 , A2 , and R113 are the same as those of R111 , A2 , and R113 in formula (2) above, and the better state is also the same.

聚醯胺醯亞胺前驅物可以進一步含有其他重複單元。 作為其他重複單元,可舉出由上述式(2)表示之重複單元、由下述式(PAI-1)表示之重複單元等。 【化學式34】 Polyamide imide precursors may further contain other repeating units. Examples of other repeating units include those represented by formula (2) above and those represented by formula (PAI-1) below. [Chemical Formula 34]

式(PAI-1)中,R 116表示2價的有機基,R 111表示2價的有機基。 式(PAI-1)中,R 116可例示直鏈狀或支鏈狀的脂肪族基、環狀的脂肪族基及芳香族基、雜芳族基團或者單鍵或藉由連接基將該等連接兩個以上而獲得之基團,碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合兩個以上而獲得之基團為較佳,碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合兩個以上而獲得之基團為更佳。 作為上述連接基,-O-、-S-、-C(=O)-、-S(=O) 2-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結兩個以上而形成之連接基為較佳,-O-、-S-、伸烷基、鹵化伸烷基、伸芳基或該等鍵結兩個以上而形成之連接基為更佳。 作為上述伸烷基,碳數1~20的伸烷基為較佳,碳數1~10的伸烷基為更佳,碳數1~4的伸烷基為進一步較佳。 作為上述鹵化伸烷基,碳數1~20的鹵化伸烷基為較佳,碳數1~10的鹵化伸烷基為更佳,碳數1~4的鹵化伸烷基為更佳。又,作為上述鹵化伸烷基中之鹵素原子,可舉出氟原子、氯原子、溴原子、碘原子等,氟原子為較佳。上述鹵化伸烷基可以具有氫原子,亦可以使所有氫原子經鹵素原子取代,但是所有氫原子經鹵素原子取代為較佳。作為較佳的鹵化伸烷基的例子,可舉出(二三氟甲基)亞甲基等。 作為上述伸芳基,伸苯基或伸萘基為較佳,伸苯基為更佳,1,3-伸苯基或1,4-伸苯基為進一步較佳。 In formula (PAI-1), R 116 represents a divalent organic group, and R 111 represents a divalent organic group. In formula (PAI-1), R 116 can exemplify a linear or branched aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaryl group, or a group obtained by linking two or more of these groups together with a single bond or a linking group. It is preferred to have a linear aliphatic group with 2 to 20 carbons, a branched aliphatic group with 3 to 20 carbons, a cyclic aliphatic group with 3 to 20 carbons, an aromatic group with 6 to 20 carbons, or a group obtained by linking two or more of these groups together with a single bond or a linking group. It is even more preferred to have an aromatic group with 6 to 20 carbons, or an aromatic group obtained by linking two or more of these groups together with a single bond or a linking group. As the linking group mentioned above, -O-, -S-, -C(=O)-, -S(=O) 2- , alkylene, halogenated alkylene, arylene, or a linking group formed by two or more of these bonds is preferred; -O-, -S-, alkylene, halogenated alkylene, arylene, or a linking group formed by two or more of these bonds is even more preferred. As the alkylene group mentioned above, alkylene having 1 to 20 carbon atoms is preferred, alkylene having 1 to 10 carbon atoms is more preferred, and alkylene having 1 to 4 carbon atoms is even more preferred. As the halogenated alkylene group mentioned above, halogenated alkylene having 1 to 20 carbon atoms is preferred, halogenated alkylene having 1 to 10 carbon atoms is even more preferred, and halogenated alkylene having 1 to 4 carbon atoms is even more preferred. Furthermore, examples of halogen atoms in the aforementioned halogenated alkyl groups include fluorine, chlorine, bromine, and iodine atoms, with fluorine atoms being preferred. The aforementioned halogenated alkyl groups may contain hydrogen atoms, or all hydrogen atoms may be substituted with halogen atoms, but substitution with halogen atoms is preferred. Examples of preferred halogenated alkyl groups include (di-trifluoromethyl)methylene. As for the aforementioned aryl groups, phenyl or naphthyl groups are preferred, with phenyl groups being more preferred, and 1,3-phenyl or 1,4-phenyl groups being even more preferred.

又,R 116從二羧酸化合物或二羧酸二鹵化物衍生為較佳。 在本發明中,將具有兩個羧基之化合物稱為二羧酸化合物,且將具有兩個被鹵化之羧基之化合物稱為二羧酸二鹵化物。 二羧酸二鹵化物中之羧基只要被鹵化即可,例如被氯化為較佳。亦即,二羧酸二鹵化物為二羧酸二氯化物化合物為較佳。 作為用於聚醯胺醯亞胺前驅物的製造中之可以被鹵化的二羧酸化合物或二羧酸二鹵化物,可舉出直鏈狀或支鏈狀的脂肪族、環狀的脂肪族或芳香族二羧酸化合物或二羧酸二鹵化物等。 該等二羧酸化合物或二羧酸二鹵化物可以僅使用1種,亦可以使用2種以上。 Furthermore, R 116 is preferably derived from dicarboxylic acid compounds or dicarboxylic acid dihalides. In this invention, a compound having two carboxyl groups is called a dicarboxylic acid compound, and a compound having two halogenated carboxyl groups is called a dicarboxylic acid dihalide. The carboxyl groups in a dicarboxylic acid dihalide only need to be halogenated; for example, chlorination is preferred. That is, a dicarboxylic acid dihalide is preferably a dicarboxylic acid dichloride compound. Examples of halogenable dicarboxylic acid compounds or dicarboxylic acid dihalides that can be used in the manufacture of polyamide imine precursors include linear or branched aliphatic, cyclic, or aromatic dicarboxylic acid compounds or dicarboxylic acid dihalides. Only one type of such dicarboxylic acid compound or dicarboxylic acid dihalide may be used, or two or more types may be used.

具體而言,作為二羧酸化合物或二羧酸二鹵化物,包含碳數2~20的直鏈的脂肪族基、碳數3~20的支鏈的脂肪族基、碳數3~20的環狀的脂肪族基、碳數6~20的芳香族基或者單鍵或藉由連接基將該等組合兩個以上而獲得之基團之二羧酸化合物或二羧酸二鹵化物為較佳,包含碳數6~20的芳香族基或者單鍵或藉由連接基將碳數6~20的芳香族基組合兩個以上而獲得之基團之二羧酸化合物或二羧酸二鹵化物為更佳。Specifically, as a dicarboxylic acid compound or dicarboxylic acid dihalogenate, it is preferred that the dicarboxylic acid compound or dicarboxylic acid dihalogenate contains a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more of these groups via a linker. It is even more preferred that the dicarboxylic acid compound or dicarboxylic acid dihalogenate contains an aromatic group having 6 to 20 carbon atoms, or a single bond or a group obtained by combining two or more of the aromatic groups having 6 to 20 carbon atoms via a linker.

又,作為二羧酸化合物的具體例,可舉出丙二酸、二甲基丙二酸、乙基丙二酸、異丙基丙二酸、二正丁基丙二酸、琥珀酸、四氟琥珀酸、甲基琥珀酸、2,2-二甲基琥珀酸、2,3-二甲基琥珀酸、二甲基甲基琥珀酸、戊二酸、六氟戊二酸、2-甲基戊二酸、3-甲基戊二酸、2,2-二甲基戊二酸、3,3-二甲基戊二酸、3-乙基-3-甲基戊二酸、己二酸、八氟己二酸、3-甲基己二酸、庚二酸、2,2,6,6-四甲基庚二酸、辛二酸、十二氟辛二酸、壬二酸、癸二酸、十六氟癸二酸、1,9-壬二酸、十二烷二酸、十三烷二酸、十四烷二酸、十五烷二酸、十六烷二酸、十七烷二酸、十八烷二酸、十九烷二酸、二十烷二酸、二十一烷二酸、二十二烷二酸、二十三烷二酸、二十四烷二酸、二十五烷二酸、二十六烷二酸、二十七烷二酸、二十八烷二酸、二十九烷二酸、三十烷二酸、三十一烷二酸、三十二烷二酸、二乙醇酸、鄰苯二甲酸、間苯二甲酸、對苯二甲酸、4,4’-聯苯羧酸、4,4’-聯苯羧酸、4,4’-二羧基二苯醚、二苯甲酮-4,4’-二羧酸等。 作為二羧酸二鹵化物的具體例,可舉出將上述二羧酸化合物的具體例中之兩個羧基進行鹵化而形成之結構的化合物。 Furthermore, specific examples of dicarboxylic acid compounds include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, 2,2,6,6-tetramethylpimelic acid, octanoic acid, dodecafluorooctanoic acid, azelaic acid, sebacic acid, and hexafluorodecanoic acid. Dicarboxylic acids, 1,9-azelaic acid, dodecanoic acid, tridecanoic acid, tetradecanoic acid, pentadecanoic acid, hexadecanoic acid, heptadecanoic acid, octadecanoic acid, nonadecanoic acid, eicosanoic acid, dodecanoic acid, tridecanoic acid, tetradecanoic acid, pentadecanoic acid, hexadecanoic acid, heptadecanoic acid, octadecanoic acid, nonadecanoic acid, triacontadecanoic acid, triacontadecanoic acid, diethanolic acid, phthalic acid, isophthalic acid, terephthalic acid, 4,4'-biphenylcarboxylic acid, 4,4'-biphenylcarboxylic acid, 4,4'-dicarboxylic acid diphenyl ether, benzophenone-4,4'-dicarboxylic acid, etc. Specific examples of dicarboxylic acid dihalides include compounds with structures formed by halogenating two carboxyl groups in the above-mentioned dicarboxylic acid compounds.

式(PAI-1)中,R 111的含義與上述式(2)中之R 111的含義相同,較佳態樣亦相同。 In formula (PAI-1), the meaning of R 111 is the same as that of R 111 in formula (2) above, and the better state is also the same.

又,聚醯胺醯亞胺前驅物在結構中具有氟原子亦較佳。聚醯胺醯亞胺前驅物中的氟原子含量為10質量%以上為較佳,又20質量%以下為較佳。Furthermore, it is preferable that the polyamide imide precursor has fluorine atoms in its structure. It is preferable that the fluorine atom content in the polyamide imide precursor is 10% by mass or more, and preferably 20% by mass or less.

又,以提高與基板的密接性為目的,聚醯胺醯亞胺前驅物可以與具有矽氧烷結構之脂肪族基共聚。具體而言,作為二胺成分,可舉出使用雙(3-胺基丙基)四甲基二矽氧烷、雙(對胺基苯基)八甲基五矽氧烷等之態樣。Furthermore, to improve adhesion to the substrate, polyamide imine precursors can be copolymerized with aliphatic groups having a silicate structure. Specifically, examples of diamine components include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.

作為本發明中的聚醯胺醯亞胺前驅物的一實施形態,可舉出由式(PAI-2)表示之重複單元、由式(PAI-1)表示之重複單元及由式(2)表示之重複單元的總含量為所有重複單元的50莫耳%以上之態樣。上述總含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述總含量的上限並無特別限定,除了末端以外的聚醯胺醯亞胺前驅物中的所有的重複單元可以為由式(PAI-2)表示之重複單元、由式(PAI-1)表示之重複單元及由式(2)表示之重複單元中的任一個。 又,作為本發明中的聚醯胺醯亞胺前驅物的另一實施形態,可舉出由式(PAI-2)表示之重複單元及由式(PAI-1)表示之重複單元的總含量為所有重複單元的50莫耳%以上之態樣。上述總含量為70莫耳%以上為更佳,90莫耳%以上為進一步較佳,超過90莫耳%為特佳。上述總含量的上限並無特別限定,除了末端以外的聚醯胺醯亞胺前驅物中的所有的重複單元可以為由式(PAI-2)表示之重複單元或由式(PAI-1)表示之重複單元中的任一個。 As an embodiment of the polyamide imide precursor of the present invention, an example is provided where the total content of the repeating unit represented by formula (PAI-2), the repeating unit represented by formula (PAI-1), and the repeating unit represented by formula (2) is 50 mol% or more of all repeating units. A total content of 70 mol% or more is preferred, 90 mol% or more is further preferred, and more than 90 mol% is particularly preferred. There is no particular limitation on the upper limit of the total content; all repeating units in the polyamide imide precursor, except for the terminal units, can be any one of the repeating units represented by formula (PAI-2), formula (PAI-1), and formula (2). Furthermore, as another embodiment of the polyamide-imide precursor of this invention, an example is provided where the total content of the repeating units represented by formula (PAI-2) and the repeating units represented by formula (PAI-1) is 50 mol% or more of all repeating units. A total content of 70 mol% or more is preferred, 90 mol% or more is further preferred, and more than 90 mol% is particularly preferred. There is no particular limitation on the upper limit of the total content; all repeating units in the polyamide-imide precursor, except for the terminal units, can be either repeating units represented by formula (PAI-2) or repeating units represented by formula (PAI-1).

聚醯胺醯亞胺前驅物的重量平均分子量(Mw)較佳為2,000~500,000,更佳為5,000~100,000,進一步較佳為10,000~50,000。又,數量平均分子量(Mn)較佳為800~250,000,更佳為2,000~50,000,進一步較佳為4,000~25,000。 聚醯胺醯亞胺前驅物的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯胺醯亞胺前驅物的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。又,當樹脂組成物作為特定樹脂包含複數種聚醯胺醯亞胺前驅物之情況下,至少1種聚醯胺醯亞胺前驅物的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯胺醯亞胺前驅物作為1個樹脂而計算之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of the polyamide-imide precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and even more preferably 10,000 to 50,000. Furthermore, the number-average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and even more preferably 4,000 to 25,000. The molecular weight dispersion of the polyamide-imide precursor is preferably 1.5 or higher, more preferably 1.8 or higher, and even more preferably 2.0 or higher. There is no specific upper limit for the molecular weight dispersity of the polyamide-imide precursor, but for example, 7.0 or below is preferred, 6.5 or below is more preferred, and 6.0 or below is even more preferred. Furthermore, when the resin composition comprises multiple polyamide-imide precursors as a specific resin, it is preferred that the weight average molecular weight, number average molecular weight, and dispersity of at least one polyamide-imide precursor are within the above-mentioned ranges. Additionally, it is also preferred that the weight average molecular weight, number average molecular weight, and dispersity calculated when considering the multiple polyamide-imide precursors as a single resin are each within the above-mentioned ranges.

〔聚醯胺醯亞胺〕 本發明中所使用之聚醯胺醯亞胺可以為鹼可溶性聚醯胺醯亞胺,亦可以為可溶於以有機溶劑為主成分之顯影液之聚醯胺醯亞胺。 在本說明書中,鹼可溶性聚醯胺醯亞胺係指相對於100g的2.38質量%四甲基銨水溶液在23℃下溶解0.1g以上之聚醯胺醯亞胺,從圖案形成性的觀點考慮,溶解0.5g以上之聚醯亞胺為較佳,溶解1.0g以上之聚醯亞胺為進一步較佳。上述溶解量的上限並無特別限定,但100g以下為較佳。 又,從所得到之有機膜的膜強度及絕緣性的觀點考慮,聚醯胺醯亞胺為在主鏈中具有複數個醯胺鍵及複數個醯亞胺結構之聚醯亞胺為較佳。 [Polyamide-Imine] The polyamide-imide used in this invention can be an alkaline-soluble polyamide-imide or a polyamide-imide soluble in a developing solution primarily composed of an organic solvent. In this specification, alkaline-soluble polyamide-imide refers to polyamide-imide that dissolves at least 0.1 g in 100 g of a 2.38% (w/w) tetramethylammonium aqueous solution at 23°C. From a pattern-forming point of view, dissolving at least 0.5 g of polyamide-imide is preferred, and dissolving at least 1.0 g of polyamide-imide is further preferred. There is no particular upper limit to the above dissolution amount, but less than 100 g is preferred. Furthermore, considering the strength and insulation properties of the obtained organic membrane, polyamide-propylene imide with a plurality of amide bonds and a plurality of propylene imide structures in the main chain is preferred.

-氟原子- 從所得到之有機膜的膜強度的觀點而言,聚醯胺醯亞胺具有氟原子為較佳。 氟原子例如包含於由後述之式(PAI-3)表示之重複單元中的R 117或R 111中為較佳,作為氟化烷基包含於由後述之式(PAI-3)表示之重複單元中的R 117或R 111中為更佳。 氟原子相對於聚醯胺醯亞胺的總質量之量為5質量%以上為較佳,又20質量%以下為較佳。 -Fluorine Atom- From the viewpoint of the membrane strength of the obtained organic membrane, it is preferable that the polyamide amide has fluorine atoms. It is preferable that the fluorine atom is contained, for example, in R 117 or R 111 of the repeating unit represented by the following formula (PAI-3), and even more preferably, it is contained as a fluorinated alkyl group in R 117 or R 111 of the repeating unit represented by the following formula (PAI-3). It is preferable that the amount of fluorine atoms relative to the total mass of the polyamide amide is 5% by mass or more, and preferably 20% by mass or less.

-乙烯性不飽和鍵- 從所獲得之有機膜的膜強度的觀點考慮,聚醯胺醯亞胺可以具有乙烯性不飽和鍵。 聚醯胺醯亞胺可以在主鏈末端具有乙烯性不飽和鍵,亦可以在側鏈中具有乙烯性不飽和鍵,但在側鏈中具有乙烯性不飽和鍵為較佳。 上述乙烯性不飽和鍵具有自由基聚合性為較佳。 乙烯性不飽和鍵包含於由後述之式(PAI-3)表示之重複單元中的R 117或R 111中為較佳,作為具有乙烯性不飽和鍵之基團包含於由後述之式(PAI-3)表示之重複單元中的R 117或R 111中為更佳。 具有乙烯性不飽和鍵之基團的較佳態樣與上述聚醯亞胺中的具有乙烯性不飽和鍵之基團的較佳態樣相同。 -Ethylene Unsaturated Bonds- From the perspective of the film strength of the obtained organic film, polyamide amide can possess ethylene unsaturated bonds. Polyamide amide can have ethylene unsaturated bonds at the main chain end or in the side chain, but it is preferred that it has ethylene unsaturated bonds in the side chain. The aforementioned ethylene unsaturated bonds are preferably free radical polymerizable. It is preferable that the ethylene unsaturated bond is contained in R117 or R111 in the repeating unit represented by the formula (PAI-3) described later, and it is even more preferable that the group having the ethylene unsaturated bond is contained in R117 or R111 in the repeating unit represented by the formula (PAI-3) described later. The preferred state of the group having the ethylene unsaturated bond is the same as the preferred state of the group having the ethylene unsaturated bond in the polyimide described above.

乙烯性不飽和鍵相對於聚醯胺醯亞胺的總質量之量為0.0001~0.1mol/g為較佳,0.001~0.05mol/g為更佳。The total mass of ethylene unsaturated bonds relative to polyamide amide is preferably 0.0001–0.1 mol/g, and even more preferably 0.001–0.05 mol/g.

-除了乙烯性不飽和鍵以外的聚合性基- 聚醯胺醯亞胺可以具有除了乙烯性不飽和鍵以外的聚合性基。 作為聚醯胺醯亞胺中的除了乙烯性不飽和鍵以外的聚合性基,可舉出與上述聚醯亞胺中的除了乙烯性不飽和鍵以外的聚合性基相同的基團。 除了乙烯性不飽和鍵以外的聚合性基例如包含於由後述之式(PAI-3)表示之重複單元中的R 111中為較佳。 除了乙烯性不飽和鍵以外的聚合性基相對於聚醯胺醯亞胺的總質量之量為0.05~10mol/g為較佳,0.1~5mol/g為更佳。 - Polymerizable groups other than ethylene unsaturated bonds- Polyamide amides may have polymerizable groups other than ethylene unsaturated bonds. Examples of polymerizable groups other than ethylene unsaturated bonds in polyamide amides include groups identical to those in the polyamides described above. It is preferable that the polymerizable groups other than ethylene unsaturated bonds are included, for example, in R 111 of the repeating unit represented by the formula (PAI-3) described later. It is preferable that the amount of polymerizable groups other than ethylene unsaturated bonds relative to the total mass of the polyamide amide is 0.05 to 10 mol/g, and more preferably 0.1 to 5 mol/g.

-極性反轉基- 聚醯胺醯亞胺可以具有酸分解性基等極性反轉基。聚醯胺醯亞胺中之酸分解性基與在上述式(2)中之R 113及R 114中所說明之酸分解性基相同,較佳態樣亦相同。 -Polar Reversing Group- Polyamide imide can have polar reversing groups such as acid-degrading groups. The acid-degrading groups in polyamide imide are the same as those described in R 113 and R 114 in the above formula (2), and the preferred state is also the same.

-酸值- 當將聚醯胺醯亞胺提供於鹼顯影時,從提高顯影性之觀點考慮,聚醯胺醯亞胺的酸值係30mgKOH/g以上為較佳,50mgKOH/g以上為更佳,70mgKOH/g以上為進一步較佳。 又,上述酸值係500mgKOH/g以下為較佳,400mgKOH/g以下為更佳,200mgKOH/g以下為進一步較佳。 又,當將聚醯胺醯亞胺提供於使用了以有機溶劑為主成分之顯影液之顯影(例如,後述之“溶劑顯影”)時,聚醯胺醯亞胺的酸值為2~35mgKOH/g為較佳,3~30mgKOH/g為更佳,5~20mgKOH/g為進一步較佳。 上述酸值藉由公知的方法測定,例如,藉由記載於JIS K 0070:1992中的方法測定。 又,作為聚醯胺醯亞胺中所含有之酸基,可舉出與聚醯亞胺中的酸基相同的基團,較佳態樣亦相同。 -Acid Value- When polyamide amide is provided in alkaline developing, from the viewpoint of improving developing properties, an acid value of 30 mg KOH/g or higher is preferred, 50 mg KOH/g or higher is even better, and 70 mg KOH/g or higher is still preferred. Furthermore, an acid value below 500 mg KOH/g is preferred, below 400 mg KOH/g is even better, and below 200 mg KOH/g is still even better. Furthermore, when polyamide-imide is provided for development using a developing solution primarily composed of an organic solvent (e.g., "solvent development" described below), the acid value of the polyamide-imide is preferably 2–35 mg KOH/g, more preferably 3–30 mg KOH/g, and even more preferably 5–20 mg KOH/g. The above acid value is determined by a known method, for example, by the method described in JIS K 0070:1992. Furthermore, as acid groups contained in polyamide-imide, groups with the same characteristics as the acid groups in polyamide-imide can be cited, and their preferred states are also the same.

-酚性羥基- 從使基於鹼顯影液之顯影速度成為適當者之觀點考慮,聚醯胺醯亞胺具有酚性羥基為較佳。 聚醯胺醯亞胺可以在主鏈末端中具有酚性羥基,亦可以在側鏈中具有酚性羥基。 酚性羥基例如包含於由後述之式(PAI-3)表示之重複單元中的R 117或R 111中為較佳。 酚性羥基相對於聚醯胺醯亞胺的總質量之量為0.1~30mol/g為較佳,1~20mol/g為更佳。 -Phenolic Hydroxyl Group- From the viewpoint of making the developing speed of alkaline developing solutions suitable, it is preferable that the polyamide imide has a phenolic hydroxyl group. The polyamide imide may have a phenolic hydroxyl group at the end of the main chain or in the side chain. It is preferable that the phenolic hydroxyl group is included, for example, in R 117 or R 111 in the repeating unit represented by the formula (PAI-3) described later. It is preferable that the amount of phenolic hydroxyl group relative to the total mass of the polyamide imide is 0.1 to 30 mol/g, and more preferably 1 to 20 mol/g.

作為本發明中所使用之聚醯胺醯亞胺,只要為具有醯亞胺結構及醯胺鍵之高分子化合物,則並無特別限定,含有由下述式(PAI-3)表示之重複單元為較佳。 【化學式35】 式(PAI-3)中,R 111及R 117的含義分別與式(PAI-2)中的R 111及R 117的含義相同,較佳態樣亦相同。 當具有聚合性基之情況下,聚合性基可以位於R 111及R 117中的至少一者,亦可以位於聚醯胺醯亞胺的末端。 The polyamide amide used in this invention is not particularly limited as long as it is a polymer compound having an amide structure and amide bonds, but it is preferred to contain a repeating unit represented by the following formula (PAI-3). [Chemical Formula 35] In formula (PAI-3), the meanings of R 111 and R 117 are the same as those in formula (PAI-2), and the preferred state is also the same. When a polymerizable group is present, the polymerizable group can be located at at least one of R 111 and R 117 , or it can be located at the end of the polyamide amide.

又,為了提高樹脂組成物的保存穩定性,用單胺、酸酐、單羧酸、單醯氯化合物、單活性酯化合物等封端劑密封聚醯胺醯亞胺的主鏈末端為較佳。封端劑的較佳態樣與上述聚醯亞胺中的封端劑的較佳態樣相同。Furthermore, to improve the storage stability of the resin composition, it is preferable to seal the main chain ends of the polyamide amide imide with end-capping agents such as monoamines, acid anhydrides, monocarboxylic acids, monochlorodiphenyl compounds, or monoactive ester compounds. The preferred state of the end-capping agent is the same as that of the end-capping agent in the polyamide mentioned above.

-醯亞胺化率(閉環率)- 從所得到之有機膜的膜強度、絕緣性等觀點考慮,聚醯胺醯亞胺的醯亞胺化率(亦稱為“閉環率”)為70%以上為較佳,80%以上為更佳,90%以上為更佳。 上述醯亞胺化率的上限並無特別限定,只要為100%以下即可。 上述醯亞胺化率藉由與上述聚醯亞胺的閉環率相同的方法測量。 -Lipidification Rate (Ring-Closed Rate)- Considering the strength and insulation properties of the resulting organic membrane, a lipimization rate (also known as "ring-closed rate") of 70% or higher for polyamide lipimide is preferred, 80% or higher is even better, and 90% or higher is still preferable. There is no particular upper limit to the above lipimization rate; it only needs to be below 100%. The above lipimization rate is measured using the same method as the ring-closed rate of polyamide.

聚醯胺醯亞胺可以全部都含有包含1種R 111或R 117之由上述式(PAI-3)表示之重複單元,亦可以含有包含2個以上的不同種類的R 131或R 132之由上述式(PAI-3)表示之重複單元。又,聚醯胺醯亞胺除了由上述式(PAI-3)表示之重複單元以外,還可以包含其他種類的重複單元。作為其他種類的重複單元,可舉出由下述式(PAI-1)或式(PAI-2)表示之重複單元等。 Polyamide amides may contain only one type of repeating unit represented by formula (PAI-3) of R 111 or R 117 , or they may contain two or more different types of repeating units represented by R 131 or R 132 represented by formula (PAI-3). Furthermore, polyamide amides may contain other types of repeating units besides those represented by formula (PAI-3). Examples of other types of repeating units include repeating units represented by formula (PAI-1) or formula (PAI-2).

聚醯胺醯亞胺例如能夠藉由公知的方法獲得聚醯胺醯亞胺前驅物,其能夠利用如下方法來合成,亦即,使用已知的醯亞胺化反應法使其完全醯亞胺化之方法或在中途停止醯亞胺化反應導入部分醯亞胺結構之方法、進而藉由將完全醯亞胺化之聚合物與其聚醯胺醯亞胺前驅物混合而導入部分醯亞胺結構之方法。Polyamide imides can be obtained, for example, by known methods. Polyamide imide precursors can be synthesized by means of methods such as fully imidizing them using known imidization reactions, stopping the imidization reaction midway to introduce a partial imide structure, or introducing a partial imide structure by mixing the fully imidized polymer with its polyamide imide precursor.

聚醯胺醯亞胺的重量平均分子量(Mw)為5,000~70,000為較佳,8,000~50,000為更佳,10,000~30,000為進一步較佳。藉由將重量平均分子量設為5,000以上,能夠提高硬化後的膜的耐折性。為了得到機械特性優異之有機膜,重量平均分子量係20,000以上為特佳。 又,聚醯胺醯亞胺的數量平均分子量(Mn)較佳為800~250,000,更佳為2,000~50,000,進一步較佳為4,000~25,000。 聚醯胺醯亞胺的分子量的分散度為1.5以上為較佳,1.8以上為更佳,2.0以上為進一步較佳。聚醯胺醯亞胺的分子量的分散度的上限值並無特別規定,例如為7.0以下為較佳,6.5以下為更佳,6.0以下為進一步較佳。 又,當樹脂組成物作為特定樹脂包含複數種聚醯胺醯亞胺之情況下,至少1種聚醯胺醯亞胺的重量平均分子量、數量平均分子量及分散度在上述範圍內為較佳。又,將上述複數種聚醯胺醯亞胺作為1個樹脂計算出之重量平均分子量、數量平均分子量及分散度分別在上述範圍內亦較佳。 The weight-average molecular weight (Mw) of polyamide-imide is preferably 5,000–70,000, more preferably 8,000–50,000, and even more preferably 10,000–30,000. Setting the weight-average molecular weight to 5,000 or higher improves the folding resistance of the cured film. For organic films with excellent mechanical properties, a weight-average molecular weight of 20,000 or higher is particularly preferred. Furthermore, the number-average molecular weight (Mn) of polyamide-imide is preferably 800–250,000, more preferably 2,000–50,000, and even more preferably 4,000–25,000. The molecular weight dispersion of polyamide-imides is preferably 1.5 or higher, more preferably 1.8 or higher, and further preferably 2.0 or higher. There is no specific upper limit for the molecular weight dispersion of polyamide-imides; for example, 7.0 or lower is preferred, 6.5 or lower is more preferred, and 6.0 or lower is further preferred. Furthermore, when the resin composition comprises multiple polyamide-imides as a specific resin, it is preferable that the weight average molecular weight, number average molecular weight, and dispersion of at least one polyamide-imide are within the above-mentioned ranges. It is also preferable that the weight average molecular weight, number average molecular weight, and dispersion calculated when considering the multiple polyamide-imides as a single resin are each within the above-mentioned ranges.

〔聚醯亞胺前驅物等的製造方法〕 聚醯亞胺前驅物等例如能夠利用如下方法來獲得:在低溫中使四羧酸二酐和二胺進行反應之方法、在低溫中使四羧酸二酐和二胺進行反應來獲得聚醯胺酸並且使用縮合劑或烷化劑進行酯化之方法、藉由四羧酸二酐及醇獲得二酯之後在縮合劑的存在下與二胺進行反應之方法、藉由四羧酸二酐及醇獲得二酯之後使用鹵化劑酸鹵化剩餘的二羧酸並且與二胺進行反應之方法等。上述製造方法中,藉由四羧酸二酐及醇獲得二酯之後使用鹵化劑酸鹵化剩餘的二羧酸並且與二胺進行反應之方法為更佳。 作為上述縮合劑,例如可舉出二環己基碳化二醯亞胺、二異丙基碳化二醯亞胺、1-乙氧基羰基-2-乙氧基-1,2-二羥基喹啉、1,1-羰基二氧基-二-1,2,3-苯并三唑、N,N’-二琥珀醯亞胺碳酸酯、三氟乙酸酐等。 作為上述烷化劑,可舉出N,N-二甲基甲醯胺二甲基縮醛、N,N-二甲基甲醯胺二乙基縮醛、N,N-二烷基甲醯胺二烷基縮醛、原甲酸三甲酯、原甲酸三乙酯等。 作為上述鹵化劑,可舉出亞硫醯氯、草醯氯、氯氧化磷等。 在聚醯亞胺前驅物等的製造方法中,在進行反應時,使用有機溶劑為較佳。有機溶劑可以為1種,亦可以為2種以上。 作為有機溶劑,能夠依據原料適當地確定,可例示吡啶、二甘醇二甲醚(二乙二醇二甲醚)、N-甲基吡咯啶酮、N-乙基吡咯啶酮、丙酸乙酯、二甲基乙醯胺、二甲基甲醯胺、四氫呋喃、γ-丁內酯等。 在聚醯亞胺前驅物等的製造方法中,進行反應時,添加鹼性化合物為較佳。鹼性化合物可以為1種,亦可以為2種以上。 鹼性化合物能夠依據原料適當地確定,可例示三乙胺、二異丙基乙胺、吡啶、1,8-二吖雙環[5.4.0]十一碳-7-烯、N,N-二甲基-4-胺基吡啶等。 [Manufacturing Methods for Polyimide Precursors, etc.] Polyimide precursors, etc., can be obtained, for example, by reacting tetracarboxylic dianhydride and diamine at low temperature; by reacting tetracarboxylic dianhydride and diamine at low temperature to obtain polyamide and then esterifying it using a condensing agent or an alkylating agent; by obtaining a diester from tetracarboxylic dianhydride and alcohol and then reacting it with diamine in the presence of a condensing agent; by obtaining a diester from tetracarboxylic dianhydride and alcohol and then halogenating the remaining dicarboxylic acid with a halogenating agent and then reacting it with diamine, etc. Of the above manufacturing methods, the method of obtaining a diester from tetracarboxylic dianhydride and alcohol, followed by acid halogenation of the remaining dicarboxylic acid with a halogenating agent and reaction with a diamine is preferred. Examples of the condensing agents mentioned above include dicyclohexylcarbodiimide, diisopropylcarbodiimide, 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroxyquinoline, 1,1-carbonyldioxy-di-1,2,3-benzotriazole, N,N'-disuccinimidyl carbonate, and trifluoroacetic anhydride. Examples of alkylating agents include N,N-dimethylformamide dimethyl acetal, N,N-dimethylformamide diethyl acetal, N,N-dialkylformamide dialkyl acetal, trimethyl orthoformate, and triethyl orthoformate. Examples of halogenating agents include thionyl chloride, oxalyl chloride, and phosphorus oxychloride. In the manufacturing methods of polyimide precursors, etc., it is preferable to use an organic solvent during the reaction. One or more organic solvents may be used. As an organic solvent, it can be appropriately determined based on the raw materials, and examples include pyridine, diethylene glycol dimethyl ether (diethylene glycol dimethyl ether), N-methylpyrrolidone, N-ethylpyrrolidone, ethyl propionate, dimethylacetamide, dimethylformamide, tetrahydrofuran, γ-butyrolactone, etc. In the manufacturing method of polyimide precursors, etc., it is preferable to add an alkaline compound during the reaction. The alkaline compound can be one type or two or more types. The alkaline compound can be appropriately determined based on the raw materials, and examples include triethylamine, diisopropylethylamine, pyridine, 1,8-diacrylbis[5.4.0]undec-7-ene, N,N-dimethyl-4-aminopyridine, etc.

-封端劑- 在製造聚醯亞胺前驅物等時,為了更加提高保存穩定性,在聚醯亞胺前驅物等的樹脂末端密封殘留之羧酸酐、酸酐衍生物或者胺基為較佳。密封殘留於樹脂末端之羧酸酐及酸酐衍生物時,作為封端劑,可舉出單醇、苯酚、硫醇、苯硫酚、單胺等,從反應性、膜的穩定性考慮,使用單醇、苯酚類或單胺為更佳。作為一元醇的較佳的化合物,可舉出甲醇、乙醇、丙醇、丁醇、己醇、辛醇、十二醇、苯甲醇、2-苯基乙醇、2-甲氧基乙醇、2-氯甲醇、糠醇等一級醇、異丙醇、2-丁醇、環己醇、環戊醇、1-甲氧基-2-丙醇等二級醇、三級丁醇、金剛烷醇等三級醇。作為酚類的較佳化合物,可舉出酚、甲氧基酚、甲基酚、萘-1-醇、萘-2-醇、羥基苯乙烯等酚類等。又,作為單胺的較佳的化合物,苯胺、2-乙炔基苯胺、3-乙炔基苯胺、4-乙炔基苯胺、5-胺基-8-羥基喹啉、1-羥基-7-胺基萘、1-羥基-6-胺基萘、1-羥基-5-胺基萘、1-羥基-4-胺基萘、2-羥基-7-胺基萘、2-羥基-6-胺基萘、2-羥基-5-胺基萘、1-羧基-7-胺基萘、1-羧基-6-胺基萘、1-羧基-5-胺基萘、2-羧基-7-胺基萘、2-羧基-6-胺基萘、2-羧基-5-胺基萘、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯磺酸、3-胺基苯磺酸、4-胺基苯磺酸、3-胺基-4,6-二羥基嘧啶、2-胺基酚、3-胺基酚、4-胺基酚、2-胺基苯硫酚、3-胺基苯硫酚、4-胺基苯硫酚為較佳。該等可以使用2種以上,亦可以藉由使複數種封端劑反應而導入複數種不同的末端基。 又,密封樹脂末端的胺基時,能夠用具有能夠與胺基反應的官能基之化合物進行密封。對胺基的較佳封端劑為羧酸酐、羧酸氯化物、羧酸溴化物、磺酸氯化物、磺酸酐、磺酸羧酸酐等為較佳,羧酸酐、羧酸氯化物為更佳。作為羧酸酐的較佳之化合物,可舉出乙酸酐、丙酸酐、草酸酐、琥珀酸酐、順丁烯二酸酐、鄰苯二甲酸酐、苯甲酸酐、5-降莰冰片烯-2,3-二羧酸酐等。又,作為羧酸氯化物的較佳化合物,可舉出乙醯氯、丙烯醯氯、丙醯氯、甲基丙烯醯氯、新戊醯氯、環己烷甲醯氯、2-乙基己醯氯、桂皮醯氯、1-金剛烷甲醯氯、七氟丁醯氯、硬脂醯、苯甲醯氯等。 -End-Capping Agents- In the manufacture of polyimide precursors, etc., it is preferable to seal the resin ends of residual carboxylic anhydrides, anhydride derivatives, or amine groups to further improve storage stability. Examples of end-capping agents include monools, phenols, thiols, thiophenols, and monoamines. Considering reactivity and film stability, monools, phenols, or monoamines are preferred. Preferred compounds for monohydric alcohols include methanol, ethanol, propanol, butanol, hexanol, octanol, dodecanol, benzyl alcohol, 2-phenylethanol, 2-methoxyethanol, 2-chloromethanol, furfuryl alcohol, etc.; secondary alcohols include isopropanol, 2-butanol, cyclohexanol, cyclopentanol, 1-methoxy-2-propanol, etc.; and tertiary alcohols include butanol and adamantyl alcohol. Preferred compounds for phenols include phenols, methoxyphenols, methylphenols, naphth-1-ol, naphth-2-ol, hydroxystyrene, etc. Furthermore, preferred compounds as monoamines include aniline, 2-ethynylaniline, 3-ethynylaniline, 4-ethynylaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxy-7-aminonaphthalene, 1-carboxy-6-aminonaphthalene, 1-carboxy-5-aminonaphthalene, 2 The following are preferred end groups: -carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminobenzenethiophenol, 3-aminobenzenethiophenol, and 4-aminobenzenethiophenol. Two or more of these can be used, and multiple different end groups can be introduced by reacting multiple end-capping agents. Furthermore, when sealing the amine groups at the ends of resins, compounds with functional groups capable of reacting with amine groups can be used for sealing. Preferred end-capping agents for amine groups include carboxylic anhydrides, carboxylic acid chlorides, carboxylic acid bromides, sulfonic acid chlorides, sulfonic acid anhydrides, and sulfonic acid carboxylic anhydrides, with carboxylic anhydrides and carboxylic acid chlorides being even more preferred. Examples of preferred carboxylic anhydrides include acetic anhydride, propionic anhydride, oxalic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, benzoic anhydride, and 5-norbornene-2,3-dicarboxylic anhydride. Furthermore, preferred compounds for the chloride formation of carboxylic acids include acetyl chloride, acrylamide chloride, propionyl chloride, methacrylamide chloride, neopentyl chloride, cyclohexanemethyl chloride, 2-ethylhexyl chloride, cinnamic acid chloride, 1-draconemethyl chloride, heptafluorobutyric acid chloride, stearyl chloride, and benzoyl chloride.

-固體析出- 在製造聚醯亞胺前驅物等時,可以包括使固體析出之步驟。具體而言,依據需要對反應液中共存之脫水縮合劑的吸水副產物進行過濾之後,將所獲得之聚合物成分投入於水、脂肪族低級醇或其混合液等的不良溶劑中,析出聚合物成分,藉此以固體形式析出,使其乾燥,藉此能夠獲得聚醯亞胺前驅物等。為了提高純化度,可以對聚醯亞胺前驅物等反覆進行再溶解、再沉澱析出、乾燥等的操作。另外,亦可以包括使用離子交換樹脂去除離子性雜質之步驟。 -Solid Precipitation- The manufacture of polyimide precursors, etc., may include a solid precipitation step. Specifically, after filtering the water-absorbing byproducts of the dehydrating condensing agent coexisting in the reaction solution as needed, the obtained polymer component is added to a poor solvent such as water, aliphatic lower alcohols, or mixtures thereof, to precipitate the polymer component in solid form. After drying, the polyimide precursor is obtained. To improve purity, the polyimide precursor, etc., may be repeatedly subjected to redissolution, redeposition, and drying. Additionally, the process of removing ionic impurities using ion exchange resins may also be included.

〔含量〕 本發明的樹脂組成物中之特定樹脂的含量相對於樹脂組成物的總固體成分為20質量%以上為較佳,30質量%以上為更佳,40質量%以上為進一步較佳,50質量%以上為更進一步較佳。又,本發明的樹脂組成物中之樹脂的含量相對於樹脂組成物的總固體成分為99.5質量%以下為較佳,99質量%以下為更佳,98質量%以下為進一步較佳,97質量%以下為更進一步較佳,95質量%以下為又更進一步較佳。 本發明的樹脂組成物可以僅包含1種特定樹脂,亦可以包含2種以上。當包含2種以上之情況下,合計量在上述範圍內為較佳。 [Content] The content of the specific resin in the resin composition of the present invention is preferably 20% by mass or more, more preferably 30% by mass or more, further preferably 40% by mass or more, and even more preferably 50% by mass or more, relative to the total solid content of the resin composition. Furthermore, the content of the resin in the resin composition of the present invention is preferably 99.5% by mass or less, more preferably 99% by mass or less, further preferably 98% by mass or less, even more preferably 97% by mass or less, and even more preferably 95% by mass or less, relative to the total solid content of the resin composition. The resin composition of the present invention may contain only one specific resin, or it may contain two or more specific resins. When two or more factors are involved, it is preferable that the total amount falls within the above range.

又,本發明的樹脂組成物含有至少2種樹脂亦較佳。 具體而言,本發明的樹脂組成物可以含有總計2種以上特定樹脂及後述之其他樹脂,可以含有2種以上特定樹脂,含有2種以上特定樹脂為較佳。 當本發明的樹脂組成物含有2種以上特定樹脂之情況下,例如含有來自於二無水物之結構(在上述式(2)中之R 115)不同之2種以上的聚醯亞胺前驅物為較佳。 Furthermore, it is preferable that the resin composition of the present invention contains at least two types of resins. Specifically, the resin composition of the present invention may contain a total of two or more specific resins and other resins described below, and it is preferable that it contains two or more specific resins. When the resin composition of the present invention contains two or more specific resins, it is preferable that it contains, for example, two or more polyimide precursors with different structures (R 115 in the above formula (2)).

<其他樹脂> 本發明的樹脂組成物可以包含上述特定樹脂和與特定樹脂不同之其他樹脂(以下,亦簡稱為“其他樹脂”)。 作為其他樹脂,可舉出酚樹脂、聚醯胺、環氧樹脂、包含聚矽氧烷、矽氧烷結構之樹脂、(甲基)丙烯酸樹脂、(甲基)丙烯酸醯胺樹脂、胺酯樹脂、丁醛樹脂、苯乙烯樹脂、聚醚樹脂、聚酯樹脂等。 例如,藉由進一步加入(甲基)丙烯酸樹脂,可以獲得塗佈性優異之樹脂組成物,又可以獲得耐溶劑性優異之圖案(硬化物)。 例如,代替後述聚合性化合物或除了後述聚合性化合物以外,將重量平均分子量為20,000以下的聚合性基值高的(例如,樹脂1g中之聚合性基的含有莫耳量為1×10 -3莫耳/g以上)(甲基)丙烯酸樹脂添加至樹脂組成物中,從而能夠提高樹脂組成物的塗佈性、圖案(硬化物)的耐溶劑性等。 <Other Resins> The resin composition of this invention may include the specific resins described above and other resins different from the specific resins (hereinafter also referred to as "other resins"). Examples of other resins include phenolic resins, polyamides, epoxy resins, resins containing polysiloxanes or siloxane structures, (meth)acrylate resins, (meth)acrylate amide resins, amine ester resins, butyraldehyde resins, styrene resins, polyether resins, and polyester resins. For example, by further adding (meth)acrylate resins, a resin composition with excellent paintability can be obtained, as well as a pattern (cured product) with excellent solvent resistance. For example, instead of the polymerizable compounds described later, or in addition to the polymerizable compounds described later, a (meth)acrylate resin with a high polymerizable group value (e.g., the molar content of polymerizable groups in 1g of resin is 1× 10⁻³ moles/g or more) with a weight average molecular weight of 20,000 or less can be added to the resin composition, thereby improving the paintability of the resin composition, the solvent resistance of the pattern (cured material), etc.

在本發明的樹脂組成物包含其他樹脂之情況下,其他樹脂的含量相對於樹脂組成物的總固體成分為0.01質量%以上為較佳,0.05質量%以上為更佳,1質量%以上為進一步較佳,2質量%以上為更進一步較佳,5質量%以上為又更進一步較佳,10質量%以上為再更進一步較佳。 又,本發明的樹脂組成物中之其他樹脂的含量相對於樹脂組成物的總固體成分為80質量%以下為較佳,75質量%以下為更佳,70質量%以下為進一步較佳,60質量%以下為更進一步較佳,50質量%以下為又更進一步較佳。 又,作為本發明的樹脂組成物的較佳的一態樣,亦能夠設為其他樹脂的含量為低含量之態樣。在上述態樣中,其他樹脂的含量相對於樹脂組成物的總固體成分為20質量%以下為較佳,15質量%以下為更佳,10質量%以下為進一步較佳,5量%以下為更進一步較佳,1質量%以下為又更進一步較佳。上述含量的下限並無特別限定,只要為0質量%以上即可。 本發明的樹脂組成物可以僅包含1種其他樹脂,亦可以包含2種以上。當包含2種以上之情況下,合計量在上述範圍內為較佳。 When the resin composition of the present invention includes other resins, it is preferable that the content of the other resins relative to the total solid content of the resin composition is 0.01% by mass or more, more preferably 0.05% by mass or more, further preferably 1% by mass or more, even more preferably 2% by mass or more, still more preferably 5% by mass or more, and even more preferably 10% by mass or more. Furthermore, it is preferable that the content of the other resins in the resin composition of the present invention relative to the total solid content of the resin composition is 80% by mass or less, more preferably 75% by mass or less, even more preferably 70% by mass or less, even more preferably 60% by mass or less, and even more preferably 50% by mass or less. Furthermore, as a preferred embodiment of the resin composition of the present invention, it is also possible to design an embodiment with a low content of other resins. In the above-mentioned embodiments, it is preferable that the content of other resins relative to the total solid content of the resin composition is 20% by mass or less, more preferably 15% by mass or less, further preferably 10% by mass or less, even more preferably 5% by mass or less, and even more preferably 1% by mass or less. There is no particular limitation on the lower limit of the above content, as long as it is 0% by mass or more. The resin composition of the present invention may contain only one type of other resin, or it may contain two or more types. When two or more types are contained, it is preferable that the total amount is within the above-mentioned range.

<聚合性化合物> 本發明的樹脂組成物包含聚合性化合物為較佳。 作為聚合性化合物,可舉出自由基交聯劑或其他交聯劑。 <Polymerizable Compounds> Preferably, the resin composition of this invention includes polymerizable compounds. Examples of polymerizable compounds include free radical crosslinkers or other crosslinking agents.

〔自由基交聯劑〕 本發明的樹脂組成物包含自由基交聯劑為較佳。 自由基交聯劑為具有自由基聚合性基之化合物。作為自由基聚合性基,包含乙烯性不飽和鍵之基團為較佳。作為上述包含乙烯性不飽和鍵之基團,可舉出乙烯基、烯丙基、乙烯基苯基、(甲基)丙烯醯基、順丁烯二醯亞胺基、(甲基)丙烯醯胺基等具有乙烯性不飽和鍵之基團。 在該等之中,作為上述包含乙烯性不飽和鍵之基團,(甲基)丙烯醯基、(甲基)丙烯醯胺基、乙烯基苯基為較佳,從反應性的觀點考慮,(甲基)丙烯醯基為更佳。 [Free Radical Crosslinker] The resin composition of this invention preferably contains a free radical crosslinker. The free radical crosslinker is a compound having a free radical polymerizable group. As a free radical polymerizable group, it is preferable to have a group containing an ethylene unsaturated bond. Examples of such groups containing ethylene unsaturated bonds include vinyl, allyl, vinylphenyl, (meth)acrylyl, cis-butenylideneimino, and (meth)acrylamide. Among these, (meth)acrylyl, (meth)acrylamide, and vinylphenyl are preferred as groups containing ethylene unsaturated bonds, and (meth)acrylyl is more preferred from a reactivity point of view.

自由基交聯劑為具有一個以上的乙烯性不飽和鍵之化合物為較佳,但是具有兩個以上之化合物為更佳。自由基交聯劑可以具有三個以上的乙烯性不飽和鍵。 作為上述具有兩個以上的乙烯性不飽和鍵之化合物,具有2~15個乙烯性不飽和鍵之化合物為較佳,具有2~10個乙烯性不飽和鍵之化合物為更佳,具有2~6個之化合物為進一步較佳。 又,從所獲得之圖案(硬化物)的膜強度的觀點考慮,本發明的樹脂組成物包含具有兩個乙烯性不飽和鍵之化合物和上述具有三個以上的乙烯性不飽和鍵之化合物亦較佳。 The free radical crosslinker is preferably a compound having one or more ethylene unsaturated bonds, but more preferably a compound having two or more. The free radical crosslinker may have three or more ethylene unsaturated bonds. Among the compounds having two or more ethylene unsaturated bonds, compounds having 2 to 15 ethylene unsaturated bonds are preferred, compounds having 2 to 10 ethylene unsaturated bonds are more preferred, and compounds having 2 to 6 ethylene unsaturated bonds are even more preferred. Furthermore, from the viewpoint of the film strength of the obtained pattern (cured material), the resin composition of the present invention comprising compounds having two ethylene unsaturated bonds and the aforementioned compounds having three or more ethylene unsaturated bonds is also preferred.

自由基交聯劑的分子量為2,000以下為較佳,1,500以下為更佳,900以下為進一步較佳。自由基交聯劑的分子量的下限為100以上為較佳。The molecular weight of the free radical crosslinker is preferably below 2,000, even better below 1,500, and further preferably below 900. The lower limit of the molecular weight of the free radical crosslinker is preferably above 100.

作為自由基交聯劑的具體例,可舉出不飽和羧酸(例如,丙烯酸、甲基丙烯酸、衣康酸、巴豆酸、異巴豆酸、順丁烯二酸等)或其酯類、醯胺類,較佳為不飽和羧酸與多元醇化合物的酯及不飽和羧酸與多元胺化合物的醯胺類。又,亦可較佳地使用具有羥基或胺基、氫硫基等親核性取代基之不飽和羧酸酯或醯胺類與單官能或多官能異氰酸酯類或環氧類的加成反應物、與單官能或多官能羧酸的脫水縮合反應物等。又,具有異氰酸酯基或環氧基等親電子性取代基之不飽和羧酸酯或醯胺類與單官能或多官能醇類、胺類、硫醇類的加成反應物以及具有鹵素基或甲苯磺醯氧基等脫離性取代基之不飽和羧酸酯或醯胺類與單官能或多官能醇類、胺類、硫醇類的取代反應物亦較佳。又,作為另一例,亦能夠使用替換成不飽和膦酸、苯乙烯等乙烯基苯衍生物、乙烯醚、烯丙醚等之化合物群組來代替上述不飽和羧酸。作為具體例,能夠參閱日本特開2016-027357號公報的0113~0122段的記載,該等內容被編入本說明書中。Specific examples of free radical crosslinkers include unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, crotonic acid, isocrotonic acid, maleic acid, etc.) or their esters and amides, preferably esters of unsaturated carboxylic acids and polyol compounds, and amides of unsaturated carboxylic acids and polyamine compounds. Furthermore, addition reactions of unsaturated carboxylic acid esters or amides with nucleophilic substituents such as hydroxyl, amino, or hydrogen thio groups with monofunctional or polyfunctional isocyanates or epoxides, and dehydration condensation reactions with monofunctional or polyfunctional carboxylic acids, are also preferred. Furthermore, addition reactions of unsaturated carboxylic acid esters or amides with electrophilic substituents such as isocyanate groups or epoxy groups with monofunctional or polyfunctional alcohols, amines, or thiols, and substitution reactions of unsaturated carboxylic acid esters or amides with deionizing substituents such as halogen groups or toluenesulfonoxy groups with monofunctional or polyfunctional alcohols, amines, or thiols are also preferred. As another example, compounds that can be substituted with unsaturated phosphonic acids, vinylbenzene derivatives such as styrene, vinyl ethers, allyl ethers, etc., can also be used instead of the aforementioned unsaturated carboxylic acids. For specific examples, please refer to paragraphs 0113 to 0122 of Japanese Patent Application Publication No. 2016-027357, the contents of which are incorporated herein by reference.

又,自由基交聯劑為在常壓下具有100℃以上的沸點之化合物亦較佳。作為其例,能夠舉出聚乙二醇二(甲基)丙烯酸酯、三羥甲基乙烷三(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、新戊四醇三(甲基)丙烯酸酯、新戊四醇四(甲基)丙烯酸酯、二新戊四醇五(甲基)丙烯酸酯、二新戊四醇六(甲基)丙烯酸酯、己二醇二(甲基)丙烯酸酯、三羥甲基丙烷三(丙烯醯氧基丙基)醚、三(丙烯醯氧基乙基)異三聚氰酸酯、甘油或三羥甲基乙烷等在多官能醇中加成環氧乙烷或環氧丙烷之後進行(甲基)丙烯酸酯化而獲得之化合物、如日本特公昭48-041708號公報、日本特公昭50-006034號公報、日本特開昭51-037193號各公報中所記載之(甲基)丙烯酸胺基甲酸乙酯類、日本特開昭48-064183號、日本特公昭49-043191號、日本特公昭52-030490號各公報中所記載之聚酯丙烯酸酯類,作為環氧樹脂與(甲基)丙烯酸的反應產物之環氧丙烯酸酯類等多官能丙烯酸酯或甲基丙烯酸酯及該等混合物。又,日本特開2008-292970號公報的0254~0257段中所記載之化合物亦較佳。又,亦能夠舉出使(甲基)丙烯酸環氧丙酯等具有環狀醚基及乙烯性不飽和鍵之化合物與多官能羧酸進行反應而獲得之多官能(甲基)丙烯酸酯等。Furthermore, it is preferable that the free radical crosslinker is a compound with a boiling point above 100°C at normal pressure. Examples include polyethylene glycol di(meth)acrylate, trihydroxymethyl ethane tri(meth)acrylate, neopentyl glycol di(meth)acrylate, neopentyl tetramethyl acrylate, neopentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, dinepentyl tetramethyl acrylate, hexaethylene glycol di(meth)acrylate, trihydroxymethyl propane tri(acryloyloxypropyl) ether, tri(acryloyloxyethyl) isocyanate, glycerol, or trihydroxymethyl ethane, which are added to polyfunctional alcohols to form ethylene oxide or propylene oxide, followed by (meth)acrylate addition. Compounds obtained by esterification, such as ethyl aminocarbamates of (meth)acrylate described in Japanese Patent Publication Nos. 48-041708, 50-006034, and 51-037193, polyester acrylates described in Japanese Patent Publication Nos. 48-064183, 49-043191, and 52-030490, epoxy acrylates as reaction products of epoxy resins and (meth)acrylic acid, and other multifunctional acrylates or methacrylates and mixtures thereof. Furthermore, compounds described in paragraphs 0254 to 0257 of Japanese Patent Publication No. 2008-292970 are also preferred. Furthermore, examples include polyfunctional (meth)acrylates obtained by reacting compounds such as glycidyl (meth)acrylate, which have cyclic ether groups and vinyl unsaturated bonds, with polyfunctional carboxylic acids.

又,作為除了上述以外的較佳的自由基交聯劑物,亦能夠使用日本特開2010-160418號公報、日本特開2010-129825號公報、日本專利第4364216號公報等中所記載之具有茀環且具有兩個以上的具有乙烯性不飽和鍵之基團之化合物或卡多(cardo)樹脂。Furthermore, as a preferred free radical crosslinking agent besides those mentioned above, compounds having a ring and having two or more ethylene-unsaturated groups, or cardo resins, as described in Japanese Patent Application Publication No. 2010-160418, Japanese Patent Application Publication No. 2010-129825, and Japanese Patent No. 4364216, can also be used.

進而,作為其他例,亦能夠舉出日本特公昭46-043946號公報、日本特公平01-040337號公報、日本特公平01-040336號公報中所記載之特定的不飽和化合物或日本特開平02-025493號公報中所記載之乙烯基膦酸系化合物等。又,亦能夠使用日本特開昭61-022048號公報中所記載之包含全氟烷基之化合物。進而,亦能夠使用在“Journal of the Adhesion Society of Japan”vol.20、No.7、300~308頁(1984年)中作為光聚合性單體及寡聚物所介紹者。Furthermore, as other examples, specific unsaturated compounds described in Japanese Patent Publication Nos. 46-043946, 01-040337, and 01-040336, or vinylphosphonic acid compounds described in Japanese Patent Application Publication No. 02-025493, can also be used. Additionally, compounds containing perfluoroalkyl groups described in Japanese Patent Application Publication No. 61-022048 can also be used. Furthermore, those described as photopolymerizable monomers and oligomers in the "Journal of the Adhesion Society of Japan" vol. 20, No. 7, pp. 300-308 (1984) can also be used.

除了上述以外,亦能夠較佳地使用日本特開2015-034964號公報的0048~0051段中所記載之化合物、國際公開第2015/199219號的0087~0131段中所記載之化合物,該等內容被編入本說明書中。In addition to the above, compounds described in paragraphs 0048 to 0051 of Japanese Patent Application Publication No. 2015-034964 and compounds described in paragraphs 0087 to 0131 of International Publication No. 2015/199219, the contents of which are incorporated herein by reference, may also be used more readily.

又,在日本特開平10-062986號公報中,作為式(1)及式(2)而與其具體例一同記載的如下化合物亦能夠用作自由基交聯劑,該化合物為在多官能醇中加成環氧乙烷或環氧丙烷之後進行(甲基)丙烯酸酯化而獲得之化合物。Furthermore, in Japanese Patent Application Publication No. 10-062986, the following compounds, which are described together with specific examples of formulas (1) and (2), can also be used as free radical crosslinking agents. These compounds are obtained by esterification of (meth)acrylate after the addition of ethylene oxide or propylene oxide to a polyfunctional alcohol.

進而,亦能夠使用日本特開2015-187211號公報的0104~0131段中所記載之化合物作為自由基交聯劑,該等內容被編入本說明書中。Furthermore, compounds described in paragraphs 0104 to 0131 of Japanese Patent Application Publication No. 2015-187211 can also be used as free radical crosslinking agents, the contents of which are incorporated in this specification.

作為自由基交聯劑,二新戊四醇三丙烯酸酯(作為市售品為KAYARAD D-330;Nippon Kayaku Co.,Ltd.製)、二新戊四醇四丙烯酸酯(作為市售品為KAYARAD D-320;Nippon Kayaku Co.,Ltd.製造、A-TMMT:Shin-Nakamura Chemical Co.,Ltd.製)、二新戊四醇五(甲基)丙烯酸酯(作為市售品為KAYARAD D-310;Nippon Kayaku Co.,Ltd.製)、二新戊四醇六(甲基)丙烯酸酯(作為市售品為KAYARAD DPHA;Nippon Kayaku Co.,Ltd.製造、A-DPH;Shin-Nakamura Chemical Co.,Ltd.製)及該等(甲基)丙烯醯基經由乙二醇殘基或丙二醇殘基鍵結之結構為較佳。亦能夠使用該等寡聚物類型。As free radical crosslinking agents, dinepentylenetetroxide triacrylate (commercially available as KAYARAD D-330; manufactured by Nippon Kayaku Co., Ltd.), dinepentylenetetroxide tetraacrylate (commercially available as KAYARAD D-320; manufactured by Nippon Kayaku Co., Ltd., A-TMMT: manufactured by Shin-Nakamura Chemical Co., Ltd.), dinepentylenetetroxide penta(meth)acrylate (commercially available as KAYARAD D-310; manufactured by Nippon Kayaku Co., Ltd.), and dinepentylenetetroxide hexa(meth)acrylate (commercially available as KAYARAD DPHA; manufactured by Nippon Kayaku Co., Ltd., A-DPH: manufactured by Shin-Nakamura Chemical Co., Ltd.) (Made by Co., Ltd.) and the structure in which the (meth)acrylic acid groups are bonded by ethylene glycol residues or propylene glycol residues is preferred. These oligomer types can also be used.

作為自由基交聯劑的市售品,例如可舉出Sartomer Company, Inc製的作為具有四個乙烯氧基鏈之4官能丙烯酸酯之SR-494、作為具有四個乙烯氧基鏈之2官能甲基丙烯酸酯之Sartomer Company, Inc製SR-209、231、239、Nippon Kayaku Co.,Ltd.製的作為具有戊烯氧基鏈鏈之6官能丙烯酸酯之DPCA-60、作為具有三個異伸丁氧基鏈之3官能丙烯酸酯之TPA-330、胺基甲酸乙酯寡聚物UAS-10、UAB-140(NIPPON PAPER INDUSTRIES CO.,LTD.製)、NK Ester M-40G、NK Ester 4G、NK Ester M-9300、NK Ester A-9300、UA-7200(Shin-Nakamura Chemical Co.,Ltd製)、DPHA-40H(Nippon Kayaku Co.,Ltd.製)、UA-306H、UA-306T、UA-306I、AH-600、T-600、AI-600(Kyoeisha chemical Co.,Ltd.製)、BLEMMER PME400(NOF CORPORATION製)等。Commercially available free radical crosslinking agents include, for example, SR-494 (a tetrafunctional acrylate with four ethoxy groups) manufactured by Sartomer Company, Inc.; SR-209, 231, and 239 (difunctional methacrylates with four ethoxy groups) manufactured by Sartomer Company, Inc.; DPCA-60 (a hexafunctional acrylate with a pentenoxy group) manufactured by Nippon Kayaku Co., Ltd.; TPA-330 (a trifunctional acrylate with three isobutoxy groups); ethyl carbamate oligomers UAS-10 and UAB-140 (manufactured by NIPPON PAPER INDUSTRIES CO.,LTD.); NK Ester M-40G, NK Ester 4G, NK Ester M-9300, and NK Ester... A-9300, UA-7200 (manufactured by Shin-Nakamura Chemical Co., Ltd.), DPHA-40H (manufactured by Nippon Kayaku Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, AI-600 (manufactured by Kyoeisha chemical Co., Ltd.), BLEMMER PME400 (NOF CORPORATION), etc.

作為自由基交聯劑,如日本特公昭48-041708號公報、日本特開昭51-037193號公報、日本特公平02-032293號公報、日本特公平02-016765號公報中所記載之胺基甲酸乙酯丙烯酸酯類、日本特公昭58-049860號公報、日本特公昭56-017654號公報、日本特公昭62-039417號公報、日本特公昭62-039418號公報中所記載之具有環氧乙烷系骨架之胺基甲酸乙酯化合物類亦較佳。進而,作為自由基交聯劑,亦能夠使用日本特開昭63-277653號公報、日本特開昭63-260909號公報、日本特開平01-105238號公報中所記載之在分子內具有胺基結構或硫化物結構之化合物。As free radical crosslinking agents, ethyl carbamate acrylates as described in Japanese Patent Publication No. 48-041708, Japanese Patent Application Publication No. 51-037193, Japanese Patent Publication No. 02-032293, Japanese Patent Publication No. 02-016765, and ethyl carbamate compounds with an ethylene oxide backbone as described in Japanese Patent Publication No. 58-049860, Japanese Patent Publication No. 56-017654, Japanese Patent Publication No. 62-039417, and Japanese Patent Publication No. 62-039418 are also preferred. Furthermore, as a free radical crosslinking agent, compounds having an amino group structure or a sulfide structure within the molecule as described in Japanese Patent Application Publication No. 63-277653, Japanese Patent Application Publication No. 63-260909, and Japanese Patent Application Publication No. 01-105238 can also be used.

自由基交聯劑可以為具有羧基、磷酸基等酸基之自由基交聯劑。具有酸基之自由基交聯劑為脂肪族多羥基化合物與不飽和羧酸的酯為較佳,使非芳香族羧酸酐與脂肪族多羥基化合物的未反應的羥基進行反應而具有酸基之自由基交聯劑為更佳。特佳為在使非芳香族羧酸酐與脂肪族多羥基化合物的未反應的羥基進行反應而具有酸基之自由基交聯劑中,脂肪族多羥基化合物為新戊四醇或二新戊四醇之化合物。作為市售品,例如作為TOAGOSEI CO., LTD.製的多元酸改質丙烯酸寡聚物,可舉出M-510、M-520等。Free radical crosslinkers can be free radical crosslinkers containing acid groups such as carboxyl groups and phosphate groups. It is preferable that the free radical crosslinker containing acid groups is an ester of an aliphatic polyhydroxy compound and an unsaturated carboxylic acid. It is even more preferable that the free radical crosslinker contains acid groups by reacting a non-aromatic carboxylic anhydride with the unreacted hydroxyl group of an aliphatic polyhydroxy compound. Particularly preferred are free radical crosslinkers containing acid groups by reacting a non-aromatic carboxylic anhydride with the unreacted hydroxyl group of an aliphatic polyhydroxy compound, in which the aliphatic polyhydroxy compound is a neopentyl tetrol or dinepentyl tetrol. Commercially available examples include, for instance, polyacid-modified acrylic oligomers manufactured by TOAGOSEI CO., LTD., such as M-510 and M-520.

具有酸基之自由基交聯劑的較佳酸值為0.1~300mgKOH/g,特佳為1~100mgKOH/g。只要自由基交聯劑的酸值在上述範圍內,則製造上的操作性優異,進而顯影性優異。又,聚合性良好。關於上述酸值,依據JIS K 0070:1992的記載來測定。The preferred acid value for free radical crosslinkers containing acid groups is 0.1–300 mg KOH/g, with a particularly preferred value of 1–100 mg KOH/g. As long as the acid value of the free radical crosslinker is within the above range, the manufacturing process is excellent, resulting in excellent developing properties. Furthermore, it exhibits good polymerizability. The above acid values are determined according to JIS K 0070:1992.

從圖案的解析性和膜的伸縮性的觀點考慮,樹脂組成物使用2官能的甲基丙烯酸酯或丙烯酸酯為較佳。 作為具體的化合物,能夠使用三乙二醇二丙烯酸酯、三乙二醇二甲基丙烯酸酯、四乙二醇二甲基丙烯酸酯、四乙二醇二丙烯酸酯、PEG(聚乙二醇)200二丙烯酸酯、PEG200二甲基丙烯酸酯、PEG600二丙烯酸酯、PEG600二甲基丙烯酸酯、聚四乙二醇二丙烯酸酯、聚四乙二醇二甲基丙烯酸酯、新戊二醇二丙烯酸酯、新戊二醇二甲基丙烯酸酯、3-甲基-1,5-戊二醇二丙烯酸酯、1,6-己二醇二丙烯酸酯、1,6己二醇二甲基丙烯酸酯、二羥甲基三環癸烷二丙烯酸酯、二羥甲基三環癸烷二甲基丙烯酸酯、雙酚A的EO(環氧乙烷)加成物二丙烯酸酯、雙酚A的EO加成物二甲基丙烯酸酯、雙酚A的PO(環氧丙烷)加成物二丙烯酸酯、雙酚A的PO加成物二甲基丙烯酸酯、2羥基-3-丙烯醯氧基丙基甲基丙烯酸酯、異三聚氰酸EO改質二丙烯酸酯、異三聚氰酸改質二甲基丙烯酸酯、具有其他胺基甲酸乙酯鍵之2官能丙烯酸酯、具有胺基甲酸乙酯鍵之2官能甲基丙烯酸酯。該等依據需要能夠混合使用2種以上。 再者,例如PEG200二丙烯酸酯係指為聚乙二醇二丙烯酸酯且聚乙二醇鏈的式量為200左右者。 關於本發明的樹脂組成物,從伴隨圖案(硬化物)的彈性模數控制而抑制翹曲的觀點考慮,能夠較佳地使用單官能自由基交聯劑作為自由基交聯劑。作為單官能自由基交聯劑,可較佳地使用正丁基(甲基)丙烯酸酯、2-乙基己基(甲基)丙烯酸酯、2-羥乙基(甲基)丙烯酸酯、丁氧基乙基(甲基)丙烯酸酯、卡必醇(甲基)丙烯酸酯、環己基(甲基)丙烯酸酯、芐基(甲基)丙烯酸酯、苯氧基乙基(甲基)丙烯酸酯、N-羥甲基(甲基)丙烯醯胺、環氧丙基(甲基)丙烯酸酯、聚乙二醇單(甲基)丙烯酸酯、聚丙二醇單(甲基)丙烯酸酯等(甲基)丙烯酸衍生物、N-乙烯基吡咯啶酮、N-乙烯基己內醯胺等N-乙烯基化合物類、烯基環氧丙醚等。作為單官能自由基交聯劑,為了抑制曝光前的揮發,在常壓下具有100℃以上的沸點之化合物亦較佳。 除此以外,作為2官能以上的自由基交聯劑,可舉出鄰苯二甲酸二烯丙酯、偏苯三酸三烯丙酯等烯丙基化合物類。 From the perspectives of pattern resolution and membrane stretchability, it is preferable to use difunctional methacrylates or acrylates in the resin composition. Specific compounds that can be used include triethylene glycol diacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, PEG (polyethylene glycol) 200 diacrylate, PEG200 dimethacrylate, PEG600 diacrylate, PEG600 dimethacrylate, polytetraethylene glycol diacrylate, polytetraethylene glycol dimethacrylate, neopentyl glycol diacrylate, neopentyl glycol dimethacrylate, 3-methyl-1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, and 1,6-hexanediol dimethacrylate. Acrylic esters, dihydroxymethyltricyclodecane diacrylate, dihydroxymethyltricyclodecane dimethacrylate, bisphenol A EO (ethylene oxide) adduct diacrylate, bisphenol A EO adduct dimethacrylate, bisphenol A PO (propylene oxide) adduct diacrylate, bisphenol A PO adduct dimethacrylate, 2-hydroxy-3-acryloxypropyl methacrylate, isocyanuric acid EO-modified diacrylate, isocyanuric acid-modified dimethacrylate, difunctional acrylates having other ethyl carbamate bonds, and difunctional methacrylates having ethyl carbamate bonds. Two or more of these can be mixed as needed. Furthermore, for example, PEG200 diacrylate refers to polyethylene glycol diacrylate with a polyethylene glycol chain molecular weight of approximately 200. Regarding the resin composition of this invention, from the viewpoint of suppressing warping by controlling the elastic modulus accompanying the pattern (cured material), a monofunctional free radical crosslinker can be preferably used as the free radical crosslinker. As a monofunctional free radical crosslinking agent, preferably used are n-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, butoxyethyl (meth)acrylate, carbitol (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, N-hydroxymethyl (meth)acrylamide, glycidyl (meth)acrylate, polyethylene glycol mono(meth)acrylate, polypropylene glycol mono(meth)acrylate, and other (meth)acrylate derivatives, N-vinyl compounds such as N-vinylpyrrolidone and N-vinylcaprolactone, and alkenyl glycidyl ethers. As a monofunctional free radical crosslinking agent, compounds with a boiling point above 100°C at ambient pressure are also preferred to suppress pre-exposure volatilization. Besides these, examples of allyl compounds, such as diallyl phthalate and triallyl trimellitate, are examples of free radical crosslinking agents with two or more functions.

在含有自由基交聯劑之情況下,其含量相對於本發明的樹脂組成物的總固體成分超過0質量%且60質量%以下為較佳。下限為5質量%以上為更佳。上限為50質量%以下為更佳,30質量%以下為進一步較佳。In the presence of a free radical crosslinker, it is preferable that its content relative to the total solid content of the resin composition of the present invention is more than 0% by mass and less than 60% by mass. A lower limit of 5% by mass or more is more preferable. An upper limit of 50% by mass or less is more preferable, and 30% by mass or less is even more preferable.

自由基交聯劑可以單獨使用1種,亦可以混合使用2種以上。在併用2種以上之情況下,其合計量在上述範圍內為較佳。Free radical crosslinking agents can be used alone or in combination of two or more. When using two or more, it is preferable that their total amount be within the range mentioned above.

〔其他交聯劑〕 本發明的樹脂組成物包含與上述自由基交聯劑不同之其他交聯劑亦較佳。 在本發明中,其他交聯劑係指除了上述自由基交聯劑以外的交聯劑,在分子內具有複數個藉由上述光酸產生劑或光鹼產生劑的感光而促進在與組成物中的其他化合物或其反應產物之間形成共價鍵之反應之基團之化合物為較佳,在分子內具有複數個藉由酸或鹼的作用而促進在與組成物中的其他化合物或其反應產物之間形成共價鍵之反應之基團之化合物為較佳。 上述酸或鹼為在曝光步驟中從光酸產生劑或光鹼產生劑產生之酸或鹼為較佳。 作為其他交聯劑,具有選自包括醯氧基甲基、羥甲基及烷氧基甲基之群組中之至少一種基團之化合物為較佳,具有選自包括醯氧基甲基、羥甲基及烷氧基甲基之群組中之至少一種基團與氮原子直接鍵結之結構之化合物為更佳。 作為其他交聯劑,例如可舉出具有使甲醛或甲醛和醇與三聚氰胺、甘脲、脲、伸烷基脲、苯并胍胺等含有胺基之化合物進行反應而經醯氧基甲基、羥甲基或烷氧基甲基取代上述胺基的氫原子之結構之化合物。該等化合物的製造方法並無特別限定,只要為具有與藉由上述方法製造的化合物相同之結構之化合物即可。又,亦可以為該等化合物的羥甲基彼此自縮合而成之寡聚物。 將作為上述含有胺基之化合物而使用了三聚氰胺之交聯劑稱為三聚氰胺系交聯劑,將使用了甘脲、脲或伸烷基脲之交聯劑稱為脲系交聯劑,將使用了伸烷基脲之交聯劑稱為伸烷基脲系交聯劑,將使用了苯并胍胺之交聯劑稱為苯并胍胺系交聯劑。 在該等之中,本發明的樹脂組成物包含選自包括脲系交聯劑及三聚氰胺系交聯劑之群組中之至少一種化合物為較佳,包含選自包括後述甘脲系交聯劑及三聚氰胺系交聯劑之群組中之至少一種化合物為更佳。 [Other Crosslinking Agents] It is preferable that the resin composition of this invention includes other crosslinking agents different from the aforementioned free radical crosslinking agents. In this invention, other crosslinking agents refer to crosslinking agents other than the aforementioned free radical crosslinking agents. Preferably, the compound has a plurality of groups within its molecule that, upon photosensitization by the aforementioned photoacid or photoalkali generator, promote the formation of covalent bonds between it and other compounds in the composition or their reaction products. Preferably, the compound has a plurality of groups within its molecule that, upon the action of an acid or alkali, promote the formation of covalent bonds between it and other compounds in the composition or their reaction products. It is also preferable that the compound has a plurality of groups within its molecule that, upon the action of an acid or alkali, promote the formation of covalent bonds between it and other compounds in the composition or their reaction products. The aforementioned acid or alkali is preferably generated from a photoacid generator or a photoalkali generator during the exposure step. As other crosslinking agents, compounds having at least one group selected from the group consisting of acetomethyl, hydroxymethyl, and alkoxymethyl are preferred; compounds having a structure in which at least one group selected from the group consisting of acetomethyl, hydroxymethyl, and alkoxymethyl is directly bonded to a nitrogen atom are even more preferred. As other crosslinking agents, examples include compounds having a structure in which the hydrogen atom of the aforementioned amine group is replaced by acetomethyl, hydroxymethyl, or alkoxymethyl groups through a reaction of formaldehyde or formaldehyde and an alcohol with melamine, glycourea, urea, alkyl urea, benzoguanamine, or other amine-containing compounds. The method for manufacturing these compounds is not particularly limited, as long as the compound has the same structure as the compound manufactured by the above method. Furthermore, the compound can also be an oligomer formed by the self-condensation of the hydroxymethyl groups of these compounds. Crosslinking agents using melamine as the above-mentioned amino-containing compounds are called melamine-based crosslinking agents; crosslinking agents using glycourea, urea, or alkylurea are called urea-based crosslinking agents; crosslinking agents using alkylurea are called alkylurea-based crosslinking agents; and crosslinking agents using benzoguanidine are called benzoguanidine-based crosslinking agents. Of these, it is preferable that the resin composition of the present invention comprises at least one compound selected from the group consisting of urea-based crosslinkers and melamine-based crosslinkers, and even more preferably, it comprises at least one compound selected from the group consisting of glycourea-based crosslinkers and melamine-based crosslinkers described below.

作為含有本發明中之烷氧基甲基及醯氧基甲基中的至少一個之化合物,能夠舉出烷氧基甲基或醯氧基甲基直接在芳香族基或下述脲結構的氮原子上或三𠯤上取代之化合物作為結構例。 上述化合物所具有之烷氧基甲基或醯氧基甲基為碳數2~5為較佳,碳數2或3為較佳,碳數2為更佳。 上述化合物所具有之烷氧基甲基及醯氧基甲基的總數為1~10為較佳,更佳為2~8,特佳為3~6。 上述化合物的分子量較佳為1500以下,180~1200為較佳。 As a compound containing at least one of the alkoxymethyl and acetoxymethyl groups of the present invention, examples of compounds in which the alkoxymethyl or acetoxymethyl group is directly substituted on the nitrogen atom or trianode of the aromatic group or the urea structure described below are provided as structural examples. Preferably, the alkoxymethyl or acetoxymethyl group in the above-mentioned compound has 2 to 5 carbon atoms, preferably 2 or 3 carbon atoms, and more preferably 2 carbon atoms. Preferably, the total number of alkoxymethyl and acetoxymethyl groups in the above-mentioned compound is 1 to 10, more preferably 2 to 8, and particularly preferably 3 to 6. Preferably, the molecular weight of the above-mentioned compound is 1500 or less, and preferably 180 to 1200.

【化學式36】 【Chemical Formula 36】

R 100表示烷基或醯基。 R 101及R 102分別獨立地表示1價的有機基,並且可以相互鍵結而形成環。 R 100 represents an alkyl or acetyl group. R 101 and R 102 each represent a monovalent organic group and can bond with each other to form a ring.

作為烷氧基甲基或醯氧基甲基直接在芳香族基上取代之化合物,例如能夠舉出下述通式的各種化合物。As compounds in which alkoxymethyl or acetomethyl groups are directly substituted on an aromatic group, examples of compounds with the following general formula can be cited.

【化學式37】 【Chemical Formula 37】

式中,X表示單鍵或2價的有機基,每個R 104分別獨立地表示烷基或醯基,R 103表示氫原子、烷基、烯基、芳基、芳烷基或藉由酸的作用進行分解而產生鹼可溶性基之基團(例如,藉由酸的作用進行脫離之基團、由-C(R 42COOR 5表示之基團(R 4分別獨立地表示氫原子或碳數1~4的烷基,R 5表示藉由酸的作用進行脫離之基團。))。 R 105分別獨立地表示烷基或烯基,a、b及c分別獨立地為1~3,d為0~4,e為0~3,f為0~3,a+d為5以下,b+e為4以下,c+f為4以下。 關於藉由酸的作用進行分解而產生鹼可溶性基之基團、藉由酸的作用進行脫離之基團、由-C(R 42COOR 5表示之基團中之R 5,例如能夠舉出-C(R 36)(R 37)(R 38)、-C(R 36)(R 37)(OR 39)、-C(R 01)(R 02)(OR 39)等。 式中,R 36~R 39分別獨立地表示烷基、環烷基、芳基、芳烷基或烯基。R 36與R 37可以相互鍵結而形成環。 作為上述烷基,碳數1~10的烷基為較佳,碳數1~5的烷基為更佳。 上述烷基可以為直鏈狀、支鏈狀中的任一個。 作為上述環烷基,碳數3~12的環烷基為較佳,碳數3~8的環烷基為更佳。 上述環烷基可以為單環結構,亦可以為縮合環等多環結構。 上述芳基為碳數6~30的芳香族烴基為較佳,苯基為更佳。 作為上述芳烷基,碳數7~20的芳烷基為較佳,碳數7~16的芳烷基為更佳。 上述芳烷基係指經烷基取代之芳基,該等烷基及芳基的較佳態樣與上述烷基及芳基的較佳態樣相同。 上述烯基為碳數3~20的烯基為較佳,碳數3~16的烯基為更佳。 又,該等基團在可以獲得本發明的效果之範圍內可以進一步具有公知的取代基。 In the formula, X represents a single bond or a divalent organic group. Each R 104 independently represents an alkyl or acetyl group. R 103 represents a hydrogen atom, alkyl, alkenyl, aryl, aralkyl, or a group that decomposes under acid to produce an alkaline soluble group (e.g., a group that decomposes under acid, or a group represented by -C(R 4 ) 2COOR 5 (R 4 independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and R 5 represents a group that decomposes under acid). R 105 independently represents an alkyl or alkenyl group. a, b, and c are 1 to 3, d is 0 to 4, e is 0 to 3, f is 0 to 3, a+d is 5 or less, b+e is 4 or less, and c+f is 4 or less. Regarding groups that decompose under the action of acid to produce an alkaline soluble group, groups that are desorbed under the action of acid, and R5 in groups represented by -C( R4 ) 2COOR5 , examples include -C( R36 )( R37 )( R38 ), -C(R36)( R37 )( OR39 ), and -C( R01 )( R02 )( OR39 ). In the formula, R36 to R39 independently represent alkyl, cycloalkyl, aryl, aralkyl, or alkenyl groups. R36 and R37 can be bonded to each other to form a ring. As the above-mentioned alkyl groups, alkyl groups with 1 to 10 carbon atoms are preferred, and alkyl groups with 1 to 5 carbon atoms are even more preferred. The alkyl group can be either linear or branched. As the cycloalkyl group, a cycloalkyl group having 3 to 12 carbon atoms is preferred, and a cycloalkyl group having 3 to 8 carbon atoms is even more preferred. The cycloalkyl group can have a monocyclic structure or a polycyclic structure such as a condensed ring. The aryl group is preferably an aromatic hydrocarbon having 6 to 30 carbon atoms, and a phenyl group is even more preferred. As the aralkyl group, an aralkyl group having 7 to 20 carbon atoms is preferred, and an aralkyl group having 7 to 16 carbon atoms is even more preferred. The aralkyl group refers to an aryl group substituted with an alkyl group, and the preferred states of such alkyl and aryl groups are the same as the preferred states of the alkyl and aryl groups described above. The alkenyl group is preferably an alkenyl group having 3 to 20 carbon atoms, and an alkenyl group having 3 to 16 carbon atoms is even more preferred. Furthermore, these groups may have known substituents to the extent that the effects of the present invention can be obtained.

R 01及R 02分別獨立地表示氫原子、烷基、環烷基、芳基、芳烷基或烯基。 R 01 and R 02 represent hydrogen atoms, alkyl, cycloalkyl, aryl, aralkyl or alkenyl groups, respectively.

作為藉由酸的作用分解產生鹼可溶性基之基團或藉由酸的作用脫離之基團,較佳為三級烷基酯基、縮醛基、枯基酯基、烯醇酯基等。進一步較佳為三級烷基酯基、縮醛基。The groups that decompose to produce alkali-soluble groups by the action of acid or that are released by the action of acid are preferably trialkyl ester groups, acetal groups, cumyl ester groups, enol ester groups, etc. More preferably, they are trialkyl ester groups or acetal groups.

作為具有烷氧基甲基之化合物,具體而言,能夠舉出以下結構。關於具有醯氧基甲基之化合物,能夠舉出將下述化合物的烷氧基甲基變更為醯氧基甲基之化合物。作為在分子內具有烷氧基甲基或醯氧基甲基之化合物,能夠舉出以下各種化合物,但是並不限定於該等。Specifically, the following structures can be cited as compounds having an alkoxymethyl group. Regarding compounds having an acetoxymethyl group, compounds in which the alkoxymethyl group of the following compounds is replaced with an acetoxymethyl group can be cited. As compounds having an alkoxymethyl group or an acetoxymethyl group within the molecule, the following compounds can be cited, but are not limited to these.

【化學式38】 【Chemical Formula 38】

【化學式39】 【Chemical Formula 39】

關於含有烷氧基甲基及醯氧基甲基中的至少一個之化合物,可以使用市售者,亦可以使用藉由公知的方法合成者。 從耐熱性的觀點考慮,烷氧基甲基或醯氧基甲基直接在芳香環或三𠯤環上取代之化合物為較佳。 For compounds containing at least one of alkoxymethyl and acetoxymethyl groups, commercially available compounds or those synthesized by known methods may be used. From a heat resistance perspective, compounds in which the alkoxymethyl or acetoxymethyl group is directly substituted onto the aromatic ring or trihalomethane ring are preferred.

作為三聚氰胺系交聯劑的具體例,可舉出六甲氧基甲基三聚氰胺、六乙氧基甲基三聚氰胺、六丙氧基甲基三聚氰胺、六丁氧基丁基三聚氰胺等。Specific examples of melamine-based crosslinking agents include hexamethoxymethyl melamine, hexaethoxymethyl melamine, hexapropoxymethyl melamine, and hexabutoxybutyl melamine.

作為脲系交聯劑的具體例,例如可舉出單羥甲基化甘脲、二羥甲基化甘脲、三羥甲基化甘脲、四羥甲基化甘脲、單甲氧基甲基化甘脲,二甲氧基甲基化甘脲、三甲氧基甲基化甘脲、四甲氧基甲基化甘脲、單乙氧基甲基化甘脲、二乙氧基甲基化甘脲、三乙氧基甲基化甘脲、四乙氧基甲基化甘脲、單丙氧基甲基化甘脲、二丙氧基甲基化甘脲、三丙氧基甲基化甘脲、四丙氧基甲基化甘脲、單丁氧基甲基化甘脲、二丁氧基甲基化甘脲、三丁氧基甲基化甘脲或四丁氧基甲基化甘脲等甘脲系交聯劑; 雙甲氧基甲基脲、雙乙氧基甲基脲、雙丙氧基甲基脲、雙丁氧基甲基脲等的脲系交聯劑、 單羥甲基化伸乙脲或二羥甲基化伸乙脲、單甲氧基甲基化伸乙脲、二甲氧基甲基化伸乙脲、單乙氧基甲基化伸乙脲、二乙氧基甲基化伸乙脲、單丙氧基甲基化伸乙脲、二丙氧基甲基化伸乙脲、單丁氧基甲基化伸乙脲或二丁氧基甲基化伸乙脲等伸乙脲系交聯劑; 單羥甲基化伸丙脲、二羥甲基化伸丙脲、單甲氧基甲基化伸丙脲、二甲氧基甲基化伸丙脲、單乙氧基甲基化伸丙脲、二乙氧基甲基化伸丙脲、單丙氧基甲基化伸丙脲、二丙氧基甲基化伸丙脲、單丁氧基甲基化伸丙脲或二丁氧基甲基化伸丙脲等伸丙脲系交聯劑; 1,3-二(甲氧基甲基)4,5-二羥基-2-咪唑啶酮、1,3-二(甲氧基甲基)-4,5-二甲氧基-2-咪唑啶酮等。 Specific examples of urea crosslinking agents include monohydroxymethylated glycourea, dihydroxymethylated glycourea, trihydroxymethylated glycourea, tetrahydroxymethylated glycourea, monomethoxymethylated glycourea, dimethoxymethylated glycourea, trimethoxymethylated glycourea, tetramethoxymethylated glycourea, monoethoxymethylated glycourea, diethoxymethylated glycourea, triethoxymethylated glycourea, tetraethoxymethylated glycourea, monopropoxymethylated glycourea, dipropoxymethylated glycourea, tripropoxymethylated glycourea, tetrapropoxymethylated glycourea, monobutoxymethylated glycourea, dibutoxymethylated glycourea, tributoxymethylated glycourea, or tetrabutoxymethylated glycourea, etc. Urea crosslinking agents such as dimethoxymethylurea, diethoxymethylurea, dipropoxymethylurea, and dibutoxymethylurea, Aldehyde crosslinking agents including monohydroxymethylated or dihydroxymethylated ethoxylated ... 1,3-Di(methoxymethyl)4,5-dihydroxy-2-imidazolidineone, 1,3-di(methoxymethyl)-4,5-dimethoxy-2-imidazolidineone, etc.

作為苯并胍胺系交聯劑的具體例,例如可舉出單羥甲基化苯并胍胺、二羥甲基化苯并胍胺、三羥甲基化苯并胍胺、四羥甲基化苯并胍胺、單甲氧基甲基化苯并胍胺、二甲氧基甲基化苯并胍胺、三甲氧基甲基化苯并胍胺、四甲氧基甲基化苯并胍胺、單乙氧基甲基化苯并胍胺、二乙氧基甲基化苯并胍胺、三乙氧基甲基化苯并胍胺、四乙氧基甲基化苯并胍胺、單丙氧基甲基化苯并胍胺、二丙氧基甲基化苯并胍胺、三丙氧基甲基化苯并胍胺、四丙氧基甲基化苯并胍胺、單丁氧基甲基化苯并胍胺、二丁氧基甲基化苯并胍胺、三丁氧基甲基化苯并胍胺、四丁氧基甲基化苯并胍胺等。Specific examples of benzoguanidine crosslinking agents include monohydroxymethylated benzoguanidine, dihydroxymethylated benzoguanidine, trihydroxymethylated benzoguanidine, tetrahydroxymethylated benzoguanidine, monomethoxymethylated benzoguanidine, dimethoxymethylated benzoguanidine, trimethoxymethylated benzoguanidine, tetramethoxymethylated benzoguanidine, monoethoxymethylated benzoguanidine, diethoxymethylated benzoguanidine, triethoxymethylated benzoguanidine, tetraethoxymethylated benzoguanidine, monopropoxymethylated benzoguanidine, dipropoxymethylated benzoguanidine, tripropoxymethylated benzoguanidine, tetrapropoxymethylated benzoguanidine, monobutoxymethylated benzoguanidine, dibutoxymethylated benzoguanidine, tributoxymethylated benzoguanidine, and tetrabutoxymethylated benzoguanidine.

除此以外,作為具有選自包括羥甲基及烷氧基甲基之群組中之至少一種基團之化合物,亦可較佳地使用在芳香環(較佳為苯環)上直接鍵結有選自包括羥甲基及烷氧基甲基之群組中之至少一種基團之化合物。 作為這種化合物的具體例,可舉出苯二甲醇、雙(羥甲基)甲酚、雙(羥甲基)二甲氧基苯、雙(羥甲基)二苯醚、雙(羥甲基)二苯甲酮、羥甲基苯甲酸羥甲基苯酯、雙(羥甲基)聯苯、二甲基雙(羥甲基)聯苯、雙(甲氧基甲基)苯、雙(甲氧基甲基)甲酚、雙(甲氧基甲基)二甲氧基苯、雙(甲氧基甲基)二苯醚、雙(甲氧基甲基)二苯甲酮、甲氧基甲基苯甲酸甲氧基甲基苯酯、雙(甲氧基甲基)聯苯、二甲基雙(甲氧基甲基)聯苯、4,4’,4’’-亞乙基三[2,6-雙(甲氧基甲基)苯酚]、5,5’-[2,2,2‐三氟‐1‐(三氟甲基)亞乙基]雙[2‐羥基‐1,3‐苯二甲醇]、3,3’,5,5’-四(甲氧基甲基)-1,1’-聯苯-4,4’-二醇等。 In addition, as a compound having at least one group selected from the group consisting of hydroxymethyl and alkoxymethyl groups, it is also preferable to use a compound having at least one group selected from the group consisting of hydroxymethyl and alkoxymethyl groups directly bonded to an aromatic ring (preferably a benzene ring). Specific examples of such compounds include benzyl glycol, bis(hydroxymethyl)cresol, bis(hydroxymethyl)dimethoxybenzene, bis(hydroxymethyl)diphenyl ether, bis(hydroxymethyl)benzophenone, hydroxymethylphenyl hydroxybenzoate, bis(hydroxymethyl)biphenyl, dimethylbis(hydroxymethyl)biphenyl, bis(methoxymethyl)benzene, bis(methoxymethyl)cresol, bis(methoxymethyl)dimethoxybenzene, bis(methoxymethyl)diphenyl ether, and bis(methoxymethyl)diphenyl ether. Ketones, methoxymethylbenzoic acid methoxymethylphenyl ester, bis(methoxymethyl)biphenyl, dimethylbis(methoxymethyl)biphenyl, 4,4',4''-ethylenetri[2,6-bis(methoxymethyl)phenol], 5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylene]bis[2-hydroxy-1,3-benzenedimethanol], 3,3',5,5'-tetra(methoxymethyl)-1,1'-biphenyl-4,4'-diol, etc.

作為其他交聯劑,亦可以使用市售品,作為較佳的市售品,可舉出46DMOC、46DMOEP(以上為ASAHI YUKIZAI CORPORATION製)、DML-PC、DML-PEP、DML-OC、DML-OEP、DML-34X、DML-PTBP、DML-PCHP、DML-OCHP、DML-PFP、DML-PSBP、DML-POP、DML-MBOC、DML-MBPC、DML-MTrisPC、DML-BisOC-Z、DML-BisOCHP-Z、DML-BPC、DMLBisOC-P、DMOM-PC、DMOM-PTBP、DMOM-MBPC、TriML-P、TriML-35XL、TML-HQ、TML-BP、TML-pp-BPF、TML-BPE、TML-BPA、TML-BPAF、TML-BPAP、TMOM-BP、TMOM-BPE、TMOM-BPA、TMOM-BPAF、TMOM-BPAP、HML-TPPHBA、HML-TPHAP、HMOM-TPPHBA、HMOM-TPHAP(以上為Honshu Chemical Industry Co.,Ltd.製)、NIKARAC(註冊商標,以下相同)MX-290、NIKARAC MX-280、NIKARAC MX-270、NIKARAC MX-279、NIKARAC MW-100LM、NIKARAC MX-750LM(以上為Sanwa Chemical Co.,Ltd.製)等。Other crosslinking agents can also be used, and some preferred commercially available products include 46DMOC, 46DMOEP (all manufactured by ASAHI YUKIZAI CORPORATION), DML-PC, DML-PEP, DML-OC, DML-OEP, DML-34X, DML-PTBP, DML-PCHP, DML-OCHP, DML-PFP, DML-PSBP, DML-POP, DML-MBOC, DML-MBPC, DML-MTrisPC, DML-BisOC-Z, DML-BisOCHP-Z, DML-BPC, DMLBisOC-P, DMOM-PC, and DMOM- PTBP, DMOM-MBPC, TriML-P, TriML-35XL, TML-HQ, TML-BP, TML-pp-BPF, TML-BPE, TML-BPA, TML-BPAF, TML-BPAP, TMOM-BP, TMOM-BPE, TMOM-BPA, TMOM-BPAF, TMOM-BPAP, HML-TPPHBA, HML-TPHAP, HMOM-TPPHBA, HMOM-TPHAP (all manufactured by Honshu Chemical Industry Co., Ltd.), NIKARAC (registered trademark, same below) MX-290, NIKARAC MX-280, NIKARAC MX-270, NIKARAC MX-279, NIKARAC MW-100LM, NIKARAC MX-750LM (all manufactured by Sanwa Chemical Co., Ltd.), etc.

又,本發明的樹脂組成物包含選自包括環氧化合物、氧環丁烷化合物及苯并噁𠯤化合物之群組中之至少一種化合物作為其他交聯劑亦較佳。Furthermore, it is preferable that the resin composition of the present invention includes at least one compound selected from the group consisting of epoxides, cyclobutanes and benzoxazines as other crosslinking agents.

-環氧化合物(具有環氧基之化合物)- 作為環氧化合物,在一分子中具有兩個以上的環氧基之化合物為較佳。環氧基在200℃以下進行交聯反應,並且不會產生由交聯引起之脫水反應,因此不易引起膜收縮。因此,含有環氧化合物對抑制本發明的樹脂組成物的低溫硬化及翹曲係有效的。 -Epoxy Compounds (Compounds Containing Epoxy Groups)- As epoxy compounds, compounds with two or more epoxy groups per molecule are preferred. Epoxy groups undergo cross-linking reactions below 200°C and do not produce dehydration reactions caused by cross-linking, thus minimizing film shrinkage. Therefore, the presence of epoxy compounds is effective in inhibiting low-temperature curing and warping of the resin composition of this invention.

環氧化合物含有聚環氧乙烷基為較佳。藉此,彈性模數進一步下降,並且能夠抑制翹曲。聚環氧乙烷基表示環氧乙烷的重複單元數為2以上者,重複單元數為2~15為較佳。The presence of polyethylene oxide in the epoxy compound is preferred. This further reduces the elastic modulus and suppresses warping. Polyethylene oxide refers to ethylene oxide with 2 or more repeating units, with 2 to 15 repeating units being preferred.

作為環氧化合物的例子,能夠舉出雙酚A型環氧樹脂;雙酚F型環氧樹脂;丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、乙二醇二縮水甘油醚、丁二醇二縮水甘油醚、六亞甲基二醇二縮水甘油醚、三羥甲基丙烷三縮水甘油醚等伸烷基二醇型環氧樹脂或多元醇烴型環氧樹脂;聚丙二醇二縮水甘油醚等聚伸烷基二醇型環氧樹脂;聚甲基(縮水甘油氧基丙基)矽氧烷等環氧環氧基之矽酮等,但是並不限定於該等。具體而言,可舉出EPICLON(註冊商標)850-S、EPICLON(註冊商標)HP-4032、EPICLON(註冊商標)HP-7200、EPICLON(註冊商標)HP-820、EPICLON(註冊商標)HP-4700、EPICLON(註冊商標)HP-4770、EPICLON(註冊商標)EXA-830LVP、EPICLON(註冊商標)EXA-8183、EPICLON(註冊商標)EXA-8169、EPICLON(註冊商標)N-660、EPICLON(註冊商標)N-665-EXP-S、EPICLON(註冊商標)N-740(以上為產品名,DIC CORPORATION製)、Rika Resin(註冊商標)BEO-20E、Rika Resin(註冊商標)BEO-60E、Rika Resin(註冊商標)HBE-100、Rika Resin(註冊商標)DME-100、Rika Resin(註冊商標)L-200(產品名,New Japan Chemical Co.,Ltd.)、EP-4003S、EP-4000S、EP-4088S、EP-3950S(以上為產品名,ADEKA CORPORATION製)、CELLOXIDE(註冊商標)2021P、CELLOXIDE(註冊商標)2081、CELLOXIDE(註冊商標)2000、EHPE3150、EPOLEAD(註冊商標)GT401、EPOLEAD(註冊商標)PB4700、EPOLEAD(註冊商標)PB3600(以上為產品名,Daicel Corporation製)、NC-3000、NC-3000-L、NC-3000-H、NC-3000-FH-75M、NC-3100、CER-3000-L、NC-2000-L、XD-1000、NC-7000L、NC-7300L、EPPN-501H、EPPN-501HY、EPPN-502H、EOCN-1020、EOCN-102S、EOCN-103S、EOCN-104S、CER-1020、EPPN-201、BREN-S、BREN-10S(以上為產品名,Nippon Kayaku Co.,Ltd.製)等。又,亦可較佳地使用以下化合物。Examples of epoxy compounds include bisphenol A type epoxy resins; bisphenol F type epoxy resins; alkyl glycol diglycidyl ether, neopentyl glycol diglycidyl ether, ethylene glycol diglycidyl ether, butylene glycol diglycidyl ether, hexamethylene glycol diglycidyl ether, trimethylolpropane triglycidyl ether, and other alkyl glycol type epoxy resins or polyol hydrocarbon type epoxy resins; polyalkylene glycol diglycidyl ether and other polyalkylene glycol type epoxy resins; and epoxy-epoxy silicones such as polymethyl (glycidyloxypropyl)siloxane, but are not limited to these. Specifically, examples include EPICLON (registered trademark) 850-S, EPICLON (registered trademark) HP-4032, EPICLON (registered trademark) HP-7200, EPICLON (registered trademark) HP-820, EPICLON (registered trademark) HP-4700, EPICLON (registered trademark) HP-4770, and EPICL. ON (registered trademark) EXA-830LVP, EPICLON (registered trademark) EXA-8183, EPICLON (registered trademark) EXA-8169, EPICLON (registered trademark) N-660, EPICLON (registered trademark) N-665-EXP-S, EPICLON (registered trademark) N-740 (the above are product names, DIC) (manufactured by CORPORATION), Rika Resin (registered trademark) BEO-20E, Rika Resin (registered trademark) BEO-60E, Rika Resin (registered trademark) HBE-100, Rika Resin (registered trademark) DME-100, Rika Resin (registered trademark) L-200 (product name, New Japan Chemical Co., Ltd.), EP-4003S, EP-4000S, EP-4088S, EP-3950S (the above are product names, ADEKA) (manufactured by CORPORATION), CELLOXIDE (registered trademark) 2021P, CELLOXIDE (registered trademark) 2081, CELLOXIDE (registered trademark) 2000, EHPE3150, EPOLEAD (registered trademark) GT401, EPOLEAD (registered trademark) PB4700, EPOLEAD (registered trademark) PB3600 (the above are product names, Daicel) (Manufactured by Nippon Kayaku Co., Ltd.), NC-3000, NC-3000-L, NC-3000-H, NC-3000-FH-75M, NC-3100, CER-3000-L, NC-2000-L, XD-1000, NC-7000L, NC-7300L, EPPN-501H, EPPN-501HY, EPPN-502H, EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, CER-1020, EPPN-201, BREN-S, BREN-10S (the above are product names, manufactured by Nippon Kayaku Co., Ltd.), etc. Furthermore, the following compounds may also be used more favorably.

【化學式40】 【Chemical Formula 40】

式中,n為1~5的整數、m為1~20的整數。In the formula, n is an integer from 1 to 5, and m is an integer from 1 to 20.

在上述結構之中,從兼顧耐熱性和伸長率的提高之觀點考慮,n為1~2、m為3~7為較佳。Among the above structures, considering both heat resistance and elongation improvement, n of 1 to 2 and m of 3 to 7 are preferred.

-氧雜環丁烷化合物(具有氧雜環丁基之化合物)- 作為氧雜環丁烷化合物,能夠舉出在一分子中具有兩個以上的氧雜環丁烷環之化合物、3-乙基-3-羥甲氧雜環丁烷、1,4-雙{[(3-乙基-3-氧雜環丁基)甲氧基]甲基}苯、3-乙基-3-(2-乙基己基甲基)氧雜環丁烷、1,4-苯二羧酸-雙[(3-乙基-3-氧雜環丁基)甲基]酯等。作為具體的例子,能夠較佳地使用TOAGOSEI CO., LTD.製的ARON OXETANE系列(例如,OXT-121、OXT-221),該等可以單獨使用或混合使用2種以上。 -Oxycyclobutane compounds (compounds containing oxycyclobutyl groups)- Examples of oxycyclobutane compounds include compounds having two or more oxycyclobutane rings in one molecule, 3-ethyl-3-hydroxymethoxycyclobutane, 1,4-bis{[(3-ethyl-3-oxycyclobutyl)methoxy]methyl}benzene, 3-ethyl-3-(2-ethylhexylmethyl)oxycyclobutane, and 1,4-benzenediacarboxylic acid-bis[(3-ethyl-3-oxycyclobutyl)methyl] ester, etc. As a concrete example, the ARON OXETANE series manufactured by TOAGOSEI CO., LTD. (e.g., OXT-121, OXT-221) is a better choice, and two or more of these can be used alone or in combination.

-苯并噁𠯤化合物(具有苯并噁唑基之化合物)- 由於由開環加成反應引起之交聯反應,苯并噁𠯤化合物在硬化時不產生脫氣,從而進一步減少熱收縮以抑制產生翹曲,因此為較佳。 -Benzoxazine compounds (compounds containing a benzoxazole group)- Because of the crosslinking reaction caused by ring-opening addition, benzooxazine compounds do not undergo degassing during hardening, thus further reducing thermal shrinkage and inhibiting warping, making them preferable.

作為苯并噁𠯤化合物的較佳例,可舉出P-d型苯并噁𠯤、F-a型苯并噁𠯤、(以上為產品名,Shikoku Chemicals Corporation製)、聚羥基苯乙烯樹脂的苯并噁𠯤加成物、酚醛清漆型二氫苯并噁𠯤化合物。該等可以單獨使用或者混合使用2種以上。Preferred examples of benzo[a]oxa compounds include P-d type benzo[a]oxa, F-a type benzo[a]oxa (these are product names, manufactured by Shikoku Chemicals Corporation), benzo[a]oxa adducts of polyhydroxystyrene resins, and phenolic varnish-type dihydrobenzo[a]oxa compounds. These can be used alone or in combination of two or more.

其他交聯劑的含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳,0.1~20質量%為更佳,0.5~15質量%為進一步較佳,1.0~10質量%為特佳。其他交聯劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的其他交聯劑之情況下,其合計在上述範圍內為較佳。The content of other crosslinking agents relative to the total solid content of the resin composition of the present invention is preferably 0.1-30% by mass, more preferably 0.1-20% by mass, further preferably 0.5-15% by mass, and especially preferably 1.0-10% by mass. The other crosslinking agents may be contained in only one type or in two or more types. When two or more other crosslinking agents are contained, it is preferable that their total content falls within the above range.

〔聚合起始劑〕 本發明的樹脂組成物含有能夠藉由光和/或熱量引發聚合之聚合起始劑為較佳。尤其含有光聚合起始劑為較佳。 聚合起始劑為自由基聚合起始劑為較佳。作為自由基聚合起始劑,並無特別限制,能夠從公知的自由基聚合起始劑中適當選擇。例如,對紫外線區域至可見區域的光線具有感光性之光自由基聚合起始劑為較佳。又,亦可以為與光激勵之增感劑產生某些作用而生成活性自由基之活性劑。 [Polymerization Initiator] The resin composition of this invention preferably contains a polymerization initiator capable of initiating polymerization by light and/or heat. Particularly, it is preferred to contain a photopolymerization initiator. The polymerization initiator is preferably a free radical polymerization initiator. There are no particular limitations on the free radical polymerization initiator, and it can be appropriately selected from known free radical polymerization initiators. For example, a photoradical polymerization initiator that is photosensitizing to light in the ultraviolet to visible region is preferred. Furthermore, an active agent that generates active free radicals by interacting with a photosensitive agent may also be used.

光自由基聚合起始劑至少含有1種在波長約240~800nm(較佳為330~500nm)的範圍內至少具有約50L・mol -1・cm -1莫耳吸光係數之化合物為較佳。關於化合物的莫耳吸光係數,能夠使用公知的方法來測定。例如,藉由紫外-可見光分光光度計(Varian Medical Systems, Inc.製Cary-5 spectrophotometer),並使用乙酸乙酯溶劑在0.01g/L的濃度下進行測定為較佳。 The photoradical polymerization initiator preferably contains at least one compound having a molar absorptivity of at least about 50 L· mol⁻¹ · cm⁻¹ in the wavelength range of about 240–800 nm (preferably 330–500 nm). The molar absorptivity of the compound can be determined using known methods. For example, it is preferable to determine it using a UV-Vis spectrophotometer (Cary-5 spectrophotometer manufactured by Varian Medical Systems, Inc.) with ethyl acetate solvent at a concentration of 0.01 g/L.

作為光自由基聚合起始劑,能夠任意使用公知的化合物。例如可舉出滷化烴衍生物(例如具有三𠯤骨架之化合物、具有噁二唑骨架之化合物、具有三鹵甲基之化合物等)、醯基膦氧化物等醯基膦化合物、六芳基雙咪唑、肟衍生物等肟化合物、有機過氧化物、硫化合物、酮化合物、芳香族鎓鹽、酮肟醚、胺基苯乙酮等α-胺基酮化合物、羥基苯乙酮等α-羥基酮化合物、偶氮系化合物、疊氮化合物、茂金屬化合物、有機硼化合物、鐵芳烴錯合物等。關於該等詳細內容,能夠參閱日本特開2016-027357號公報的0165~0182段、國際公開第2015/199219號的0138~0151段的記載,該內容被編入本說明書中。又,可舉出日本特開2014-130173號公報的0065~0111段、日本專利第6301489號公報中所記載之化合物、MATERIAL STAGE 37~60p,vol.19,No.3,2019中所記載之過氧化物系光聚合起始劑、國際公開第2018/221177號中所記載之光聚合起始劑、國際公開第2018/110179號中所記載之光聚合起始劑、日本特開2019-043864號公報中所記載之光聚合起始劑、日本特開2019-044030號公報中所記載之光聚合起始劑、日本特開2019-167313號公報中所記載之過氧化物系起始劑,該等內容亦被編入本說明書中。As a photoradical polymerization initiator, any known compound can be used. Examples include halogenated hydrocarbon derivatives (such as compounds with a trihalomethane skeleton, compounds with an oxadiazole skeleton, compounds with a trihalomethane skeleton, etc.), acetylphosphine compounds such as acetylphosphine oxides, hexaaryl diimidazoles, oxime compounds such as oxime derivatives, organic peroxides, sulfur compounds, ketone compounds, aromatic onium salts, ketoxime ethers, α-amino ketone compounds such as aminoacetophenone, α-hydroxy ketone compounds such as hydroxyacetophenone, azo compounds, azide compounds, metallocene compounds, organoboron compounds, and iron-aromatic hydrocarbon complexes. For details regarding these contents, please refer to paragraphs 0165-0182 of Japanese Patent Application Publication No. 2016-027357 and paragraphs 0138-0151 of International Publication No. 2015/199219, which are incorporated herein by reference. Furthermore, examples can be found in paragraphs 0065-0111 of Japanese Patent Application Publication No. 2014-130173, the compounds described in Japanese Patent No. 6301489, and the MATERIAL STAGE. The peroxide-based photopolymerization initiators described in 37–60p, vol.19, No.3, 2019, the photopolymerization initiators described in International Publication No. 2018/221177, the photopolymerization initiators described in International Publication No. 2018/110179, the photopolymerization initiators described in Japanese Patent Application Publication No. 2019-043864, the photopolymerization initiators described in Japanese Patent Application Publication No. 2019-044030, and the peroxide-based initiators described in Japanese Patent Application Publication No. 2019-167313 are also incorporated herein by reference.

作為酮化合物,例如可例示日本特開2015-087611號公報的0087段中所記載之化合物,該內容被編入本說明書中。市售品中,亦可較佳地使用KAYACURE-DETX-S(Nippon Kayaku Co.,Ltd.製)。As a ketone compound, for example, the compound described in paragraph 0087 of Japanese Patent Application Publication No. 2015-087611, the contents of which are incorporated in this specification, may be cited. KAYACURE-DETX-S (manufactured by Nippon Kayaku Co., Ltd.) may also be preferred in commercially available products.

在本發明的一實施態樣中,作為光自由基聚合起始劑,能夠較佳地使用羥基苯乙酮化合物、胺基苯乙酮化合物及醯基膦化合物。更具體而言,例如能夠使用日本特開平10-291969號公報中所記載之胺基苯乙酮系起始劑、日本專利第4225898號中所記載之醯基氧化膦系起始劑,該內容被編入本說明書中。In one embodiment of the present invention, hydroxyacetophenone compounds, aminoacetophenone compounds, and amide phosphine compounds are preferably used as photoradical polymerization initiators. More specifically, for example, aminoacetophenone-based initiators as described in Japanese Patent Application Publication No. 10-291969 and amide phosphine oxide-based initiators as described in Japanese Patent No. 4225898 can be used, the contents of which are incorporated herein by reference.

作為α-羥基酮系起始劑,能夠使用Omnirad 184、Omnirad 1173、Omnirad 2959、Omnirad 127(以上為IGM Resins B.V.公司製)、IRGACURE 184(IRGACURE為註冊商標)、DAROCUR 1173、IRGACURE 500、IRGACURE-2959、IRGACURE 127(產品名:均為BASF公司製)。As α-hydroxyketone initiators, Omnirad 184, Omnirad 1173, Omnirad 2959, Omnirad 127 (all manufactured by IGM Resins B.V.), IRGACURE 184 (IRGACURE is a registered trademark), DAROCUR 1173, IRGACURE 500, IRGACURE-2959, and IRGACURE 127 (all manufactured by BASF) can be used.

作為α-胺基酮系起始劑,能夠使用Omnirad 907、Omnirad 369、Omnirad 369E、Omnirad 379EG(以上為IGM Resins B.V.公司製)、IRGACURE 907、IRGACURE 369及IRGACURE 379(產品名:均為BASF公司製)。As α-aminoketone initiators, Omnirad 907, Omnirad 369, Omnirad 369E, Omnirad 379EG (all manufactured by IGM Resins B.V.), IRGACURE 907, IRGACURE 369 and IRGACURE 379 (all manufactured by BASF) can be used.

作為胺基苯乙酮系起始劑,亦能夠使用極大吸收波長與365nm或405nm等波長光源匹配之日本特開2009-191179號公報中所記載之化合物,該內容被編入本說明書中。As an aminoacetophenone-based initiator, compounds described in Japanese Patent Application Publication No. 2009-191179, which have extremely high absorption wavelengths and are matched with light sources of wavelengths such as 365 nm or 405 nm, can also be used, and this content is incorporated into this specification.

作為醯基氧化膦系起始劑,可舉出2,4,6-三甲基苯甲醯基-二苯基-氧化膦等。又,能夠使用Omnirad 819、Omnirad TPO(以上為IGM Resins B.V.公司製)、IRGACURE-819或IRGACURE-TPO(產品名:均為BASF公司製)。Examples of acetylated phosphine oxide initiators include 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide. Additionally, Omnirad 819, Omnirad TPO (both manufactured by IGM Resins B.V.), IRGACURE-819, or IRGACURE-TPO (all manufactured by BASF) can be used.

作為茂金屬化合物,可例示IRGACURE-784、IRGACURE-784EG(均為BASF公司製)、Keycure VIS 813(King Brother Chem製)等。Examples of metallocene compounds include IRGACURE-784, IRGACURE-784EG (both manufactured by BASF), and Keycure VIS 813 (manufactured by King Brother Chem).

作為光自由基聚合起始劑,可以更佳地舉出肟化合物。藉由使用肟化合物,能夠更有效地提高曝光寬容度。肟化合物的曝光寬容度(曝光餘裕度)較廣,並且亦作為光硬化促進劑而起作用,因此為特佳。Oxime compounds are a better example of photoradical polymerization initiators. Using oxime compounds allows for a more effective increase in exposure tolerance. Oxime compounds are particularly advantageous because they offer a wider exposure tolerance (exposure margin) and also act as photocuring accelerators.

作為肟化合物的具體例,可舉出日本特開2001-233842號公報中所記載之化合物、日本特開2000-080068號公報中所記載之化合物、日本特開2006-342166號公報中所記載之化合物、J.C.S.Perkin II(1979年、pp.1653-1660)中所記載之化合物、J.C.S.Perkin II(1979年、pp.156-162)中所記載之化合物、Journal of Photopolymer Science and Technology(1995年、pp.202-232)中所記載之化合物、日本特開2000-066385號公報中所記載之化合物、日本特表2004-534797號公報中所記載之化合物、日本特開2017-019766號公報中所記載之化合物、日本專利第6065596號公報中所記載之化合物、國際公開第2015/152153號中所記載之化合物、國際公開第2017/051680號中所記載之化合物、日本特開2017-198865號公報中所記載之化合物、國際公開第2017/164127號的0025~0038段中所記載之化合物、國際公開第2013/167515號中所記載之化合物等,該內容被編入本說明書中。Specific examples of oxime compounds include compounds described in Japanese Patent Application Publication No. 2001-233842, Japanese Patent Application Publication No. 2000-080068, Japanese Patent Application Publication No. 2006-342166, compounds described in J.C.S. Perkin II (1979, pp. 1653-1660), compounds described in J.C.S. Perkin II (1979, pp. 156-162), and compounds described in the Journal of Photopolymer Science and... Compounds described in Technology (1995, pp. 202-232), compounds described in Japanese Patent Application Publication No. 2000-066385, compounds described in Japanese Patent Application Publication No. 2004-534797, compounds described in Japanese Patent Application Publication No. 2017-019766, compounds described in Japanese Patent Application Publication No. 6065596, and international publication No. 2 The compounds described in 015/152153, the compounds described in International Publication No. 2017/051680, the compounds described in Japanese Patent Application Publication No. 2017-198865, the compounds described in paragraphs 0025 to 0038 of International Publication No. 2017/164127, and the compounds described in International Publication No. 2013/167515 are included in this specification.

作為較佳的肟化合物,例如可舉出下述結構的化合物、3-苯甲醯氧基亞胺基丁烷-2-酮、3-乙醯氧基亞胺基丁烷-2-酮、3-丙醯氧基亞胺基丁烷-2-酮、2-乙醯氧基亞胺基戊烷-3-酮、2-乙醯氧基亞胺基-1-苯基丙烷-1-酮、2-苯甲醯氧基亞胺基-1-苯基丙烷-1-酮、3-(4-甲苯磺醯氧基)亞胺基丁烷-2-酮及2-乙氧基羰氧基亞胺基-1-苯基丙烷-1-酮等。在本發明的樹脂組成物中,尤其使用肟化合物(肟系的光自由基聚合起始劑)作為光自由基聚合起始劑為較佳。肟系光自由基聚合起始劑在分子內具有>C=N-O-C(=O)-的連接基。Preferred oxime compounds include, for example, compounds with the following structures: 3-benzoxylidene-iminobutane-2-one, 3-acetoxylidene-iminobutane-2-one, 3-propoxylidene-iminobutane-2-one, 2-acetoxylidene-iminopentane-3-one, 2-acetoxylidene-1-phenylpropane-1-one, 2-benzoxylidene-1-phenylpropane-1-one, 3-(4-toluenesulfonoxy)iminobutane-2-one, and 2-ethoxycarbonyloxylidene-1-phenylpropane-1-one. In the resin composition of the present invention, the use of oxime compounds (oxime-based photoradical polymerization initiators) as photoradical polymerization initiators is particularly preferred. Oxime-based photoradical polymerization initiators have a linker group >C=N-O-C(=O)- within the molecule.

【化學式41】 【Chemical Formula 41】

市售品中,亦可較佳地使用IRGACURE OXE 01、IRGACURE OXE 02、IRGACURE OXE 03、IRGACURE OXE 04(以上為BASF公司製)、ADEKA OPTOMER N-1919(ADEKA CORPORATION製造、日本特開2012-014052號公報中所記載之光自由基聚合起始劑2)。又,亦能夠使用TR-PBG-304、TR-PBG-305(Changzhou Tronly New Electronic Materials Co.,Ltd.製)、ADEKA ARKLSNCI-730、NCI-831及ADEKA ARKLSNCI-930(ADEKA Corporation製)。又,能夠使用DFI-091(DAITO CHEMIX Co.,Ltd.製)、SpeedCure PDO(SARTOMER ARKEMA製)。又,亦能夠使用下述結構的肟化合物。 【化學式42】 Among commercially available products, IRGACURE OXE 01, IRGACURE OXE 02, IRGACURE OXE 03, and IRGACURE OXE 04 (all manufactured by BASF) and ADEKA OPTOMER N-1919 (manufactured by ADEKA CORPORATION, the photoradical polymerization initiator 2 disclosed in Japanese Patent Application Publication No. 2012-014052) are also suitable. Furthermore, TR-PBG-304, TR-PBG-305 (manufactured by Changzhou Tronly New Electronic Materials Co., Ltd.), ADEKA ARKLSNCI-730, NCI-831, and ADEKA ARKLSNCI-930 (manufactured by ADEKA Corporation) are also suitable. Furthermore, DFI-091 (manufactured by DAITO CHEMIX Co., Ltd.) and SpeedCure PDO (manufactured by SARTOMER ARKEMA) can be used. Also, oxime compounds with the following structure can be used. [Chemical Formula 42]

作為光自由基聚合起始劑,亦能夠使用具有茀環之肟化合物。作為具有茀環之肟化合物的具體例,可舉出日本特開2014-137466號公報中所記載之化合物、日本專利06636081號中所記載之化合物,該內容被編入本說明書中。Oxime compounds with cyclohexane can also be used as photoradical polymerization initiators. Specific examples of oxime compounds with cyclohexane include the compound described in Japanese Patent Application Publication No. 2014-137466 and the compound described in Japanese Patent No. 06636081, the contents of which are incorporated herein by reference.

作為光自由基聚合起始劑,亦能夠使用具有咔唑環中的至少一個苯環成為萘環之骨架之肟化合物。作為這種肟化合物的具體例,可舉出國際公開第2013/083505號中所記載之化合物,該內容被編入本說明書中。As a photoradical polymerization initiator, oxime compounds having at least one benzene ring in the carbazole ring forming a naphthalene ring skeleton can also be used. Specific examples of such oxime compounds include the compound described in International Publication No. 2013/083505, which is incorporated herein by reference.

又,亦能夠使用具有氟原子之肟化合物。作為這種肟化合物的具體例,可舉出日本特開2010-262028號公報中所記載之化合物、日本特表2014-500852號公報的0345段中所記載之化合物24、36~40、日本特開2013-164471號公報的0101段中所記載之化合物(C-3)等,該內容被編入本說明書中。Furthermore, oxime compounds containing fluorine atoms can also be used. Specific examples of such oxime compounds include compounds described in Japanese Patent Application Publication No. 2010-262028, compounds 24, 36-40 described in paragraph 0345 of Japanese Patent Application Publication No. 2014-500852, and compound (C-3) described in paragraph 0101 of Japanese Patent Application Publication No. 2013-164471, the contents of which are incorporated in this specification.

作為光聚合起始劑,能夠使用具有硝基之肟化合物。將具有硝基之肟化合物設為二聚體亦較佳。作為具有硝基之肟化合物的具體例,可舉出日本特開2013-114249號公報的0031~0047段、日本特開2014-137466號公報的0008~0012、0070~0079段中所記載之化合物、日本專利4223071號公報的0007~0025段中所記載之化合物,該內容被編入本說明書中。又,作為具有硝基之肟化合物,亦可舉出ADEKA ARKLSNCI-831(ADEKA Corporation製)。As a photopolymerization initiator, oxime compounds containing nitro groups can be used. It is also preferable to use oxime compounds containing nitro groups as dimers. Specific examples of oxime compounds containing nitro groups include the compounds described in paragraphs 0031 to 0047 of Japanese Patent Application Publication No. 2013-114249, paragraphs 0008 to 0012 and 0070 to 0079 of Japanese Patent Application Publication No. 2014-137466, and paragraphs 0007 to 0025 of Japanese Patent Application Publication No. 4223071, the contents of which are incorporated herein by reference. Furthermore, ADEKA ARKLSNCI-831 (manufactured by ADEKA Corporation) is another example of an oxime compound containing nitro groups.

作為光自由基聚合起始劑,亦能夠使用具有苯并呋喃骨架之肟化合物。作為具體例,可舉出國際公開第2015/036910號中所記載之OE-01~OE-75。Oxime compounds with a benzofuran skeleton can also be used as photoradical polymerization initiators. For example, OE-01 to OE-75 are described in International Publication No. 2015/036910.

作為光自由基聚合起始劑,亦能夠使用在咔唑骨架鍵結有具有羥基之取代基之肟化合物。作為該等光聚合起始劑可舉出國際公開第2019/088055號中所記載之化合物等,該內容被編入本說明書中。As a photoradical polymerization initiator, it can also be used in oxime compounds with hydroxyl substituents bonded to the carbazole skeleton. Examples of such photopolymerization initiators include compounds described in International Publication No. 2019/088055, the contents of which are incorporated herein by reference.

作為光聚合起始劑,亦能夠使用具有在芳香族環導入拉電子基團而成之芳香族環基Ar OX1之肟化合物(以下,亦稱為肟化合物OX)。作為上述芳香族環基Ar OX1所具有之拉電子基團,可舉出醯基、硝基、三氟甲基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、氰基,醯基及硝基為較佳,從容易形成耐光性優異之膜之理由考慮,醯基為更佳,苯甲醯基為進一步較佳。苯甲醯基可以具有取代基。作為取代基,鹵素原子、氰基、硝基、羥基、烷基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烯基、烷基硫基、芳基硫基、醯基或胺基為較佳,烷基、烷氧基、芳基、芳氧基、雜環氧基、烷基硫基、芳基硫基或胺基為更佳,烷氧基、烷基硫基或胺基為進一步較佳。 As a photopolymerization initiator, an oxime compound having an aromatic cycloalcoholic group Ar OX1 (hereinafter also referred to as an oxime compound OX) can also be used. Examples of electron-withdrawing groups in the aforementioned aromatic cycloalcoholic Ar OX1 include vinyl, nitro, trifluoromethyl, alkylsulfinyl, arylsulfinyl, alkylsulfinyl, arylsulfinyl, and cyano groups. Vinyl and nitro groups are preferred, and vinyl is even more preferred considering its ease of forming films with excellent lightfastness, while benzoyl is further preferred. Benzyl may have substituents. As substituents, halogen atoms, cyano, nitro, hydroxyl, alkyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkenyl, alkylthio, arylthio, acetyl, or amino are preferred, alkyl, alkoxy, aryl, aryloxy, heterocyclic, alkylthio, arylthio, or amino are even more preferred, and alkoxy, alkylthio, or amino are even more preferred.

肟化合物OX為選自由式(OX1)表示之化合物及由式(OX2)表示之化合物中之至少1種為較佳,由式(OX2)表示之化合物為更佳。 【化學式43】 式中,R X1表示烷基、烯基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烷基硫基、芳基硫基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、醯基、醯氧基、胺基、膦醯基、胺甲醯基或胺磺醯基, R X2表示烷基、烯基、烷氧基、芳基、芳氧基、雜環基、雜環氧基、烷基硫烷基、芳基硫烷基、烷基亞磺醯基、芳基亞磺醯基、烷基磺醯基、芳基磺醯基、醯氧基或胺基, R X3~R X14分別獨立地表示氫原子或取代基。 其中,R X10~R X14中的至少一個為拉電子基團。 The oxime compound OX is preferably selected from at least one of the compounds represented by formula (OX1) and formula (OX2), with the compound represented by formula (OX2) being more preferred. [Chemical Formula 43] In the formula, RX1 represents alkyl, alkenyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkylthio, arylthio, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, acetyl, acetoxy, amino, phosphinyl, aminomethyl, or aminosulfonyl; RX2 represents alkyl, alkenyl, alkoxy, aryl, aryloxy, heterocyclic, heterocyclic, alkylthioalkyl, arylthioalkyl, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, acetoxy, or amino; and RX3 to RX14 each independently represent a hydrogen atom or a substituent. At least one of RX10 to RX14 is an electron-withdrawing group.

上述式中,R X12為拉電子基團,R X10、R X11、R X13、R X14為氫原子為較佳。 In the above formula, RX12 is an electron-withdrawing group, and RX10 , RX11 , RX13 , and RX14 are preferably hydrogen atoms.

作為肟化合物OX的具體例,可舉出日本專利第4600600號公報的0083~0105段中所記載之化合物,該內容被編入本說明書中。As a specific example of an oxime compound OX, the compound described in paragraphs 0083 to 0105 of Japanese Patent No. 4600600 is cited, the contents of which are incorporated in this specification.

作為最佳的肟化合物,可舉出日本特開2007-269779號公報中所示之具有特定取代基之肟化合物或日本特開2009-191061號公報中所示之具有硫基芳基之肟化合物等,該內容被編入本說明書中。Examples of the best oxime compounds include those with specific substituents shown in Japanese Patent Application Publication No. 2007-269779 or those with thioaryl groups shown in Japanese Patent Application Publication No. 2009-191061, the contents of which are incorporated herein by reference.

從曝光靈敏度的觀點考慮,光自由基聚合起始劑為選自包括三鹵甲基三𠯤化合物、苄基二甲基縮酮化合物、α-羥基酮化合物、α-胺基酮化合物、醯基膦化合物、氧化膦化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、鎓鹽化合物、苯并噻唑化合物、二苯甲酮化合物、苯乙酮化合物及其衍生物、環戊二烯基-苯-鐵錯合物及其鹽、鹵甲基噁二唑化合物、3-芳基取代香豆素化合物之群組中之化合物為較佳。From the perspective of exposure sensitivity, photoradical polymerization initiators are preferably selected from the group consisting of trihalomethane trihalomethane compounds, benzyl dimethyl ketone compounds, α-hydroxy ketone compounds, α-amino ketone compounds, acetophosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazolium dimers, onmium salts, benzothiazole compounds, benzophenone compounds, acetophenone compounds and their derivatives, cyclopentadienyl-benzene-iron complexes and their salts, halomethanediazole compounds, and 3-aryl-substituted coumarin compounds.

進一步較佳的光自由基聚合起始劑為三鹵甲基三𠯤化合物、α-胺基酮化合物、醯基膦化合物、氧化膦化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、鎓鹽化合物、二苯甲酮化合物、苯乙酮化合物,選自包括三鹵甲基三𠯤化合物、α-胺基酮化合物、茂金屬化合物、肟化合物、三芳基咪唑二聚體、二苯甲酮化合物之群組中之至少一種化合物為更進一步較佳,使用茂金屬化合物或肟化合物為又更進一步較佳。A further preferred photoradical polymerization initiator is a trihalomethane trihalomethane compound, an α-aminoketone compound, an acetophosphine compound, a phosphine oxide compound, a metallocene compound, an oxime compound, a triarylimidazolium dimer, an onium salt compound, a benzophenone compound, or an acetophenone compound. It is even more preferred to select at least one compound from the group consisting of trihalomethane trihalomethane compounds, α-aminoketone compounds, metallocene compounds, oxime compounds, triarylimidazolium dimers, and benzophenone compounds. It is even more preferred to use a metallocene compound or an oxime compound.

又,光自由基聚合起始劑亦能夠使用二苯甲酮、N,N’-四甲基-4,4’-二胺基二苯甲酮(米其勒酮(Michler’s ketone))等N,N’-四烷基-4,4’-二胺基二苯甲酮,2-苄基-2-二甲基胺基-1-(4-口末啉基苯基)-丁酮-1,2-甲基-1-[4-(甲硫基)苯基]-2-口末啉基-丙酮-1等芳香族酮、烷基蒽醌等與芳香環縮環而形成之醌類、安息香烷基醚等安息香醚化合物、安息香、烷基安息香等安息香化合物、苄基二甲基縮酮等苄基衍生物等。又,亦能夠使用由下述式(I)表示之化合物。Furthermore, photoradical polymerization initiators can also include benzophenone, N,N'-tetraalkyl-4,4'-diaminobenzophenone (Michler's ketone), and other N,N'-tetraalkyl-4,4'-diaminobenzophenones; aromatic ketones such as 2-benzyl-2-dimethylamino-1-(4-methylpheninylphenyl)-butanone-1,2-methyl-1-[4-(methylthio)phenyl]-2-methylpheninyl-acetone-1; quinones formed by condensation of aromatic rings with alkyl anthraquinones; benzoin ether compounds such as benzoin alkyl ethers; benzoin compounds such as benzoin and alkyl benzoin; and benzyl derivatives such as benzyl dimethyl ketone. Additionally, compounds represented by the following formula (I) can also be used.

【化學式44】 【Chemical Formula 44】

式(I)中,R I00為碳數1~20的烷基、藉由1個以上的氧原子而中斷之碳數2~20的烷基、碳數1~12的烷氧基、苯基或碳數1~20的烷基、碳數1~12的烷氧基、鹵素原子、環戊基、環己基、碳數2~12的烯基、經藉由1個以上的氧原子而中斷之碳數2~18的烷基及碳數1~4的烷基中的至少一個取代的苯基或聯苯基,R I01為由式(II)表示之基團或為與R I00相同的基團,R I02~R I04分別獨立地為碳數1~12的烷基、碳數1~12的烷氧基或鹵素原子。 In formula (I), RI00 is an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms interrupted by one or more oxygen atoms, an alkoxy group having 1 to 12 carbon atoms, a phenyl group, or an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, a halogen atom, a cyclopentyl group, a cyclohexyl group, an alkenyl group having 2 to 12 carbon atoms, an alkyl group having 2 to 18 carbon atoms interrupted by one or more oxygen atoms, and an alkyl group having 1 to 4 carbon atoms, at least one of which is a substituted phenyl or biphenyl group. RI01 is a group represented by formula (II) or is the same group as RI00 . RI02 to RI04 are each independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, or a halogen atom.

【化學式45】 【Chemical Formula 45】

式中,R I05~R I07與上述式(I)的R I02~R I04相同。 In the formula, RI05 to RI07 are the same as RI02 to RI04 in the above formula (I).

又,光自由基聚合起始劑亦能夠使用國際公開第2015/125469號的0048~0055段中所記載之化合物,該內容被編入本說明書中。Furthermore, the photoradical polymerization initiator can also be the compound described in paragraphs 0048 to 0055 of International Publication No. 2015/125469, which is incorporated in this specification.

作為光自由基聚合起始劑,亦可以使用2官能或者3官能以上的光自由基聚合起始劑。藉由使用該等光自由基聚合起始劑,由光自由基聚合起始劑的一個分子產生2個以上的自由基,因此可獲得良好的靈敏度。又,在使用非對稱結構的化合物之情況下,結晶性下降而在溶劑等中的溶解性得到提高,隨時間而變得難以析出,從而能夠提高樹脂組成物的經時穩定性。作為2官能或者3官能以上的光自由基聚合起始劑的具體例,可舉出日本特表2010-527339號公報、日本特表2011-524436號公報、國際公開第2015/004565號、日本特表2016-532675號公報的0407~0412段、國際公開第2017/033680號的0039~0055段中所記載之肟化合物的二聚體、日本特表2013-522445號公報中所記載之化合物(E)及化合物(G)、國際公開第2016/034963號中所記載之Cmpd1~7、日本特表2017-523465號公報的0007段中所記載之肟酯類光起始劑、日本特開2017-167399號公報的0020~0033段中所記載之光起始劑、日本特開2017-151342號公報的0017~0026段中所記載之光聚合起始劑(A)、日本專利第6469669號公報中所記載之肟酯光起始劑等,該內容被編入本說明書中。As photoradical polymerization initiators, difunctional or trifunctional or higher photoradical polymerization initiators can also be used. By using such photoradical polymerization initiators, two or more free radicals are generated from one molecule of the initiator, thus achieving good sensitivity. Furthermore, when using compounds with asymmetrical structures, crystallinity decreases while solubility in solvents and the like increases, making them less prone to precipitation over time, thereby improving the long-term stability of the resin composition. Specific examples of photoradical polymerization initiators with two or more functions include dimers of oxime compounds described in Japanese Patent Application Publication No. 2010-527339, Japanese Patent Application Publication No. 2011-524436, International Publication No. 2015/004565, paragraphs 0407 to 0412 of Japanese Patent Application Publication No. 2016-532675, and paragraphs 0039 to 0055 of International Publication No. 2017/033680; and compounds (E) and ( ) described in Japanese Patent Application Publication No. 2013-522445. G), Cmpd1 to 7 as described in International Publication No. 2016/034963, oxime ester photoinitiators as described in paragraph 0007 of Japanese Patent Application Publication No. 2017-523465, photoinitiators as described in paragraphs 0020 to 0033 of Japanese Patent Application Publication No. 2017-167399, photopolymerization initiators (A) as described in paragraphs 0017 to 0026 of Japanese Patent Application Publication No. 2017-151342, and oxime ester photoinitiators as described in Japanese Patent Application Publication No. 6469669, etc., are incorporated herein by reference.

在包含光聚合起始劑之情況下,其含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳,更佳為0.1~20質量%,進一步較佳為0.5~15質量%,更進一步較佳為1.0~10質量%。光聚合起始劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的光聚合起始劑之情況下,合計量在上述範圍內為較佳。 另外,由於有時光聚合起始劑亦作為熱聚合起始劑而發揮功能,因此有時藉由烘箱或加熱板等的加熱進而進行基於光聚合起始劑之交聯。 When a photopolymerization initiator is included, its content relative to the total solid content of the resin composition of the present invention is preferably 0.1–30% by mass, more preferably 0.1–20% by mass, even more preferably 0.5–15% by mass, and still more preferably 1.0–10% by mass. The photopolymerization initiator may be one type or two or more types. When two or more photopolymerization initiators are included, the total amount is preferably within the above range. Furthermore, since the photopolymerization initiator sometimes also functions as a thermal polymerization initiator, crosslinking based on the photopolymerization initiator is sometimes carried out by heating in an oven or heating plate.

〔增感劑〕 樹脂組成物可以含有增感劑。增感劑吸收特定的活性放射線而成為電子激勵狀態。成為電子激發狀態之增感劑與熱自由基聚合起始劑、光自由基聚合起始劑等接觸而產生電子轉移、能量轉移、發熱等作用。藉此,熱自由基聚合起始劑、光自由基聚合起始劑引發化學變化而分解,並生成自由基、酸或鹼。 作為能夠使用的增感劑,能夠使用二苯甲酮系、米其勒酮系、氧雜萘鄰酮系、吡唑偶氮系、苯胺基偶氮系、三苯基甲烷系、蒽醌系、蒽系、蒽吡啶酮系、亞苄基系、氧雜菁系、吡唑并三唑偶氮系、吡啶酮偶氮系、花青系、啡噻𠯤系、吡咯并吡唑次甲基偶氮系、𠮿口星系、酞菁系、苯并哌喃系、靛藍系等化合物。 作為增感劑,例如可舉出米其勒酮、4,4’-雙(二乙胺基)二苯甲酮、2,5-雙(4’-二乙胺基亞苄基)環戊烷、2,6-雙(4’-二乙胺基亞苄基)環己酮、2,6-雙(4’-二乙胺基亞苄基)-4-甲基環己酮、4,4’-雙(二甲基胺基)查耳酮、4,4’-雙(二乙胺基)查耳酮、對二甲基胺基苯亞烯丙基二氫茚酮、對二甲基胺基亞苄基二氫茚酮、2-(對二甲基胺基苯基亞聯苯基)-苯并噻唑、2-(對二甲基胺基苯基亞乙烯基)苯并噻唑、2-(對二甲基胺基苯基亞乙烯基)異萘并噻唑、1,3-雙(4’-二甲基胺基亞苄基)丙酮、1,3-雙(4’-二乙胺基亞苄基)丙酮、3,3’-羰基-雙(7-二乙胺基香豆素)、3-乙醯基-7-二甲基胺基香豆素、3-乙氧基羰基-7-二甲基胺基香豆素、3-苄氧基羰基-7-二甲基胺基香豆素、3-甲氧基羰基-7-二乙胺基香豆素、3-乙氧基羰基-7-二乙胺基香豆素(7-(二乙胺基)香豆素-3-羧酸乙酯)、N-苯基-N’-乙基乙醇胺、N-苯基二乙醇胺、N-對甲苯基二乙醇胺、N-苯基乙醇胺、4-口末啉基二苯甲酮、二甲基胺基苯甲酸異戊酯、二乙胺基苯甲酸異戊酯、2-巰基苯并咪唑、1-苯基-5-巰基四唑、2-巰基苯并噻唑、2-(對二甲基胺基苯乙烯基)苯并噁唑、2-(對二甲基胺基苯乙烯基)苯并噻唑、2-(對二甲基胺基苯乙烯基)萘并(1,2-d)噻唑、2-(對二甲基胺基苯甲醯基)苯乙烯、二苯基乙醯胺、苯甲醯苯胺、N-甲基乙醯苯胺、3’,4’-二甲基乙醯苯胺等。 又,可以使用其他敏化色素。 關於敏化色素的詳細內容,能夠參閱日本特開2016-027357號公報的0161~0163段的記載,該內容被編入本說明書中。 [Sensitizers] Resin components may contain sensitizers. Sensitizers absorb specific active radiation to become electronically excited. These excited sensitizers then come into contact with thermal free radical polymerization initiators, photofree radical polymerization initiators, etc., resulting in electron transfer, energy transfer, and heating. Consequently, the thermal free radical polymerization initiators and photofree radical polymerization initiators undergo chemical changes and decompose, generating free radicals, acids, or bases. As usable sensitizers, compounds such as benzophenone, milchnerone, oxanaphthone, pyrazole azo, aniline azo, triphenylmethane, anthraquinone, anthracene, anthraquinone, benzylene, oxocyanine, pyrazolotriazole azo, pyridone azo, anthocyanin, phenanthrene, pyrrolopyrazole methylene azo, phthalocyanine, benzopiperanone, and indigo compounds can be used. Examples of sensitizers include milchnerone, 4,4'-bis(diethylamino)benzophenone, 2,5-bis(4'-diethylaminobenzyl)cyclopentane, 2,6-bis(4'-diethylaminobenzyl)cyclohexanone, 2,6-bis(4'-diethylaminobenzyl)-4-methylcyclohexanone, 4,4'-bis(dimethylamino)chalcone, 4,4'-bis(diethylamino)chalcone, p-dimethylaminophenylenepropanedihydroindene, and p-dimethylamino Benzylene dihydroindone, 2-(p-dimethylaminophenylbenzylene)-benzothiazole, 2-(p-dimethylaminophenylvinylene)benzothiazole, 2-(p-dimethylaminophenylvinylene)isonaphthothiazole, 1,3-bis(4'-dimethylaminobenzylene)acetone, 1,3-bis(4'-diethylaminobenzylene)acetone, 3,3'-carbonyl-bis(7-diethylaminocoumarin), 3-acetylated-7-dimethylaminocoumarin, 3-ethoxy Carbonyl-7-dimethylaminocoumarin, 3-benzyloxycarbonyl-7-dimethylaminocoumarin, 3-methoxycarbonyl-7-diethylaminocoumarin, 3-ethoxycarbonyl-7-diethylaminocoumarin (7-(diethylamino)coumarin-3-carboxylic acid ethyl ester), N-phenyl-N'-ethylethanolamine, N-phenyldiethanolamine, N-p-tolyldiethanolamine, N-phenylethanolamine, 4-methyl-3-pyrophyllylbenzophenone, isoamyl dimethylaminobenzoate, diethylamine Isoamyl benzoate, 2-phenylbenzimidazole, 1-phenyl-5-phenyltetrazolium, 2-phenylbenzothiazole, 2-(p-dimethylaminostyryl)benzoxazole, 2-(p-dimethylaminostyryl)benzothiazole, 2-(p-dimethylaminostyryl)naphtho(1,2-d)thiazole, 2-(p-dimethylaminobenzoyl)styrene, diphenylacetylamine, benzoaniline, N-methylacetylaniline, 3',4'-dimethylacetylaniline, etc. Also, other sensitizing dyes can be used. For detailed information on sensitizing dyes, please refer to paragraphs 0161 to 0163 of Japanese Patent Application Publication No. 2016-027357, which is incorporated herein by reference.

在樹脂組成物包含增感劑之情況下,增感劑的含量相對於樹脂組成物的總固體成分為0.01~20質量%為較佳,0.1~15質量%為更佳,0.5~10質量%為進一步較佳。增感劑可以單獨使用1種,亦可以併用2種以上。When the resin composition contains a sensitizer, the content of the sensitizer relative to the total solid content of the resin composition is preferably 0.01–20% by weight, more preferably 0.1–15% by weight, and even more preferably 0.5–10% by weight. A single sensitizer may be used alone, or two or more may be used in combination.

〔鏈轉移劑〕 本發明的樹脂組成物可以含有鏈轉移劑。關於鏈轉移劑,例如在高分子詞典第三版(高分子學會(The Society of Polymer Science,Japan)編,2005年)683-684頁中被定義。作為鏈轉移劑,例如可使用在分子內具有-S-S-、-SO 2-S-、-N-O-、SH、PH、SiH及GeH之化合物群組、用於RAFT(Reversible Addition Fragmentation chain Transfer,可逆加成碎斷鏈轉移)聚合之具有硫代羰基硫基之二硫代苯甲酸、三硫碳酸酯、二硫胺基甲酸酯、黃原酸酯化合物等。該等對低活性自由基供給氫而生成自由基或者在被氧化之後可以藉由去質子來生成自由基。尤其,能夠較佳地使用硫醇化合物。 [Chain Transfer Agent] The resin composition of this invention may contain a chain transfer agent. Chain transfer agents are defined, for example, in the 3rd edition of the Polymer Dictionary (edited by the Society of Polymer Science, Japan, 2005), pages 683-684. Examples of chain transfer agents include compounds containing -SS-, -SO-, -S- , -NO-, SH, PH, SiH, and GeH within the molecule, as well as dithiobenzoic acid, trithiocarbonate, dithiocarbamate, xanthate compounds, etc., with thiocarbonyl thio groups used in RAFT (Reversible Addition Fragmentation Chain Transfer) polymerization. These compounds can generate free radicals by donating hydrogen to low-activity free radicals or by deprotonation after oxidation. In particular, it allows for better use of thiol compounds.

又,鏈轉移劑亦能夠使用國際公開第2015/199219號的0152~0153段中所記載之化合物,該內容被編入本說明書中。Furthermore, the chain transfer agent can also use the compounds described in paragraphs 0152 to 0153 of International Publication No. 2015/199219, which is incorporated in this specification.

在本發明的樹脂組成物具有鏈轉移劑之情況下,鏈轉移劑的含量相對於本發明的樹脂組成物的總固體成分100質量份為0.01~20質量份為較佳,0.1~10質量份為更佳,0.5~5質量份為進一步較佳。鏈轉移劑可以僅為1種,亦可以為2種以上。在鏈轉移劑為2種以上之情況下,其合計在上述範圍內為較佳。When the resin composition of the present invention contains a chain transfer agent, the content of the chain transfer agent relative to 100 parts by weight of the total solid content of the resin composition of the present invention is preferably 0.01 to 20 parts by weight, more preferably 0.1 to 10 parts by weight, and even more preferably 0.5 to 5 parts by weight. The chain transfer agent may be only one type or may be two or more types. When there are two or more chain transfer agents, it is preferable that their total content is within the above-mentioned range.

〔光酸產生劑〕 本發明的樹脂組成物含有光酸產生劑為較佳。 光酸產生劑表示藉由200nm~900nm的光照射而產生布忍斯特酸及路易斯酸中的至少一者之化合物。所照射之光較佳為波長300nm~450nm的光,更佳為330nm~420nm的光。在單獨使用光酸產生劑或與增感劑的併用時,能夠藉由感光而產生酸的光酸產生劑為較佳。 作為所產生之酸的例子,可較佳地舉出鹵化氫、羧酸、磺酸、亞磺酸、硫代亞磺酸、磷酸、磷酸單酯、磷酸二酯、硼衍生物、磷衍生物、銻衍生物、過氧化鹵素、磺醯胺等。 [Photosensitive Acid Generator] The resin composition of this invention preferably contains a photosensitive acid generator. The photosensitive acid generator refers to a compound that produces at least one of Brinzyl acid and Lewis acid upon irradiation with light of 200 nm to 900 nm. The irradiated light is preferably light with a wavelength of 300 nm to 450 nm, more preferably light with a wavelength of 330 nm to 420 nm. When used alone or in combination with a sensitizer, the photosensitive acid generator is preferably capable of producing acid by photosensitivity. Examples of the acids produced include hydrogen halides, carboxylic acids, sulfonic acids, sulfinic acids, thiosulfinic acids, phosphoric acid, monophosphate esters, diesters, boron derivatives, phosphorus derivatives, antimony derivatives, halogen peroxides, and sulfenamides.

作為本發明的樹脂組成物中所使用之光酸產生劑,例如可舉出醌二疊氮化合物、肟磺酸鹽化合物、有機鹵化化合物、有機硼酸鹽化合物、二碸化合物、鎓鹽化合物等。 從靈敏度、保存穩定性的觀點考慮,有機鹵素化合物、肟磺酸鹽化合物、鎓鹽化合物為較佳,從所形成之膜的機械特性等之觀點考慮,肟酯為較佳。 Examples of photoacid generators used in the resin composition of this invention include quinone diazide compounds, oxime sulfonate compounds, organic halogenated compounds, organoborate compounds, disulfonate compounds, and onmium salt compounds. From the viewpoints of sensitivity and storage stability, organohalogen compounds, oxime sulfonate compounds, and onmium salt compounds are preferred; from the viewpoints of the mechanical properties of the formed film, oxime esters are preferred.

作為醌二疊氮化合物,可舉出醌二疊氮的磺酸酯鍵於1價或多元的羥基化合物而獲得者,醌二疊氮的磺酸磺醯胺鍵於1價或多元的胺化合物而獲得者,醌二疊氮的磺酸酯鍵和/或磺醯胺鍵於聚羥基聚胺化合物而獲得者等。該等聚羥基化合物、聚胺基化合物、聚羥基聚胺基化合物的所有官能基可以未經醌二疊氮取代,但是進行平均而官能基整體的40莫耳%以上經醌二疊氮取代為較佳。藉由含有這種醌二疊氮化合物,能夠獲得對作為通常的紫外線之水銀燈的i射線(波長365nm)、h射線(波長405nm)、g射線(波長436nm)進行感光之樹脂組成物。Examples of quinone diazonium compounds include those obtained by attaching a quinone diazonium sulfonate bond to a monovalent or polyvalent hydroxyl group, those obtained by attaching a quinone diazonium sulfonate sulfonamide bond to a monovalent or polyvalent amine group, and those obtained by attaching a quinone diazonium sulfonate bond and/or a sulfonamide bond to a polyhydroxy polyamine compound. All functional groups of these polyhydroxy compounds, polyamine compounds, and polyhydroxy polyamine compounds may not be substituted with quinone diazonium, but it is preferable that at least 40 mol% of the total functional groups are substituted with quinone diazonium on average. By using this quinone diazide compound, it is possible to obtain a resin composition that is photosensitive to i-rays (wavelength 365nm), h-rays (wavelength 405nm), and g-rays (wavelength 436nm) of a mercury lamp, which is a typical ultraviolet light source.

作為羥基化合物,具體而言,能夠舉出酚、三羥基二苯甲酮、4甲氧基酚、異丙醇、辛醇、三級丁醇、環己醇、萘酚、Bis-Z、BisP-EZ、TekP-4HBPA、TrisP-HAP、TrisP-PA、TrisP-SA、TrisOCR-PA、BisOCHP-Z、BisP-MZ、BisP-PZ、BisP-IPZ、BisOCP-IPZ、BisP-CP、BisRS-2P、BisRS-3P、BisP-OCHP、亞甲基三-FR-CR、BisRS-26X、DML-MBPC、DML-MBOC、DML-OCHP、DML-PCHP、DML-PC、DML-PTBP、DML-34X、DML-EP、DML-POP、二羥甲基-BisOC-P、DML-PFP、DML-PSBP、DML-MTrisPC、TriML-P、TriML-35XL、TML-BP、TML-HQ、TML-pp-BPF、TML-BPA、TMOM-BP、HML-TPPHBA、HML-TPHAP(以上為產品名,Honshu Chemical Industry Co.,Ltd.製)、BIR-OC、BIP-PC、BIR-PC、BIR-PTBP、BIR-PCHP、BIP-BIOC-F、4PC、BIR-BIPC-F、TEP-BIP-A、46DMOC、46DMOEP、TM-BIP-A(以上為產品名,ASAHI YUKIZAI CORPORATION製)、2,6-二甲氧基甲基-4-三級丁基酚、2,6-二甲氧基甲基-對甲酚、2,6-二乙醯氧基甲基-對甲酚、萘酚、四羥基二苯甲酮、沒食子酸甲基酯、雙酚A、雙酚E、亞甲基雙酚、BisP-AP(產品名,Honshu Chemical Industry Co.,Ltd.製)、酚醛清漆樹脂等,但是並不限定於該等。As hydroxyl compounds, specifically, examples include phenols, trihydroxybenzophenone, 4-methoxyphenol, isopropanol, octanol, terbutanol, cyclohexanol, naphthol, Bis-Z, BisP-EZ, TekP-4HBPA, TrisP-HAP, TrisP-PA, TrisP-SA, TrisOCR-PA, BisOCHP-Z, BisP-MZ, BisP-PZ, BisP-IPZ, BisOCP-IPZ, BisP-CP, BisRS-2P, BisRS-3P, BisP-OCHP, methylene tri-FR-CR, and BisRS- 26X, DML-MBPC, DML-MBOC, DML-OCHP, DML-PCHP, DML-PC, DML-PTBP, DML-34X, DML-EP, DML-POP, Dihydroxymethyl-BisOC-P, DML-PFP, DML-PSBP, DML-MTrisPC, TriML-P, TriML-35XL, TML-BP, TML-HQ, TML-pp-BPF, TML-BPA, TMOM-BP, HML-TPPHBA, HML-TPHAP (These are product names, Honshu) The products include, but are not limited to, BIR-OC, BIP-PC, BIR-PTBP, BIR-PCHP, BIP-BIOC-F, 4PC, BIR-BIPC-F, TEP-BIP-A, 46DMOC, 46DMOEP, TM-BIP-A (the above are product names, manufactured by ASAHI YUKIZAI CORPORATION), 2,6-dimethoxymethyl-4-tert-butylphenol, 2,6-dimethoxymethyl-p-cresol, 2,6-diacetoxymethyl-p-cresol, naphthol, tetrahydroxybenzophenone, methyl gallate, bisphenol A, bisphenol E, methylene bisphenol, BisP-AP (product name, manufactured by Honshu Chemical Industry Co., Ltd.), phenolic varnish resins, etc.

作為胺基化合物,具體而言,能夠舉出苯胺、甲基苯胺、二乙胺、丁胺、1,4-伸苯基二胺、1,3-伸苯基二胺、4,4’-二胺基二苯醚、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基碸、4,4’-二胺基二苯醚等,但是並不限定於該等。As an amino compound, examples include aniline, methylaniline, diethylamine, butylamine, 1,4-epenylphenyldiamine, 1,3-epenylphenyldiamine, 4,4'-diaminodiphenyl ether, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl ether, etc., but are not limited to these.

又,作為聚羥基聚胺基化合物,具體而言,能夠舉出2,2-雙(3-胺基-4-羥基苯基)六氟丙烷、3,3’-二羥基聯苯胺等,但是並不限定於該等。Furthermore, examples of polyhydroxy polyamine compounds include 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane and 3,3'-dihydroxybenzidine, but they are not limited to these.

在該等之中,包含酚化合物及與4-萘醌二疊氮磺醯基的酯作為醌二疊氮化合物為較佳。解析度藉此,能夠獲得對i射線曝光之更高的靈敏度和更高的解析度。Among these, phenolic compounds and esters containing a 4-naphthoquinone diazidesulfonate group are preferred as quinone diazide compounds. This allows for higher sensitivity and resolution for i-ray exposure.

本發明的樹脂組成物中所使用之醌二疊氮化合物的含量相對於樹脂100質量份為1~50質量份為較佳,10~40質量份為更佳。藉由將醌二疊氮化合物的含量設在該範圍內,可以獲得曝光部和未曝光部的對比度,從而能夠實現更高靈敏度化,因此為較佳。進而,可以依據需要添加增感劑等。The content of the quinone diazonium compound used in the resin composition of this invention is preferably 1 to 50 parts by weight per 100 parts by weight of the resin, and more preferably 10 to 40 parts by weight. By setting the content of the quinone diazonium compound within this range, the contrast between the exposed and unexposed areas can be obtained, thereby achieving higher sensitivity, which is therefore preferable. Furthermore, sensitizers, etc., can be added as needed.

光酸產生劑為包含肟磺酸鹽基之化合物(以下,亦簡稱為“肟磺酸鹽化合物”)為較佳。 肟磺酸鹽化合物只要具有肟磺酸鹽基,則並無特別限制,但是由下述式(OS-1)、後述式(OS-103)、式(OS-104)或式(OS-105)表示之肟磺酸鹽化合物為較佳。 The photoacid generator is preferably a compound containing an oxime sulfonate group (hereinafter also referred to as "oxime sulfonate compound"). There are no particular restrictions on the presence of an oxime sulfonate group, but oxime sulfonate compounds represented by the following formula (OS-1), the formula described later (OS-103), formula (OS-104), or formula (OS-105) are preferred.

【化學式46】 【Chemical Formula 46】

式(OS-1)中,X 3表示烷基、烷氧基或鹵素原子。在存在複數個X 3之情況下,分別可以相同,亦可以不同。上述X 3中之烷基及烷氧基可以具有取代基。作為上述X 3中之烷基,碳數1~4的直鏈狀或支鏈狀烷基為較佳。作為上述X 3中之烷氧基,碳數1~4的直鏈狀或支鏈狀烷氧基為較佳。作為上述X 3中之鹵素原子,氯原子或氟原子為較佳。 式(OS-1)中,m3表示0~3的整數,0或1為較佳。在m3為2或3時,複數個X 3可以相同亦可以不同。 式(OS-1)中,R 34表示烷基或芳基,碳數1~10的烷基、碳數1~10的烷氧基、碳數1~5的鹵化烷基、碳數1~5的鹵化烷氧基、可以經W取代的苯基、可以經W取代的萘基或可以經W取代的蒽基為較佳。W表示鹵素原子、氰基、硝基、碳數1~10的烷基、碳數1~10的烷氧基、碳數1~5的鹵化烷基或碳數1~5的鹵化烷氧基、碳數6~20的芳基、碳數6~20的鹵化芳基。 In formula (OS-1), X3 represents an alkyl, alkoxy, or halogen atom. When there are multiple X3 atoms, they may be the same or different. The alkyl and alkoxy atoms in X3 may have substituents. As the alkyl group in X3 , a straight-chain or branched alkyl group having 1 to 4 carbon atoms is preferred. As the alkoxy group in X3 , a straight-chain or branched alkoxy group having 1 to 4 carbon atoms is preferred. As the halogen atom in X3 , a chlorine or fluorine atom is preferred. In formula (OS-1), m3 represents an integer from 0 to 3, with 0 or 1 being preferred. When m3 is 2 or 3, the multiple X3 atoms may be the same or different. In formula (OS-1), R 34 represents an alkyl or aryl group, preferably an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, a halogenated alkoxy group having 1 to 5 carbon atoms, a phenyl group that can be substituted with W, a naphthyl group that can be substituted with W, or an anthracene group that can be substituted with W. W represents a halogen atom, a cyano group, a nitro group, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, or a halogenated alkoxy group having 1 to 5 carbon atoms, an aryl group having 6 to 20 carbon atoms, or a halogenated aryl group having 6 to 20 carbon atoms.

式(OS-1)中,m3為3,X 3為甲基,X 3的取代位置為鄰位,R 34為碳數1~10的直鏈狀烷基、7,7-二甲基-2-氧代降崁基甲基或對甲苯基的化合物為特佳。 In formula (OS-1), m3 is 3, X3 is methyl, X3 is substituted at an ortho position, and R34 is preferably a straight-chain alkyl group with 1 to 10 carbon atoms, 7,7-dimethyl-2-oxonorcanylmethyl or p-tolyl.

作為由式(OS-1)表示之肟磺酸鹽化合物的具體例,可例示日本特開2011-209692號公報的0064~0068段、日本特開2015-194674號公報的0158~0167段中所記載之以下化合物,該等內容被編入本說明書中。As specific examples of oxime sulfonate compounds represented by formula (OS-1), the following compounds described in paragraphs 0064 to 0068 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0158 to 0167 of Japanese Patent Application Publication No. 2015-194674 are examples, and these contents are incorporated herein by reference.

【化學式47】 【Chemical Formula 47】

式(OS-103)~式(OS-105)中,R s1表示烷基、芳基或雜芳基,有時存在複數個之R s2分別獨立地表示氫原子、烷基、芳基或鹵素原子,有時存在複數個之R s6分別獨立地表示鹵素原子、烷基、烷氧基、磺酸基、胺基磺醯基或烷氧基磺醯基,Xs表示O或S,ns表示1或2,ms表示0~6的整數。 式(OS-103)~式(OS-105)中,由R s1表示之烷基(碳數1~30為較佳)、芳基(碳數6~30為較佳)或雜芳基(碳數4~30為較佳)在可以獲得本發明的效果之範圍內可以具有公知的取代基。 In formulas (OS-103) to (OS-105), Rs1 represents an alkyl, aryl, or heteroaryl group; sometimes there are multiple Rs2, each independently representing a hydrogen atom, alkyl, aryl, or halogen atom; sometimes there are multiple Rs6, each independently representing a halogen atom, alkyl, alkoxy, sulfonic acid group, aminosulfonyl, or alkoxysulfonyl group; Xs represents O or S; ns represents 1 or 2; and ms represents an integer from 0 to 6. In formulas (OS-103) to (OS-105), the alkyl (preferably with 1 to 30 carbons), aryl (preferably with 6 to 30 carbons), or heteroaryl (preferably with 4 to 30 carbons) represented by Rs1 may have known substituents within the range that allows the effects of the present invention to be obtained.

式(OS-103)~式(OS-105)中,R s2為氫原子、烷基(碳數1~12為較佳)或芳基(碳數6~30為較佳)為較佳,氫原子或烷基為更佳。在化合物中有時存在兩個以上之R s2中,一個或兩個為烷基、芳基或鹵素原子為較佳,一個為烷基、芳基或鹵素原子為更佳,一個為烷基且其餘為氫原子為特佳。由R s2表示之烷基或芳基在可以獲得本發明的效果之範圍內可以具有公知的取代基。 式(OS-103)、式(OS-104)或式(OS-105)中,Xs表示O或S,O為較佳。上述式(OS-103)~(OS-105)中,包含Xs作為環員之環為5員環或6員環。 In formulas (OS-103) to (OS-105), Rs2 is preferably a hydrogen atom, an alkyl group (preferably with 1 to 12 carbon atoms), or an aryl group (preferably with 6 to 30 carbon atoms), with a hydrogen atom or alkyl group being more preferred. In compounds where two or more Rs2 groups are present, it is preferred that one or two are alkyl, aryl, or halogen atoms, more preferred that one is an alkyl, aryl, or halogen atom, and especially preferred that one is an alkyl group and the remainder are hydrogen atoms. The alkyl or aryl group represented by Rs2 may have known substituents within the range that allows the effects of the present invention to be obtained. In formulas (OS-103), (OS-104), or (OS-105), Xs represents O or S, with O being preferred. In the above formulas (OS-103) to (OS-105), the ring containing Xs as a member is a 5-member ring or a 6-member ring.

式(OS-103)~式(OS-105)中,ns表示1或2,在Xs為O之情況下,ns為1為較佳,又在Xs為S之情況下,ns為2為較佳。 式(OS-103)~式(OS-105)中,由R s6表示之烷基(碳數1~30為較佳)及烷氧基(碳數1~30為較佳)可以具有取代基。 式(OS-103)~式(OS-105)中,ms表示0~6的整數,0~2的整數為較佳,0或1為更佳,0為特佳。 In formulas (OS-103) to (OS-105), ns represents 1 or 2. When Xs is O, ns being 1 is preferred, and when Xs is S, ns being 2 is preferred. In formulas (OS-103) to (OS-105), the alkyl group (preferably having 1 to 30 carbon atoms) and alkoxy group (preferably having 1 to 30 carbon atoms) represented by R s6 may have substituents. In formulas (OS-103) to (OS-105), ms represents an integer from 0 to 6, with integers from 0 to 2 being preferred, 0 or 1 being more preferred, and 0 being particularly preferred.

又,由上述式(OS-103)表示之化合物為由下述式(OS-106)、式(OS-110)或式(OS-111)表示之化合物為特佳,由上述式(OS-104)表示之化合物為由下述式(OS-107)表示之化合物為特佳,由上述式(OS-105)表示之化合物為由下述式(OS-108)或式(OS-109)表示之化合物為特佳。 【化學式48】 Furthermore, the compound represented by formula (OS-103) is preferably represented by formula (OS-106), formula (OS-110), or formula (OS-111); the compound represented by formula (OS-104) is preferably represented by formula (OS-107); and the compound represented by formula (OS-105) is preferably represented by formula (OS-108) or formula (OS-109). [Chemical Formula 48]

式(OS-106)~式(OS-111)中,R t1表示烷基、芳基或雜芳基,R t7表示氫原子或溴原子,R t8表示氫原子、碳數1~8的烷基、鹵素原子、氯甲基、溴甲基、溴乙基、甲氧基甲基、苯基或氯苯基,R t9表示氫原子、鹵素原子、甲基或甲氧基,R t2表示氫原子或甲基。 式(OS-106)~式(OS-111)中,R t7表示氫原子或溴原子,氫原子為較佳。 In formulas (OS-106) to (OS-111), Rt1 represents an alkyl, aryl, or heteroaryl group; Rt7 represents a hydrogen atom or a bromine atom; Rt8 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, a chloromethyl, bromomethyl, bromoethyl, methoxymethyl, phenyl, or chlorophenyl group; Rt9 represents a hydrogen atom, a halogen atom, a methyl or methoxy group; and Rt2 represents a hydrogen atom or a methyl group. In formulas (OS-106) to (OS-111), Rt7 represents a hydrogen atom or a bromine atom, with a hydrogen atom being preferred.

式(OS-106)~式(OS-111)中,R t8表示氫原子、碳數1~8的烷基、鹵素原子、氯甲基、溴甲基、溴乙基、甲氧基甲基、苯基或氯苯基,碳數1~8的烷基、鹵素原子或苯基為較佳,碳數1~8的烷基為更佳,碳數1~6的烷基為進一步較佳,甲基為特佳。 In formulas (OS-106) to (OS-111), R t8 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, a chloromethyl group, a bromomethyl group, a bromoethyl group, a methoxymethyl group, a phenyl group, or a chlorophenyl group. It is preferred that the alkyl group having 1 to 8 carbon atoms or a halogen atom or a phenyl group has 1 to 8 carbon atoms, even more preferred, and alkyl group having 1 to 6 carbon atoms is even more preferred. Methyl is particularly preferred.

式(OS-106)~式(OS-111)中,R t9表示氫原子、鹵素原子、甲基或甲氧基,氫原子為較佳。 R t2表示氫原子或甲基,氫原子為較佳。 又,在上述肟磺酸鹽化合物中,關於肟的立體結構(E,Z),可以為其中任一者,亦可以為混合物。 作為由上述式(OS-103)~式(OS-105)表示之肟磺酸鹽化合物的具體例,可例示日本特開2011-209692號公報的0088~0095段、日本特開2015-194674號公報的0168~0194段中所記載之化合物,該等內容被編入本說明書中。 In formulas (OS-106) to (OS-111), Rt9 represents a hydrogen atom, a halogen atom, a methyl group, or a methoxy group, with a hydrogen atom being preferred. Rt2 represents a hydrogen atom or a methyl group, with a hydrogen atom being preferred. Furthermore, in the above-mentioned oxime sulfonate compounds, the stereostructure (E, Z) of the oxime can be any one of them or a mixture thereof. As specific examples of oxime sulfonate compounds represented by the above formulas (OS-103) to (OS-105), the compounds described in paragraphs 0088 to 0095 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0168 to 0194 of Japanese Patent Application Publication No. 2015-194674 are examples, and these contents are incorporated herein by reference.

作為包含至少一個肟磺酸鹽基之肟磺酸鹽化合物的較佳的其他態樣,可舉出由下述式(OS-101)、式(OS-102)表示之化合物。As a preferred alternative to oxime sulfonate compounds containing at least one oxime sulfonate group, compounds represented by the following formulas (OS-101) and (OS-102) can be cited.

【化學式49】 【Chemical Formula 49】

式(OS-101)或式(OS-102)中,R u9表示氫原子、烷基、烯基、烷氧基、烷氧羰基、醯基、胺甲醯基、胺磺醯基、磺基、氰基、芳基或雜芳基。R u9為氰基或芳基之態樣為更佳,R u9為氰基、苯基或萘基之態樣為進一步較佳。 式(OS-101)或式(OS-102)中,R u2a表示烷基或芳基。 式(OS-101)或式(OS-102)中,Xu表示-O-、-S-、-NH-、-NR u5-、-CH 2-、-CR u6H-或CR u6R u7-,R u5~R u7分別獨立地表示烷基或芳基。 In formula (OS-101) or (OS-102), Ru9 represents a hydrogen atom, alkyl, alkenyl, alkoxy, alkoxycarbonyl, acetyl, aminomethyl, aminosulfonyl, sulfonyl, cyano, aryl, or heteroaryl. It is preferred that Ru9 is cyano or aryl, and it is further preferred that Ru9 is cyano, phenyl, or naphthyl. In formula (OS-101) or (OS-102), Ru2a represents an alkyl or aryl group. In formula (OS-101 ) or (OS-102), Xu represents -O-, -S-, -NH-, -NRu5-, -CH2-, -CRu6H-, or CRu6Ru7-, where Ru5 to Ru7 each independently represent an alkyl or aryl group.

式(OS-101)或式(OS-102)中,R u1~R u4分別獨立地表示氫原子、鹵素原子、烷基、烯基、烷氧基、胺基、烷氧羰基、烷基羰基、芳基羰基、醯胺基、磺基、氰基或芳基。R u1~R u4中的兩個分別可以相互鍵結而形成環。此時,環可以進行縮環而與苯環一同形成縮合環。作為R u1~R u4,氫原子、鹵素原子或烷基為較佳,又R u1~R u4中的至少兩個相互鍵結而形成芳基之態樣亦較佳。其中,R u1~R u4均為氫原子之態樣為較佳。上述取代基均可以進一步具有取代基。 In formula (OS-101) or formula (OS-102), Ru1 to Ru4 independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkoxy group, an amino group, an alkoxycarbonyl group, an alkylcarbonyl group, an arylcarbonyl group, a amide group, a sulfonyl group, a cyano group, or an aryl group. Two of Ru1 to Ru4 can be bonded together to form a ring. In this case, the ring can undergo ring condensation to form a condensed ring together with the benzene ring. Preferably, Ru1 to Ru4 are hydrogen atoms, halogen atoms, or alkyl groups, and it is also preferable that at least two of Ru1 to Ru4 are bonded together to form an aryl group. Preferably, all of Ru1 to Ru4 are hydrogen atoms. All of the above substituents can further have substituents.

由上述式(OS-101)表示之化合物為由式(OS-102)表示之化合物為更佳。 又,在上述肟磺酸鹽化合物中,關於肟或苯并噻唑環的立體結構(E,Z等),分別可以為其中任一者,亦可以為混合物。 作為由式(OS-101)表示之化合物的具體例,可例示日本特開2011-209692號公報的0102~0106段、日本特開2015-194674號公報的0195~0207段中所記載之化合物,該等內容被編入本說明書中。 在上述化合物之中,下述b-9、b-16、b-31、b-33為較佳。 【化學式50】 作為市售品,能夠舉出WPAG-336(FUJIFILM Wako Pure Chemical Corporation製)、WPAG-443(FUJIFILM Wako Pure Chemical Corporation製)、MBZ-101(Midori Kagaku Co.,Ltd.製)等。 The compound represented by formula (OS-101) is preferably represented by formula (OS-102). Furthermore, in the above-mentioned oxime sulfonate compounds, the stereostructure (E, Z, etc.) of the oxime or benzothiazole ring can be either one or a mixture thereof. Specific examples of compounds represented by formula (OS-101) include the compounds described in paragraphs 0102 to 0106 of Japanese Patent Application Publication No. 2011-209692 and paragraphs 0195 to 0207 of Japanese Patent Application Publication No. 2015-194674, the contents of which are incorporated herein by reference. Among the above-mentioned compounds, b-9, b-16, b-31, and b-33 are preferred. [Chemical Formula 50] Commercially available products include WPAG-336 (manufactured by FUJIFILM Wako Pure Chemical Corporation), WPAG-443 (manufactured by FUJIFILM Wako Pure Chemical Corporation), and MBZ-101 (manufactured by Midori Kagaku Co., Ltd.).

又,亦可舉出由下述結構式表示之化合物作為較佳例。 【化學式51】 Furthermore, a better example can be given by a compound represented by the following structural formula: [Chemical Formula 51]

作為有機鹵化化合物,具體而言,可舉出若林等“Bull Chem.Soc Japan”42、2924(1969)、美國專利第3,905,815號說明書、日本特公昭46-4605號、日本特開昭48-36281號公報、日本特開昭55-32070號公報、日本特開昭60-239736號公報、日本特開昭61-169835號公報、日本特開昭61-169837號公報、日本特開昭62-58241號公報、日本特開昭62-212401號公報、日本特開昭63-70243號公報、日本特開昭63-298339號公報、M.P.Hutt“Jurnal of Heterocyclic Chemistry”1(No3),(1970)等中所記載之化合物,該等內容被編入本說明書中。尤其,可舉出經三鹵甲基取代之噁唑化合物:對稱三𠯤化合物作為較佳例。 更佳地,可舉出至少一個單、二或三鹵素取代甲基與對稱三𠯤環鍵結而成之對稱三𠯤衍生物,具體而言,例如可舉出2,4,6-三(單氯甲基)-對稱三𠯤、2,4,6-三(二氯甲基)-對稱三𠯤、2,4,6-三(三氯甲基)-對稱三𠯤、2-甲基-4,6-雙(三氯甲基)-對稱三𠯤、2-正丙基-4,6-雙(三氯甲基)-對稱三𠯤、2-(α,α,β-三氯乙基)-4,6-雙(三氯甲基)-對稱三𠯤、2-苯基-4,6-雙(三氯甲基)-對稱三𠯤、2-(對甲氧基苯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-(3,4-環氧苯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-(對氯苯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-〔1-(對甲氧基苯基)-2,4-丁二烯基〕-4,6-雙(三氯甲基)-對稱三𠯤、2-苯乙烯基-4,6-雙(三氯甲基)-對稱三𠯤、2-(對甲氧基苯乙烯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-(對異丙氧基苯乙烯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-(對甲苯基)-4,6-雙(三氯甲基)-對稱三𠯤、2-(4-萘氧基萘基)-4,6-雙(三氯甲基)-對稱三𠯤、2-苯硫基-4,6-雙(三氯甲基)-對稱三𠯤、2-苄硫基-4,6-雙(三氯甲基)-對稱三𠯤、2,4,6-三(二溴甲基)-對稱三𠯤、2,4,6-三(三溴甲基)-對稱三𠯤、2-甲基-4,6-雙(三溴甲基)-對稱三𠯤、2-甲氧基-4,6-雙(三溴甲基)-對稱三𠯤等。 As for organic halogenated compounds, specific examples include Wakabayashi et al.'s "Bull Chem. Soc Japan" 42,2924 (1969), U.S. Patent No. 3,905,815, Japanese Patent Publication Nos. 46-4605, 48-36281, 55-32070, 60-239736, 61-169835, 61-169837, 62-58241, 62-212401, 63-70243, 63-298339, and M.P. Hutt's "Jurnal of Heterocyclic Compounds described in Chemistry 1 (No. 3), (1970), etc., are incorporated herein by reference. In particular, oxazole compounds substituted with trihalomethanes, such as symmetrical trihalomethane compounds, are preferred examples. More preferably, symmetrical trihalomethane derivatives formed by the bonding of at least one mono, di, or trihalomethane-substituted methyl group with a symmetrical trihalomethane ring are examples. Specifically, examples include 2,4,6-tris(monochloromethyl)-symmetrical trihalomethane, 2,4,6-tris(dichloromethyl)-symmetrical trihalomethane, 2,4,6-tris(trichloromethyl)-symmetrical trihalomethane, 2-methyl-4,6-bis(trichloromethyl)-symmetrical trihalomethane, and 2-n-propyl-4,6-bis(trichloromethyl)-symmetrical trihalomethane. Tris(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-symmetric tri ... [Phenyl]-2,4-butadienyl]-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl)-2-styryl-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl)-2-(p-methoxystyryl)-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl)-2-(p-isopropoxystyryl)-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl)-2-(p-tolyl)-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl)-2-(4-naphthoxy) Naphthyl)-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl), 2-phenylthio-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl), 2-benzylthio-4,6-bis(trichloromethyl)-symmetric tris(trichloromethyl), 2,4,6-tris(dibromomethyl)-symmetric tris(trichloromethyl)-symmetric tris(trichloromethyl), 2-methyl-4,6-bis(tribromomethyl)-symmetric tris(trichloromethyl), 2-methoxy-4,6-bis(tribromomethyl)-symmetric tris(trichloromethyl), etc.

作為有機硼酸鹽化合物,例如可舉出日本特開昭62-143044號公報、日本特開昭62-150242號公報、日本特開平9-188685號公報、日本特開平9-188686號公報、日本特開平9-188710號公報、日本特開2000-131837號公報、日本特開2002-107916號公報、日本專利第2764769號公報、日本特開2002-116539號公報等及Kunz,Martin“Rad Tech'98.Proceeding April 19-22,1998,Chicago”等中所記載之有機硼酸鹽、日本特開平6-157623號公報、日本特開平6-175564號公報、日本特開平6-175561號公報中所記載之有機硼鋶錯合物或有機硼氧代鋶錯合物、日本特開平6-175554號公報、日本特開平6-175553號公報中所記載之有機硼錪錯合物、日本特開平9-188710號公報中所記載之有機硼鏻錯合物、日本特開平6-348011號公報、日本特開平7-128785號公報、日本特開平7-140589號公報、日本特開平7-306527號公報、日本特開平7-292014號公報等有機硼過渡金屬配位錯合物等作為具體例,該等內容被編入本說明書中。Examples of organoborate compounds include, for instance, Japanese Patent Application Publication No. 62-143044, Japanese Patent Application Publication No. 62-150242, Japanese Patent Application Publication No. 9-188685, Japanese Patent Application Publication No. 9-188686, Japanese Patent Application Publication No. 9-188710, Japanese Patent Application Publication No. 2000-131837, Japanese Patent Application Publication No. 2002-107916, Japanese Patent No. 2764769, Japanese Patent Application Publication No. 2002-116539, and Kunz, Martin, “Rad Tech’98. Proceeding April”. The organoborates described in "Chicago" etc., Japanese Patent Application Publication Nos. 6-157623, 6-175564, and 6-175561, and the organoboronium complexes or organoboronoxystrontium complexes described in Japanese Patent Application Publication Nos. 6-175554 and 6-175553, etc. Specific examples include organoboronium complexes described in Japanese Patent Application Publication No. 9-188710, and organoboronium transition metal coordination complexes such as Japanese Patent Application Publication No. 6-348011, Japanese Patent Application Publication No. 7-128785, Japanese Patent Application Publication No. 7-140589, Japanese Patent Application Publication No. 7-306527, and Japanese Patent Application Publication No. 7-292014, the contents of which are incorporated herein by reference.

作為二碸化合物,可舉出日本特開昭61-166544號公報、日本專利申請2001-132318公報等中所記載之化合物及重氮二碸化合物。Examples of disulfide compounds include compounds described in Japanese Patent Application Publication No. 61-166544 and Japanese Patent Application No. 2001-132318, as well as diazonium compounds.

作為上述鎓鹽化合物,例如可舉出S.I.Schlesinger,Photogr.Sci.Eng.,18,387(1974)、T.S.Bal et al,Polymer,21,423(1980)中所記載之重氮鹽、美國專利第4,069,055號說明書、日本特開平4-365049號公報等中所記載之銨鹽、美國專利第4,069,055號、美國專利第4,069,056號的各說明書中所記載之鏻鹽、歐洲專利第104,143號、美國專利第339,049號、美國專利第410,201號的各說明書、日本特開平2-150848號、日本特開平2-296514號公報中所記載之錪鹽、歐洲專利第370,693號、歐洲專利第390,214號、歐洲專利第233,567號、歐洲專利第297,443號、歐洲專利第297,442號、美國專利第4,933,377號、美國專利第161,811號、美國專利第410,201號、美國專利第339,049號、美國專利第4,760,013號、美國專利第4,734,444號、美國專利第2,833,827號、德國專利第2,904,626號、德國專利第3,604,580號、德國專利第3,604,581號的各說明書中所記載之鋶鹽、J.V.Crivello et al,Macromolecules,10(6),1307(1977)、J.V.Crivello et al,J.Polymer Sci.,Polymer Chem.Ed.,17,1047(1979)中所記載之硒鹽、C.S.Wen et al,Teh,Proc.Conf.Rad.Curing ASIA,p478 Tokyo,Oct(1988)中所記載之砷鹽、吡啶鎓鹽等鎓鹽等,該等內容被編入本說明書中。Examples of such onium salt compounds include S.I. Schlesinger, Photogr. Sci. Eng., 18, 387 (1974), and T.S. Bal et al. Diazo salts as described in al, Polymer, 21,423 (1980), ammonium salts as described in U.S. Patent No. 4,069,055, Japanese Patent Application Publication No. 4-365049, phosphonium salts as described in the specifications of U.S. Patent Nos. 4,069,055 and 4,069,056, European Patent Nos. 104,143, 339,049 and 410,201, tin salts as described in Japanese Patent Application Publication Nos. 2-150848 and 2-296514, European Patent Nos. 370,693 and 39 The strontium salts described in the specifications of J.V. Crivello's patents 0,214, 233,567, 297,443, 297,442, 4,933,377, 161,811, 410,201, 339,049, 4,760,013, 4,734,444, 2,833,827, 2,904,626, 3,604,580, and 3,604,581, and J.V. Crivello's patents. Selenium salts described in J.V. Crivello et al., Macromolecules, 10(6), 1307(1977), and arsenic salts, pyridinium salts, etc. described in C.S. Wen et al., Teh, Proc. Conf. Rad. Curing ASIA, p478 Tokyo, Oct (1988) are included in this specification.

作為鎓鹽,可舉出由下述通式(RI-I)~(RI-III)表示之鎓鹽。 【化學式52】 式(RI-I)中,Ar 11表示可以具有1~6個取代基之碳數20以下的芳基,作為較佳的取代基,可舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數6~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的烷基胺基、碳數2~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基的碳數為6~20的芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z 11 -表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子為較佳。式(RI-II)中,Ar 21、Ar 22分別獨立地表示可以具有1~6個取代基的碳數1~20的芳基,作為較佳的取代基,可舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數1~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的單烷基胺基、烷基的碳數分別獨立地為1~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z 21 -表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性、反應性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、羧酸離子為較佳。式(RI-III)中,R 31、R 32、R 33分別獨立地表示可以具有1~6個取代基之碳數6~20的芳基或烷基、烯基、炔基,較佳地,從反應性、穩定性的方面考慮,芳基為較佳。作為較佳的取代基,可舉出碳數1~12的烷基、碳數2~12的烯基、碳數2~12的炔基、碳數1~12的芳基、碳數1~12的烷氧基、碳數1~12的芳氧基、鹵素原子、碳數1~12的單烷基胺基、烷基的碳數分別獨立地為1~12的二烷基胺基、烷基的碳數為1~12的烷基醯胺基或芳基醯胺基、羰基、羧基、氰基、磺醯基、碳數1~12的硫代烷基、碳數1~12的硫代芳基。Z 31 -表示1價的陰離子,其為鹵素離子、過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、硫代磺酸離子、硫酸離子,從穩定性、反應性的方面考慮,過氯酸離子、六氟磷酸鹽離子、四氟硼酸鹽離子、磺酸離子、亞磺酸離子、羧酸離子為較佳。 Examples of onium salts represented by the following general formulas (RI-I) to (RI-III) can be cited. [Chemical Formula 52] In formula (RI-I), Ar 11 represents an aryl group having 1 to 6 substituents with 20 or fewer carbon atoms. Examples of preferred substituents include alkyl groups having 1 to 12 carbon atoms, alkenyl groups having 2 to 12 carbon atoms, alkynyl groups having 2 to 12 carbon atoms, aryl groups having 6 to 12 carbon atoms, alkoxy groups having 1 to 12 carbon atoms, aryloxy groups having 1 to 12 carbon atoms, halogen atoms, alkylamino groups having 1 to 12 carbon atoms, dialkylamino groups having 2 to 12 carbon atoms, alkylamide groups of alkyl groups having 1 to 12 carbon atoms, or arylamide groups of aryl groups having 6 to 20 carbon atoms, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups having 1 to 12 carbon atoms, and thioaryl groups having 1 to 12 carbon atoms. Z 11 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. From a stability perspective, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, and sulfinic acid ion are preferred. In formula (RI-II), Ar 21 and Ar 22 independently represent aryl groups with 1 to 20 carbon atoms that may have 1 to 6 substituents. Examples of preferred substituents include alkyl groups with 1 to 12 carbon atoms, alkenyl groups with 2 to 12 carbon atoms, alkynyl groups with 2 to 12 carbon atoms, aryl groups with 1 to 12 carbon atoms, alkoxy groups with 1 to 12 carbon atoms, aryloxy groups with 1 to 12 carbon atoms, halogen atoms, monoalkylamino groups with 1 to 12 carbon atoms, dialkylamino groups with 1 to 12 carbon atoms of each alkyl group, alkylamide or arylamide groups with 1 to 12 carbon atoms of an alkyl group, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups with 1 to 12 carbon atoms, and thioaryl groups with 1 to 12 carbon atoms. Z 21 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. Considering stability and reactivity, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, or carboxylic acid ion are preferred. In formula (RI-III), R 31 , R 32 , and R 33 independently represent aryl, alkyl, alkenyl, or alkynyl groups with 6 to 20 carbon atoms that can have 1 to 6 substituents. Preferably, aryl groups are preferred in terms of reactivity and stability. Preferred substituents include alkyl groups having 1 to 12 carbon atoms, alkenyl groups having 2 to 12 carbon atoms, alkynyl groups having 2 to 12 carbon atoms, aryl groups having 1 to 12 carbon atoms, alkoxy groups having 1 to 12 carbon atoms, aryloxy groups having 1 to 12 carbon atoms, halogen atoms, monoalkylamino groups having 1 to 12 carbon atoms, dialkylamino groups having 1 to 12 carbon atoms in each alkyl group, alkylamide or arylamide groups having 1 to 12 carbon atoms in an alkyl group, carbonyl groups, carboxyl groups, cyano groups, sulfonyl groups, thioalkyl groups having 1 to 12 carbon atoms, and thioaryl groups having 1 to 12 carbon atoms. Z 31 - indicates a monovalent anion, which can be a halogen ion, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, thiosulfonic acid ion, or sulfate ion. Considering stability and reactivity, perchlorate ion, hexafluorophosphate ion, tetrafluoroborate ion, sulfonic acid ion, sulfinic acid ion, or carboxylic acid ion are preferred.

作為較佳的光酸產生劑的具體例,可舉出以下者。 【化學式53】 【化學式54】 【化學式55】 【化學式56】 Specific examples of better photosensitive acid generators include the following: [Chemical Formula 53] 【Chemical Formula 54】 【Chemical Formula 55】 【Chemical Formula 56】

光酸產生劑相對於樹脂組成物的總固體成分使用0.1~20質量%為較佳,使用0.5~18質量%為更佳,使用0.5~10質量%為進一步較佳,使用0.5~3質量%為更進一步較佳,使用0.5~1.2質量%為又更進一步較佳。 光酸產生劑可以單獨使用1種,亦可以組合使用複數種。在組合使用複數種的情況下,該等合計量在上述範圍內為較佳。 又,為了對所期望的光源賦予感光性,與增感劑併用亦較佳。 The photoacid generator is preferably used at 0.1–20% by mass relative to the total solids content of the resin composition, more preferably at 0.5–18% by mass, further preferably at 0.5–10% by mass, even more preferably at 0.5–3% by mass, and still more preferably at 0.5–1.2% by mass. The photoacid generator can be used alone or in combination with other agents. When used in combination with other agents, the total amount within the above-mentioned ranges is preferred. Furthermore, it is preferable to use it in combination with a sensitizer to impart photosensitivity to the desired light source.

<鹼產生劑> 本發明的樹脂組成物可以包含鹼產生劑。其中,鹼產生劑為能夠藉由物理或化學作用而產生鹼之化合物。作為對本發明的樹脂組成物來說較佳的鹼產生劑,可舉出熱鹼產生劑及光鹼產生劑。 尤其,在樹脂組成物包含環化樹脂的前驅物之情況下,樹脂組成物包含鹼產生劑為較佳。藉由使樹脂組成物含有熱鹼產生劑,例如藉由加熱而能夠促進前驅物的環化反應,成為硬化物的機械特性或耐藥品性良好者,例如作為半導體封裝中所包含之再配線層用層間絕緣膜的性能變得良好。 作為鹼產生劑,可以為離子型鹼產生劑,亦可以為非離子型鹼產生劑。作為從鹼產生劑產生之鹼,例如可舉出二級胺、三級胺。 對本發明之鹼產生劑並無特別限制,能夠使用公知的鹼產生劑。作為公知的鹼產生劑,例如能夠使用胺甲醯基肟化合物、胺甲醯基羥胺化合物、胺甲酸化合物、甲醯胺化合物、乙醯胺化合物、胺基甲酸酯化合物、苄胺基甲酸酯化合物、硝基苄胺基甲酸酯化合物、磺酸醯胺化合物、咪唑衍生物化合物、胺醯亞胺化合物、吡啶衍生物化合物、α-胺基苯乙酮衍生物化合物、四級銨鹽衍生物化合物、吡啶鎓鹽、α-內酯環衍生物化合物、胺醯亞胺化合物、鄰苯二甲醯亞胺衍生物化合物、醯氧基亞胺基化合物等。 作為非離子型鹼產生劑的具體的化合物,可舉出由式(B1)、式(B2)或式(B3)表示之化合物。 【化學式57】 <Alkali Generator> The resin composition of the present invention may contain an alkali generator. The alkali generator is a compound capable of generating alkali through physical or chemical action. Preferred alkali generators for the resin composition of the present invention include thermo-alkali generators and photo-alkali generators. In particular, when the resin composition contains a precursor of a cyclized resin, it is preferable that the resin composition contains an alkali generator. By incorporating a thermal alkali generator into the resin composition, such as one that promotes the cyclization reaction of precursors through heating, the cured material exhibits excellent mechanical properties or chemical resistance. For example, its performance as an interlayer insulating film for rewiring layers in semiconductor packaging is improved. The alkali generator can be either ionic or nonionic. Examples of alkalis generated from the alkali generator include, for instance, secondary and tertiary amines. There are no particular limitations on the alkali generator used in this invention; known alkali generators can be used. Commonly known alkali-generating agents include, for example, aminomethyloxime compounds, aminomethylhydroxylamine compounds, carbamic acid compounds, methylamine compounds, acetamide compounds, carbamate compounds, benzyl carbamate compounds, nitrobenzyl carbamate compounds, sulfonic acid amide compounds, imidazole derivative compounds, aminoimine compounds, pyridine derivative compounds, α-aminoacetophenone derivative compounds, quaternary ammonium salt derivative compounds, pyridinium salts, α-lactone ring derivative compounds, aminoimine compounds, phthalimine derivative compounds, and acetoimine compounds. Specific compounds that are nonionic alkali-generating agents include those represented by formulas (B1), (B2), or (B3). [Chemical Formula 57]

式(B1)及式(B2)中,Rb 1、Rb 2及Rb 3分別獨立地為不具有三級胺結構的有機基、鹵素原子或氫原子。其中,Rb 1及Rb 2不會同時成為氫原子。又,Rb 1、Rb 2及Rb 3均不具有羧基。再者,在本說明書中,三級胺結構係指3價的氮原子的三個鍵結鍵均與烴系碳原子進行共價鍵之結構。因此,在所鍵結之碳原子為形成羰基之碳原子之情況亦即在與氮原子一同形成醯胺基之情況下,並不限於此。 In formulas (B1) and (B2), Rb1 , Rb2 , and Rb3 are independently organic groups, halogen atoms, or hydrogen atoms that do not possess a tertiary amine structure. Rb1 and Rb2 do not simultaneously constitute hydrogen atoms. Furthermore, Rb1 , Rb2 , and Rb3 do not possess a carboxyl group. Moreover, in this specification, a tertiary amine structure refers to a structure where all three bonds of a trivalent nitrogen atom are covalently bonded to hydrocarbon carbon atoms. Therefore, it is not limited to the case where the bonded carbon atoms are carbon atoms forming a carbonyl group, i.e., when they form a amide group together with the nitrogen atom.

式(B1)、式(B2)中,Rb 1、Rb 2及Rb 3中的至少一個包含環狀結構為較佳,至少兩個包含環狀結構為更佳。作為環狀結構,可以為單環及縮合環中的任一個,單環或兩個單環縮合而成之縮合環為較佳。單環為5員環或6員環為較佳,6員環為更佳。單環為環己環及苯環為較佳,環己環為更佳。 In formulas (B1) and (B2), it is preferable that at least one of Rb1 , Rb2 , and Rb3 contains a cyclic structure, and it is even more preferable that at least two contain a cyclic structure. The cyclic structure can be either a monocyclic ring or a condensed ring, preferably a monocyclic ring or a condensed ring formed by the condensation of two monocyclic rings. It is preferable that the monocyclic ring is a 5-membered or 6-membered ring, with a 6-membered ring being more preferred. It is preferable that the monocyclic ring is a cyclohexyl ring or a benzene ring, with a cyclohexyl ring being more preferred.

更具體而言,Rb 1及Rb 2為氫原子、烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、烯基(碳數2~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)或芳烷基(碳數7~25為較佳,7~19為更佳,7~12為進一步較佳)為較佳。該等基團可以在發揮本發明的效果之範圍內具有取代基。Rb 1與Rb 2可以相互鍵結而形成環。作為所形成之環,4~7員的含氮雜環為較佳。尤其,Rb 1及Rb 2為可以具有取代基之直鏈、支鏈或環狀的烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)為較佳,可以具有取代基之環烷基(碳數3~24為較佳,3~18為更佳,3~12為進一步較佳)為更佳,可以具有取代基之環己基為進一步較佳。 More specifically, Rb1 and Rb2 are preferably hydrogen atoms, alkyl groups (preferably with 1-24 carbon atoms, more preferably with 2-18 carbon atoms, and even more preferably with 3-12 carbon atoms), alkenyl groups (preferably with 2-24 carbon atoms, more preferably with 2-18 carbon atoms, and even more preferably with 3-12 carbon atoms), aryl groups (preferably with 6-22 carbon atoms, more preferably with 6-18 carbon atoms, and even more preferably with 6-10 carbon atoms), or aralkyl groups (preferably with 7-25 carbon atoms, more preferably with 7-19 carbon atoms, and even more preferably with 7-12 carbon atoms). These groups may have substituents within the scope of achieving the effects of the present invention. Rb1 and Rb2 may bond to each other to form a ring. A nitrogen-containing heterocycle with 4-7 members is preferred as the formed ring. In particular, Rb 1 and Rb 2 are preferably straight-chain, branched or cyclic alkyl groups (preferably with 1 to 24 carbons, more preferably with 2 to 18 carbons, and even more preferably with 3 to 12 carbons) that may have substituents, and are preferably cycloalkyl groups (preferably with 3 to 24 carbons, more preferably with 3 to 18 carbons, and even more preferably with 3 to 12 carbons) that may have substituents, and are even more preferably cyclohexyl groups that may have substituents.

作為Rb 3,可舉出烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、烯基(碳數2~24為較佳,2~12為更佳,2~6為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳)、芳烯基(碳數8~24為較佳,8~20為更佳,8~16為進一步較佳)、烷氧基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、芳氧基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)或芳烷氧基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳)。其中,環烷基(碳數3~24為較佳,3~18為更佳,3~12為進一步較佳)、芳烯基、芳烷氧基為較佳。Rb 3在發揮本發明的效果之範圍內還可以具有取代基。 Examples of Rb 3 include alkyl groups (preferably with 1-24 carbons, more preferably with 2-18 carbons, and even more preferably with 3-12 carbons), aryl groups (preferably with 6-22 carbons, more preferably with 6-18 carbons, and even more preferably with 6-10 carbons), alkenyl groups (preferably with 2-24 carbons, more preferably with 2-12 carbons, and even more preferably with 2-6 carbons), and aralkyl groups (preferably with 7-23 carbons, more preferably with 7-19 carbons, and even more preferably with 7-12 carbons). The preferred carbon groups are aryl (preferably 8-24 carbons, more preferably 8-20, and even more preferably 8-16 carbons), alkoxy (preferably 1-24 carbons, more preferably 2-18, and even more preferably 3-12 carbons), aryloxy (preferably 6-22 carbons, more preferably 6-18, and even more preferably 6-12 carbons), or arylalkoxy (preferably 7-23 carbons, more preferably 7-19, and even more preferably 7-12 carbons). Cycloalkyl (preferably 3-24 carbons, more preferably 3-18, and even more preferably 3-12 carbons), aryl, and arylalkoxy are preferred. Rb3 may also have substituents within the scope of the invention's effects.

由式(B1)表示之化合物為由下述式(B1-1)或下述式(B1-2)表示之化合物為較佳。 【化學式58】 The compound represented by formula (B1) is preferably represented by formula (B1-1) or formula (B1-2) below. [Chemical Formula 58]

式中,Rb 11及Rb 12和Rb 31及Rb 32的含義分別與式(B1)中之Rb 1及Rb 2的含義相同。 Rb 13為烷基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳)、烯基(碳數2~24為較佳,2~18為更佳,3~12為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),在發揮本發明的效果之範圍內可以具有取代基。其中,Rb 13為芳烷基為較佳。 In the formula, Rb 11 and Rb 12 , and Rb 31 and Rb 32 have the same meanings as Rb 1 and Rb 2 in formula (B1), respectively. Rb 13 is an alkyl group (preferably with 1 to 24 carbons, more preferably with 2 to 18 carbons, and even more preferably with 3 to 12 carbons), an alkenyl group (preferably with 2 to 24 carbons, more preferably with 2 to 18 carbons, and even more preferably with 3 to 12 carbons), an aryl group (preferably with 6 to 22 carbons, more preferably with 6 to 18 carbons, and even more preferably with 6 to 12 carbons), or an aralkyl group (preferably with 7 to 23 carbons, more preferably with 7 to 19 carbons, and even more preferably with 7 to 12 carbons). Substituents may be present within the scope of achieving the effects of the present invention. Among them, it is preferred that Rb 13 is an aralkyl group.

Rb 33及Rb 34分別獨立地為氫原子、烷基(碳數1~12為較佳,1~8為更佳,1~3為進一步較佳)、烯基(碳數2~12為較佳,2~8為更佳,2~3為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~11為進一步較佳),氫原子為較佳。 Rb 33 and Rb 34 are respectively independently hydrogen atoms, alkyl groups (preferably with 1 to 12 carbons, more preferably with 1 to 8 carbons, and even more preferably with 1 to 3 carbons), alkenyl groups (preferably with 2 to 12 carbons, more preferably with 2 to 8 carbons, and even more preferably with 2 to 3 carbons), aryl groups (preferably with 6 to 22 carbons, more preferably with 6 to 18 carbons, and even more preferably with 6 to 10 carbons), aralkyl groups (preferably with 7 to 23 carbons, more preferably with 7 to 19 carbons, and even more preferably with 7 to 11 carbons), and hydrogen atoms are preferred.

Rb 35為烷基(碳數1~24為較佳,1~12為更佳,3~8為進一步較佳)、烯基(碳數2~12為較佳,2~10為更佳,3~8為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),芳基為較佳。 Rb 35 is alkyl (preferably 1-24 carbons, more preferably 1-12, and even more preferably 3-8 carbons), alkenyl (preferably 2-12 carbons, more preferably 2-10, and even more preferably 3-8 carbons), aryl (preferably 6-22 carbons, more preferably 6-18, and even more preferably 6-12 carbons), aralkyl (preferably 7-23 carbons, more preferably 7-19, and even more preferably 7-12 carbons), with aryl being preferred.

又,由式(B1-1)表示之化合物為由式(B1-1a)表示之化合物亦較佳。 【化學式59】 Furthermore, it is preferable that the compound represented by formula (B1-1) is also represented by formula (B1-1a). [Chemical Formula 59]

Rb 11及Rb 12的含義與式(B1-1)中之Rb 11及Rb 12的含義相同。 Rb 15及Rb 16為氫原子、烷基(碳數1~12為較佳,1~6為更佳,1~3為進一步較佳)、烯基(碳數2~12為較佳,2~6為更佳,2~3為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~11為進一步較佳),氫原子或甲基為較佳。 Rb 17為烷基(碳數1~24為較佳,1~12為更佳,3~8為進一步較佳)、烯基(碳數2~12為較佳,2~10為更佳,3~8為進一步較佳)、芳基(碳數6~22為較佳,6~18為更佳,6~12為進一步較佳)、芳烷基(碳數7~23為較佳,7~19為更佳,7~12為進一步較佳),其中,芳基為較佳。 The meanings of Rb 11 and Rb 12 are the same as those of Rb 11 and Rb 12 in formula (B1-1). Rb 15 and Rb 16 are preferably hydrogen atoms, alkyl groups (preferably with 1 to 12 carbons, more preferably with 1 to 6 carbons, and even more preferably with 1 to 3 carbons), alkenyl groups (preferably with 2 to 12 carbons, more preferably with 2 to 6 carbons, and even more preferably with 2 to 3 carbons), aryl groups (preferably with 6 to 22 carbons, more preferably with 6 to 18 carbons, and even more preferably with 6 to 10 carbons), aralkyl groups (preferably with 7 to 23 carbons, more preferably with 7 to 19 carbons, and even more preferably with 7 to 11 carbons), hydrogen atoms, or methyl groups. Rb 17 is an alkyl group (preferably with 1 to 24 carbons, more preferably with 1 to 12 carbons, and even more preferably with 3 to 8 carbons), an alkenyl group (preferably with 2 to 12 carbons, more preferably with 2 to 10 carbons, and even more preferably with 3 to 8 carbons), an aryl group (preferably with 6 to 22 carbons, more preferably with 6 to 18 carbons, and even more preferably with 6 to 12 carbons), or an aralkyl group (preferably with 7 to 23 carbons, more preferably with 7 to 19 carbons, and even more preferably with 7 to 12 carbons), wherein an aryl group is preferred.

【化學式60】 【Chemical Formula 60】

在式(B3)中,L表示烴基,該烴基為在連接相鄰之氧原子和碳原子之連接鏈的路徑上具有飽和烴基之2價的烴基,並且連接鏈的路徑上的原子數為3個以上。又,R N1及R N2分別獨立地表示1價的有機基。 In formula (B3), L represents an hydrocarbon group, which is a divalent hydrocarbon group with a saturated hydrocarbon on the path of the linking chain connecting adjacent oxygen and carbon atoms, and the number of atoms on the linking chain is three or more. Furthermore, RN1 and RN2 each independently represent a monovalent organic group.

在本說明書中,“連接鏈”係指,在連接連接對象的兩個原子或連接原子群組之間之路徑上的原子鏈中以最短(最小原子數)的方式連接該等連接對象者。例如,在由下述式表示之化合物中,L由伸苯基伸乙基構成,並且具有伸乙基作為飽和烴基,連接鏈由四個碳原子構成,連接鏈的路徑上的原子數(亦即,為構成連接鏈之原子的數量,以下,亦稱為“連接鏈長度”或者“連接鏈的長度”。)為4個。 【化學式61】 In this specification, "linkage chain" refers to an atomic chain that connects two atoms or groups of atoms in the shortest possible (smallest number of atoms) path. For example, in a compound represented by the following formula, L is composed of phenyl-ethyl groups and has ethyl groups as saturated hydrocarbons, the linkage chain consists of four carbon atoms, and the number of atoms in the linkage chain path (i.e., the number of atoms constituting the linkage chain, hereinafter also referred to as "linkage chain length") is 4. [Chemical Formula 61]

式(B3)之L中的碳數(亦包含除了連接鏈中的碳原子以外的碳原子)為3~24為較佳。上限為12以下為更佳,10以下為進一步較佳,8以下為特佳。下限為4以上為更佳。從快速進行上述分子內環化反應之觀點考慮,L的連接鏈長度的上限為12以下為較佳,8以下為更佳,6以下為進一步較佳,5以下為特佳。尤其,L的連接鏈長度為4或5為較佳,4為最佳。作為鹼產生劑的具體的較佳化合物,例如亦可舉出國際公開第2020/066416號的0102~0168段中所記載之化合物、國際公開第2018/038002號的0143~0177段中所記載之化合物。The number of carbon atoms in L in formula (B3) (including carbon atoms other than those in the linker chain) is preferably 3 to 24. An upper limit of 12 or less is more preferred, 10 or less is even more preferred, and 8 or less is particularly preferred. A lower limit of 4 or more is more preferred. Considering the need for rapid intramolecular cyclization reactions, the upper limit of the linker chain length of L is preferably 12 or less, more preferably 8 or less, even more preferably 6 or less, and particularly preferred 5 or less. In particular, a linker chain length of 4 or 5 is preferred, with 4 being optimal. Preferred compounds as alkali-generating agents include, for example, those described in paragraphs 0102 to 0168 of International Publication No. 2020/066416 and those described in paragraphs 0143 to 0177 of International Publication No. 2018/038002.

又,鹼產生劑包含由下述式(N1)表示之化合物亦較佳。 【化學式62】 Furthermore, it is preferable that the alkali-generating agent contains a compound represented by the following formula (N1). [Chemical Formula 62]

式(N1)中,R N1及R N2分別獨立地表示1價的有機基,RC1表示氫原子或保護基,L表示2價的連接基。 In formula (N1), RN1 and RN2 independently represent monovalent organic groups, RC1 represents a hydrogen atom or a protecting group, and L represents a divalent linking group.

L為2價的連接基,2價的有機基為較佳。連接基的連接鏈長度為1以上為較佳,2以上為更佳。作為上限,12以下為較佳,8以下為更佳,5以下為進一步較佳。連接鏈長度為在式中的兩個羰基之間成為最短路程之原子排列中存在之原子的數量。L is a divalent linker, preferably a divalent organic group. A linker chain length of 1 or more is preferred, and 2 or more is even better. As an upper limit, 12 or less is preferred, 8 or less is even better, and 5 or less is even better. The linker chain length is the number of atoms present in the atomic arrangement that forms the shortest path between the two carbonyl groups in the formula.

式(N1)中,R N1及R N2分別獨立地表示1價的有機基(碳數1~24為較佳,2~18為更佳,3~12為進一步較佳),烴基(碳數1~24為較佳,1~12為更佳,1~10為進一步較佳)為較佳,具體而言,能夠舉出脂肪族烴基(碳數1~24為較佳,1~12為更佳,1~10為進一步較佳)或芳香族烴基(碳數6~22為較佳,6~18為更佳,6~10為進一步較佳),脂肪族烴基為較佳。若作為R N1及R N2使用脂肪族烴基,則所產生之鹼的鹼性高,因此為較佳。再者,脂肪族烴基及芳香族烴基可以具有取代基,又脂肪族烴基及芳香族烴基可以在脂肪族烴鏈中或芳香環中、取代基中具有氧原子。尤其,可例示脂肪族烴基在烴鏈中具有氧原子之態樣。 In formula (N1), RN1 and RN2 independently represent monovalent organic groups (preferably with 1-24 carbons, more preferably with 2-18, and even more preferably with 3-12 carbons) and hydrocarbon groups (preferably with 1-24 carbons, more preferably with 1-12, and even more preferably with 1-10 carbons). Specifically, aliphatic hydrocarbon groups (preferably with 1-24 carbons, more preferably with 1-12, and even more preferably with 1-10) or aromatic hydrocarbon groups (preferably with 6-22 carbons, more preferably with 6-18, and even more preferably with 6-10 carbons) are preferred. If aliphatic hydrocarbon groups are used as RN1 and RN2 , the resulting base is highly basic, and therefore preferred. Furthermore, aliphatic and aromatic hydrocarbons can have substituents, and they can have oxygen atoms in the aliphatic hydrocarbon chain, the aromatic ring, or the substituents. In particular, examples of aliphatic hydrocarbons having oxygen atoms in the hydrocarbon chain can be illustrated.

作為構成R N1及R N2之脂肪族烴基,可舉出直鏈或支鏈的鏈狀烷基、環狀烷基、與鏈狀烷基和環狀烷基的組合有關之基團、在鏈中具有氧原子之烷基。直鏈或支鏈的鏈狀烷基為碳數1~24者為較佳,2~18為更佳,3~12為進一步較佳。關於直鏈或支鏈的鏈狀烷基,例如可舉出甲基、乙基、丙基、丁基、戊基、己基、庚基、辛基、壬基、癸基、十一基、十二烷基、異丙基、異丁基、二級丁基、三級丁基、異戊基、新戊基、三級戊基、異己基等。 環狀烷基為碳數3~12者為較佳,3~6為更佳。關於環狀烷基,例如可舉出環丙基、環丁基、環戊基、環己基、環辛基等。 與鏈狀烷基和環狀烷基的組合有關之基團為碳數4~24者為較佳,4~18為更佳,4~12為進一步較佳。關於與鏈狀烷基和環狀烷基的組合有關之基團,例如可舉出環己基甲基、環己基乙基、環己基丙基、甲基環己基甲基、乙基環己基乙基等。 在鏈中具有氧原子之烷基為碳數2~12者為較佳,2~6為更佳,2~4為進一步較佳。在鏈中具有氧原子之烷基可以為鏈狀,亦可以為環狀,並且可以為直鏈,亦可以為支鏈。 其中,從提高後述分解生成鹼的沸點之觀點考慮,R N1及R N2為碳數5~12的烷基為較佳。其中,在重視與金屬(例如銅)的層積層時的密接性之配方中,具有環狀的烷基之基團或碳數1~8的烷基為較佳。 Examples of aliphatic hydrocarbons constituting RN1 and RN2 include linear or branched chain alkyl groups, cyclic alkyl groups, groups related to combinations of linear and cyclic alkyl groups, and alkyl groups having oxygen atoms in the chain. Linear or branched chain alkyl groups with 1 to 24 carbon atoms are preferred, 2 to 18 are more preferred, and 3 to 12 are even more preferred. Examples of linear or branched chain alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, isopropyl, isobutyl, dibutyl, tributyl, isopentyl, neopentyl, tripentyl, and isohexyl. Cyclic alkyl groups are preferably composed of 3 to 12 carbon atoms, with 3 to 6 being more preferred. Examples of cyclic alkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cyclooctyl. Groups relating to the combination of cyclic and chain alkyl groups are preferably composed of 4 to 24 carbon atoms, with 4 to 18 being more preferred, and 4 to 12 being even more preferred. Examples of groups relating to the combination of cyclic and chain alkyl groups include cyclohexylmethyl, cyclohexylethyl, cyclohexylpropyl, methylcyclohexylmethyl, and ethylcyclohexylethyl. Alkyl groups having an oxygen atom in the chain are preferably composed of 2 to 12 carbon atoms, with 2 to 6 being more preferred, and 2 to 4 being even more preferred. The alkyl group containing oxygen atoms in the chain can be chain-like or cyclic, and can be straight or branched. From the viewpoint of increasing the boiling point of the alkali produced by decomposition (described later), RN1 and RN2 are preferably alkyl groups with 5 to 12 carbon atoms. In formulations where adhesion to metals (e.g., copper) is important, cyclic alkyl groups or alkyl groups with 1 to 8 carbon atoms are preferred.

R N1及R N2可以相互連接而形成環狀結構。在形成環狀結構時,可以在鏈中具有氧原子等。又,R N1及R N2所形成之環狀結構可以為單環,亦可以為縮合環,但是單環為較佳。作為所形成之環狀結構,式(N1)中的含有氮原子之5員環或6員環為較佳,例如可舉出吡咯環、咪唑環、吡唑環、吡咯啉環、吡咯啶環、咪唑啶環、吡唑啶環、哌啶環、哌𠯤環、口末啉環等,可較佳地舉出吡咯啉環、吡咯啶環、哌啶環、哌𠯤環、口末啉環。 RN1 and RN2 can be linked together to form a ring structure. When forming a ring structure, oxygen atoms or the like can be present in the chain. Furthermore, the ring structure formed by RN1 and RN2 can be a monocyclic ring or a condensed ring, but a monocyclic ring is preferred. As for the formed ring structure, a 5-membered or 6-membered ring containing a nitrogen atom in formula (N1) is preferred. Examples include pyrrole ring, imidazole ring, pyrazole ring, pyrrolidine ring, imidazoleidine ring, pyrazoleidine ring, piperidine ring, piperidine ring, and oxymeta-line ring. Pyrrole ring, pyrridine ring, piperidine ring, piperidine ring, and oxymeta-line ring are preferred.

R C1表示氫原子或保護基,氫原子為較佳。 R C1 represents a hydrogen atom or a protecting group, with a hydrogen atom being preferred.

作為保護基,藉由酸或鹼的作用進行分解之保護基為較佳,可較佳地舉出用酸進行分解之保護基。As a protective group, a protective group that can be decomposed by the action of acid or alkali is preferred, and a good example is a protective group that can be decomposed by acid.

作為保護基的具體例,可舉出鏈狀或環狀的烷基或在鏈中具有氧原子之鏈狀或環狀的烷基。作為鏈狀或環狀的烷基,可舉出甲基、乙基、異丙基、三級丁基、環己基等。作為在鏈中具有氧原子之鏈狀的烷基,具體而言,可舉出烷基氧基烷基,更具體而言,可舉出甲氧基甲(MOM)基、乙氧基乙(EE)基等。作為在鏈中具有氧原子之環狀的烷基,可舉出環氧基、縮水甘油基、氧雜環丁基、四氫呋喃基、四氫吡喃(THP)基等。Specific examples of protecting groups include chain-like or cyclic alkyl groups or chain-like or cyclic alkyl groups having an oxygen atom in the chain. Examples of chain-like or cyclic alkyl groups include methyl, ethyl, isopropyl, tributyl, and cyclohexyl. Examples of chain-like alkyl groups having an oxygen atom in the chain include alkyloxyalkyl groups, and more specifically, methoxymethyl (MOM) and ethoxyethyl (EE) groups. Examples of cyclic alkyl groups having an oxygen atom in the chain include epoxy, glycidyl, oxocyclobutyl, tetrahydrofuranyl, and tetrahydropyranyl (THP) groups.

作為構成L之2價的連接基,並無特別限定,但是烴基為較佳,脂肪族烴基為更佳。烴基可以具有取代基,又亦可以在烴鏈中具有除了碳原子以外的種類的原子。更具體而言,可以在鏈中具有氧原子的2價的烴連接基為較佳,可以在鏈中具有氧原子的2價的脂肪族烴基、2價的芳香族烴基或與可以在鏈中具有氧原子的2價的脂肪族烴基和2價的芳香族烴基的組合有關之基團為更佳,可以在鏈中具有氧原子的2價的脂肪族烴基為進一步較佳。該等基團不具有氧原子為較佳。 2價的烴連接基為碳數1~24者為較佳,2~12為更佳,2~6為進一步較佳。2價的脂肪族烴基為碳數1~12者為較佳,2~6為更佳,2~4為進一步較佳。2價的芳香族烴基為碳數6~22者為較佳,6~18為更佳,6~10為進一步較佳。與2價的脂肪族烴基和2價的芳香族烴基的組合有關之基團(例如,伸芳基烷基)為碳數7~22者為較佳,7~18為更佳,7~10為進一步較佳。 There are no particular limitations on the linking group constituting the divalent L, but an hydrocarbon group is preferred, and an aliphatic hydrocarbon group is even more preferred. The hydrocarbon group may have substituents, and may also have atoms other than carbon atoms in the hydrocarbon chain. More specifically, a divalent hydrocarbon linking group having an oxygen atom in the chain is preferred; groups relating to aliphatic hydrocarbons, aromatic hydrocarbons, or combinations of divalent aliphatic hydrocarbons and aromatic hydrocarbons having an oxygen atom in the chain are even more preferred; and divalent aliphatic hydrocarbons having an oxygen atom in the chain are even more preferred. It is preferable that these groups do not have an oxygen atom. The divalent hydrocarbon linking group preferably has 1 to 24 carbon atoms, more preferably 2 to 12, and even more preferably 2 to 6. The divalent aliphatic hydrocarbon preferably has 1 to 12 carbon atoms, more preferably 2 to 6, and even more preferably 2 to 4. The divalent aromatic hydrocarbon preferably has 6 to 22 carbon atoms, more preferably 6 to 18, and even more preferably 6 to 10. Groups related to the combination of divalent aliphatic and divalent aromatic hydrocarbons (e.g., arylalkyl groups) preferably have 7 to 22 carbon atoms, more preferably 7 to 18, and even more preferably 7 to 10.

作為連接基L,具體而言,直鏈或支鏈的鏈狀伸烷基、環狀伸烷基、與鏈狀伸烷基和環狀伸烷基的組合有關之基團、在鏈中具有氧原子之伸烷基、直鏈或支鏈的鏈狀的伸烯基、環狀的伸烯基、伸芳基、伸芳基伸烷基為較佳。 直鏈或支鏈的鏈狀伸烷基為碳數1~12者為較佳,2~6為更佳,2~4為進一步較佳。 環狀伸烷基為碳數3~12者為較佳,3~6為更佳。 與鏈狀伸烷基和環狀伸烷基的組合有關之基團為碳數4~24者為較佳,4~12為更佳,4~6為進一步較佳。 在鏈中具有氧原子之伸烷基可以為鏈狀,亦可以為環狀,並且可以為直鏈,亦可以為支鏈。在鏈中具有氧原子之伸烷基為碳數1~12者為較佳,1~6為更佳,1~3為進一步較佳。 As a linking group L, specifically, linear or branched chain-like alkylene groups, cyclic alkylene groups, groups relating to combinations of linear and cyclic alkylene groups, alkylene groups having an oxygen atom in the chain, linear or branched chain-like alkenyl groups, cyclic alkenyl groups, aryl groups, and arylalkylene groups are preferred. Cirral or branched chain-like alkylene groups having 1 to 12 carbon atoms are preferred, 2 to 6 are more preferred, and 2 to 4 are even more preferred. Cyclic alkylene groups having 3 to 12 carbon atoms are preferred, and 3 to 6 are more preferred. The groups relating to combinations of chain-like and cyclic alkyl groups preferably have 4 to 24 carbon atoms, more preferably 4 to 12, and even more preferably 4 to 6. The alkyl group having an oxygen atom in the chain can be chain-like or cyclic, and can be straight or branched. The alkyl group having an oxygen atom in the chain preferably has 1 to 12 carbon atoms, more preferably 1 to 6, and even more preferably 1 to 3.

直鏈或支鏈的鏈狀的伸烯基為碳數2~12者為較佳,2~6為更佳,2~3為進一步較佳。直鏈或支鏈的鏈狀的伸烯基的C=C鍵的數量為1~10者為較佳,1~6為更佳,1~3為進一步較佳。 環狀的伸烯基為碳數3~12者為較佳,3~6為更佳。環狀的伸烯基的C=C鍵的數量為1~6為較佳,1~4為更佳,1~2為進一步較佳。 伸芳基為碳數6~22者為較佳,6~18為更佳,6~10為進一步較佳。 伸芳基伸烷基為碳數7~23者為較佳,7~19為更佳,7~11為進一步較佳。 其中,鏈狀伸烷基、環狀伸烷基、在鏈中具有氧原子之伸烷基、鏈狀的伸烯基、伸芳基、伸芳基、伸烷基為較佳,1,2-伸乙基、丙烷二基(尤其1,3-丙烷二基)、環己烷二基(尤其1,2-環己烷二基)、伸乙烯基(尤其順式伸乙烯基)、伸苯基(1,2-伸苯基)、伸苯基亞甲基(尤其1,2-伸苯基亞甲基)、氧伸乙基(尤其1,2-乙烯氧基-1,2-伸乙基)為更佳。 The linear or branched chain-like alkenyl group preferably has 2 to 12 carbon atoms, more preferably 2 to 6, and even more preferably 2 to 3. The number of C=C bonds in the linear or branched chain-like alkenyl group is preferably 1 to 10, more preferably 1 to 6, and even more preferably 1 to 3. The cyclic alkenyl group preferably has 3 to 12 carbon atoms, more preferably 3 to 6. The number of C=C bonds in the cyclic alkenyl group is preferably 1 to 6, more preferably 1 to 4, and even more preferably 1 to 2. The aryl group preferably has 6 to 22 carbon atoms, more preferably 6 to 18, and even more preferably 6 to 10. The arylalkyl group having 7 to 23 carbon atoms is preferred, 7 to 19 is more preferred, and 7 to 11 is even more preferred. Among these, chain-like arylalkyl groups, cyclic arylalkyl groups, arylalkyl groups having oxygen atoms in the chain, chain-like alkenyl groups, arylalkyl groups, arylalkyl groups, and arylalkyl groups are preferred; 1,2-arylethyl, propanediyl (especially 1,3-propanediyl), cyclohexanediyl (especially 1,2-cyclohexanediyl), vinylyl (especially cis-arylethyl), phenyl (1,2-arylphenyl), phenylmethylene (especially 1,2-arylphenylmethylene), and oxyethylyl (especially 1,2-ethyleneoxy-1,2-arylethyl) are more preferred.

作為鹼產生劑,可舉出下述例,但是本發明並不僅由此做限定性解釋。Examples of alkali-producing agents include the following, but the invention is not to be construed as such.

【化學式63】 【Chemical Formula 63】

非離子型熱鹼產生劑的分子量為800以下為較佳,600以下為更佳,500以下為進一步較佳。作為下限,100以上為較佳,200以上為更佳,300以上為進一步較佳。For nonionic thermal alkali generators, a molecular weight of 800 or less is preferred, 600 or less is even better, and 500 or less is still preferred. As a lower limit, a molecular weight of 100 or more is preferred, 200 or more is even better, and 300 or more is still even better.

作為離子型鹼產生劑的具體的較佳化合物,例如亦可舉出國際公開第2018/038002號的0148~0163段中所記載之化合物。Preferred compounds as ionic base generators include, for example, those described in paragraphs 0148 to 0163 of International Publication No. 2018/038002.

作為銨鹽的具體例,能夠舉出以下化合物,但是本發明並不限定於該等。 【化學式64】 Specific examples of ammonium salts include the following compounds, but the invention is not limited to these. [Formula 64]

作為亞胺鹽的具體例,能夠舉出以下化合物,但是本發明並不限定於該等。 【化學式65】 Specific examples of imine salts include the following compounds, but the invention is not limited to these. [Formula 65]

在本發明的樹脂組成物包含鹼產生劑之情況下,鹼產生劑的含量相對於本發明的樹脂組成物中的樹脂100質量份為0.1~50質量份為較佳。下限為0.3質量份以上為更佳,0.5質量份以上為進一步較佳。上限為30質量份以下為更佳,20質量份以下為進一步較佳,10質量份以下為更進一步較佳,可以為5質量份以下,亦可以為4質量份以下。 鹼產生劑能夠使用1種或2種以上。在使用2種以上之情況下,合計量在上述範圍內為較佳。 When the resin composition of the present invention contains an alkali-generating agent, the content of the alkali-generating agent relative to 100 parts by weight of the resin composition of the present invention is preferably 0.1 to 50 parts by weight. A lower limit of 0.3 parts by weight or more is more preferred, and 0.5 parts by weight or more is further preferred. An upper limit of 30 parts by weight or less is more preferred, 20 parts by weight or less is further preferred, 10 parts by weight or less is even more preferred, and it can be 5 parts by weight or less, or even 4 parts by weight or less. One or more alkali-generating agents can be used. When two or more are used, the total amount within the above range is preferred.

<溶劑> 本發明的樹脂組成物含有溶劑為較佳。 溶劑能夠任意使用公知的溶劑。溶劑較佳為有機溶劑。作為有機溶劑,可舉出酯類、醚類、酮類、環狀烴類、亞碸類、醯胺類、脲類、醇類等化合物。 <Soluble> It is preferable that the resin composition of this invention contains a solvent. Any known solvent can be used. The solvent is preferably an organic solvent. Examples of organic solvents include esters, ethers, ketones, cyclic hydrocarbons, monoxides, amides, ureas, and alcohols.

作為酯類,例如可舉出乙酸乙酯、乙酸正丁酯、乙酸異丁酯、乙酸己酯、甲酸戊酯、乙酸異戊酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例如,烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例如,3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例如,2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯、己酸乙酯、庚酸乙酯、丙二酸二甲酯、丙二酸二乙酯等作為較佳者。Examples of esters include ethyl acetate, n-butyl acetate, isobutyl acetate, hexyl acetate, amyl formate, isoamyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetic acid, ethyl alkoxyacetic acid, butyl alkoxyacetic acid (e.g., methyl methoxyacetic acid, ethyl methoxyacetic acid, butyl methoxyacetic acid, methyl ethoxyacetic acid, ethyl ethoxyacetic acid, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., methyl 3-alkoxypropionic acid, ethyl 3-alkoxypropionic acid, etc. (e.g., methyl 3-methoxypropionic acid, ethyl 3-methoxypropionic acid, methyl 3-ethoxypropionic acid, ethyl 3-ethoxypropionic acid). Alkyl esters of 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, ethyl hexanoate, ethyl heptanoate, dimethyl malonate, diethyl malonate, etc. are preferred.

作為醚類,例如可舉出乙二醇二甲醚、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇乙基甲基醚、二乙二醇丁基甲基醚、三乙二醇二甲醚、四乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚、丙二醇二甲醚、丙二醇單甲醚乙酸酯、丙二醇單乙醚乙酸酯、乙二醇單丁醚、乙二醇單丁醚乙酸酯、二乙二醇乙基甲基醚、丙二醇單丙醚乙酸酯、二丙二醇二甲醚等作為較佳者。As ethers, examples of preferred choices include ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol butyl methyl ether, triethylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol dimethyl ether acetate, propylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol ethyl methyl ether, propylene glycol monopropyl ether acetate, and dipropylene glycol dimethyl ether.

作為酮類,例如可舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、3-甲基環己酮、左旋葡聚糖酮、二氫葡聚糖酮等作為較佳者。Among the ketones, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 3-methylcyclohexanone, L-glucanone, and dihydroglucanone are good examples.

作為環狀烴類,例如可舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類作為較佳者。As cyclic hydrocarbons, aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene are good examples.

作為亞碸類,例如可舉出二甲基亞碸作為較佳者。As for ionoids, dimethyl ionoids can be cited as a better example.

作為醯胺類,可舉出N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、N-環己酯-2-吡咯啶酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、N,N-二甲基異丁醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-甲醯基口末啉、N-乙醯基口末啉等作為較佳者。Among the amides, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, N,N-dimethylisobutylamide, 3-methoxy-N,N-dimethylpropionic acid, 3-butoxy-N,N-dimethylpropionic acid, N-methoxy-N,N-dimethylpropionic acid, N-methoxy-N-acety-N-propionic acid, and N-acety-N-propionic acid are considered as better choices.

作為脲類,可舉出N,N,N’,N’-四甲基脲、1,3-二甲基-2-咪唑啶酮等作為較佳者。Among ureas, N,N,N',N'-tetramethylurea and 1,3-dimethyl-2-imidazolidinone are considered better options.

作為醇類,可舉出甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、1-戊醇、1-己醇、苯甲醇、乙二醇單甲基醚、1-甲氧基-2-丙醇、2-乙氧基乙醇、二乙二醇單乙醚、二乙二醇單二乙二醇單己醚、三乙二醇單甲基醚、丙二醇單丙二醇單乙醚、丙二醇單甲醚、聚乙二醇單甲基醚、聚丙二醇、四乙二醇、乙二醇單丁醚、乙二醇單乙二醇單芐醚、乙二醇單乙二醇單苯基醚、甲基苯基甲醇、正戊醇、甲基戊醇及雙丙酮醇等。Examples of alcohols include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 1-hexanol, benzyl alcohol, ethylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-ethoxyethanol, diethylene glycol monoethyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, propylene glycol monopropylene glycol monoethyl ether, propylene glycol monomethyl ether, polyethylene glycol monomethyl ether, polypropylene glycol, tetraethylene glycol, ethylene glycol monobutyl ether, ethylene glycol monoethylene glycol monobenzyl ether, ethylene glycol monoethylene glycol monophenyl ether, methylphenylmethanol, n-pentanol, methylpentanol, and diacetone alcohol.

關於溶劑,從塗佈面性狀的改善等觀點考慮,混合2種以上之形態亦較佳。Regarding solvents, from the perspective of improving coating properties, it is better to mix two or more forms.

在本發明中,選自3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙基溶纖劑乙酸酯、乳酸乙酯、二乙二醇二甲醚、乙酸丁酯、3-甲氧基丙酸甲酯、2-庚酮、環己酮、環戊酮、γ-丁內酯、二甲基亞碸、乙基卡必醇乙酸酯、丁基卡必醇乙酸酯、N-甲基-2-吡咯啶酮、丙二醇甲醚及丙二醇甲醚乙酸酯、左旋葡聚糖酮、二氫葡聚糖酮中之一種溶劑或由2種以上構成之混合溶劑為較佳。併用二甲基亞碸和γ-丁內酯或併用N-甲基-2-吡咯啶酮和乳酸乙酯為特佳。In this invention, solvents selected from one or more of the following are preferred: methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl solvent acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, cyclohexanone, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, ethyl carbitol acetate, butyl carbitol acetate, N-methyl-2-pyrrolidone, propylene glycol methyl ether and propylene glycol methyl ether acetate, L-glucanone, and dihydroglucanone. The combined use of dimethyl sulfoxide and γ-butyrolactone, or the combined use of N-methyl-2-pyrrolidone and ethyl lactate, is particularly preferred.

從塗佈性的觀點考慮,將溶劑的含量設為本發明的樹脂組成物的總固體成分濃度成為5~80質量%之量為較佳,設為成為5~75質量%之量為更佳,設為成為10~70質量%之量為進一步較佳,設為成為20~70質量%為更進一步較佳。關於溶劑含量,只要依據塗膜的所期望厚度和塗佈方法進行調節即可。From a coatability perspective, it is preferable to set the solvent content to 5-80% by mass of the total solids concentration of the resin composition of the present invention, more preferably 5-75% by mass, further preferably 10-70% by mass, and even more preferably 20-70% by mass. The solvent content can be adjusted according to the desired film thickness and coating method.

本發明的樹脂組成物可以僅含有1種溶劑,亦可以含有2種以上。在含有2種以上的溶劑之情況下,其合計在上述範圍內為較佳。The resin composition of the present invention may contain only one solvent or two or more solvents. When it contains two or more solvents, it is preferable that the total amount is within the above range.

<金屬接著性改良劑> 本發明的樹脂組成物包含用於提高與電極或配線等中所使用之金屬材料的接著性之金屬接著性改良劑為較佳。作為金屬接著性改良劑,可舉出具有烷氧基甲矽烷基之矽烷偶合劑、鋁系接著助劑、鈦系接著助劑、具有磺醯胺結構之化合物及具有硫脲之化合物、磷酸衍生物化合物、β酮酸酯化合物、胺基化合物等。 <Metal Adhesion Modifier> The resin composition of this invention preferably includes a metal adhesion modifier for improving adhesion to metal materials used in electrodes or wiring. Examples of metal adhesion modifiers include silane coupling agents having alkoxysilyl groups, aluminum-based adhesives, titanium-based adhesives, compounds having sulfonamide structures and compounds having thiourea structures, phosphoric acid derivative compounds, β-ketoester compounds, and amino compounds.

〔矽烷偶合劑〕 作為矽烷偶合劑,例如可舉出國際公開第2015/199219號的0167段中所記載之化合物、日本特開2014-191002號公報的0062~0073段中所記載之化合物、國際公開第2011/080992號的0063~0071段中所記載之化合物、日本特開2014-191252號公報的0060~0061段中所記載之化合物、日本特開2014-041264號公報的0045~0052段中所記載之化合物、國際公開第2014/097594號的0055段中所記載之化合物、日本特開2018-173573的0067~0078段中所記載之化合物,該等內容被編入本說明書中。又,如日本特開2011-128358號公報的0050~0058段中所記載,使用不同的2種以上的矽烷偶合劑亦較佳。又,矽烷偶合劑使用下述化合物亦較佳。以下式中,Me表示甲基,Et表示乙基。 [Silane Coupling Agents] Examples of silane coupling agents include, for example, the compounds described in paragraph 0167 of International Publication No. 2015/199219, the compounds described in paragraphs 0062-0073 of Japanese Patent Application Publication No. 2014-191002, the compounds described in paragraphs 0063-0071 of International Publication No. 2011/080992, and Japanese Patent Application Publication No. 2014-191252. The compounds described in paragraphs 0060-0061 of Japanese Patent Application Publication No. 2014-041264, paragraphs 0045-0052 of Japanese Patent Application Publication No. 2014/097594, and paragraphs 0067-0078 of Japanese Patent Application Publication No. 2018-173573 are incorporated herein by reference. Furthermore, as described in paragraphs 0050-0058 of Japanese Patent Application Publication No. 2011-128358, it is preferable to use two or more different silane coupling agents. Also, it is preferable to use the following compounds as silane coupling agents. In the following formulas, Me represents methyl and Et represents ethyl.

【化學式66】 【Chemical Formula 66】

作為其他矽烷偶合劑,例如可舉出乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、對苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基三甲氧基矽烷、3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-三乙氧基甲矽烷基-N-(1,3-二甲基-亞丁基)丙胺、N-苯基-3-胺基丙基三甲氧基矽烷、三-(三甲氧基甲矽烷基丙基)異氰脲酸酯、3-脲基丙基三烷氧基矽烷、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷、3-三甲氧基甲矽烷基丙基琥珀酸酐。該等能夠單獨使用1種或組合使用2種以上。Other silane coupling agents include, for example, vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-epoxypropoxypropylmethyldimethoxysilane, 3-epoxypropoxypropyltrimethoxysilane, 3-epoxypropoxypropylmethyldiethoxysilane, 3-epoxypropoxypropyltriethoxysilane, p-styryltrimethoxysilane, 3-methacryloxypropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyl Trimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, tris-(trimethoxysilylpropyl)isocyanurate, 3-ureopropyltrialkoxysilane, 3-piperylpropylmethyldimethoxysilane, 3-piperylpropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane, 3-trimethoxysilylpropylpropylsuccinic anhydride. These can be used alone or in combination of two or more.

〔鋁系接著助劑〕 作為鋁系接著助劑,例如能夠舉出鋁三(乙醯乙酸乙酯)鋁、三(乙醯丙酮)鋁、乙醯乙酸乙酯二異丙醇鋁等。 [Aluminum-based bonding aids] Examples of aluminum-based bonding aids include aluminum tri(ethyl acetate)aluminum, aluminum tri(acetyl acetone)aluminum, and aluminum diisopropanol for ethyl acetate.

又,作為其他金屬接著性改良劑,亦能夠使用日本特開2014-186186號公報的0046~0049段中所記載之化合物、日本特開2013-072935號公報的0032~0043段中所記載之硫化物系化合物,該等內容被編入本說明書中。Furthermore, as other metal adhesion modifiers, compounds described in paragraphs 0046 to 0049 of Japanese Patent Application Publication No. 2014-186186 and sulfide compounds described in paragraphs 0032 to 0043 of Japanese Patent Application Publication No. 2013-072935 can also be used, and these contents are incorporated in this specification.

金屬接著性改良劑的含量相對於特定樹脂100質量份,較佳為0.01~30質量份,更佳為在0.1~10質量份的範圍內,進一步較佳為在0.5~5質量份的範圍內。藉由設為上述下限值以上,圖案與金屬層的接著性變得良好,藉由設為上述上限值以下,圖案的耐熱性、機械特性變得良好。金屬接著性改良劑可以僅為1種,亦可以為2種以上。在使用2種以上之情況下,其合計在上述範圍內為較佳。The content of the metal adhesion modifier relative to 100 parts by weight of a specific resin is preferably 0.01 to 30 parts by weight, more preferably 0.1 to 10 parts by weight, and even more preferably 0.5 to 5 parts by weight. By setting the content above the lower limit above, the adhesion between the pattern and the metal layer becomes good; by setting the content below the upper limit above, the heat resistance and mechanical properties of the pattern become good. The metal adhesion modifier may be a single type or two or more types. When using two or more types, it is preferable that their total content is within the above range.

<遷移抑制劑> 本發明的樹脂組成物還包含遷移抑制劑為較佳。藉由包含遷移抑制劑,能夠有效地抑制來自於金屬層(金屬配線)的金屬離子轉移至膜內。 <Migration Inhibitor> It is preferable that the resin composition of this invention also contains a migration inhibitor. By including the migration inhibitor, the transfer of metal ions from the metal layer (metal wiring) into the membrane can be effectively inhibited.

作為遷移抑制劑,並無特別限制,可舉出具有雜環(吡咯環、呋喃環、噻吩環、咪唑環、噁唑環、噻唑環、吡唑環、異噁唑環、異噻唑環、四唑環、吡啶環、嗒𠯤環、嘧啶環、吡𠯤環、哌啶環、哌𠯤環、嗎啉環、2H-吡喃環及6H-吡喃環、三𠯤環)之化合物、具有硫脲類及氫硫基之化合物、受阻酚系化合物、水楊酸衍生物系化合物、醯肼衍生物系化合物。尤其,能夠較佳地使用1,2,4-三唑、苯并三唑、3-胺基-1,2,4-三唑、3,5-二胺基-1,2,4-三唑等三唑系化合物、1H-四唑、5-苯基四唑、5-胺基-1H-四唑等四唑系化合物。There are no particular limitations on its role as a migration inhibitor. Examples of such inhibitors include compounds with heterocyclic rings (pyrrole ring, furan ring, thiophene ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, isoxazole ring, isothiazole ring, tetrazolium ring, pyridine ring, pyridoxazole ring, pyrimidine ring, pyridoxazole ring, piperidine ring, piperidine ring, morpholinium ring, 2H-pyran ring and 6H-pyran ring, tripyranium ring), compounds with thiourea and hydrogen sulfide groups, hindered phenolic compounds, salicylic acid derivative compounds, and acehydrazine derivative compounds. In particular, triazole compounds such as 1,2,4-triazole, benzotriazole, 3-amino-1,2,4-triazole, and 3,5-diamino-1,2,4-triazole, as well as tetraazole compounds such as 1H-tetrazole, 5-phenyltetrazole, and 5-amino-1H-tetrazole, can be used more effectively.

或者,亦能夠使用捕捉鹵素離子等陰離子之離子捕捉劑。Alternatively, ion trapping agents that capture anions such as halogen ions can be used.

作為其他遷移抑制劑,能夠使用日本特開2013-015701號公報的0094段中所記載之防鏽劑、日本特開2009-283711號公報的0073~0076段中所記載之化合物、日本特開2011-059656號公報的0052段中所記載之化合物、日本特開2012-194520號公報的0114段、0116段及0118段中所記載之化合物、國際公開第2015/199219號的0166段中所記載之化合物等,該等內容被編入本說明書中。As other migration inhibitors, the rust inhibitor described in paragraph 0094 of Japanese Patent Application Publication No. 2013-015701, the compounds described in paragraphs 0073 to 0076 of Japanese Patent Application Publication No. 2009-283711, the compounds described in paragraph 0052 of Japanese Patent Application Publication No. 2011-059656, the compounds described in paragraphs 0114, 0116 and 0118 of Japanese Patent Application Publication No. 2012-194520, and the compounds described in paragraph 0166 of International Publication No. 2015/199219, etc., can be used, and these contents are incorporated in this specification.

作為遷移抑制劑的具體例,能夠舉出下述化合物。The following compounds can be cited as examples of migration inhibitors.

【化學式67】 【Chemical Formula 67】

在本發明的樹脂組成物具有遷移抑制劑之情況下,遷移抑制劑的含量相對於本發明的樹脂組成物的總固體成分為0.01~5.0質量%為較佳,0.05~2.0質量%為更佳,0.1~1.0質量%為進一步較佳。When the resin composition of the present invention contains a migration inhibitor, the content of the migration inhibitor relative to the total solid content of the resin composition of the present invention is preferably 0.01 to 5.0% by mass, more preferably 0.05 to 2.0% by mass, and even more preferably 0.1 to 1.0% by mass.

遷移抑制劑可以僅為1種,亦可以為2種以上。在遷移抑制劑為2種以上之情況下,其合計在上述範圍內為較佳。There may be only one migration inhibitor or two or more. When there are two or more migration inhibitors, it is preferable that their total number is within the above range.

<聚合抑制劑> 本發明的樹脂組成物包含聚合抑制劑為較佳。作為聚合抑制劑,可舉出酚系化合物、醌系化合物、胺基系化合物、N-氧基自由基化合物系化合物、硝基系化合物、亞硝基系化合物、雜芳香環系化合物、金屬化合物等。 <Polymerization Inhibitor> The resin composition of this invention preferably includes a polymerization inhibitor. Examples of polymerization inhibitors include phenolic compounds, quinone compounds, amino compounds, N-oxygen radical compounds, nitro compounds, nitroso compounds, heteroaromatic ring compounds, and metallic compounds.

作為聚合抑制劑的具體的化合物,例如較佳地使用對氫醌、鄰氫醌、鄰甲氧基酚、對甲氧基酚、二-三級丁基-對甲酚、五倍子酚、對-三級丁基鄰苯二酚、1,4-苯醌、二苯基-對苯醌、4,4’-硫代雙(3-甲基-6-三級丁基酚)、2,2’-亞甲基雙(4-甲基-6-三級丁基酚)、N-亞硝基苯基羥基胺第一鈰鹽、N-亞硝基-N-苯基羥基胺鋁鹽、N-亞硝基二苯胺、N-苯基萘胺、伸乙基二胺四乙酸、1,2-環己二胺四乙酸、乙二醇醚二胺四乙酸、2,6-二-三級丁基-4-甲基酚、5-亞硝基-8-羥基喹啉、1-亞硝基-2-萘酚、2-亞硝基-1-萘酚、2-亞硝基-5-(N-乙基-N-磺基丙基胺)酚、N-亞硝基-N-(1-萘基)羥胺銨鹽、雙(4-羥基-3,5-三級丁基)苯基甲烷、1,3,5-三(4-三級丁基-3-羥基)-2,6-二甲基芐基)-1,3,5-三𠯤-2,4,6-(1H,3H,5H)-三酮、4-羥基-2,2,6,6-四甲基哌啶1-氧自由基、2,2,6,6-四甲基哌啶1-氧基自由基、吩噻𠯤、啡噁𠯤、1,1-二苯基-2-吡咯肼、二丁基二硫代碳酸銅(II)、硝基苯、N-亞硝基-N-苯基羥胺鋁鹽、N-亞硝基-N-苯基羥基胺銨鹽等。又,亦能夠使用日本特開2015-127817號公報的0060段中所記載之聚合抑制劑及國際公開第2015/125469號的0031~0046段中所記載之化合物,該內容被編入本說明書中。Specific compounds used as polymerization inhibitors include, preferably, p-hydroquinone, ortho-hydroquinone, ortho-methoxyphenol, p-methoxyphenol, di-tertiary butyl-p-cresol, gallnutol, p-tertiary butylcatechol, 1,4-benzoquinone, diphenyl-p-benzoquinone, 4,4'-thiobis(3-methyl-6-tertiary butylphenol), and 2,2'-methylenebis(4-methyl-6-tertiary butylphenol). Butylphenol), N-nitrosophenylhydroxylamine monocerium salt, N-nitroso-N-phenylhydroxylamine aluminum salt, N-nitrosodiphenylamine, N-phenylnaphthylamine, ethylenediaminetetraacetic acid, 1,2-cyclohexanediaminetetraacetic acid, ethylene glycol ether diaminetetraacetic acid, 2,6-di-tertiary butyl-4-methylphenol, 5-nitroso-8-hydroxyquinoline, 1-nitroso-2-naphthol, 2- Nitrosamino-1-naphthol, 2-nitroso-5-(N-ethyl-N-sulfopropylamine)phenol, N-nitroso-N-(1-naphthyl)hydroxyamine ammonium salt, bis(4-hydroxy-3,5-triterpenoid)phenylmethane, 1,3,5-tris(4-triterpenoid-3-hydroxy)-2,6-dimethylbenzyl)-1,3,5-tris(1H,3H)-2,4,6-(1H,3H) The following compounds are permitted: (5H)-trione, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxy radical, 2,2,6,6-tetramethylpiperidine 1-oxy radical, phenthiazolinone, phenoxazolinone, 1,1-diphenyl-2-pyrrolidinehydrazine, dibutyldithiocopper(II), nitrobenzene, N-nitroso-N-phenylhydroxyamine aluminum salt, N-nitroso-N-phenylhydroxyamine ammonium salt, etc. Furthermore, polymerization inhibitors described in paragraph 0060 of Japanese Patent Application Publication No. 2015-127817 and compounds described in paragraphs 0031 to 0046 of International Publication No. 2015/125469 may also be used, and these contents are incorporated herein by reference.

在本發明的樹脂組成物包含聚合抑制劑之情況下,聚合抑制劑的含量相對於本發明的樹脂組成物的總固體成分為0.01~20質量%為較佳0.02~15質量%為更佳,0.05~10質量%為進一步較佳。When the resin composition of the present invention contains a polymerization inhibitor, the content of the polymerization inhibitor relative to the total solid content of the resin composition of the present invention is preferably 0.01 to 20% by mass, more preferably 0.02 to 15% by mass, and even more preferably 0.05 to 10% by mass.

聚合抑制劑可以僅為1種,亦可以為2種以上。在聚合抑制劑為2種以上之情況下,其合計在上述範圍內為較佳。The polymerization inhibitor may be one type or two or more types. When there are two or more polymerization inhibitors, it is preferable that their total amount is within the above range.

<酸捕捉劑> 為了減少因從曝光至加熱為止的經時而引起之性能變化,本發明的樹脂組成物含有酸捕捉劑為較佳。其中,酸捕捉劑係指藉由存在於系統中而能夠捕捉產生酸之化合物,酸度低且pKa高的化合物為較佳。作為酸捕捉劑,具有胺基之化合物為較佳,一級胺、二級胺、三級胺、銨鹽、三級醯胺等為較佳,一級胺、二級胺、三級胺、銨鹽為較佳,二級胺、三級胺、銨鹽為更佳。 作為酸捕捉劑,能夠較佳地舉出具有咪唑結構、二氮雜雙環結構、鎓結構、三烷基胺結構、苯胺結構或吡啶結構之化合物、具有羥基和/或醚鍵之烷基胺衍生物、具有羥基和/或醚鍵之苯胺衍生物等。在具有鎓結構之情況下,酸捕捉劑為具有選自銨、重氮、錪、鋶、鏻、吡啶鎓等中之陽離子和酸度比由酸產生劑所產生之酸更低的酸的陰離子之鹽為較佳。 <Acid Scavenger> To reduce performance changes caused by the time elapsed between exposure and heating, the resin composition of this invention preferably contains an acid scavenger. The acid scavenger refers to a compound that can capture acid-producing compounds by being present in the system; compounds with low acidity and high pKa are preferred. As an acid scavenger, compounds with an amino group are preferred, including primary amines, secondary amines, tertiary amines, ammonium salts, and tertiary amides; primary amines, secondary amines, tertiary amines, and ammonium salts are preferred, with secondary amines, tertiary amines, and ammonium salts being even more preferred. As acid scavengers, preferred examples include compounds with imidazole, diazabicyclic, onium, trialkylamine, aniline, or pyridine structures; alkylamine derivatives with hydroxyl and/or ether bonds; and aniline derivatives with hydroxyl and/or ether bonds. In the case of an onium structure, the acid scavenger is preferably a salt having a cation selected from ammonium, diazo, monazine, strontium, phosphonium, or pyridinium, and an anion of an acid with a lower acidity than that produced by the acid generator.

作為具有咪唑結構之酸捕捉劑,可舉出咪唑、2,4,5-三苯基咪唑、苯并咪唑、2-苯基苯并咪唑等。作為具有二氮雜雙環結構之酸捕捉劑,可舉出1,4-二氮雜雙環[2,2,2]辛烷、1,5-二氮雜雙環[4,3,0]壬-5-烯、1,8-二氮雜雙環[5,4,0]十一碳-7-烯等。作為具有鎓結構之酸捕捉劑,可舉出氧化四丁基銨、氫氧化三芳基鋶、氫氧化苯甲醯甲基鋶、具有2-氧代烷基之鋶氫氧化物、具體而言氫氧化三苯基鋶、氫氧化三(三級丁基苯基)鋶、氫氧化雙(三級丁基苯基)錪、氫氧化苯甲醯甲基噻吩鎓、氫氧化2-氧代丙基噻吩鎓等。作為具有三烷基胺結構之酸捕捉劑,能夠舉出三(正丁基)胺、三(正辛基)胺等。作為具有苯胺結構之酸捕捉劑,能夠舉出2,6-二異丙基苯胺、N,N-二甲基苯胺、N,N-二丁基苯胺、N,N-二己基苯胺等。作為具有吡啶結構之酸捕捉劑,能夠舉出吡啶、4-甲基吡啶等。作為具有羥基和/或醚鍵之烷基胺衍生物,能夠舉出乙醇胺、二乙醇胺、三乙醇胺、N-苯基二乙醇胺、三(甲氧基乙氧基乙基)胺等。作為具有羥基和/或醚鍵之苯胺衍生物,能夠舉出N,N-雙(羥乙基)苯胺等。Examples of acid scavengers with an imidazole structure include imidazole, 2,4,5-triphenylimidazolium, benzimidazole, and 2-phenylbenzimidazole. Examples of acid scavengers with a diazabicyclic structure include 1,4-diazabicyclic[2,2,2]octane, 1,5-diazabicyclic[4,3,0]non-5-ene, and 1,8-diazabicyclic[5,4,0]undec-7-ene. Examples of acid scavengers with a tunica structure include tetrabutylammonium hydroxide, triarylstromium hydroxide, benzylmethylstromium hydroxide, strom hydroxides with a 2-oxoalkyl group, specifically triphenylstromium hydroxide, tris(tri-butylphenyl)stromium hydroxide, bis(tri-butylphenyl)monium hydroxide, benzylmethylthiophenonium hydroxide, and 2-oxopropylthiophenonium hydroxide. Examples of acid scavengers with a trialkylamine structure include tri(n-butyl)amine and tri(n-octyl)amine. Examples of acid scavengers with an aniline structure include 2,6-diisopropylaniline, N,N-dimethylaniline, N,N-dibutylaniline, and N,N-dihexylaniline. Examples of acid scavengers with a pyridine structure include pyridine and 4-methylpyridine. Examples of alkylamine derivatives with hydroxyl and/or ether bonds include ethanolamine, diethanolamine, triethanolamine, N-phenyldiethanolamine, and tris(methoxyethoxyethyl)amine. Examples of aniline derivatives with hydroxyl and/or ether bonds include N,N-bis(hydroxyethyl)aniline.

作為較佳的酸捕捉劑的具體例,可舉出乙醇胺、二乙醇胺、三乙醇胺、乙基胺、二乙胺、三乙胺、己胺、十二胺、環己胺、環己基甲基胺、環己基二甲基胺、苯胺、N-甲基苯胺、N,N-二甲基苯胺、二苯基胺、吡啶、丁胺、異丁胺、二丁胺、三丁胺、二環己胺、DBU(二氮雜雙環十一碳)、DABCO(1,4-二氮雜雙環[2.2.2]辛烷)、N,N-二異丙基乙基胺、四甲基氫氧化銨、乙二胺、1,5-二胺基戊烷、N-甲基己胺、N-甲基二環己胺、三辛基胺、N-乙基乙二胺、N,N-二乙基乙二胺、N,N,N’,N’-四丁基-1,6-己烷二胺、精三胺、二胺基環己烷、雙(2-甲氧基乙基)胺、哌啶、甲基哌啶、哌𠯤、托烷、N-苯基苄胺、1,2-二苯胺基乙烷(dianilinoethane)、2-胺基乙醇、甲苯胺、胺基酚、己基苯胺、伸苯基二胺、苯基乙基胺、二苄胺、吡咯、N-甲基吡咯、胍、胺基吡咯啶、吡唑、吡唑啉、胺基口末啉、胺基烷基口末啉等。Specific examples of preferred acid scavengers include ethanolamine, diethanolamine, triethanolamine, ethylamine, diethylamine, triethylamine, hexylamine, dodecylamine, cyclohexylamine, cyclohexylmethylamine, cyclohexyldimethylamine, aniline, N-methylaniline, N,N-dimethylaniline, diphenylamine, pyridine, butylamine, isobutylamine, dibutylamine, tributylamine, dicyclohexylamine, DBU (diazabicycloundecane), DABCO (1,4-diazabicyclo[2.2.2]octane), N,N-diisopropylethylamine, tetramethylammonium hydroxide, ethylenediamine, 1,5-diaminopentane, N-methylhexylamine, N-methyl Dicyclohexylamine, trioctylamine, N-ethylethylenediamine, N,N-diethylethylenediamine, N,N,N',N'-tetrabutyl-1,6-hexanediamine, succinyltriamine, diaminocyclohexane, bis(2-methoxyethyl)amine, piperidine, methylpiperidine, piperidine, tropane, N-phenylbenzylamine, 1,2-diphenylaminoethane, 2-aminoethanol, toluidine, aminophenol, hexylaniline, phenylenediamine, phenylethylamine, dibenzylamine, pyrrole, N-methylpyrrole, guanidine, aminopyrrolidine, pyrazole, pyrazoline, aminopyroline, aminoalkylpyroline, etc.

該等酸捕捉劑可以單獨使用1種,可以組合使用2種以上。 本發明之組成物可以含有酸捕捉劑,亦可以不含有酸捕捉劑,但是在含有之情況下,酸捕捉劑的含量以組成物的總固體成分為標準,通常為0.001~10質量%,較佳為0.01~5質量%。 These acid scavenging agents can be used alone or in combination of two or more. The composition of this invention may contain an acid scavenging agent or may not contain an acid scavenging agent. However, when it does contain an acid scavenging agent, the content of the acid scavenging agent is based on the total solid content of the composition, typically 0.001 to 10% by mass, preferably 0.01 to 5% by mass.

酸產生劑與酸捕捉劑的使用比例為酸產生劑/酸捕捉劑(莫耳比)=2.5~300為較佳。亦即,從靈敏度、解析度的觀點考慮,莫耳比為2.5以上為較佳,從抑制由浮雕圖案隨著曝光後至加熱處理為止的經時變厚而引起之解析度的降低的觀點考慮,300以下為較佳。酸產生劑/酸捕捉劑(莫耳比)更佳為5.0~200,進一步較佳為7.0~150。The optimal ratio of acid generator to acid scavenger is 2.5 to 300 (molar ratio). That is, from the perspective of sensitivity and resolution, a molar ratio of 2.5 or higher is preferable; from the perspective of suppressing the decrease in resolution caused by the thickening of the relief pattern over time from exposure to heat treatment, a ratio below 300 is preferable. A molar ratio of 5.0 to 200 is more preferred, and 7.0 to 150 is even more desirable.

<其他添加劑> 本發明的樹脂組成物在可以獲得本發明的效果之範圍內依據需要能夠配合各種的添加物、例如界面活性劑、高級脂肪酸衍生物、熱聚合起始劑、無機粒子、紫外線吸收劑、有機鈦化合物、抗氧化劑、抗凝聚劑、酚系化合物、其他高分子化合物、可塑劑及其他助劑類(例如,消泡劑、阻燃劑等)等。藉由適當含有該等成分,能夠調整膜物理性質等性質。關於該等成分,例如能夠參閱日本特開2012-003225號公報的0183段以後(所對應之美國專利申請公開第2013/0034812號說明書的0237段)的記載及日本特開2008-250074號公報的0101~0104段、0107~0109段等的記載,該等內容被編入本說明書中。在配合該等添加劑之情況下,將其合計配合量設為本發明的樹脂組成物的固體成分的3質量%以下為較佳。 <Other Additives> The resin composition of this invention can be combined with various additives as needed, within the scope of achieving the effects of this invention, such as surfactants, higher fatty acid derivatives, thermal polymerization initiators, inorganic particles, ultraviolet absorbers, organic titanium compounds, antioxidants, anti-coagulants, phenolic compounds, other polymers, plasticizers, and other auxiliaries (e.g., defoamers, flame retardants, etc.). By appropriately containing these components, the physical properties of the membrane can be adjusted. Regarding these components, please refer to paragraphs 0183 onwards in Japanese Patent Application Publication No. 2012-003225 (corresponding to paragraph 0237 of the specification of U.S. Patent Application Publication No. 2013/0034812) and paragraphs 0101-0104, 0107-0109, etc., in Japanese Patent Application Publication No. 2008-250074, the contents of which are incorporated herein. When incorporating these additives, it is preferable that their total amount be 3% by weight or less of the solid content of the resin composition of the present invention.

〔界面活性劑〕 作為界面活性劑,能夠使用氟系界面活性劑、矽酮系界面活性劑、烴系界面活性劑等各種界面活性劑。界面活性劑可以為非離子型界面活性劑,亦可以為陽離子型界面活性劑,亦可以為陰離子型界面活性劑。 [Surfactants] As surfactants, various types of surfactants can be used, including fluorinated surfactants, silicone surfactants, and hydrocarbon surfactants. Surfactants can be nonionic, cationic, or anionic.

藉由在本發明的感光性樹脂組成物中含有界面活性劑,進一步提高作為塗佈液進行製備時的液體特性(尤其,流動性),從而能夠進一步改善塗佈厚的均勻性或省液性。亦即,在使用適用了含有界面活性劑之組成物之塗佈液而形成膜之情況下,被塗佈面與塗佈液的界面張力降低而改善對被塗佈面的潤濕性,從而提高對被塗佈面的塗佈性。因此,能夠更佳地進行厚度不均勻的小的均勻厚度的膜形成。By including a surfactant in the photosensitive resin composition of this invention, the liquid properties (especially flowability) during preparation as a coating liquid are further improved, thereby further improving the uniformity or liquid-saving properties of the coating thickness. That is, when forming a film using a coating liquid containing a surfactant composition, the interfacial tension between the coated surface and the coating liquid is reduced, improving the wetting of the coated surface and thus enhancing the coating properties. Therefore, it is possible to better form films with small, uniform thicknesses despite uneven thickness.

作為氟系界面活性劑,例如可舉出MEGAFACE F171、MEGAFACE F172、MEGAFACE F173、MEGAFACE F176、MEGAFACE F177、MEGAFACE F141、MEGAFACE F142、MEGAFACE F143、MEGAFACE F144、MEGAFACE R30、MEGAFACE F437、MEGAFACE F475、MEGAFACE F479、MEGAFACE F482、MEGAFACE F554、MEGAFACE F780、RS-72-K(以上為DIC CORPORATION製)、Fluorad FC430、Fluorad FC431、Fluorad FC171、Novell FC4430、Novell FC4432(以上為3M Japan Limited製)、Surflon S-382、Surflon SC-101、Surflon SC-103、Surflon SC-104、Surflon SC-105、Surflon SC-1068、Surflon SC-381、Surflon SC-383、Surflon S-393、Surflon KH-40(以上為ASAHI GLASS CO.,LTD.製)、PF636、PF656、PF6320、PF6520、PF7002(OMNOVA Solutions Inc.製)等。氟系界面活性劑亦能夠使用日本特開2015-117327號公報的0015~0158段中所記載之化合物、日本特開2011-132503號公報的0117~0132段中所記載之化合物,該等內容被編入本說明書中。亦能夠使用嵌段聚合物作為氟系界面活性劑,作為具體例,例如可舉出日本特開2011-89090號公報中所記載之化合物,該等內容被編入本說明書中。 氟系界面活性劑亦能夠較佳地使用含氟高分子化合物,該含氟高分子化合物包含來自於具有氟原子之(甲基)丙烯酸酯化合物之重複單元和來自於具有兩個以上(較佳為5個以上)的伸烷氧基(較佳為乙烯氧基、丙烯氧基)之(甲基)丙烯酸酯化合物之重複單元,亦可例示下述化合物作為本發明中所使用之氟系界面活性劑。 【化學式68】 Examples of fluorinated surfactants include MEGAFACE F171, MEGAFACE F172, MEGAFACE F173, MEGAFACE F176, MEGAFACE F177, MEGAFACE F141, MEGAFACE F142, MEGAFACE F143, MEGAFACE F144, MEGAFACE R30, MEGAFACE F437, MEGAFACE F475, MEGAFACE F479, MEGAFACE F482, MEGAFACE F554, MEGAFACE F780, RS-72-K (manufactured by DIC CORPORATION), Fluorad FC430, Fluorad FC431, Fluorad FC171, Novell FC4430, Novell FC4432 (manufactured by 3M Japan Limited), and Surflon. S-382, Surflon SC-101, Surflon SC-103, Surflon SC-104, Surflon SC-105, Surflon SC-1068, Surflon SC-381, Surflon SC-383, Surflon S-393, Surflon KH-40 (the above is ASAHI GLASS CO., LTD.), PF636, PF656, PF6320, PF6520, PF7002 (manufactured by OMNOVA Solutions Inc.), etc. Fluorinated surfactants may also use compounds described in paragraphs 0015 to 0158 of Japanese Patent Application Publication No. 2015-117327 and paragraphs 0117 to 0132 of Japanese Patent Application Publication No. 2011-132503, the contents of which are incorporated herein by reference. Block polymers may also be used as fluorinated surfactants; for example, compounds described in Japanese Patent Application Publication No. 2011-89090 may be cited, the contents of which are incorporated herein by reference. Fluorinated surfactants can also preferably use fluorinated polymers comprising repeating units derived from (meth)acrylate compounds having fluorine atoms and repeating units derived from (meth)acrylate compounds having two or more (preferably five or more) alkoxy groups (preferably ethoxy or propenoxy). Examples of fluorinated surfactants used in this invention include the following compound: [Chemical Formula 68]

上述化合物的重量平均分子量較佳為3,000~50,000,5,000~30,000為更佳。 氟系界面活性劑亦能夠將在側鏈上具有乙烯性不飽和基之含氟聚合物用作氟系界面活性劑。作為具體例,可舉出日本特開2010-164965號公報的0050~0090段及0289~0295段中所記載之化合物,該內容被編入本說明書中。又,作為市售品,例如可舉出DIC CORPORATION製的MEGAFACE RS-101、RS-102、RS-718K等。 The weight-average molecular weight of the above-mentioned compounds is preferably 3,000 to 50,000, and more preferably 5,000 to 30,000. Fluoropolymers with vinyl unsaturated groups on their side chains can also be used as fluorine surfactants. Specific examples include compounds described in paragraphs 0050 to 0090 and 0289 to 0295 of Japanese Patent Application Publication No. 2010-164965, the contents of which are incorporated herein by reference. Commercially available examples include MEGAFACE RS-101, RS-102, and RS-718K manufactured by DIC CORPORATION.

氟系界面活性劑中的氟含有率為3~40質量%為較佳,更佳為5~30質量%,特佳為7~25質量%。在塗佈膜的厚度的均勻性或省液性的方面而言,氟含有率在該範圍內的氟系界面活性劑係有效的,在組成物中之溶解性亦良好。Fluorinated surfactants are preferably composed of 3–40% by mass, more preferably 5–30% by mass, and especially preferably 7–25% by mass. Fluorinated surfactants with fluorine content within this range are effective in terms of uniformity of coating thickness and liquid-saving properties, and also exhibit good solubility in the composition.

作為矽酮系界面活性劑,例如可舉出Toray Silicone DC3PA、Toray Silicone SH7PA、Toray Silicone DC11PA、Toray Silicone SH21PA、Toray Silicone SH28PA、Toray Silicone SH29PA、Toray Silicone SH30PA、Toray Silicone SH8400(以上為Dow Corning Toray Co.,Ltd.製)、TSF-4440、TSF-4300、TSF-4445、TSF-4460、TSF-4452(以上為Momentive performance Materials Inc.製)、KP-341、KF6001、KF6002(以上為Shin-Etsu Chemical Co., Ltd.製)、BYK307、BYK323、BYK330(以上為BYK Chemie GmbH製)等。Examples of silicone-based surfactants include Toray Silicone DC3PA, Toray Silicone SH7PA, Toray Silicone DC11PA, Toray Silicone SH21PA, Toray Silicone SH28PA, Toray Silicone SH29PA, Toray Silicone SH30PA, Toray Silicone SH8400 (manufactured by Dow Corning Toray Co., Ltd.), TSF-4440, TSF-4300, TSF-4445, TSF-4460, TSF-4452 (manufactured by Momentive Performance Materials Inc.), KP-341, KF6001, KF6002 (manufactured by Shin-Etsu Chemical Co., Ltd.), BYK307, BYK323, and BYK330 (manufactured by BYK Chemie GmbH).

作為烴系界面活性劑,例如可舉出PIONIN A-76、Newkalgen FS-3PG、PIONIN B-709、PIONIN B-811-N、PIONIN D-1004、PIONIN D-3104、PIONIN D-3605、PIONIN D-6112、PIONIN D-2104-D、PIONIN D-212、PIONIN D-931、PIONIN D-941、PIONIN D-951、PIONIN E-5310、PIONIN P-1050-B、PIONIN P-1028-P、PIONIN P-4050-T等(以上為TAKEMOTO OIL&FAT CO.,LTD.製)等。Examples of hydrocarbon surfactants include PIONIN A-76, Newkalgen FS-3PG, PIONIN B-709, PIONIN B-811-N, PIONIN D-1004, PIONIN D-3104, PIONIN D-3605, PIONIN D-6112, PIONIN D-2104-D, PIONIN D-212, PIONIN D-931, PIONIN D-941, PIONIN D-951, PIONIN E-5310, PIONIN P-1050-B, PIONIN P-1028-P, and PIONIN P-4050-T (all manufactured by TAKEMOTO OIL & FAT CO.,LTD.).

作為非離子型界面活性劑,可例示甘油、三羥甲基丙烷、三羥甲基乙烷以及該等乙氧基化物及丙氧基化物(例如,甘油丙氧基化物、甘油乙氧基化物等)、聚氧乙烯月桂基醚、聚氧乙烯硬脂基醚、聚氧乙烯油基醚、聚氧乙烯辛基苯基醚、聚氧乙烯壬基苯基醚、聚乙二醇二月桂酸酯、聚乙二醇二硬脂酸酯、山梨糖醇酐脂肪酸酯等。作為市售品,可舉出Pluronic(註冊商標)L10、L31、L61、L62、10R5、17R2、25R2(BASF公司製)、Tetronic 304、701、704、901、904、150R1(BASF公司製)、Solsperse 20000(Lubrizol Japan Ltd.製)、NCW-101、NCW-1001、NCW-1002(Wako Pure Chemical Industries, Ltd.製)、PIONIN D-6112、D-6112-W、D-6315(TAKEMOTO OIL & FAT CO.,LTD製)、OLFIN E1010、Surfynol 104、400、440(Nissin Chemical co.,ltd.製)等。Examples of nonionic surfactants include glycerol, trihydroxymethylpropane, trihydroxymethylethane and their ethoxylated and propoxylated derivatives (e.g., glycerol propoxylated, glycerol ethoxylated, etc.), polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene oil-based ether, polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether, polyethylene glycol dilaurate, polyethylene glycol distearate, sorbitan fatty acid esters, etc. Commercially available products include Pluronic (registered trademark) L10, L31, L61, L62, 10R5, 17R2, 25R2 (manufactured by BASF), Tetronic 304, 701, 704, 901, 904, 150R1 (manufactured by BASF), Solsperse 20000 (manufactured by Lubrizol Japan Ltd.), NCW-101, NCW-1001, NCW-1002 (manufactured by Wako Pure Chemical Industries, Ltd.), PIONIN D-6112, D-6112-W, D-6315 (manufactured by TAKEMOTO OIL & FAT CO.,LTD), OLFIN E1010, Surfynol 104, 400, 440 (manufactured by Nissin Chemical Co., Ltd.), etc.

作為陽離子系界面活性劑,具體而言,可舉出有機矽氧烷聚合物KP-341(Shin-Etsu Chemical Co., Ltd.製)、(甲基)丙烯酸系(共)聚合物Polyflow No.75、No.77、No.90、No.95(KYOEISHA CHEMICAL Co.,LTD.製)、W001(Yusho Co.,Ltd.製)等。As cationic surfactants, examples include organosiloxane polymer KP-341 (manufactured by Shin-Etsu Chemical Co., Ltd.), (meth)acrylic acid (co)polymers Polyflow No.75, No.77, No.90, No.95 (manufactured by KYOEISHA CHEMICAL Co.,LTD.), and W001 (manufactured by Yusho Co.,Ltd.).

作為陰離子系界面活性劑,具體而言,可舉出W004、W005、W017(Yusho Co.,Ltd.製)、SANDET BL(SANYO KASEI Co.Ltd.製)等。As anionic surfactants, examples include W004, W005, W017 (manufactured by Yusho Co., Ltd.), and SANDET BL (manufactured by SANYO KASEI Co., Ltd.).

界面活性劑可以僅使用1種,亦可以組合使用2種以上。 界面活性劑的含量相對於組成物的總固體成分為0.001~2.0質量%為較佳,0.005~1.0質量%為更佳。 A single surfactant can be used, or two or more can be used in combination. The surfactant content relative to the total solids of the composition is preferably 0.001–2.0% by mass, and more preferably 0.005–1.0% by mass.

〔高級脂肪酸衍生物〕 為了防止因氧引起的聚合阻礙,可以在本發明的樹脂組成物中添加如二十二酸或二十二酸醯胺的高級脂肪酸衍生物,從而使其在塗佈後的乾燥過程中不均勻地存在於本發明的樹脂組成物的表面上。 [Higher Fatty Acid Derivatives] To prevent polymerization hindrance caused by oxygen, higher fatty acid derivatives such as docosanoic acid or docosanoylamine can be added to the resin composition of the present invention, thereby causing them to exist unevenly on the surface of the resin composition of the present invention during the drying process after coating.

又,高級脂肪酸衍生物亦能夠使用國際公開第2015/199219號的0155段中所記載之化合物,該內容被編入本說明書中。Furthermore, higher fatty acid derivatives may also use compounds described in paragraph 0155 of International Publication No. 2015/199219, which is incorporated in this specification.

在本發明的樹脂組成物具有高級脂肪酸衍生物之情況下,高級脂肪酸衍生物的含量相對於本發明的樹脂組成物的總固體成分為0.1~10質量%為較佳。高級脂肪酸衍生物可以僅為1種,亦可以為2種以上。在高級脂肪酸衍生物為2種以上之情況下,其合計在上述範圍內為較佳。When the resin composition of the present invention contains higher fatty acid derivatives, the content of higher fatty acid derivatives relative to the total solid content of the resin composition of the present invention is preferably 0.1% to 10% by mass. There may be only one type of higher fatty acid derivative, or there may be two or more types. When there are two or more types of higher fatty acid derivatives, it is preferable that their total content is within the above-mentioned range.

〔熱聚合起始劑〕 本發明的樹脂組成物可以包含熱聚合起始劑,尤其可以包含熱自由基聚合起始劑。熱自由基聚合起始劑為藉由熱的能量而產生自由基並起始或促進具有聚合性之化合物的聚合反應之化合物。藉由添加熱自由基聚合起始劑,亦能夠使樹脂及聚合性化合物進行聚合反應,因此能夠進一步提高耐溶劑性。又,上述之光聚合起始劑亦具有藉由熱量引發聚合之功能之情況,並且具有能夠作為熱聚合起始劑而添加之情況。 [Thermal Polymerization Initiator] The resin composition of this invention may contain a thermal polymerization initiator, particularly a thermal free radical polymerization initiator. A thermal free radical polymerization initiator is a compound that generates free radicals through thermal energy and initiates or promotes the polymerization reaction of a polymerizable compound. By adding a thermal free radical polymerization initiator, the resin and polymerizable compound can also undergo polymerization, thus further improving solvent resistance. Furthermore, the aforementioned photopolymerization initiator also has the function of initiating polymerization through heat, and can be added as a thermal polymerization initiator.

作為熱自由基聚合起始劑,具體而言,可舉出日本特開2008-063554號公報的0074~0118段中所記載之化合物,該內容被編入本說明書中。As a thermal free radical polymerization initiator, specifically, the compounds described in paragraphs 0074 to 0118 of Japanese Patent Application Publication No. 2008-063554, the contents of which are incorporated in this specification, can be cited.

在包含熱聚合起始劑之情況下,其含量相對於本發明的樹脂組成物的總固體成分為0.1~30質量%為較佳,更佳為0.1~20質量%,進一步較佳為0.5~15質量%。熱聚合起始劑可以僅含有1種,亦可以含有2種以上。在含有2種以上的熱聚合起始劑之情況下,合計量在上述範圍內為較佳。When a thermal polymerization initiator is included, its content relative to the total solid content of the resin composition of the present invention is preferably 0.1 to 30% by mass, more preferably 0.1 to 20% by mass, and even more preferably 0.5 to 15% by mass. The thermal polymerization initiator may contain only one type or two or more types. When two or more thermal polymerization initiators are included, the total amount is preferably within the above range.

〔無機粒子〕 本發明的樹脂組成物可以包含無機粒子。作為無機粒子,具體而言,能夠包含碳酸鈣、磷酸鈣、二氧化矽、高嶺土、滑石、二氧化鈦、氧化鋁、硫酸鋇、氟化鈣、氟化鋰、沸石、硫化鉬、玻璃等。 [Inorganic Particles] The resin composition of this invention may contain inorganic particles. Specifically, these inorganic particles may include calcium carbonate, calcium phosphate, silicon dioxide, kaolin, talc, titanium dioxide, aluminum oxide, barium sulfate, calcium fluoride, lithium fluoride, zeolite, molybdenum sulfide, glass, etc.

作為上述無機粒子的平均粒徑,0.01~2.0μm為較佳,0.02~1.5μm為更佳,0.03~1.0μm為進一步較佳,0.04~0.5μm為特佳。 無機粒子的上述平均粒徑為一次粒徑,並且為體積平均粒徑。關於體積平均粒徑,能夠藉由基於Nanotrac WAVE II EX-150(Nikkiso Co., Ltd.製)之動態光散射法進行測定。 在難以進行上述測定之情況下,亦能夠藉由離心沉降透光法、X射線透過法、雷射繞射/散射法進行測定。 The preferred average particle size for the aforementioned inorganic particles is 0.01–2.0 μm, more preferably 0.02–1.5 μm, further preferably 0.03–1.0 μm, and exceptionally preferably 0.04–0.5 μm. The aforementioned average particle size for the inorganic particles refers to the primary particle size and the volume average particle size. The volume average particle size can be determined using dynamic light scattering based on the Nanotrac WAVE II EX-150 (manufactured by Nikkiso Co., Ltd.). In cases where the above determination is difficult, it can also be determined using centrifugal sedimentation transmission, X-ray transmission, or laser diffraction/scattering methods.

〔紫外線吸收劑〕 本發明的組成物可以包含紫外線吸收劑。作為紫外線吸收劑,能夠使用水楊酸酯系、二苯甲酮系、苯并三唑系、取代丙烯腈系、三𠯤系等紫外線吸收劑。 作為水楊酸酯系紫外線吸收劑的例子,可舉出水楊酸苯酯、水楊酸對辛基苯酯、水楊酸對三級丁基苯酯等,作為二苯甲酮系紫外線吸收劑的例子,可舉出2,2’-二羥基-4-甲氧基二苯甲酮、2,2’-二羥基-4,4’-二甲氧基二苯甲酮、2,2’,4,4’-四羥基二苯甲酮、2-羥基-4-甲氧基二苯甲酮、2,4-二羥基二苯甲酮、2-羥基-4-辛氧基二苯甲酮等。又,作為苯并三唑系紫外線吸收劑的例子,可舉出2-(2’-羥基-3’,5’-二-三級丁基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-三級丁基-5’-甲基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-三級戊基-5’-異丁基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-異丁基-5’-甲基苯基)-5-氯苯并三唑、2-(2’-羥基-3’-異丁基-5’-丙基苯基)-5-氯苯并三唑、2-(2’-羥基-3’,5’-二-三級丁基苯基)苯并三唑、2-(2’-羥基-5’-甲基苯基)苯并三唑、2-[2’-羥基-5’-(1,1,3,3-四甲基)苯基]苯并三唑等。 [Ultraviolet Absorber] The composition of this invention may include an ultraviolet absorber. As an ultraviolet absorber, salicylate-based, benzophenone-based, benzotriazole-based, substituted acrylonitrile-based, triazine-based, and other ultraviolet absorbers can be used. Examples of salicylate-based UV absorbers include phenyl salicylate, p-octylphenyl salicylate, and p-tert-butylphenyl salicylate. Examples of benzophenone-based UV absorbers include 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2,4-dihydroxybenzophenone, and 2-hydroxy-4-octyloxybenzophenone. Furthermore, examples of benzotriazole-based ultraviolet absorbers include 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-pentyl-5'-isobutylphenyl)-5-chlorobenzotriazole, and 2-(2'-hydroxy-3'-isobutylphenyl)-5-chlorobenzotriazole. Butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-propylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-[2'-hydroxy-5'-(1,1,3,3-tetramethyl)phenyl]benzotriazole, etc.

作為取代丙烯腈系紫外線吸收劑的例子,可舉出2-氰基-3,3-二苯基丙烯酸乙酯、2-氰基-3,3-二苯基丙烯酸2-乙基己酯等。進而,作為三𠯤系紫外線吸收劑的例子,可舉出2-[4-[(2-羥基-3-十二烷氧基丙基)氧基]-2-羥基苯基]-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-[4-[(2-羥基-3-十三烷氧基丙基)氧基]-2-羥基苯基]-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-(2,4-二羥基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤等單(羥基苯基)三𠯤化合物;2,4-雙(2-羥基-4-丙氧基苯基)-6-(2,4-二甲基苯基)-1,3,5-三𠯤、2,4-雙(2-羥基-3-甲基-4-丙氧基苯基)-6-(4-甲基苯基)-1,3,5-三𠯤、2,4-雙(2-羥基-3-甲基-4-己氧基苯基)-6-(2,4-二甲基苯基)-1,3,5-三𠯤等雙(羥基苯基)三𠯤化合物;2,4-雙(2-羥基-4-丁氧基苯基)-6-(2,4-二丁氧基苯基)-1,3,5-三𠯤、2,4,6-三(2-羥基-4-辛氧基苯基)-1,3,5-三𠯤、2,4,6-三[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-1,3,5-三𠯤等三(羥基苯基)三𠯤化合物等。Examples of acrylonitrile-based UV absorbers that can replace cyano-3,3-diphenylacrylate include ethyl 2-cyano-3,3-diphenylacrylate and 2-ethylhexyl 2-cyano-3,3-diphenylacrylate. Furthermore, examples of triterpenoid-based UV absorbers include 2-[4-[(2-hydroxy-3-dodecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-triterpenoid, 2-[4-[(2-hydroxy-3-tetrazoloxypropyl)oxy]-2-hydroxyphenyl]-4,6 -Bis(2,4-dimethylphenyl)-1,3,5-tris(hydroxyphenyl) compounds, 2-(2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-tris(hydroxyphenyl) compounds, etc.; 2,4-bis(2-hydroxy-4-propoxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-tris(hydroxyphenyl) compounds, 2,4-Bis(2-hydroxy-3-methyl-4-propoxyphenyl)-6-(4-methylphenyl)-1,3,5-tris(2,4-bis(2-hydroxy-3-methyl-4-hexyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-tris(2,4-bis(2-hydroxy-3-methyl-4-hexyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-tris(2,4-bis(2-hydroxy-4-)) Tris(hydroxyphenyl)tris(2,4-dibutoxyphenyl)-1,3,5-tris(2,4,6-tris(2-hydroxy-4-octoxyphenyl)-1,3,5-tris(2,4,6-tris(2-hydroxyphenyl)tris(2,4,6-tris[2-hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-1,3,5-tris(2,4,6-tris(2-hydroxyphenyl) ...-hydroxyphenyl)tri

在本發明中,上述各種紫外線吸收劑可以單獨使用1種,亦可以組合使用2種以上。 本發明的組成物可以包含紫外線吸收劑,亦可以不包含紫外線吸收劑,但是在包含之情況下,紫外線吸收劑的含量相對於本發明的組成物的總固體成分質量為0.001質量%以上且1質量%以下為較佳,0.01質量%以上且0.1質量%以下為更佳。 In this invention, the aforementioned ultraviolet absorbers can be used individually or in combination of two or more. The composition of this invention may or may not contain an ultraviolet absorber, but when it does, the content of the ultraviolet absorber relative to the total solid content of the composition of this invention is preferably 0.001% by mass or more and 1% by mass or less, and more preferably 0.01% by mass or more and 0.1% by mass or less.

〔有機鈦化合物〕 本實施形態的樹脂組成物可以含有有機鈦化合物。由於樹脂組成物含有有機鈦化合物,因此即使在低溫下進行硬化之情況下亦能夠形成耐藥品性優異之樹脂層。 [Organic Titanium Compounds] The resin composition of this embodiment may contain organic titanium compounds. Because the resin composition contains organic titanium compounds, a resin layer with excellent chemical resistance can be formed even when cured at low temperatures.

作為能夠使用的有機鈦化合物,可舉出有機基經由共價鍵或離子鍵與鈦原子鍵結者。 將有機鈦化合物的具體例示於以下I)~VII)中: I)鈦螯合化合物:其中,樹脂組成物的保存穩定性優異,並且可以獲得良好的硬化圖案,從而具有兩個以上的烷氧基之鈦螯合化合物為更佳。具體的例子為二異丙醇雙(三乙醇胺)鈦、二(正丁醇)雙(2,4-戊二酮)鈦、二異丙醇雙(2,4-戊二酮)鈦、二異丙醇雙(四甲基庚二酮)鈦、二異丙醇雙(乙醯乙酸乙酯)鈦等。 II)四烷氧基鈦化合物:例如為四(正丁醇)鈦、四乙醇鈦、四(2-乙基己醇)鈦、四異丁醇鈦、四異丙醇鈦、四甲醇鈦、四甲氧基丙醇鈦、四甲基苯氧化鈦、四(正壬醇)鈦、四(正丙醇)鈦、四硬脂醇鈦、四[雙{2,2-(烯丙氧基甲基)丁醇}]鈦等。 III)二茂鈦化合物:例如為五甲基環戊二烯基三甲醇鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟苯基)鈦、雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦等。 IV)單烷氧基鈦化合物:例如為三(二辛基磷酸酯)異丙醇鈦、三(十二烷苯基磺酸酯)異丙醇鈦等。 V)氧化鈦化合物:例如為氧化鈦雙(戊二酮)、氧化鈦雙(四甲基庚二酮)、酞菁氧化鈦等。 VI)四乙醯丙酮鈦化合物:例如為四乙醯丙酮鈦等。 VII)鈦酸酯偶合劑:例如為異丙基三十二烷基苯磺醯鈦酸鹽等。 As usable organic titanium compounds, those in which the organic group is bonded to titanium atoms via covalent or ionic bonds can be cited. Specific examples of organic titanium compounds are shown in I) to VII) below: I) Titanium chelate compounds: Among these, titanium chelate compounds with two or more alkoxy groups are preferred, as they exhibit excellent resin composition stability and yield good curing patterns. Specific examples include diisopropoxide bis(triethanolamine) titanium, di(n-butanol) bis(2,4-pentanedione) titanium, diisopropoxide bis(2,4-pentanedione) titanium, diisopropoxide bis(tetramethylheptanedione) titanium, and diisopropoxide bis(ethyl acetoacetate) titanium, etc. II) Tetraalkoxytitanium compounds: Examples include tetra(n-butanol)titanium, tetraethanoltitanium, tetra(2-ethylhexanol)titanium, tetraisobutanoltitanium, tetraisopropanoltitanium, tetraethanoltitanium, tetramethoxypropanoltitanium, tetramethylphenyloxytitanium, tetra(n-nonanol)titanium, tetra(n-propanol)titanium, tetrastearyltitanium, tetra[bis{2,2-(allyloxymethyl)butanol}]titanium, etc. III) Titanium diacene compounds: Examples include pentamethylcyclopentadienyltrimethylamine titanium, bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluorophenyl)titanium, and bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium. IV) Monoalkoxy titanium compounds: Examples include tris(dioctyl phosphate)isopropanol titanium and tris(dodecanephenyl sulfonate)isopropanol titanium. V) Titanium oxide compounds: Examples include titanium bis(pentanedione), titanium bis(tetramethylheptanedione), and titanium phthalocyanine oxide. VI) Tetraacetone titanium compounds: Examples include tetraacetone titanium. VII) Titanium ester coupling agents: for example, isopropyltris(2-dodecylbenzenesulfonate) titanium salt, etc.

其中,作為有機鈦化合物,從發揮更良好的耐藥品性之觀點考慮,選自包括上述I)鈦螯合化合物、II)四烷氧基鈦化合物及III)二茂鈦化合物之群組中之至少一種化合物為較佳。尤其,二異丙醇雙(乙醯乙酸乙酯)鈦、四(正丁醇)鈦及雙(η5-2,4-環戊二烯-1-基)雙(2,6-二氟-3-(1H-吡咯-1-基)苯基)鈦為較佳。Among these, from the viewpoint of exhibiting better drug resistance, it is preferable to select at least one compound from the group consisting of I) titanium chelates, II) tetraalkoxy titanium compounds and III) titanium dicene compounds. In particular, diisopropanol bis(ethyl acetoacetate)titanium, tetra(n-butanol)titanium and bis(n5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrolo-1-yl)phenyl)titanium are preferred.

在配合有機鈦化合物之情況下,其配合量相對於特定樹脂100質量份為0.05~10質量份為較佳,更較佳為0.1~2質量份。在配合量為0.05質量份以上之情況下,所獲得之硬化圖案更有效地顯現出良好的耐熱性及耐藥品性,另一方面,在配合量為10質量份以下之情況下,組成物的保存穩定性更優異。When incorporating organotitanium compounds, the amount of these compounds relative to 100 parts by weight of a specific resin is preferably 0.05 to 10 parts by weight, and more preferably 0.1 to 2 parts by weight. When the amount of these compounds is 0.05 parts by weight or more, the resulting curing pattern exhibits better heat resistance and chemical resistance. On the other hand, when the amount of these compounds is 10 parts by weight or less, the composition exhibits better storage stability.

〔抗氧化劑〕 本發明的組成物可以包含抗氧化劑。藉由含有抗氧化劑作為添加劑,能夠提高硬化後的膜的伸長特性和與金屬材料的密接性。作為抗氧化劑,可舉出酚化合物、亞磷酸酯化合物及硫醚化合物等。作為酚化合物,能夠使用作為酚系抗氧化劑已知之任意的酚化合物。作為較佳的酚化合物,可舉出受阻酚化合物。在與酚性羥基相鄰之部位(鄰位)上具有取代基之化合物為較佳。作為上述取代基,碳數1~22的經取代或未經取代的烷基為較佳。又,抗氧化劑為在相同分子內具有酚基及亞磷酸酯基之化合物亦較佳。又,抗氧化劑亦能夠較佳地使用磷系抗氧化劑。作為磷系抗氧化劑,可舉出三[2-[[2,4,8,10-四(1,1-二甲基乙基)二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-6-基]氧基]乙基]胺、三[2-[(4,6,9,11-四-三級丁基二苯并[d,f][1,3,2]二氧雜膦雜環庚二烯-2-基)氧基]乙基]胺及亞磷酸乙基雙(2,4-二-三級丁基-6-甲基苯基)等。作為抗氧化劑的市售品,例如可舉出Adekastab AO-20、Adekastab AO-30、Adekastab AO-40、Adekastab AO-50、Adekastab AO-50F、Adekastab AO-60、Adekastab AO-60G、Adekastab AO-80及Adekastab AO-330(以上為ADEKA CORPORATION製)等。又,抗氧化劑亦能夠使用日本專利第6268967號公報的0023~0048段中所記載之化合物,該內容被編入本說明書中。又,本發明的組成物依據需要可以含有潛在的抗氧化劑。作為潛在的抗氧化劑,可舉出發揮抗氧化劑作用之部位被保護基保護之化合物,且為藉由在100~250℃下進行加熱或在酸/鹼觸媒存在下在80~200℃下進行加熱以使保護基脫離而發揮抗氧化劑作用之化合物。作為潛在的抗氧化劑,可舉出國際公開第2014/021023號、國際公開第2017/030005號及日本特開2017-008219號公報中所記載之化合物,該內容被編入本說明書中。作為潛在的抗氧化劑的市售品,可舉出ADEKA ARKLSGPA-5001(ADEKA CORPORATION製)等。 作為較佳的抗氧化劑的例子,可舉出2,2-硫代雙(4-甲基-6-三級丁基酚)、2,6-二-三級丁基酚及由式(3)表示之化合物。 [Antioxidant] The composition of this invention may include an antioxidant. By including an antioxidant as an additive, the elongation properties and adhesion to metal materials of the cured film can be improved. Examples of antioxidants include phenolic compounds, phosphite compounds, and thioether compounds. As a phenolic compound, any phenolic compound known as a phenolic antioxidant can be used. As a preferred phenolic compound, hindered phenolic compounds are examples. Compounds having a substituent at the site (orthoside) adjacent to the phenolic hydroxyl group are preferred. As the aforementioned substituent, substituted or unsubstituted alkyl groups having 1 to 22 carbon atoms are preferred. Furthermore, compounds having both phenolic and phosphite groups within the same molecule are also preferred as antioxidants. Furthermore, phosphorus-based antioxidants can be used more effectively as antioxidants. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetra(1,1-dimethylethyl)dibenzo[d,f][1,3,2]dioxanephosphine-heptacyclohepta-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tertiary butyldibenzo[d,f][1,3,2]dioxanephosphine-heptacyclohepta-2-yl)oxy]ethyl]amine, and ethyl bis(2,4-di-tertiary butyl-6-methylphenyl) phosphite. Commercially available antioxidants include, for example, Adekastab AO-20, Adekastab AO-30, Adekastab AO-40, Adekastab AO-50, Adekastab AO-50F, Adekastab AO-60, Adekastab AO-60G, Adekastab AO-80, and Adekastab AO-330 (all manufactured by ADEKA CORPORATION). Furthermore, the antioxidants may also include compounds described in paragraphs 0023 to 0048 of Japanese Patent No. 6268967, which are incorporated herein by reference. Additionally, the composition of this invention may contain potential antioxidants as needed. As potential antioxidants, compounds whose antioxidant activity is achieved by the removal of the protective group at the site of antioxidant action can be cited, and which exert their antioxidant activity by heating at 100–250°C or at 80–200°C in the presence of an acid/base catalyst to remove the protective group. Compounds described in International Publication No. 2014/021023, International Publication No. 2017/030005, and Japanese Patent Application Publication No. 2017-008219 are examples of potential antioxidants, which are incorporated herein by reference. Commercially available products that are potential antioxidants include ADEKA ARKLSGPA-5001 (manufactured by ADEKA CORPORATION). Examples of better antioxidants include 2,2-thiobis(4-methyl-6-tertiary butylphenol), 2,6-di-tertiary butylphenol, and compounds represented by formula (3).

【化學式69】 【Chemical Formula 69】

通式(3)中,R 5表示氫原子或碳數2以上(較佳為碳數2~10)的烷基,R 6表示碳數2以上(較佳為碳數2~10)的伸烷基。R 7表示碳數2以上(較佳為碳數2~10)的伸烷基、包含氧原子及氮原子中的至少任一個之1~4價的有機基。k表示1~4的整數。 In general formula (3), R5 represents a hydrogen atom or an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), and R6 represents an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms). R7 represents an alkyl group having 2 or more carbon atoms (preferably 2 to 10 carbon atoms), or an organic group containing at least one of oxygen and nitrogen atoms in a 1 to 4 valence. k represents an integer from 1 to 4.

由式(3)表示之化合物抑制樹脂所具有之脂肪族基和酚性羥基的氧化劣化。又,能夠藉由對金屬材料的防鏽作用來抑制金屬氧化。The compound represented by formula (3) inhibits the oxidative degradation of the aliphatic and phenolic hydroxyl groups in the resin. Furthermore, it can inhibit metal oxidation by preventing rust on metal materials.

能夠同時作用於樹脂和金屬材料,因此k為2~4的整數為更佳。作為R 7,可舉出烷基、環烷基、烷氧基、烷基醚基、烷基甲矽烷基、烷氧基甲矽烷基、芳基、芳基醚基、羧基、羰基、烯丙基、乙烯基、雜環基、-O-、-NH-、-NHNH-、組合了該等者等,可以進一步具有取代基。其中,從在顯影液中的溶解性和金屬密接性的觀點考慮,具有烷基醚基、-NH-為較佳,從與樹脂的相互作用和金屬錯合物形成時之金屬密接性的觀點考慮,-NH-為更佳。 It can act on both resins and metal materials simultaneously, therefore, k being an integer from 2 to 4 is preferred. Examples of R7 include alkyl, cycloalkyl, alkoxy, alkyl ether, alkylsilyl, alkoxysilyl, aryl, aryl ether, carboxyl, carbonyl, allyl, vinyl, heterocyclic, -O-, -NH-, -NHNH-, and combinations thereof, and may further have substituents. Among these, alkyl ether and -NH- are preferred from the viewpoint of solubility in the developing solution and metal adhesion; -NH- is more preferred from the viewpoint of interaction with resin and metal adhesion during metal complex formation.

關於由通式(3)表示之化合物,作為例子,可舉出以下者,但是並不限於下述結構。For compounds represented by general formula (3), examples can be given, but are not limited to the following structures.

【化學式70】 【Chemical Formula 70】

【化學式71】 【Chemical Formula 71】

【化學式72】 【Chemical Formula 72】

【化學式73】 【Chemical Formula 73】

抗氧化劑的添加量相對於樹脂為0.1~10質量份為較佳,0.5~5質量份為更佳。藉由將添加量設為0.1質量份以上,即使在高溫高濕環境下,亦容易獲得提高伸長特性或對金屬材料之密接性的效果,並且藉由將添加量設為10質量份以下,例如藉由與光敏劑的相互作用來提高樹脂組成物的靈敏度。抗氧化劑可以僅使用1種,亦可以使用2種以上。在使用2種以上之情況下,該等合計量在上述範圍內為較佳。The optimal amount of antioxidant added relative to the resin is 0.1 to 10 parts by weight, with 0.5 to 5 parts by weight being more preferred. By setting the addition amount to 0.1 parts by weight or more, it is easy to obtain effects that improve elongation properties or adhesion to metal materials, even in high-temperature and high-humidity environments. Conversely, by setting the addition amount to 10 parts by weight or less, the sensitivity of the resin composition can be improved, for example, through interaction with photosensitizers. Only one type of antioxidant may be used, or two or more may be used. When using two or more antioxidants, the total amount within the above-mentioned range is preferred.

〔抗凝聚劑〕 本實施形態的樹脂組成物依據需要可以含有抗凝聚劑。作為抗凝聚劑,可舉出聚丙烯酸鈉等。 [Anti-coagulant] The resin composition of this embodiment may contain an anti-coagulant as needed. Examples of anti-coagulants include sodium polyacrylate.

在本發明中,抗凝聚劑可以單獨使用1種,亦可以組合使用2種以上。 本發明的組成物可以包含抗凝聚劑,亦可以不包含抗凝聚劑,但是在包含之情況下,抗凝聚劑的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且10質量%以下為較佳,0.02質量%以上且5質量%以下為更佳。 In this invention, the anti-coagulant can be used alone or in combination with two or more types. The composition of this invention may or may not contain an anti-coagulant, but when it does, the content of the anti-coagulant relative to the total solid content of the composition of this invention is preferably 0.01% by mass or more and 10% by mass or less, and more preferably 0.02% by mass or more and 5% by mass or less.

〔酚系化合物〕 本實施形態的樹脂組成物依據需要可以含有酚系化合物。作為酚系化合物,可舉出Bis-Z、BisP-EZ、TekP-4HBPA、TrisP-HAP、TrisP-PA、BisOCHP-Z、BisP-MZ、BisP-PZ、BisP-IPZ、BisOCP-IPZ、BisP-CP、BisRS-2P、BisRS-3P、BisP-OCHP、亞甲基三-FR-CR、BisRS-26X(以上為產品名,Honshu Chemical Industry Co.,Ltd.製)、BIP-PC、BIR-PC、BIR-PTBP、BIR-BIPC-F(以上為產品名,ASAHI YUKIZAI CORPORATION製)等。 [Phenolic Compounds] The resin composition of this embodiment may contain phenolic compounds as needed. Examples of phenolic compounds include Bis-Z, BisP-EZ, TekP-4HBPA, TrisP-HAP, TrisP-PA, BisOCHP-Z, BisP-MZ, BisP-PZ, BisP-IPZ, BisOCP-IPZ, BisP-CP, BisRS-2P, BisRS-3P, BisP-OCHP, methylene tri-FR-CR, BisRS-26X (the above are product names, manufactured by Honshu Chemical Industry Co., Ltd.), BIP-PC, BIR-PC, BIR-PTBP, and BIR-BIPC-F (the above are product names, manufactured by ASAHI YUKIZAI CORPORATION).

在本發明中,酚系化合物可以單獨使用1種,亦可以組合使用2種以上。 本發明的組成物可以包含酚系化合物,亦可以不包含酚系化合物,但是在包含之情況下,酚系化合物的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且30質量%以下為較佳,0.02質量%以上且20質量%以下為更佳。 In this invention, a single phenolic compound may be used alone, or two or more may be used in combination. The composition of this invention may or may not contain phenolic compounds. However, when phenolic compounds are included, the content of the phenolic compounds relative to the total solid content of the composition of this invention is preferably 0.01% by mass or more and 30% by mass or less, and more preferably 0.02% by mass or more and 20% by mass or less.

〔其他高分子化合物〕 作為其他高分子化合物,可舉出矽氧烷樹脂、將(甲基)丙烯酸進行共聚而獲得之(甲基)丙烯酸聚合物、酚醛清漆樹脂、甲酚樹脂、聚羥基苯乙烯樹脂及該等共聚物等。其他高分子化合物可以為導入有羥甲基、烷氧基甲基、環氧基等交聯基之改質體。 [Other Polymer Compounds] Other polymer compounds include silicone resins, (meth)acrylic acid polymers obtained by copolymerizing (meth)acrylic acid, phenolic varnish resins, cresol resins, polyhydroxystyrene resins, and copolymers thereof. Other polymer compounds may be modifiers incorporating cross-linking groups such as hydroxymethyl, alkoxymethyl, and epoxy groups.

在本發明中,其他高分子化合物可以單獨使用1種,亦可以組合使用2種以上。 本發明的組成物可以包含其他高分子化合物,亦可以不包含其他高分子化合物,但是在包含之情況下,其他高分子化合物的含量相對於本發明的組成物的總固體成分質量為0.01質量%以上且30質量%以下為較佳,0.02質量%以上且20質量%以下為更佳。 In this invention, one or more other polymeric compounds may be used alone or in combination. The composition of this invention may or may not contain other polymeric compounds. However, when other polymeric compounds are included, it is preferable that the content of these other polymeric compounds relative to the total solid content of the composition of this invention is 0.01% by mass or more and 30% by mass or less, and more preferably 0.02% by mass or more and 20% by mass or less.

<樹脂組成物的特性> 關於本發明的樹脂組成物的黏度,能夠藉由樹脂組成物的固體成分濃度來調整。從塗佈膜厚的觀點考慮,1,000mm 2/s~12,000mm 2/s為較佳,2,000mm 2/s~10,000mm 2/s為更佳,2,500mm 2/s~8,000mm 2/s為進一步較佳。只要在上述範圍內,則容易獲得均勻性高的塗佈膜。若為1,000mm 2/s以上,則容易以例如作為再配線用絕緣膜所需要之膜厚進行塗佈,若為12,000mm 2/s以下,則可獲得塗佈面狀優異之塗膜。 <Characteristics of the Resin Composition> The viscosity of the resin composition of this invention can be adjusted by the concentration of the solid component of the resin composition. From the viewpoint of coating film thickness, 1,000 mm² /s to 12,000 mm² /s is preferred, 2,000 mm² /s to 10,000 mm² /s is more preferred, and 2,500 mm² /s to 8,000 mm² /s is even more preferred. As long as it is within the above range, a coating film with high uniformity can be easily obtained. If the thickness is 1,000 mm² /s or higher, it is easy to apply a coating with the thickness required, for example, as an insulation film for rewiring. If the thickness is 12,000 mm² /s or lower, a coating with excellent surface finish can be obtained.

<關於樹脂組成物的含有物質的限制> 本發明的樹脂組成物的含水率小於2.0質量%為較佳,小於1.5質量%為更佳,小於1.0質量%為進一步較佳。若為小於2.0%,則提高樹脂組成物的保存穩定性。 作為維持水分的含量之方法,可舉出調整保管條件中之濕度及降低保管時的收容容器的孔隙率等。 <Limitations Regarding the Content of Substances in the Resin Composition> The moisture content of the resin composition of this invention is preferably less than 2.0% by mass, more preferably less than 1.5% by mass, and even more preferably less than 1.0% by mass. A moisture content less than 2.0% improves the storage stability of the resin composition. Methods for maintaining the moisture content include adjusting the humidity during storage and reducing the porosity of the storage container.

從絕緣性的觀點考慮,本發明的樹脂組成物的金屬含量小於5質量ppm(parts per million(百萬分率))為較佳,小於1質量ppm為更佳,小於0.5質量ppm為進一步較佳。作為金屬,可舉出鈉、鉀、鎂、鈣、鐵、銅、鉻、鎳等,但是作為有機化合物與金屬的錯合物而包含之金屬除外。在包含複數個金屬之情況下,該等金屬的合計在上述範圍內為較佳。From an insulation point of view, it is preferable that the metal content of the resin composition of the present invention is less than 5 parts per million (ppm), more preferably less than 1 ppm, and even more preferably less than 0.5 ppm. Examples of metals include sodium, potassium, magnesium, calcium, iron, copper, chromium, and nickel, but excluding metals contained as complexes of organic compounds and metals. When multiple metals are included, it is preferable that the total amount of these metals is within the above-mentioned range.

又,作為減少意外包含於本發明的樹脂組成物中之金屬雜質之方法,能夠舉出如下方法:選擇金屬含量少的原料作為構成本發明的樹脂組成物之原料;對構成本發明的樹脂組成物之原料進行過濾器過濾;將聚四氟乙烯等內襯於裝置內以在盡可能抑制污染之條件下進行蒸餾。Furthermore, as a method to reduce the metal impurities accidentally included in the resin composition of the present invention, the following methods can be cited: selecting raw materials with low metal content as raw materials for constituting the resin composition of the present invention; filtering the raw materials constituting the resin composition of the present invention using a filter; and lining the device with polytetrafluoroethylene or the like to carry out distillation under conditions that suppress contamination as much as possible.

若考慮本發明的樹脂組成物作為半導體材料的用途,則從配線腐蝕性的觀點考慮,鹵素原子的含量小於500質量ppm為較佳,小於300質量ppm為更佳,小於200質量ppm為進一步較佳。其中,以鹵素離子的狀態存在者小於5質量ppm為較佳,小於1質量ppm為更佳,小於0.5質量ppm為進一步較佳。作為鹵素原子,可舉出氯原子及溴原子。氯原子及溴原子或氯離子及溴離子的合計分別在上述範圍內為較佳。 作為調節鹵素原子的含量之方法,可較佳地舉出離子交換處理等。 Considering the application of the resin composition of this invention as a semiconductor material, from the viewpoint of wiring corrosion, a halogen atom content of less than 500 ppm by mass is preferable, less than 300 ppm by mass is more preferable, and less than 200 ppm by mass is even more preferable. Among these, a halogen ion content of less than 5 ppm by mass is preferable, less than 1 ppm by mass is more preferable, and less than 0.5 ppm by mass is even more preferable. Examples of halogen atoms include chlorine and bromine atoms. It is preferable that the total number of chlorine and bromine atoms, or chlorine and bromine ions, falls within the above-mentioned ranges. As a method for adjusting the halogen atom content, ion exchange treatment is a preferred example.

作為本發明的樹脂組成物的收容容器,能夠使用先前公知的收容容器。又,作為收容容器,為了抑制雜質混入原材料或本發明的樹脂組成物中,使用由6種6層樹脂構成容器內壁之多層瓶、將6種樹脂形成為7層結構之瓶亦較佳。作為這種容器,例如可舉出日本特開2015-123351號公報中所記載之容器。As a container for the resin composition of the present invention, previously known containers can be used. Furthermore, as a container, in order to suppress the contamination of impurities into the raw materials or the resin composition of the present invention, it is preferable to use a multi-layered bottle with an inner wall composed of six layers of six different resins, or a bottle with a seven-layered structure of the six resins. For example, the container described in Japanese Patent Application Publication No. 2015-123351 can be cited as such a container.

<樹脂組成物的硬化物> 藉由將本發明的樹脂組成物進行硬化,能夠獲得該樹脂組成物的硬化物。 本發明的硬化物為硬化本發明的樹脂組成物而成之硬化物。 樹脂組成物的硬化藉由加熱進行為較佳,加熱溫度在120℃~400℃的範圍內為更佳,在140℃~380℃的範圍內為進一步較佳,在170℃~350℃的範圍內為特佳。樹脂組成物的硬化物的形態並無特別限定,能夠依據用途選擇薄膜狀、棒狀、球狀、顆粒狀等。在本發明中,該硬化物為薄膜狀為較佳。又,藉由樹脂組成物的圖案加工,亦能夠依據在壁面上形成保護膜,形成用於導通的穴(Beer hall)、調整阻抗或者靜電容量或者內部應力、賦放熱功能予等用途選擇該硬化物的形狀。該硬化物(包括硬化物之膜)的膜厚為0.5μm以上且150μm以下為較佳。 將本發明的樹脂組成物進行硬化時的收縮率為50%以下為較佳,45%以下為更佳,40%以下為進一步較佳。其中,收縮率係指樹脂組成物的硬化前後的體積變化的百分率,並且能夠藉由下述的式來進行計算。 收縮率[%]=100-(硬化後的體積÷硬化前的體積)×100 <Curing Compound of Resin Composition> A cured compound of the resin composition of the present invention can be obtained by curing the resin composition of the present invention. The cured compound of the present invention is a cured compound obtained by curing the resin composition of the present invention. Curing of the resin composition is preferably carried out by heating, preferably within the range of 120°C to 400°C, further preferably within the range of 140°C to 380°C, and particularly preferably within the range of 170°C to 350°C. The morphology of the cured compound of the resin composition is not particularly limited, and can be selected as film, rod, sphere, granule, etc., depending on the application. In the present invention, the cured compound is preferably in film form. Furthermore, by pattern processing of the resin composition, the shape of the cured material can be selected according to applications such as forming a protective film on the wall surface, creating beer halls for conductivity, adjusting impedance or electrostatic capacitance or internal stress, and imparting heat dissipation. The film thickness of the cured material (including the cured film) is preferably 0.5 μm or more and 150 μm or less. The shrinkage rate during curing of the resin composition of the present invention is preferably 50% or less, more preferably 45% or less, and even more preferably 40% or less. Here, shrinkage rate refers to the percentage change in volume of the resin composition before and after curing, and can be calculated using the following formula. Shrinkage rate [%] = 100 - (Volume after hardening ÷ Volume before hardening) × 100

<樹脂組成物的硬化物的特性> 本發明的樹脂組成物的硬化物的醯亞胺化反應率為70%以上為較佳,80%以上為更佳,90%以上為進一步較佳。若為70%以上,則有時成為機械特性優異之硬化物。 本發明的樹脂組成物的硬化物的斷裂伸長率為30%以上為較佳,40%以上為更佳,50%以上為進一步較佳。 本發明的樹脂組成物的硬化物的玻璃轉移溫度(Tg)為180℃以上為較佳,210℃以上為更佳,230℃以上為進一步較佳。 <Characteristics of the Cured Resin Composition> The amide reaction rate of the cured resin composition of the present invention is preferably 70% or higher, more preferably 80% or higher, and further preferably 90% or higher. A rate of 70% or higher sometimes results in a cured product with excellent mechanical properties. The elongation at break of the cured resin composition of the present invention is preferably 30% or higher, more preferably 40% or higher, and further preferably 50% or higher. The glass transition temperature (Tg) of the cured resin composition of the present invention is preferably 180°C or higher, more preferably 210°C or higher, and further preferably 230°C or higher.

<樹脂組成物的製備> 本發明的樹脂組成物能夠藉由混合上述各成分來製備。混合方法並無特別限定,能夠藉由先前公知的方法來進行。 混合能夠採用基於攪拌葉片之混合、基於球磨之混合、使罐本身旋轉之混合等。 混合中的溫度為10~30℃為較佳,15~25℃為更佳。 <Preparation of Resin Composition> The resin composition of this invention can be prepared by mixing the above-mentioned components. The mixing method is not particularly limited and can be carried out using previously known methods. Mixing can be performed using methods such as mixing with stirring blades, mixing with ball milling, or mixing by rotating the container itself. The mixing temperature is preferably 10–30°C, and more preferably 15–25°C.

又,為了去除本發明的樹脂組成物中的灰塵或微粒等異物,進行使用過濾器之過濾為較佳。可舉出過濾器孔徑例如為5μm以下之態樣,1μm以下為較佳,0.5μm以下為更佳,0.1μm以下為進一步較佳。過濾器的材質為聚四氟乙烯、聚乙烯或尼龍為較佳。當過濾器的材質為聚乙烯之情況下,HDPE(高密度聚乙烯)為更佳。過濾器可以使用藉由有機溶劑預先清洗者。在過濾器的過濾步驟中,亦可以串聯或並聯連接複數種過濾器而使用。在使用複數種過濾器之情況下,可以組合使用孔徑或材質不同之過濾器。作為連接態樣,例如可舉出作為第1段串聯連接孔徑1μm的HDPE過濾器且作為第2段串聯連接孔徑0.2μm的HDPE過濾器之態樣。又,可以將各種材料過濾複數次。在過濾複數次之情況下,可以為循環過濾。又,亦可以在加壓之後進行過濾。當進行加壓和過濾之情況下,可舉出進行加壓之壓力例如為0.01MPa以上且1.0MPa以下之態樣,0.03MPa以上且0.9MPa以下為較佳,0.05MPa以上且0.7MPa以下為更佳,0.05MPa以上且0.5MPa以下為進一步較佳。 除了使用過濾器之過濾以外,還可以進行使用吸附材料之雜質去除處理。亦可以組合過濾器過濾與使用吸附材料之雜質去除處理。作為吸附材料,能夠使用公知的吸附材料。例如,可舉出矽膠、沸石等無機系吸附材料、活性碳等有機系吸附材料。 另外,亦可以實施使用過濾器進行過濾之後將填充於瓶之樹脂組成物置於減壓下進行脫氣之步驟。 Furthermore, to remove foreign matter such as dust or particulate matter from the resin composition of this invention, filtration using a filter is preferable. Examples of filter pore sizes include, for instance, 5 μm or less, preferably 1 μm or less, more preferably 0.5 μm or less, and even more preferably 0.1 μm or less. The filter material is preferably polytetrafluoroethylene, polyethylene, or nylon. When the filter material is polyethylene, HDPE (high-density polyethylene) is preferred. The filter can be pre-cleaned with an organic solvent. Multiple filters can also be connected in series or parallel during the filtration process. When using multiple filters, filters with different pore sizes or materials can be used in combination. For example, a connection could be made by first connecting a 1μm pore size HDPE filter in series, and then connecting a 0.2μm pore size HDPE filter in series as a second stage. Furthermore, various materials can be filtered multiple times. Multiple filtrations can constitute circulating filtration. Alternatively, filtration can be performed after pressurization. When pressurization and filtration are performed, the pressurization pressure can be, for example, 0.01 MPa or higher and 1.0 MPa or lower, preferably 0.03 MPa or higher and 0.9 MPa or lower, more preferably 0.05 MPa or higher and 0.7 MPa or lower, and even more preferably 0.05 MPa or higher and 0.5 MPa or lower. In addition to filtration using a filter, impurity removal can also be performed using adsorption materials. A combination of filter filtration and impurity removal using adsorption materials can also be used. Known adsorption materials can be used. Examples include inorganic adsorption materials such as silicone and zeolite, and organic adsorption materials such as activated carbon. Alternatively, the resin composition in the bottle can be degassed under reduced pressure after filtration using a filter.

(硬化物的製造方法) 本發明的硬化物的製造方法包括將樹脂組成物適用於基材上而形成膜之膜形成步驟為較佳。 又,本發明的硬化物的製造方法包括上述膜形成步驟、選擇性地曝光藉由膜形成步驟形成之膜之曝光步驟及使用顯影液顯影藉由曝光步驟曝光之膜來形成圖案之顯影步驟為更佳。 本發明的硬化物的製造方法包括上述膜形成步驟、上述曝光步驟、上述顯影步驟以及加熱藉由顯影步驟獲得之圖案之加熱步驟及曝光藉由顯影步驟獲得之圖案之顯影後曝光步驟中的至少一者為特佳。 又,本發明之製造方法包括上述膜形成步驟及加熱上述膜之步驟亦較佳。 以下,對各步驟的詳細內容進行說明。 (Method for Manufacturing Cured Material) The method for manufacturing cured material of the present invention preferably includes a film formation step of applying a resin composition to a substrate to form a film. Furthermore, the method for manufacturing cured material of the present invention preferably includes the above-described film formation step, an exposure step of selectively exposing the film formed by the film formation step, and a developing step of using a developing solution to develop a pattern on the film exposed by the exposure step. The method for manufacturing cured material of the present invention preferably includes at least one of the above-described film formation step, the above-described exposure step, the above-described developing step, a heating step of heating the pattern obtained by the developing step, and a post-developing exposure step of exposing the pattern obtained by the developing step. Furthermore, the manufacturing method of this invention, including the aforementioned film formation step and the step of heating the aforementioned film, is also preferred. The details of each step are explained below.

<膜形成步驟> 本發明的樹脂組成物能夠用於適用於基材上來形成膜之膜形成步驟。 本發明的硬化物的製造方法包括將樹脂組成物適用於基材上而形成膜之膜形成步驟為較佳。 <Film Formation Steps> The resin composition of this invention can be used in a film formation step adapted to form a film on a substrate. A preferred method for manufacturing the cured material of this invention includes a film formation step in which the resin composition is adapted to a substrate to form a film.

〔基材〕 基材的種類能夠依據用途適當設定,但是並無特別限制,可舉出矽、氮化矽、多晶矽、氧化矽、非晶矽等半導體製作基材、石英、玻璃、光學膜、陶瓷材料、蒸鍍膜、磁性膜、反射膜、Ni、Cu、Cr、Fe等金屬基材(例如,可以為由金屬形成之基材及例如藉由電鍍或蒸鍍等而形成金屬層之基材中的任一個)、紙、SOG(Spin On Glass:旋塗式玻璃)、TFT(薄膜晶體管)陣列基材、模具基材、電漿顯示面板(PDP)的電極板等。在本發明中,尤其半導體製作基材為較佳,矽基材、Cu基材及模具基材為更佳。 又,在該等基材的表面上可以設置有由六甲基二矽氮烷(HMDS)等製成之密接層和氧化層等層。 又,基材的形狀並無特別限定,可以為圓形,亦可以為矩形。 作為基材的尺寸,若為圓形,則例如直徑為100~450mm,較佳為200~450mm。若為矩形,則例如短邊的長度為100~1000mm,較佳為200~700mm。 又,作為基材,例如可以使用板狀、較佳為面板狀的基材(基板)。 [Substrate] The type of substrate can be appropriately set according to the application, but there are no particular limitations. Examples include semiconductor substrates such as silicon, silicon nitride, polycrystalline silicon, silicon oxide, and amorphous silicon; quartz, glass, optical films, ceramic materials, vapor-deposited films, magnetic films, reflective films; metal substrates such as Ni, Cu, Cr, and Fe (e.g., any substrate formed of metal and substrates with metal layers formed by electroplating or vapor deposition); paper; SOG (Spin On Glass); TFT (Thin Film Transistor) array substrates; mold substrates; and electrode plates for plasma display panels (PDPs). In this invention, semiconductor substrates are particularly preferred, with silicon substrates, Cu substrates, and mold substrates being even more preferred. Furthermore, a bonding layer and an oxide layer made of hexamethyldisilazane (HMDS) or similar materials may be provided on the surface of these substrates. Furthermore, the shape of the substrate is not particularly limited; it can be circular or rectangular. Regarding the dimensions of the substrate, if it is circular, the diameter is, for example, 100–450 mm, preferably 200–450 mm. If it is rectangular, the length of the shorter side is, for example, 100–1000 mm, preferably 200–700 mm. Furthermore, a plate-shaped substrate (substrate) may be used, for example, preferably a panel-shaped substrate.

又,在樹脂層(例如,包括硬化物之層)的表面或金屬層的表面上適用樹脂組成物而形成膜之情況下,樹脂層或金屬層成為基材。Furthermore, in cases where a film is formed by applying a resin composition to the surface of a resin layer (e.g., including a layer of hardener) or a metal layer, the resin layer or metal layer becomes the substrate.

作為將本發明的樹脂組成物適用於基材上之方法,塗佈為較佳。As a method for applying the resin composition of the present invention to a substrate, coating is preferred.

作為所適用之方法,具體而言,可例示浸塗法、氣刀塗佈法、簾式塗佈法、線棒塗佈法、凹版塗佈法、擠壓塗佈法、噴塗法、旋塗法、狹縫塗佈法、噴墨法等。從膜的厚度的均勻性的觀點考慮,更佳為旋塗法、狹縫塗佈法、噴塗法或噴墨法,從膜的厚度的均勻性的觀點及生產率的觀點考慮,旋塗法及狹縫塗佈法為較佳。依據方法調整樹脂組成物的固體成分濃度或塗佈條件,從而能夠獲得所期望的厚度的膜。又,亦能夠依據基材的形狀適當選擇塗佈方法,若為晶圓等圓形基材,則旋塗法、噴塗法、噴墨法等為較佳,若為矩形基材,則狹縫塗佈法或噴塗法、噴墨法等為較佳。在為旋塗法的情況下,例如能夠以500~3,500rpm的轉速適用10秒鐘~3分鐘左右。 又,亦能夠適用將藉由上述賦予方法預先賦予至偽支撐體上而形成之塗膜轉印到基材上之方法。 關於轉印方法,本發明中亦能夠較佳地使用日本特開2006-023696號公報的0023段、0036~0051段或日本特開2006-047592號公報的0096~0108段中所記載之製作方法。 又,可以進行在基材的端部中去除多餘的膜的步驟。在這種步驟的例子中,可舉出邊珠沖洗(EBR)、背面沖洗(Back rinse)等。 又,亦可以採用預濕步驟,該預濕步驟在將樹脂組成物塗佈於基材上之前,對基材塗佈各種溶劑以提高基材的潤濕性之後,塗佈樹脂組成物。 Specifically, applicable methods include dip coating, air knife coating, curtain coating, wire rod coating, gravure coating, extrusion coating, spray coating, spin coating, slit coating, and inkjet coating. From the perspective of film thickness uniformity, spin coating, slit coating, spray coating, or inkjet coating are preferred. From the perspectives of film thickness uniformity and productivity, spin coating and slit coating are more advantageous. By adjusting the solid content concentration of the resin composition or the coating conditions according to the method, a film of the desired thickness can be obtained. Furthermore, the coating method can be appropriately selected according to the shape of the substrate. For circular substrates such as wafers, spin coating, spray coating, and inkjet coating are preferred; for rectangular substrates, slit coating, spray coating, or inkjet coating are preferred. In the case of spin coating, for example, a rotation speed of 500–3,500 rpm can be used for approximately 10 seconds to 3 minutes. Also, a method of transferring a coating pre-applied to a dummy support using the above-described application method can be applied to the substrate. Regarding the transfer method, the present invention can also preferably utilize the manufacturing methods described in paragraphs 0023, 0036-0051 of Japanese Patent Application Publication No. 2006-023696 or paragraphs 0096-0108 of Japanese Patent Application Publication No. 2006-047592. Furthermore, a step of removing excess film from the ends of the substrate can be performed. Examples of such steps include edge bead rinsing (EBR) and back rinse. Also, a pre-wetting step can be used, in which various solvents are applied to the substrate to improve its wettability before applying the resin composition to the substrate.

<乾燥步驟> 上述膜在膜形成步驟(層形成步驟)之後,為了去除溶劑,可以提供給乾燥所形成之膜(層)之步驟(乾燥步驟)中。 亦即,本發明的硬化物的製造方法可以包括乾燥步驟,該乾燥步驟乾燥藉由膜形成步驟而形成之膜。 又,上述乾燥步驟在膜形成步驟之後且在曝光步驟之前進行為較佳。 乾燥步驟中之膜的乾燥溫度為50~150℃為較佳,70℃~130℃為更佳,90℃~110℃為進一步較佳。又,亦可以藉由減壓來進行乾燥。作為乾燥時間,可例示30秒鐘~20分鐘,1分鐘~10分鐘為較佳,2分鐘~7分鐘為更佳。 <Drying Step> The above-mentioned film is provided in a drying step (drying step) after the film formation step (layer formation step) to remove solvent from the formed film (layer). That is, the method for manufacturing the cured material of the present invention may include a drying step, which dries the film formed by the film formation step. Furthermore, it is preferable that the above-mentioned drying step is performed after the film formation step and before the exposure step. The drying temperature of the film in the drying step is preferably 50-150°C, more preferably 70-130°C, and even more preferably 90-110°C. Also, drying can be performed by depressurization. As for drying time, 30 seconds to 20 minutes, 1 minute to 10 minutes is better, and 2 minutes to 7 minutes is even better.

<曝光步驟> 上述膜可以提供於選擇性地曝光膜之曝光步驟中。 亦即,本發明的硬化物的製造方法可以包括曝光步驟,該曝光步驟選擇性地曝光藉由膜形成步驟而形成之膜。 選擇性地曝光表示對膜的一部分進行曝光。又,藉由選擇性地曝光,在膜上形成經曝光之區域(曝光部)和未經曝光的區域(非曝光部)。 關於曝光量,只要能夠將本發明的樹脂組成物硬化,則並無特別限定,例如以在波長365nm下的曝光能量換算為50~10,000mJ/cm 2為較佳,200~8,000mJ/cm 2為更佳。 <Exposure Step> The above-mentioned film can be provided in the exposure step of selectively exposing the film. That is, the method for manufacturing the cured material of the present invention may include an exposure step that selectively exposes the film formed by the film forming step. Selective exposure means exposing a portion of the film. Furthermore, by selective exposure, exposed areas (exposed portions) and unexposed areas (non-exposed portions) are formed on the film. Regarding the exposure amount, there is no particular limitation as long as it is sufficient to cure the resin composition of the present invention; for example, an exposure energy equivalent to 50 to 10,000 mJ/ cm² at a wavelength of 365 nm is preferred, and 200 to 8,000 mJ/ cm² is more preferred.

曝光波長能夠在190~1,000nm的範圍內適當設定,240~550nm為較佳。The exposure wavelength can be appropriately set within the range of 190–1,000 nm, with 240–550 nm being the optimal range.

關於曝光波長,若以與光源的關係進行說明,則可舉出(1)半導體雷射(波長830nm、532nm、488nm、405nm、375nm、355nm etc.)、(2)金屬鹵化物燈、(3)高壓水銀燈、g射線(波長436nm)、h射線(波長405nm)、i射線(波長365nm)、寬(g、h、i射線的3波長)、(4)準分子雷射、KrF準分子雷射(波長248nm)、ArF準分子雷射(波長193nm)、F2準分子雷射(波長157nm)、(5)極紫外線;EUV(波長13.6nm)、(6)電子束、(7)YAG雷射的第二諧波532nm且第三諧波355nm等。關於本發明的樹脂組成物,尤其基於高壓水銀燈之曝光為較佳,其中,基於i射線之曝光為較佳。藉此,可以獲得尤其高的曝光靈敏度。 又,曝光的方式並無特別限定,只要為曝光包括本發明的樹脂組成物之膜的至少一部分之方式即可,但是可舉出使用了光罩之曝光、基於雷射直接成像法之曝光等。 Regarding the exposure wavelength, if we explain it in terms of its relationship with the light source, we can cite (1) semiconductor lasers (wavelengths 830nm, 532nm, 488nm, 405nm, 375nm, 355nm) as examples. (etc.), (2) metal halide lamps, (3) high-pressure mercury lamps, g-rays (wavelength 436nm), h-rays (wavelength 405nm), i-rays (wavelength 365nm), broadband (wavelengths of g, h, and i-rays), (4) excimer lasers, KrF excimer lasers (wavelength 248nm), ArF excimer lasers (wavelength 193nm), F2 excimer lasers (wavelength 157nm), (5) extreme ultraviolet; EUV (wavelength 13.6nm), (6) electron beams, (7) YAG lasers with a second harmonic of 532nm and a third harmonic of 355nm, etc. Regarding the resin composition of the present invention, exposure to high-pressure mercury lamps is particularly preferred, among which exposure to i-rays is preferred. This allows for exceptionally high exposure sensitivity. Furthermore, the exposure method is not particularly limited, as long as it exposes at least a portion of the film containing the resin composition of this invention. Examples include exposure using a photomask and exposure based on direct laser imaging.

<曝光後加熱步驟> 上述膜可以提供給在曝光後進行加熱之步驟(曝光後加熱步驟)中。 亦即,本發明的硬化物的製造方法可以包括曝光後加熱步驟,該曝光後加熱步驟加熱藉由曝光步驟進行曝光之膜。 曝光後加熱步驟能夠在曝光步驟之後且在顯影步驟之前進行。 曝光後加熱步驟中之加熱溫度為50℃~140℃為較佳,60℃~120℃為更佳。 曝光後加熱步驟中之加熱時間為30秒鐘~300分鐘為較佳,1分鐘~10分鐘為更佳。 關於曝光後加熱步驟中之升溫速度,從加熱開始時的溫度至最高加熱溫度為1~12℃/分鐘為較佳,2~10℃/分鐘為更佳,3~10℃/分鐘為進一步較佳。 又,升溫速度可以在加熱過程中適當變更。 作為曝光後加熱步驟中之加熱機構,並無特別限定,能夠使用公知的加熱板、烘箱、紅外線加熱器等。 又,藉由在加熱時使氮氣、氦氣、氬氣等非活性氣體流過等而在低氧濃度的環境下進行亦較佳。 <Post-exposure heating step> The above-described film can be provided for a heating step following exposure (post-exposure heating step). That is, the method for manufacturing the cured material of the present invention may include a post-exposure heating step, which heats the film exposed by the exposure step. The post-exposure heating step can be performed after the exposure step and before the developing step. The heating temperature in the post-exposure heating step is preferably 50°C to 140°C, and more preferably 60°C to 120°C. The heating time in the post-exposure heating step is preferably 30 seconds to 300 minutes, and more preferably 1 minute to 10 minutes. Regarding the heating rate in the post-exposure heating step, a rate of 1–12°C/min from the initial heating temperature to the maximum heating temperature is preferred, 2–10°C/min is more preferred, and 3–10°C/min is even better. Furthermore, the heating rate can be appropriately varied during the heating process. There are no particular limitations on the heating mechanism used in the post-exposure heating step; known heating plates, ovens, infrared heaters, etc., can be used. Furthermore, it is also preferable to conduct the process in a low-oxygen environment by allowing inert gases such as nitrogen, helium, or argon to flow through during heating.

<顯影步驟> 曝光後的上述膜可以提供於使用顯影液進行顯影而形成圖案之顯影步驟中。 亦即,本發明的硬化物的製造方法可以包括顯影步驟,該顯影步驟使用顯影液對藉由曝光步驟進行曝光之膜進行顯影而形成圖案。藉由進行顯影,去除膜的曝光部及非曝光部中的一個來形成圖案。 其中,將藉由顯影步驟去除膜的非曝光部之顯影稱為負型顯影,將藉由顯影步驟去除膜的曝光部之顯影稱為正型顯影。 <Developing Step> The exposed film can be used in a developing step to form a pattern by developing it with a developing solution. That is, the method for manufacturing the cured material of the present invention may include a developing step in which a developing solution is used to develop the film exposed in the exposure step to form a pattern. By performing development, one of the exposed and unexposed portions of the film is removed to form the pattern. The development that removes the unexposed portions of the film in the developing step is called negative development, and the development that removes the exposed portions of the film in the developing step is called positive development.

〔顯影液〕 作為顯影步驟中所使用之顯影液,可舉出含有鹼水溶液或有機溶劑之顯影液。 [Developer] Developers used in the developing process include those containing alkaline solutions or organic solvents.

當顯影液為鹼水溶液之情況下,作為鹼水溶液能夠含有之鹼性化合物,可舉出無機鹼類、一級胺類、二級胺類、三級胺類、四級銨鹽,TMAH(氫氧化四甲基銨)、氫氧化鉀、碳酸鈉、氫氧化鈉、矽酸鈉、偏矽酸鈉、氨、乙胺、正丙基胺、二乙胺、二正丁基胺、三乙胺、甲基二乙胺、二甲基乙醇胺、三乙醇胺、氫氧化四乙基銨、氫氧化四丙基銨、氫氧化四丁基銨、氫氧化四戊基銨、氫氧化四己基銨、氫氧化四辛基銨、氫氧化乙基三甲基銨、氫氧化丁基三甲基銨、氫氧化甲基三戊基銨、氫氧化二丁基二戊基銨、氫氧化二甲基雙(2-羥乙基)銨、氫氧化三甲基苯基銨、氫氧化三甲基苄基銨、氫氧化三乙基苄基銨、吡咯、哌啶為較佳,更佳為TMAH。例如在使用TMAH之情況下,顯影液中之鹼性化合物的含量在顯影液總質量中為0.01~10質量%為較佳,0.1~5質量%為更佳,0.3~3質量%為進一步較佳。When the developing solution is an alkaline aqueous solution, the alkaline compounds that can be contained in an alkaline aqueous solution include inorganic bases, primary amines, secondary amines, tertiary amines, quaternary ammonium salts, TMAH (tetramethylammonium hydroxide), potassium hydroxide, sodium carbonate, sodium hydroxide, sodium silicate, sodium metasilate, ammonia, ethylamine, n-propylamine, diethylamine, di-n-butylamine, triethylamine, methyldiethylamine, dimethylethanolamine, triethanolamine, and tetraethylammonium hydroxide. The preferred compounds are tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, tetrapentylammonium hydroxide, tetrahexylammonium hydroxide, tetraoctylammonium hydroxide, ethyltrimethylammonium hydroxide, butyltrimethylammonium hydroxide, methyltripentylammonium hydroxide, dibutyldipentylammonium hydroxide, dimethylbis(2-hydroxyethyl)ammonium hydroxide, trimethylphenylammonium hydroxide, trimethylbenzylammonium hydroxide, triethylbenzylammonium hydroxide, pyrrole, and piperidine, with TMAH being even more preferred. For example, when using TMAH, the content of alkaline compounds in the developer is preferably 0.01 to 10% by mass, more preferably 0.1 to 5% by mass, and even more preferably 0.3 to 3% by mass.

當顯影液含有有機溶劑之情況下,有機溶劑作為酯類例如可較佳地舉出乙酸乙酯、乙酸正丁酯、甲酸戊酯、乙酸異戊酯、乙酸異丁酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例:烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例:3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例:2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯等,以及作為醚類,例如可較佳地舉出二乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚(PGME)、丙二醇單甲醚乙酸酯(PGMEA)、丙二醇單乙醚乙酸酯、丙二醇單丙醚乙酸酯等,以及作為酮類,例如可較佳地舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、N-甲基-2-吡咯啶酮等,以及作為環狀烴類,例如可較佳地舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類、作為亞碸類,可較佳地舉出二甲基亞碸以及作為醇類,可較佳地舉出甲醇、乙醇、丙醇、異丙醇、丁醇、戊醇、辛醇、二乙二醇、丙二醇、甲基異丁基甲醇、三乙二醇等以及作為醯胺類,可較佳地舉出N-甲基吡咯啶酮、N-乙基吡咯啶酮、二甲基甲醯胺等。When the developing solution contains organic solvents, the organic solvents preferably include esters such as ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., 3-alkoxy...). Methyl propionate, ethyl 3-alkoxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), alkyl 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., 2-methoxy-2-methylpropionate) Methyl ester, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, etc., and as ethers, preferably diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and Examples of ketones include, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone; examples of cyclic hydrocarbons include, for example, aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene; examples of iones include, for example, dimethyl iones; examples of alcohols include, for example, methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutyl methanol, triethylene glycol; and examples of amides include, for example, N-methylpyrrolidone, N-ethylpyrrolidone, and dimethylformamide.

在顯影液包含有機溶劑之情況下,有機溶劑能夠使用1種或混合使用2種以上。在本發明中,尤其包含選自包括環戊酮、γ-丁內酯、二甲基亞碸、N-甲基-2-吡咯啶酮及環己酮之群組中之至少一種之顯影液為較佳,包含選自包括環戊酮、γ-丁內酯及二甲基亞碸之群組中之至少一種之顯影液為更佳,包含環戊酮之顯影液為最佳。When the developing solution contains an organic solvent, one or more organic solvents may be used. In this invention, it is particularly preferred that the developing solution contains at least one selected from the group consisting of cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methyl-2-pyrrolidone, and cyclohexanone; it is even more preferred that the developing solution contains at least one selected from the group consisting of cyclopentanone, γ-butyrolactone, and dimethyl sulfoxide; and the developing solution containing cyclopentanone is the most preferred.

當顯影液含有有機溶劑之情況下,有機溶劑相對於顯影液的總質量之含量為50質量%以上為較佳,70質量%以上為更佳,80質量%以上為進一步較佳,90質量%以上為特佳。又,上述含量可以為100質量%。When the developing solution contains organic solvents, the content of organic solvents relative to the total mass of the developing solution is preferably 50% by mass or more, more preferably 70% by mass or more, even more preferably 80% by mass or more, and especially preferably 90% by mass or more. Furthermore, the above content can be 100% by mass.

顯影液可以進一步含有其他成分。 作為其他成分,例如可舉出公知的界面活性劑和公知的消泡劑等。 Developer solutions may further contain other ingredients. These other ingredients include, for example, well-known surfactants and well-known defoamers.

〔顯影液的供給方法〕 關於顯影液的供給方法,只要能夠形成所期望的圖案,則並無特別限制,存在將形成有膜之基材浸漬於顯影液中之方法、使用噴嘴向形成於基材上之膜供給顯影液以進行旋覆浸沒顯影或連續供給顯影液之方法。噴嘴的種類並無特別限制,可舉出直式噴嘴、噴淋噴嘴、噴霧噴嘴等。 從顯影液的滲透性、非圖像部的去除性、製造上的效率的觀點考慮,使用直式噴嘴供給顯影液之方法或使用噴霧噴嘴連續供給之方法為較佳,從顯影液向圖像部的滲透性的觀點考慮,使用噴霧噴嘴進行供給之方法為更佳。 又,可以採用在使用直式噴嘴連續供給顯影液之後,旋轉基材以從基材上去除顯影液,在旋轉乾燥之後再次使用直式噴嘴連續供給之後,旋轉基材以從基材上去除顯影液之步驟,亦可以反覆進行複數次該步驟。 又,作為顯影步驟中之顯影液的供給方法,能夠採用將顯影液連續地供給至基材之步驟、在基材上使顯影液保持大致靜止狀態之步驟、在基材上利用超聲波等使顯影液振動之步驟及組合了該等之步驟等。 [Developer Supply Method] Regarding the developer supply method, there are no particular limitations as long as the desired pattern can be formed. Methods include immersing the substrate with the film formed in the developer, using a nozzle to supply the developer to the film formed on the substrate for swirling immersion development, or continuously supplying the developer. There are no particular limitations on the type of nozzle; examples include straight nozzles, spray nozzles, and mist nozzles. From the perspectives of developer penetration, non-image area removal, and manufacturing efficiency, using a vertical nozzle to supply developer or using a continuous spray nozzle is preferable. From the perspective of developer penetration into the image area, using a spray nozzle is even better. Furthermore, a process can be adopted where, after continuously supplying developer using a vertical nozzle, the substrate is rotated to remove the developer, and after drying, the substrate is again continuously supplied using a vertical nozzle, and then rotated to remove the developer. This process can be repeated multiple times. Furthermore, as a method for supplying the developer in the developing step, methods can include continuously supplying the developer to the substrate, maintaining the developer in a substantially static state on the substrate, vibrating the developer on the substrate using ultrasound or the like, and combinations thereof.

作為顯影時間,10秒鐘~10分鐘為較佳,20秒鐘~5分鐘為更佳。顯影時的顯影液的溫度並無特別限定,能夠較佳為在10~45℃下進行,更較佳為在18℃~30℃下進行。The optimal development time is 10 seconds to 10 minutes, with 20 seconds to 5 minutes being even better. There is no particular limitation on the temperature of the developing solution during development, but it is best to perform the process at 10 to 45°C, and even better at 18 to 30°C.

在顯影步驟中,在使用了顯影液之處理之後,可以進一步進行使用沖洗液之圖案的清洗(沖洗)。又,可以採用與圖案接觸之顯影液沒有完全乾燥之前供給沖洗液等的方法。In the developing step, after treatment with developer, the pattern can be further cleaned (rinsed) using rinsing solution. Alternatively, rinsing solution can be supplied before the developer in contact with the pattern is completely dry.

〔沖洗液〕 在顯影液為鹼水溶液之情況下,作為沖洗液,例如能夠使用水。在顯影液為包含有機溶劑之顯影液之情況下,作為沖洗液,例如能夠使用與顯影液中所包含之溶劑不同之溶劑(例如,水、與顯影液中所包含之有機溶劑不同之有機溶劑)。 [Rinse Solution] When the developer is an alkaline aqueous solution, water can be used as the rinsing solution, for example. When the developer contains an organic solvent, a solvent different from the solvent contained in the developer can be used as the rinsing solution (e.g., water, or an organic solvent different from the organic solvent contained in the developer).

作為沖洗液包含有機溶劑時的有機溶劑,作為酯類,例如可較佳地舉出乙酸乙酯、乙酸正丁酯、甲酸戊酯、乙酸異戊酯、乙酸異丁酯、丙酸丁酯、丁酸異丙酯、丁酸乙酯、丁酸丁酯、乳酸甲酯、乳酸乙酯、γ-丁內酯、ε-己內酯、δ-戊內酯、烷氧基乙酸烷基酯(例:烷氧基乙酸甲酯、烷氧基乙酸乙酯、烷氧基乙酸丁酯(例如,甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等))、3-烷氧基丙酸烷基酯類(例:3-烷氧基丙酸甲酯、3-烷氧基丙酸乙酯等(例如,3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯等))、2-烷氧基丙酸烷基酯類(例:2-烷氧基丙酸甲酯、2-烷氧基丙酸乙酯、2-烷氧基丙酸丙酯等(例如,2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-甲氧基丙酸丙酯、2-乙氧基丙酸甲酯、2-乙氧基丙酸乙酯))、2-烷氧基-2-甲基丙酸甲酯及2-烷氧基-2-甲基丙酸乙酯(例如,2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等)、丙酮酸甲酯、丙酮酸乙酯、丙酮酸丙酯、乙醯乙酸甲酯、乙醯乙酸乙酯、2-氧代丁酸甲酯、2-氧代丁酸乙酯等,以及作為醚類,例如可較佳地舉出二乙二醇二甲醚、四氫呋喃、乙二醇單甲醚、乙二醇單乙醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、丙二醇單甲醚(PGME)、丙二醇單甲醚乙酸酯(PGMEA)、丙二醇單乙醚乙酸酯、丙二醇單丙醚乙酸酯等,以及作為酮類,例如可較佳地舉出甲基乙基酮、環己酮、環戊酮、2-庚酮、3-庚酮、N-甲基-2-吡咯啶酮等,以及作為環狀烴類,例如可較佳地舉出甲苯、二甲苯、苯甲醚等芳香族烴類、檸檬烯等環式萜烯類、作為亞碸類,可較佳地舉出二甲基亞碸以及作為醇類,可較佳地舉出甲醇、乙醇、丙醇、異丙醇、丁醇、戊醇、辛醇、二乙二醇、丙二醇、甲基異丁基甲醇、三乙二醇等以及作為醯胺類,可較佳地舉出N-甲基吡咯啶酮、N-乙基吡咯啶酮、二甲基甲醯胺等。When the rinsing solution contains organic solvents, the organic solvents, preferably esters, include ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetic acid esters (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), and alkyl 3-alkoxypropionic acid esters (e.g., 3-alkoxy...). Methyl propionate, ethyl 3-alkoxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), alkyl 2-alkoxypropionates (e.g., methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (e.g., 2-methoxy-2-methylpropionate) Methyl ester, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, etc., and as ethers, preferably diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl solvent acetate, ethyl solvent acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and Examples of ketones include, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone; examples of cyclic hydrocarbons include, for example, aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene; examples of iones include, for example, dimethyl iones; examples of alcohols include, for example, methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutyl methanol, triethylene glycol; and examples of amides include, for example, N-methylpyrrolidone, N-ethylpyrrolidone, and dimethylformamide.

在沖洗液包含有機溶劑之情況下,有機溶劑能夠使用1種或混合使用2種以上。在本發明中,尤其環戊酮、γ-丁內酯、二甲基亞碸、N-甲基吡咯啶酮、環己酮、PGMEA、PGME為較佳,環戊酮、γ-丁內酯、二甲基亞碸、PGMEA、PGME為更佳,環己酮、PGMEA為進一步較佳。When the rinsing solution contains organic solvents, one or more organic solvents may be used, or a mixture of two or more may be used. In this invention, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, N-methylpyrrolidone, cyclohexanone, PGMEA, and PGME are particularly preferred, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, PGMEA, and PGME are even more preferred, and cyclohexanone and PGMEA are further preferred.

在沖洗液包含有機溶劑之情況下,沖洗液的50質量%以上為有機溶劑為較佳,70質量%以上為有機溶劑為更佳,90質量%以上為有機溶劑為進一步較佳。又,亦可以為沖洗液的100質量%為有機溶劑。When the rinsing solution contains organic solvents, it is preferable that 50% or more by mass of the rinsing solution is an organic solvent, more preferably 70% or more by mass, and even more preferably 90% or more by mass. Alternatively, 100% by mass of the rinsing solution may also be an organic solvent.

沖洗液可以進一步含有其他成分。 作為其他成分,例如可舉出公知的界面活性劑和公知的消泡劑等。 Rinsing solutions may further contain other ingredients. Examples of these other ingredients include, for example, well-known surfactants and well-known defoamers.

〔沖洗液的供給方法〕 關於沖洗液的供給方法,只要能夠形成所期望的圖案,則並無特別限制,存在將基材浸漬於沖洗液中之方法、藉由液盤將沖洗液供給至基材之方法、以噴淋形式將沖洗液供給至基材之方法、藉由直式噴嘴等機構將沖洗液連續供給至基材之方法。 從沖洗液的滲透性、非圖像部的去除性、製造上的效率的觀點考慮,存在使用噴淋噴嘴、直式噴嘴、噴霧噴嘴等供給沖洗液之方法,使用噴霧噴嘴連續供給之方法為較佳,從沖洗液向圖像部的滲透性的觀點考慮,使用噴霧噴嘴進行供給之方法為更佳。噴嘴的種類並無特別限制,可舉出直式噴嘴、噴淋噴嘴、噴霧噴嘴等。 亦即,沖洗步驟為藉由直式噴嘴將沖洗液供給或連續供給至上述曝光後的膜中之步驟為較佳,藉由噴霧噴嘴供給沖洗液之步驟為更佳。 又,作為沖洗步驟中之沖洗液的供給方法,能夠採用將沖洗液連續地供給至基材之步驟、在基材上使沖洗液保持大致靜止狀態之步驟、在基材上利用超聲波等使沖洗液振動之步驟及組合了該等之步驟等。 [Rinsing Solution Supply Method] Regarding the rinsing solution supply method, there are no particular limitations as long as the desired pattern can be formed. Methods include immersing the substrate in the rinsing solution, supplying the rinsing solution to the substrate via a liquid tray, supplying the rinsing solution to the substrate via spraying, and continuously supplying the rinsing solution to the substrate via a mechanism such as a straight nozzle. From the perspectives of rinse fluid penetration, removal of non-image areas, and manufacturing efficiency, there are various methods for supplying rinse fluid, including spray nozzles, straight nozzles, and mist nozzles. Continuous supply via a mist nozzle is preferable, and from the perspective of rinse fluid penetration into the image area, a mist nozzle is even better. There are no particular limitations on the type of nozzle; examples include straight nozzles, spray nozzles, and mist nozzles. That is, it is preferable that the rinsing step involves supplying or continuously supplying the rinsing solution to the exposed film using a straight nozzle, and even better that it is supplied using a spray nozzle. Furthermore, as a method for supplying the rinsing solution in the rinsing step, methods such as continuously supplying the rinsing solution to the substrate, keeping the rinsing solution substantially still on the substrate, vibrating the rinsing solution on the substrate using ultrasound or the like, and combinations thereof can be used.

作為沖洗時間,10秒鐘~10分鐘為較佳,20秒鐘~5分鐘為更佳。沖洗時的沖洗液的溫度並無特別限定,能夠較佳為在10~45℃下進行,更較佳為在18℃~30℃下進行。The preferred rinsing time is 10 seconds to 10 minutes, and even better is 20 seconds to 5 minutes. There is no particular limitation on the temperature of the rinsing solution, but it is best to carry out the rinsing at 10 to 45°C, and even better at 18 to 30°C.

<加熱步驟> 藉由顯影步驟而獲得之圖案(在進行沖洗步驟之情況下為沖洗後的圖案)可以提供給加熱藉由上述顯影而獲得之圖案之加熱步驟中。 亦即,本發明的硬化物的製造方法可以包括加熱步驟,該加熱步驟加熱藉由顯影步驟而獲得之圖案。 又,本發明的硬化物的製造方法可以包括加熱步驟,該加熱步驟加熱在不進行顯影步驟的狀態下藉由其他方法而獲得之圖案或藉由膜形成步驟而獲得之膜。 在加熱步驟中,使聚醯亞胺前驅物等樹脂環化而成為聚醯亞胺等樹脂。 又,亦進行特定樹脂或除了特定樹脂以外的交聯劑中之未反應的交聯性基的交聯等。 作為加熱步驟中之加熱溫度(最高加熱溫度),50~450℃為較佳,150~350℃為更佳,150~250℃為進一步較佳,160~250℃為更進一步較佳,160~230℃為特佳。 <Heating Step> The pattern obtained by the developing step (or, in the case of a rinsing step, the rinsed pattern) can be provided to the heating step that heats the pattern obtained by the aforementioned developing step. That is, the method for manufacturing the cured material of the present invention may include a heating step that heats the pattern obtained by the developing step. Furthermore, the method for manufacturing the cured material of the present invention may include a heating step that heats a pattern obtained by other methods without a developing step, or a film obtained by a film forming step. In the heating step, resins such as polyimide precursors are cyclized to form polyimide resins. Furthermore, crosslinking of unreacted crosslinking groups in specific resins or crosslinking agents other than specific resins is also performed. The heating temperature (maximum heating temperature) in the heating step is preferably 50–450°C, more preferably 150–350°C, further preferably 150–250°C, even more preferably 160–250°C, and particularly preferably 160–230°C.

加熱步驟藉由加熱,利用從上述鹼產生劑產生之鹼等的作用,在上述圖案內促進上述聚醯亞胺前驅物的環化反應之步驟為較佳。The heating step is preferable to promote the cyclization reaction of the polyimide precursor within the above pattern by heating and utilizing the action of the alkali produced from the above-mentioned alkali generator.

關於加熱步驟中之加熱,從加熱開始時的溫度至最高加熱溫度以1~12℃/分鐘的升溫速度進行為較佳。上述升溫速度為2~10℃/分鐘為更佳,3~10℃/分鐘為進一步較佳。藉由將升溫速度設為1℃/分鐘以上,能夠確保生產率,並且防止酸或溶劑的過度揮發,藉由將升溫速度設為12℃/分鐘以下,能夠緩和硬化物的殘存應力。 另外,在為能夠急速加熱的烘箱的情況下,從加熱開始時的溫度至最高加熱溫度以1~8℃/秒鐘的升溫速度進行為較佳,2~7℃/秒鐘為更佳,3~6℃/秒鐘為進一步較佳。 Regarding the heating process, it is preferable to increase the temperature from the initial heating temperature to the maximum heating temperature at a rate of 1–12 °C/min. A rate of 2–10 °C/min is more preferable, and 3–10 °C/min is even more preferable. Setting the heating rate to 1 °C/min or higher ensures productivity and prevents excessive volatilization of acid or solvent, while setting the heating rate to 12 °C/min or lower helps to mitigate residual stress in the hardened material. Furthermore, in the case of an oven capable of rapid heating, it is preferable to increase the temperature from the initial heating temperature to the maximum heating temperature at a rate of 1–8 °C/sec, more preferable at 2–7 °C/sec, and even more preferable at 3–6 °C/sec.

加熱開始時的溫度為20℃~150℃為較佳,20℃~130℃為更佳,25℃~120℃為進一步較佳。加熱開始時的溫度係指,開始加熱至最高加熱溫度之步驟時的溫度。例如,在將本發明的樹脂組成物適用於基材上之後使其乾燥之情況下,為該乾燥後的膜(層)的溫度,例如從比本發明的樹脂組成物中所包含之溶劑的沸點低30~200℃的溫度開始升溫為較佳。The initial heating temperature is preferably 20°C to 150°C, more preferably 20°C to 130°C, and even more preferably 25°C to 120°C. The initial heating temperature refers to the temperature at which the heating begins and reaches the maximum heating temperature. For example, after applying the resin composition of the present invention to a substrate and allowing it to dry, it is the temperature of the dried film (layer), preferably starting the heating from a temperature 30°C to 200°C lower than the boiling point of the solvent contained in the resin composition of the present invention.

加熱時間(在最高加熱溫度下的加熱時間)為5~360分鐘為較佳,10~300分鐘為更佳,15~240分鐘為進一步較佳。The heating time (heating time at the highest heating temperature) is preferably 5 to 360 minutes, even better is 10 to 300 minutes, and even better is 15 to 240 minutes.

尤其,在形成多層積層體之情況下,從層間的密接性的觀點考慮,加熱溫度為30℃以上為較佳,80℃以上為更佳,100℃以上為進一步較佳,120℃以上為特佳。 上述加熱溫度的上限為350℃以下為較佳,250℃以下為更佳,240℃以下為進一步較佳。 In particular, when forming multilayered bodies, from the perspective of interlayer adhesion, a heating temperature of 30°C or higher is preferred, 80°C or higher is even better, 100°C or higher is further preferred, and 120°C or higher is exceptionally preferred. The upper limit of the above heating temperatures is preferably below 350°C, even better below 250°C, and further preferred below 240°C.

加熱可以階段性地進行。作為例子,可以進行如下步驟:從25℃以3℃/分鐘升溫至120℃且在120℃下保持60分鐘,並且從120℃以2℃/分鐘升溫至180℃且在180℃下保持120分鐘。又,如美國專利第9159547號說明書中所記載,一邊照射紫外線一邊進行處理亦較佳。藉由這種預處理步驟,能夠提高膜的特性。預處理步驟在10秒鐘~2小時左右的短時間內進行即可,15秒鐘~30分鐘為更佳。預處理可以為兩階段以上的步驟,例如可以在100~150℃的範圍內進行第1階段的預處理步驟,之後在150~200℃的範圍內進行第2階段的預處理步驟。 進而,可以在加熱之後進行冷卻,作為此時的冷卻速度,1~5℃/分鐘為較佳。 Heating can be performed in stages. For example, the following steps can be taken: increase the temperature from 25°C to 120°C at a rate of 3°C/min and hold at 120°C for 60 minutes, then increase the temperature from 120°C to 180°C at a rate of 2°C/min and hold at 180°C for 120 minutes. Alternatively, as described in U.S. Patent No. 9159547, it is preferable to perform the treatment while irradiating the membrane with ultraviolet light. This pretreatment step can improve the membrane's properties. The pretreatment step can be performed in a short time, approximately 10 seconds to 2 hours, with 15 seconds to 30 minutes being more ideal. Pretreatment can consist of two or more steps. For example, the first pretreatment step can be performed at a temperature range of 100–150°C, followed by a second pretreatment step at a temperature range of 150–200°C. Furthermore, cooling can be performed after heating, with a cooling rate of 1–5°C/min being preferable.

在防止特定樹脂分解的方面而言,藉由在加熱步驟中使氮氣、氦氣、氬氣等非活性氣體流過且在減壓下進行等而在低氧濃度的環境下進行為較佳。氧濃度為50ppm(體積比)以下為較佳,20ppm(體積比)以下為更佳。 作為加熱步驟中之加熱機構,並無特別限定,但是例如可舉出加熱板、紅外線爐、電烘箱、熱風式烘箱、紅外線烘箱等。 To prevent the decomposition of certain resins, it is preferable to conduct the heating process in a low-oxygen environment by passing inert gases such as nitrogen, helium, or argon under reduced pressure. An oxygen concentration of 50 ppm (by volume) or less is preferred, and 20 ppm (by volume) or less is even better. The heating mechanism used in the heating process is not particularly limited, but examples include heating plates, infrared furnaces, electric ovens, hot air ovens, and infrared ovens.

<顯影後曝光步驟> 藉由顯影步驟而獲得之圖案(在進行沖洗步驟之情況下為沖洗後的圖案)代替上述加熱步驟或除了上述加熱步驟以外亦可以提供於曝光顯影步驟之後的圖案之顯影後曝光步驟中。 亦即,本發明的硬化物的製造方法可以包括顯影後曝光步驟,該顯影後曝光步驟曝光藉由顯影步驟而獲得之圖案。本發明的硬化物的製造方法可以包括加熱步驟及顯影後曝光步驟,亦可以僅包括加熱步驟及顯影後曝光步驟中的一者。 在顯影後曝光步驟中,例如能夠促進藉由光鹼產生劑的感光而進行聚醯亞胺前驅物等的環化之反應或藉由光酸產生劑的感光而進行酸分解性基的脫離之反應等。 在顯影後曝光步驟中,只要曝光在顯影步驟中所獲得之圖案的至少一部分即可,但是曝光上述圖案的全部為較佳。 顯影後曝光步驟中之曝光量以在感光性化合物具有靈敏度之波長下之曝光能量換算為50~20,000mJ/cm 2為較佳,100~15,000mJ/cm 2為更佳。 顯影後曝光步驟例如能夠使用上述曝光步驟中之光源來進行,使用寬頻帶光為較佳。 <Post-development exposure step> The pattern obtained by the development step (or the pattern after rinsing if a rinsing step is performed) can replace the heating step described above, or can be provided in a post-development exposure step other than the heating step described above, in order to provide the pattern after the exposure and development step. That is, the method for manufacturing the cured material of the present invention may include a post-development exposure step, which exposes the pattern obtained by the development step. The method for manufacturing the cured material of the present invention may include a heating step and a post-development exposure step, or may include only one of the heating step and the post-development exposure step. In the post-development exposure step, reactions such as cyclization of polyimide precursors by photoalkali generators or desorption of acid-degrading groups by photoacid generators can be promoted. In the post-development exposure step, it is sufficient to expose at least a portion of the pattern obtained in the development step, but exposing the entire pattern is preferable. The exposure amount in the post-development exposure step is preferably 50–20,000 mJ/ cm² , more preferably 100–15,000 mJ/ cm² , based on the exposure energy at the wavelength where the photosensitive compound is sensitive. The post-development exposure step can be performed using the light source described in the exposure step above, with broadband light being preferable.

<金屬層形成步驟> 藉由顯影步驟而獲得之圖案(提供給加熱步驟及曝光後顯影步驟中的至少一者之圖案為較佳)可以提供給在圖案上形成金屬層之金屬層形成步驟中。 亦即,本發明的硬化物的製造方法包括金屬層形成步驟為較佳,該金屬層形成步驟在藉由顯影步驟而獲得之圖案(提供給加熱步驟及顯影後曝光步驟中的至少一者之圖案為較佳)上形成金屬層。 <Metal Layer Formation Step> The pattern obtained by the developing step (preferably a pattern provided to at least one of the heating step and the post-development developing step) can be provided to the metal layer formation step in which a metal layer is formed on the pattern. That is, the method for manufacturing the cured material of the present invention preferably includes a metal layer formation step, which forms a metal layer on the pattern obtained by the developing step (preferably a pattern provided to at least one of the heating step and the post-development exposure step).

作為金屬層,並無特別限定,能夠使用現有的金屬種類,可例示銅、鋁、鎳、釩、鈦、鉻、鈷、金、鎢、錫、銀及包含該等金屬之合金,銅及鋁為更佳,銅為進一步較佳。As a metal layer, there are no particular limitations; existing metal types can be used, such as copper, aluminum, nickel, vanadium, titanium, chromium, cobalt, gold, tungsten, tin, silver, and alloys containing these metals, with copper and aluminum being preferred, and copper being even more preferred.

金屬層的形成方法並無特別限定,能夠適用現有的方法。例如,能夠使用日本特開2007-157879號公報、日本特表2001-521288號公報、日本特開2004-214501號公報、日本特開2004-101850號公報、美國專利第7888181B2、美國專利第9177926B2中所記載之方法。例如,可以考慮光微影、PVD(物理蒸鍍法)、CVD(化學氣相沉積法)、剝離、電解電鍍、無電解電鍍、蝕刻、印刷及組合了該等之方法等。更具體而言,可舉出組合了濺射、光微影及蝕刻之圖案化方法、組合了光微影和電解電鍍之圖案化方法。作為電鍍的較佳態樣,可舉出使用了硫酸銅或氰化銅電鍍液之電解電鍍。There are no particular limitations on the method for forming the metal layer, and existing methods can be used. For example, methods described in Japanese Patent Application Publication No. 2007-157879, Japanese Patent Application Publication No. 2001-521288, Japanese Patent Application Publication No. 2004-214501, Japanese Patent Application Publication No. 2004-101850, US Patent No. 7888181B2, and US Patent No. 9177926B2 can be used. For example, photolithography, PVD (physical vapor deposition), CVD (chemical vapor deposition), peeling, electrolytic electroplating, electroless electroplating, etching, printing, and combinations thereof can be considered. More specifically, examples include patterning methods that combine sputtering, photolithography, and etching, and patterning methods that combine photolithography and electroplating. As a preferred example of electroplating, electroplating using copper sulfate or copper cyanide plating solutions can be cited.

作為金屬層的厚度,最厚的壁厚的部分為0.01~50μm為較佳,1~10μm為更佳。As for the thickness of the metal layer, it is preferable for the thickest part of the wall to be 0.01 to 50 μm, and even better if it is 1 to 10 μm.

<用途> 作為能夠適用本發明的硬化物的製造方法或本發明的硬化物的領域,可舉出半導體元件的絕緣膜、再配線層用層間絕緣膜、應力緩衝膜等。除此以外,亦可舉出密封膜、基板材料(柔性印刷電路板的基底膜或覆蓋膜、層間絕緣膜)或藉由對如上述實際安裝用途的絕緣膜進行蝕刻而形成圖案之情況等。關於該等用途,例如能夠參閱Science&Technology Co.,Ltd.“聚醯亞胺的高功能化和應用技術”2008年4月、柿本雅明/監修、CMC技術圖書館“聚醯亞胺材料的基礎和開發”2011年11月發行、日本聚醯亞胺/芳香族系高分子研究會/編“最新聚醯亞胺 基礎和應用”NTS,2010年8月等。 <Applications> Examples of applications applicable to the manufacturing method of the cured material of this invention or to the cured material of this invention include insulating films for semiconductor devices, interlayer insulating films for redistribution layers, and stress-relief films. Other applications include sealing films, substrate materials (base films or cover films of flexible printed circuit boards, interlayer insulating films), or patterns formed by etching insulating films used for practical installation purposes as described above. For information on these applications, please refer to, for example, Science & Technology Co., Ltd., “High Functionalization and Application Technology of Polyimides,” April 2008; Masaaki Kakimoto, supervised; CMC Technical Library, “Basic and Development of Polyimide Materials,” November 2011; and Japan Polyimide/Aromatic Polymer Research Association, ed., “Latest Polyimide Basics and Applications,” NTS, August 2010, etc.

又,本發明的硬化物的製造方法或本發明的硬化物亦能夠用於膠印版面或網版版面等版面的製造、蝕刻成形組件的用途、電子尤其微電子中之保護漆及介電層的製造等中。Furthermore, the method for manufacturing the cured material of the present invention or the cured material of the present invention can also be used in the manufacture of offset printing plates or screen printing plates, for etching and forming components, and in the manufacture of protective coatings and dielectric layers in electronics, especially microelectronics.

(積層體及積層體的製造方法) 本發明的積層體係指具有複數層包括本發明的硬化物之層之結構體。 本發明的積層體為包括2層以上的包含硬化物之層之積層體,並且亦可以設為積層3層以上而成之積層體。 上述積層體中所包括之2層以上的上述包括硬化物之層中的至少一個為包括本發明的硬化物之層,從抑制硬化物的收縮或上述收縮所伴隨之硬化物的變形等之觀點考慮,上述積層體中所包括之所有包括硬化物之層為包括本發明的硬化物之層亦較佳。 (Laminated Body and Method for Manufacturing the Laminated Body) The laminated body of the present invention refers to a structure having a plurality of layers comprising the hardened material of the present invention. The laminated body of the present invention comprises two or more layers containing hardened material, and may also be a laminated body consisting of three or more layers. At least one of the two or more layers containing hardened material in the aforementioned laminated body is a layer containing the hardened material of the present invention. From the viewpoint of suppressing the shrinkage of the hardened material or the deformation of the hardened material accompanying the shrinkage, it is also preferable that all the layers containing hardened material in the aforementioned laminated body are layers containing the hardened material of the present invention.

亦即,本發明的積層體的製造方法包括本發明的硬化物的製造方法為較佳,包括重複複數次本發明的硬化物的製造方法之步驟為更佳。That is, it is preferable that the method of manufacturing the laminate of the present invention includes the method of manufacturing the hardened material of the present invention, and it is even more preferable that the method of manufacturing the hardened material of the present invention is repeated several times.

本發明的積層體包含2層以上的包括硬化物之層,在任意上述包括硬化物之層之間的任一層之間包含金屬層之態樣為較佳。關於上述金屬層,藉由上述金屬層形成步驟而形成為較佳。 亦即,本發明的積層體的製造方法在複數次進行之硬化物的製造方法期間,還包括在包括硬化物之層上形成金屬層之金屬層形成步驟為較佳。金屬層形成步驟的較佳態樣如上所述。 作為上述積層體,例如可舉出至少包含依次積層有第一個包括硬化物之層、金屬層、第二個包括硬化物之層這三個層之層結構之積層體作為較佳者。 上述第一個包括硬化物之層及上述第二個包括硬化物之層均為包括本發明的硬化物之層為較佳。用於形成上述第一個包括硬化膜之層之本發明的樹脂組成物和用於形成上述第二個包括硬化膜之層之本發明的樹脂組成物可以為組成相同的組成物,亦可以為組成不同之組成物。本發明的積層體中之金屬層可較佳地用作再配線層等金屬配線。 The laminate of the present invention comprises two or more layers including a hardened material, and preferably includes a metal layer between any of the aforementioned layers including the hardened material. The metal layer is preferably formed by the aforementioned metal layer forming step. That is, the method for manufacturing the laminate of the present invention preferably includes a metal layer forming step of forming a metal layer on the layers including the hardened material during the plurality of hardened material manufacturing steps. The preferred form of the metal layer forming step is as described above. As an example of the aforementioned laminate, a preferred embodiment is a laminate comprising at least three layers sequentially stacked: a first layer including a hardened material, a metal layer, and a second layer including a hardened material. Preferably, both the first and second layers including a hardened material are layers containing the hardened material of the present invention. The resin composition used to form the first layer including the hardened film and the resin composition used to form the second layer including the hardened film can be of the same composition or different compositions. The metal layer in the laminate of the present invention is preferably used as a rewiring layer or other metal wiring.

<積層步驟> 本發明的積層體的製造方法包括積層步驟為較佳。 積層步驟為包括在圖案(樹脂層)或金屬層的表面上再次依序進行(a)膜形成步驟(層形成步驟)、(b)曝光步驟、(c)顯影步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者之一系列步驟。其中,亦可以為重複(a)膜形成步驟及(d)加熱步驟及顯影後曝光步驟中的至少一者之態樣。又,亦可以在(d)加熱步驟及顯影後曝光步驟中的至少一者之後包括(e)金屬層形成步驟。在積層步驟中可以進一步適當包括上述乾燥步驟等,這係毋庸置疑的。 <Lamination Steps> The method for manufacturing the laminate of the present invention preferably includes a lamination step. The lamination step includes a series of steps comprising performing, on the surface of a pattern (resin layer) or metal layer, at least one of (a) a film formation step (layer formation step), (b) an exposure step, (c) a developing step, (d) a heating step, and a post-development exposure step. Alternatively, it may be possible to repeat at least one of (a) the film formation step and (d) the heating step and the post-development exposure step. Furthermore, it may be possible to include (e) the metal layer formation step after at least one of (d) the heating step and the post-development exposure step. It goes without saying that the aforementioned drying steps can be appropriately included in the lamination process.

在積層步驟之後進一步進行積層步驟之情況下,可以在上述曝光步驟之後,上述加熱步驟之後或上述金屬層形成步驟之後,進一步進行表面活化處理步驟。作為表面活化處理,可例示電漿處理。對表面活性化處理的詳細內容將進行後述。If a further layering step is performed after the layering step, a surface activation treatment step can be performed after the exposure step, the heating step, or the metal layer formation step described above. Plasma treatment can be cited as an example of a surface activation treatment. Details of the surface activation treatment will be described later.

上述積層步驟進行2~20次為較佳,進行2~9次為更佳。 例如,如樹脂層/金屬層/樹脂層/金屬層/樹脂層/金屬層,將樹脂層設為2層以上且20層以下之構成為較佳,並且設為2層以上且9層以下之構成為進一步較佳。 上述各層的組成、形狀及膜厚等可以分別相同,亦可以不同。 Performing the above lamination steps 2 to 20 times is preferred, and 2 to 9 times is even better. For example, in a resin layer/metal layer/resin layer/metal layer/resin layer/metal layer configuration, having 2 or more but less than 20 resin layers is preferred, and having 2 or more but less than 9 layers is even more preferred. The composition, shape, and film thickness of each of the above layers can be the same or different.

在本發明中,尤其以在設置金屬層之後進一步覆蓋上述金屬層之方式形成上述本發明的樹脂組成物的硬化物(樹脂層)之態樣為較佳。具體而言,可舉出依序重複(a)膜形成步驟、(b)曝光步驟、(c)顯影步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者(e)金屬層形成步驟之態樣或依序重複(a)膜形成步驟、(d)加熱步驟及顯影後曝光步驟中的至少一者、(e)金屬層形成步驟之態樣。藉由交替進行積層本發明的樹脂組成物層(樹脂層)之積層步驟和金屬層形成步驟,能夠交替積層本發明的樹脂組成物層(樹脂層)和金屬層。In this invention, it is particularly preferred that the hardened resin composition (resin layer) of the present invention is formed by further covering the metal layer after the metal layer is applied. Specifically, examples include repeating at least one of (a) film formation step, (b) exposure step, (c) development step, (d) heating step and post-development exposure step, and (e) metal layer formation step in sequence, or repeating at least one of (a) film formation step, (d) heating step and post-development exposure step, and (e) metal layer formation step in sequence. By alternately performing the lamination steps of the resin composition layer (resin layer) and the metal layer formation step of the present invention, it is possible to alternately laminate the resin composition layer (resin layer) and the metal layer of the present invention.

(表面活性化處理步驟) 本發明的積層體的製造方法包括對上述金屬層及樹脂組成物層的至少一部分進行表面活性化處理之表面活性化處理步驟為較佳。 表面活性化處理步驟通常在金屬層形成步驟之後進行,但是亦可以在上述顯影步驟之後(較佳為加熱步驟及顯影後曝光步驟中的至少一者之後),對樹脂組成物層進行表面活性化處理步驟之後,進行金屬層形成步驟。 關於表面活性化處理,可以僅對金屬層的至少一部分進行,亦可以僅對曝光後的樹脂組成物層的至少一部分進行,亦可以分別對金屬層及曝光後的樹脂組成物層這兩者的至少一部分進行。對金屬層的至少一部分進行表面活性化處理為較佳,對金屬層中在表面上形成樹脂組成物層之區域的一部分或全部進行表面活性化處理為較佳。如此,藉由對金屬層的表面進行表面活性化處理,能夠提高與設置於其表面上之樹脂組成物層(膜)的密接性。 又,對曝光後的樹脂組成物層(樹脂層)的一部分或全部亦進行表面活性化處理為較佳。如此,藉由對樹脂組成物層的表面進行表面活性化處理,能夠提高與設置於經表面活性化處理之表面上之金屬層和樹脂層的密接性。尤其,在進行負型顯影之情況等使樹脂組成物層硬化之情況下,不易受到表面處理之損壞,從而容易提高密接性。 作為表面活性化處理,具體而言,選自各種原料氣體(氧氣、氫氣、氬氣、氮氣、氮氣/氫氣混合氣體、氬氣/氧氣混合氣體等)的電漿處理、電暈放電處理、基於CF 4/O 2、NF 3/O 2、SF 6、NF 3、NF 3/O 2之蝕刻處理、基於紫外線(UV)臭氧法之表面處理、浸漬於鹽酸水溶液中以去除氧化皮膜之後浸漬於包含具有至少一種胺基和硫醇基之化合物之有機表面處理劑中的浸漬處理、使用了刷子之機械粗面化處理,電漿處理為較佳,尤其使用氧氣作為原料氣體之氧氣電漿處理為較佳。在進行電暈放電處理之情況下,能量為500~200,000J/m 2為較佳,1000~100,000J/m 2為更佳,10,000~50,000J/m 2為最佳。 (Surface Activation Treatment Step) The method for manufacturing the laminate of the present invention preferably includes a surface activation treatment step of surface activating at least a portion of the aforementioned metal layer and resin composition layer. The surface activation treatment step is usually performed after the metal layer formation step, but it can also be performed after the aforementioned development step (preferably after at least one of the heating step and the post-development exposure step), after performing the surface activation treatment step on the resin composition layer, followed by the metal layer formation step. Regarding the surface activation treatment, it can be performed on at least a portion of the metal layer, on at least a portion of the exposed resin composition layer, or on at least a portion of both the metal layer and the exposed resin composition layer. It is preferable to perform surface activation treatment on at least a portion of the metal layer, and it is preferable to perform surface activation treatment on a portion or all of the area of the metal layer where the resin composition layer is formed on the surface. In this way, by performing surface activation treatment on the surface of the metal layer, the adhesion to the resin composition layer (film) disposed on its surface can be improved. Furthermore, it is preferable to also perform surface activation treatment on a portion or all of the exposed resin composition layer (resin layer). Thus, by surface-activating the surface of the resin composition layer, the adhesion between the resin composition layer and the metal layer disposed on the surface-activated surface can be improved. In particular, when the resin composition layer hardens due to processes such as negative development, it is less susceptible to damage from the surface treatment, thereby easily improving adhesion. As a surface activation treatment, specifically, plasma treatment using various raw material gases (oxygen, hydrogen, argon, nitrogen, nitrogen/hydrogen mixture, argon/oxygen mixture, etc.), corona discharge treatment, etching treatment based on CF4 / O2 , NF3 / O2 , SF6 , NF3 , NF3 / O2 , surface treatment based on ultraviolet (UV) ozone method, immersion treatment after removing the oxide film in hydrochloric acid aqueous solution and then immersion in an organic surface treatment agent containing at least one amine group and thiol group, and mechanical roughening treatment using a brush are preferred, especially oxygen plasma treatment using oxygen as the raw material gas. When performing corona discharge treatment, an energy of 500–200,000 J/ is preferred, 1,000–100,000 J/ is even better, and 10,000–50,000 J/ is optimal.

(半導體元件之製造方法) 又,在本發明中亦揭示含有本發明的硬化物或本發明的積層體之半導體元件。 又,本發明亦揭示包括本發明的硬化物的製造方法或本發明的積層體的製造方法之半導體元件的製造方法。作為將本發明的樹脂組成物用於再配線層用層間絕緣膜的形成中之半導體元件的具體例,能夠參閱日本特開2016-027357號公報的0213~0218段的記載及圖1的記載,該等內容被編入本說明書中。 [實施例] (Method for Manufacturing Semiconductor Devices) Furthermore, this invention also discloses semiconductor devices containing the cured material or the laminate of this invention. Furthermore, this invention also discloses a method for manufacturing semiconductor devices including a method for manufacturing the cured material or the laminate of this invention. As a specific example of a semiconductor device using the resin composition of this invention in the formation of an interlayer insulating film for a redistribution layer, please refer to paragraphs 0213 to 0218 of Japanese Patent Application Publication No. 2016-027357 and Figure 1, the contents of which are incorporated herein by reference. [Examples]

以下,舉出實施例對本發明進行更具體的說明。以下實施例所示之材料、使用量、比例、處理內容、處理步驟等只要不脫離本發明的宗旨,則能夠適當地進行變更。從而,本發明的範圍並不限定於以下所示之具體例。除非另有說明,則“份”、“%”為質量標準。The following examples provide a more detailed description of the invention. The materials, quantities, proportions, processing methods, and steps shown in the following examples can be appropriately modified as long as they do not depart from the spirit of the invention. Therefore, the scope of the invention is not limited to the specific examples shown below. Unless otherwise stated, "parts" and "%" are quality standards.

<化合物B-1的合成> 〔B-1a的合成〕 加入50.0g(0.338mol)的鄰苯二甲酸酐、66.4g(0.51mol)的甲基丙烯酸2-羥乙酯、250mg的作為聚合抑制劑的氫醌單甲醚(MEHQ)及2.1g的二甲基胺基吡啶(DMAP),加熱至外溫65℃並且攪拌了2小時。反應結束之後,冷卻至25℃之後,倒入550ml的水、55.2g的碳酸氫鈉、200ml的乙酸乙酯中。攪拌30分鐘之後,去除了有機相。用150ml的乙酸乙酯萃取水相,去除乙酸乙酯溶液,進而再次進行了相同的操作。向所獲得之水相加入500ml的乙酸乙酯,用濃鹽酸調節成pH=2~3的酸性溶液之後進行了分液。用飽和食鹽水(200ml)清洗3次乙酸乙酯相,用無水硫酸鈉進行了乾燥。向乙酸乙酯溶液添加250mg的MEHQ,在減壓下濃縮乙酸乙酯,獲得了120g的作為目標物之B-1a的無色透明油狀物,其產率為100%。 <Synthesis of Compound B-1> [Synthesis of B-1a] 50.0 g (0.338 mol) of phthalic anhydride, 66.4 g (0.51 mol) of 2-hydroxyethyl methacrylate, 250 mg of hydroquinone monomethyl ether (MEHQ) as a polymerization inhibitor, and 2.1 g of dimethylaminopyridine (DMAP) were added. The mixture was heated to 65°C and stirred for 2 hours. After the reaction was complete, it was cooled to 25°C and poured into 550 ml of water, 55.2 g of sodium bicarbonate, and 200 ml of ethyl acetate. After stirring for 30 minutes, the organic phase was removed. The aqueous phase was extracted with 150 ml of ethyl acetate to remove the ethyl acetate solution, and the same operation was repeated. 500 ml of ethyl acetate was added to the obtained aqueous phase, and the solution was adjusted to an acidic pH of 2-3 with concentrated hydrochloric acid before separation. The ethyl acetate phase was washed three times with saturated brine (200 ml) and dried with anhydrous sodium sulfate. 250 mg of MEHQ was added to the ethyl acetate solution, and the ethyl acetate was concentrated under reduced pressure to obtain 120 g of a colorless, transparent oily substance as the target compound B-1a, with a yield of 100%.

〔B-1的合成〕 向三口圓底燒瓶加入55.0g(0.2mol)的B-1及300ml的乙腈,冷卻至-5℃並且進行攪拌,添加了24.2g(0.24mol)的三乙胺。將該溶液冷卻至5℃以下之後,滴加了27.5g(0.24mol)的甲磺醯氯。滴加結束之後,在0℃下攪拌30分鐘之後,加入了39.0(0.30mol)的甲基丙烯酸2-羥乙酯及6.1g的DMAP。將該溶液冷卻至10℃以下之後,滴加了24.2g(0.24mol)的三乙胺。滴加結束之後,在25℃下攪拌3小時,接著加熱至75℃並且攪拌了10分鐘。將反應液冷卻至25℃之後,一邊攪拌一邊將其倒入1200ml的水中。加入10ml的濃鹽酸調節成pH=3~4左右。用500ml的乙酸乙酯進行萃取,並且用飽和食鹽水進行了水洗。接著,用將20g的碳酸氫鈉溶解於500ml的水中之碳酸氫鈉水溶液清洗乙酸乙酯溶液之後,用水(400ml)清洗了2次。用無水硫酸鈉乾燥乙酸乙酯溶液,在減壓下在外溫40℃下進行了濃縮。向殘渣加入50ml的氯仿/正己烷=1/2的混合溶劑使其溶解,用管柱層析法(載體:矽膠、洗提液:正己烷/乙酸乙酯=3/1)進行了純化。從所獲得之溶液在減壓下蒸餾溶劑,獲得了50.7g的作為目標物之B-1的油狀物,其產率為64.7%。 化合物B-1的H 1-NMR測量結果如下。 7.74(2H)、7.71(2H)、6.15(2H)、5.59(2H)、4.56(4H)、4.46(4H) 【化學式74】 [Synthesis of B-1] 55.0 g (0.2 mol) of B-1 and 300 mL of acetonitrile were added to a three-necked round-bottom flask. The mixture was cooled to -5°C and stirred. 24.2 g (0.24 mol) of triethylamine was then added. After cooling the solution to below 5°C, 27.5 g (0.24 mol) of methanesulfonyl chloride was added dropwise. After the addition was complete, the mixture was stirred at 0°C for 30 minutes. Then, 39.0 g (0.30 mol) of 2-hydroxyethyl methacrylate and 6.1 g of DMAP were added. After cooling the solution to below 10°C, 24.2 g (0.24 mol) of triethylamine was added dropwise. After the addition was complete, the mixture was stirred at 25°C for 3 hours, then heated to 75°C and stirred for 10 minutes. The reaction solution was cooled to 25°C and poured into 1200ml of water while stirring. 10ml of concentrated hydrochloric acid was added to adjust the pH to approximately 3-4. Extraction was performed with 500ml of ethyl acetate, followed by washing with saturated brine. The ethyl acetate solution was then washed twice with 400ml of water, followed by washing with anhydrous sodium bicarbonate solution (20g dissolved in 500ml of water). The ethyl acetate solution was dried with anhydrous sodium sulfate and concentrated under reduced pressure at an external temperature of 40°C. The residue was dissolved in 50 ml of a chloroform/n-hexane mixture (1:2), and purified by column chromatography (support: silicone, eluent: n-hexane/ethyl acetate = 3:1). The obtained solution was distilled off under reduced pressure to obtain 50.7 g of the target compound B-1 as an oil, with a yield of 64.7%. The ¹H -NMR results for compound B-1 are as follows: 7.74 (2H), 7.71 (2H), 6.15 (2H), 5.59 (2H), 4.56 (4H), 4.46 (4H) [Formula 74]

<化合物B-2的合成> 〔B-2a的合成〕 向50.0g(0.26mol)的偏苯三酸酐、45.3g(0.39mol)的丙烯酸2-羥乙酯、0.5g的作為聚合抑制劑的二丁基羥基甲苯(BHT)加入45ml的N,N-二甲基乙醯胺(DMAc),在25℃下進行了攪拌。向該溶液加入1.83g(0.013mol)的二甲基胺基吡啶(DMAP),加熱至60℃並且攪拌了6小時。反應結束之後,將其倒入400ml的水中,添加200ml的乙酸乙酯進行了萃取。去除乙酸乙酯之後,向水相添加400ml的乙酸乙酯,一邊攪拌一邊滴加濃鹽酸,調節成pH=2~3的酸性。去除水相,用飽和食鹽水清洗了3次乙酸乙酯溶液。用無水硫酸鈉乾燥乙酸乙酯溶液之後,添加0.5g的BHT,在減壓下進行濃縮,過濾白色的結晶,在60℃下使其乾燥8小時,獲得了76.0g的作為目標物之B-2a,其產率為94.7%。 <Synthesis of Compound B-2> [Synthesis of B-2a] 50.0 g (0.26 mol) of trimellitic anhydride, 45.3 g (0.39 mol) of 2-hydroxyethyl acrylate, and 0.5 g of dibutylhydroxytoluene (BHT) as a polymerization inhibitor were added to 45 mL of N,N-dimethylacetamide (DMAc), and the mixture was stirred at 25 °C. 1.83 g (0.013 mol) of dimethylaminopyridine (DMAP) was added to the solution, and the mixture was heated to 60 °C and stirred for 6 hours. After the reaction was complete, the solution was poured into 400 mL of water, and 200 mL of ethyl acetate was added for extraction. After removing the ethyl acetate, 400 mL of ethyl acetate was added to the aqueous phase, and concentrated hydrochloric acid was added dropwise while stirring to adjust the pH to acidic 2–3. The aqueous phase was removed, and the ethyl acetate solution was washed three times with saturated brine. After drying the ethyl acetate solution with anhydrous sodium sulfate, 0.5 g of BHT was added, and concentration was carried out under reduced pressure. The white crystals were filtered and dried at 60°C for 8 hours to obtain 76.0 g of B-2a as the target compound, with a yield of 94.7%.

〔B-2b的合成〕 向120g(1.03mol)的丙烯酸2-羥乙酯、115g(1.14mol)的三乙胺加入350ml的乙酸乙酯,冷卻至-5℃並且進行了攪拌。一邊將該溶液保持10℃以下,一邊滴加了124g(1.08mol)的甲磺酸氯化物。滴加結束之後,在0℃下攪拌1小時,接著在室溫下攪拌了2小時。反應結束之後,加入400ml的水及200ml的乙酸乙酯並且進行了萃取。向乙酸乙酯溶液添加1.0g的作為聚合抑制劑的二丁基羥基甲苯(BHT),在減壓下進行濃縮,獲得了196g的作為目標物之B-2b的油狀物,其產率為97.6%。 [Synthesis of B-2b] 120 g (1.03 mol) of 2-hydroxyethyl acrylate and 115 g (1.14 mol) of triethylamine were added to 350 mL of ethyl acetate. The mixture was cooled to -5 °C and stirred. While keeping the solution below 10 °C, 124 g (1.08 mol) of chloride methanesulfonic acid was added dropwise. After the addition was complete, the mixture was stirred at 0 °C for 1 hour, followed by stirring at room temperature for 2 hours. After the reaction was complete, 400 mL of water and 200 mL of ethyl acetate were added, and extraction was performed. 1.0 g of dibutylhydroxytoluene (BHT) as a polymerization inhibitor was added to an ethyl acetate solution, and concentration was carried out under reduced pressure to obtain 196 g of an oily product of the target compound B-2b, with a yield of 97.6%.

〔B-2的合成〕 向三口圓底燒瓶加入70.0g(0.227mol)的B-2a、73.7g(0.59mol)的二異丙基乙胺、2.0g的BHT、350ml的DMAc,將內溫加熱至80℃。經30分鐘向該溶液滴加了106g(0.55mol)的B-2b。滴加結束之後,在內溫80℃下加熱攪拌了5小時。反應結束之後,冷卻至25℃,一邊攪拌一邊將其倒入1500ml的水中。添加750ml的乙酸乙酯進行了萃取。用飽和食鹽水清洗3次乙酸乙酯溶液,用無水硫酸鈉進行了乾燥。向乙酸乙酯溶液添加1.0g的BHT,在減壓下進行了濃縮。向殘渣添加600ml的氯仿/正己烷=2/1的混合溶劑使其溶解之後,用管柱層析法(載體:矽膠、洗提液:正己烷/乙酸乙酯=4/1進行了純化。向所獲得之乙酸乙酯溶液添加70mg的4-甲氧基苯酚,在減壓下進行濃縮,獲得了85.4g的作為目標物之B-2,其產率為74.5%。 化合物B-2的H 1-NMR測量結果如下。 8.42(1H)、8.23(1H)、7.79(1H)、6.46(3H)、6.16(3H)、5.88(3H)、4.57(6H)、4.48(6H) 【化學式75】 [Synthesis of B-2] 70.0 g (0.227 mol) of B-2a, 73.7 g (0.59 mol) of diisopropylethylamine, 2.0 g of BHT, and 350 ml of DMAc were added to a three-necked round-bottom flask, and the internal temperature was heated to 80°C. After 30 minutes, 106 g (0.55 mol) of B-2b was added dropwise to the solution. After the addition was complete, the mixture was heated and stirred at 80°C for 5 hours. After the reaction was complete, it was cooled to 25°C and poured into 1500 ml of water while stirring. Extraction was performed by adding 750 ml of ethyl acetate. The ethyl acetate solution was washed three times with saturated brine and dried with anhydrous sodium sulfate. 1.0 g of BHT was added to an ethyl acetate solution, and concentration was carried out under reduced pressure. The residue was dissolved by adding 600 ml of a chloroform/n-hexane (2/1) mixed solvent, and then purified by column chromatography (support: silicone, eluent: n-hexane/ethyl acetate (4/1)). 70 mg of 4-methoxyphenol was added to the obtained ethyl acetate solution, and concentration was carried out under reduced pressure to obtain 85.4 g of the target compound B-2, with a yield of 74.5%. The ¹H -NMR results of compound B-2 are as follows: 8.42 (¹H), 8.23 (¹H), 7.79 (¹H), 6.46 (³H), 6.16 (³H), 5.88 (³H), 4.57 (⁶H), 4.48 (⁶H) [Formula 75]

<化合物B-3的合成> 〔B-3a的合成〕 向三口圓底燒瓶添加9.31g(0.030mol)的4,4’-氧基二鄰苯二甲酸酐、11.71g(0.090mol)的甲基丙烯酸2-羥乙酯、35mg的作為聚合抑制劑的4-甲氧基苯酚、0.61g(5mmol)的N,N-二甲基胺基吡啶(DMAP),在外溫60~65℃下經2.5小時進行了攪拌。將反應液溶解於300ml的乙酸乙酯中,將30g的碳酸氫鈉倒入加入到300ml的水之水溶液中,在25℃下攪拌了30分鐘。分離有機相,進而用飽和碳酸氫鈉水溶液進行了萃取。收集水相,一邊加入濃鹽酸一邊調節成pH3以下時,油狀物被分離。藉由200ml的乙酸乙酯萃取該油狀物,用硫酸鎂進行乾燥之後,在減壓下進行濃縮,藉此以油狀物獲得了12.52g的作為目標物之B-3a。未對該油狀物進行純化,用於下一反應步驟中。 <Synthesis of Compound B-3> [Synthesis of B-3a] 9.31 g (0.030 mol) of 4,4'-oxydiphthalic anhydride, 11.71 g (0.090 mol) of 2-hydroxyethyl methacrylate, 35 mg of 4-methoxyphenol as a polymerization inhibitor, and 0.61 g (5 mmol) of N,N-dimethylaminopyridine (DMAP) were added to a three-necked round-bottom flask and stirred at 60–65 °C for 2.5 hours. The reaction solution was dissolved in 300 mL of ethyl acetate, and 30 g of sodium bicarbonate was added to an aqueous solution of 300 mL of water. The mixture was stirred at 25 °C for 30 minutes. The organic phase was separated and then extracted with a saturated sodium bicarbonate aqueous solution. The aqueous phase was collected, and the pH was adjusted to below 3 while adding concentrated hydrochloric acid, resulting in the separation of the oil. The oil was extracted with 200 ml of ethyl acetate, dried with magnesium sulfate, and then concentrated under reduced pressure to obtain 12.52 g of B-3a as the target compound. This oil was not purified and was used in the next reaction step.

〔B-3b的合成〕 向三口圓底燒瓶加入26.03g(0.200mol)的甲基丙烯酸2-羥乙酯、23.78g(0.235mol)的三乙胺、0.75g的4-甲氧基苯酚、85ml的乙酸乙酯,在冰冷下5~15℃下滴加了24.51g(0.214mol)的甲醯氯化物。返回到室溫,使其反應了2小時之後,加入85ml的水攪拌了30分鐘。反應結束之後,分液有機相,用200ml的飽和食鹽水、繼而用2N(2mol/L)鹽酸清洗之後,再次用200ml的飽和食鹽水清洗了2次。用硫酸鈉乾燥了萃取之有機相之後,在減壓下進行濃縮,藉此獲得了41.42g的作為目標物之B-3a,其產率為99.6%。 [Synthesis of B-3b] 26.03 g (0.200 mol) of 2-hydroxyethyl methacrylate, 23.78 g (0.235 mol) of triethylamine, 0.75 g of 4-methoxyphenol, and 85 mL of ethyl acetate were added to a three-necked round-bottom flask. 24.51 g (0.214 mol) of formaldehyde chloride was added dropwise at 5–15 °C under ice-cold conditions. After returning to room temperature and allowing the reaction to proceed for 2 hours, 85 mL of water was added and the mixture was stirred for 30 minutes. After the reaction was complete, the organic phase was separated and washed with 200 mL of saturated brine, then with 2N (2 mol/L) hydrochloric acid, and finally twice more with 200 mL of saturated brine. After drying the extracted organic phase with sodium sulfate, it was concentrated under reduced pressure to obtain 41.42 g of the target compound B-3a, with a yield of 99.6%.

〔B-3的合成〕 向三口圓底燒瓶加入62.5g的二甲基丙烯醯氧4,4’-氧基二鄰苯二甲酸二酯B-3a、82.93g(600mmol)的碳酸鉀、8.30g(0.050mol)的碘化鉀、200ml的N,N-二甲基乙醯胺(DMAc),在25℃下向其添加了41.42g(0.199mol)的B-3a。在內溫50℃下攪拌了4.5小時。反應結束之後,將反應液倒入500ml的乙酸乙酯,用300ml的飽和碳酸氫鈉水溶液清洗4次,用300ml的飽和食鹽水清洗1次,用硫酸鈉乾燥有機相之後,在減壓下進行濃縮,並且進行管柱層析(載體:矽膠、洗提液:正己烷/乙酸乙酯=3/1),獲得了49.31g的作為目標物之B-3,其產率為62.3%。 化合物B-3的H 1-NMR測量結果如下。 7.84(2H)、7.28(2H)、7.14(2H)、6.10(4H)、5.59(4H)、4.54(8H)、4.44(8H)、1.95(12H) 【化學式76】 [Synthesis of B-3] 62.5 g of dimethacryloxy-4,4'-oxydiphthalate diester B-3a, 82.93 g (600 mmol) of potassium carbonate, 8.30 g (0.050 mol) of potassium iodide, and 200 ml of N,N-dimethylacetamide (DMAc) were added to a three-necked round-bottom flask. 41.42 g (0.199 mol) of B-3a was then added at 25 °C. The mixture was stirred for 4.5 hours at an internal temperature of 50 °C. After the reaction was complete, the reaction solution was poured into 500 ml of ethyl acetate, washed four times with 300 ml of saturated sodium bicarbonate solution, washed once with 300 ml of saturated brine, dried with sodium sulfate, concentrated under reduced pressure, and then subjected to column chromatography (support: silicone, eluent: n-hexane/ethyl acetate = 3/1), yielding 49.31 g of target compound B-3, with a yield of 62.3%. The 1H -NMR results of compound B-3 are as follows. 7.84 (2H), 7.28 (2H), 7.14 (2H), 6.10 (4H), 5.59 (4H), 4.54 (8H), 4.44 (8H), 1.95 (12H) [Chemical Formula 76]

<化合物B-4的合成> 〔B-4a的合成〕 向三口圓底燒瓶加入4.44g(0.010mol)的4,4’-(六氟亞異丙基)氧二鄰苯二甲酸酐、34.84g(0.300mol)的丙烯酸2-羥乙酯、100mg的作為聚合抑制劑的二丁基羥基甲苯(BHT)、0.61g(5mmol)的N,N-二甲基胺基吡啶(DMAP)、18.5ml的N,N-二甲基乙醯胺(DMAc),在外溫55℃下攪拌了4小時。將反應液溶解於400ml的乙酸乙酯中,將20g的碳酸氫鈉倒入加入到400ml的水之水溶液中,在25℃下攪拌了30分鐘。分離水相,進而用200ml的乙酸乙酯清洗4次之後,一邊加入濃鹽酸一邊調整為pH3以下時,油狀物被分離。用1000ml的乙酸乙酯萃取該油狀物,用硫酸鎂進行乾燥之後,在減壓下進行濃縮,藉此以油狀物獲得了78.0g的作為目標物之B-4a。未對該油狀物進行純化,用於下一反應步驟中。 <Synthesis of Compound B-4> [Synthesis of B-4a] 4.44 g (0.010 mol) of 4,4'-(hexafluoroisopropyl)oxophthalic anhydride, 34.84 g (0.300 mol) of 2-hydroxyethyl acrylate, 100 mg of dibutylhydroxytoluene (BHT) as a polymerization inhibitor, 0.61 g (5 mmol) of N,N-dimethylaminopyridine (DMAP), and 18.5 ml of N,N-dimethylacetamide (DMAc) were added to a three-necked round-bottom flask and stirred at 55 °C for 4 hours. The reaction solution was dissolved in 400 ml of ethyl acetate, and 20 g of sodium bicarbonate was added to an aqueous solution of 400 ml of water. The mixture was stirred at 25 °C for 30 minutes. The aqueous phase was separated, and the sample was washed four times with 200 ml of ethyl acetate. While adjusting the pH to below 3 with concentrated hydrochloric acid, the oil was separated. The oil was extracted with 1000 ml of ethyl acetate, dried with magnesium sulfate, and concentrated under reduced pressure to obtain 78.0 g of B-4a as the target compound. This oil was not purified and was used in the next reaction step.

〔B-4的合成〕 向三口圓底燒瓶加入78.0g的二丙烯醯氧基4,4’-(六氟亞異丙基)二鄰苯二甲酸二酯B-4a、82.93g(600mmol)的碳酸鉀、8.30g(0.050mol)的碘化鉀、200ml的N,N-二甲基乙醯胺(DMAc),在25℃下向其添加了46.61g(0.240mol)的B-2b。在內溫55℃下攪拌了30分鐘之後,在內溫80℃下攪拌了5小時。反應結束之後,將反應液冷卻至25℃,倒入600ml的乙酸乙酯,用300ml的飽和碳酸氫鈉水溶液清洗2次,用300ml的飽和食鹽水清洗1次,用硫酸鈉乾燥有機相之後,在減壓下進行濃縮,進行管柱層析(載體:矽膠、洗提液:正己烷/乙酸乙酯=2/1),獲得了59.59g的作為目標物之B-4,其產率為68.2%。 化合物B-4的H 1-NMR測量結果如下。 7.83(2H)、7.74(2H)、7.50(2H)、6.44(4H)、6.12(4H)、5.87(4H)、4.57(8H)、4.47(8H) 【化學式77】 [Synthesis of B-4] 78.0 g of diallyloxy-4,4'-(hexafluoroisopropyl)diphthalate B-4a, 82.93 g (600 mmol) of potassium carbonate, 8.30 g (0.050 mol) of potassium iodide, and 200 ml of N,N-dimethylacetamide (DMAc) were added to a three-necked round-bottom flask. 46.61 g (0.240 mol) of B-2b was added at 25 °C. After stirring at an internal temperature of 55 °C for 30 minutes, the mixture was stirred at an internal temperature of 80 °C for 5 hours. After the reaction was complete, the reaction solution was cooled to 25°C, poured into 600 ml of ethyl acetate, washed twice with 300 ml of saturated sodium bicarbonate solution, washed once with 300 ml of saturated brine, dried with sodium sulfate, concentrated under reduced pressure, and subjected to column chromatography (support: silicone, eluent: n-hexane/ethyl acetate = 2/1). 59.59 g of B-4 was obtained as the target compound, with a yield of 68.2%. The 1H -NMR results of compound B-4 are as follows. 7.83 (2H), 7.74 (2H), 7.50 (2H), 6.44 (4H), 6.12 (4H), 5.87 (4H), 4.57 (8H), 4.47 (8H) [Chemical Formula 77]

<化合物B-5的合成> 參閱日本特公昭45-20787號公報中所記載之方法,合成了下述化合物B-5。 【化學式78】 <Synthesis of Compound B-5> Compound B-5 was synthesized by referring to the method described in Japanese Patent Publication No. 45-20787. [Chemical Formula 78]

<化合物B-6~B-8的合成> 適當變更原料,除此以外,藉由與上述化合物B-1的合成方法相同的方法合成了化合物B-6~B-8。化合物B-6~B-8為下述結構的化合物。 【化學式79】 <Synthesis of Compounds B-6 to B-8> Compounds B-6 to B-8 were synthesized by means of the same method as that used for the synthesis of compound B-1, with appropriate modifications to the starting materials. Compounds B-6 to B-8 have the following structures: [Chemical Formula 79]

<合成例1> 〔由均苯四甲酸二酐、4,4’-二胺基二苯基醚及苯甲醇合成聚醯亞胺前驅物(A-1:不具有自由基聚合性基之聚醯亞胺前驅物)〕 使14.06g(64.5毫莫耳)的均苯四甲酸二酐(在140℃下乾燥12小時)及14.22g(131.58毫莫耳)的苯甲醇懸浮於50mL的N-甲基吡咯啶酮中,用分子篩使其乾燥。在100℃下將懸浮液加熱3小時。將反應混合物冷卻至室溫,加入21.43g(270.9毫莫耳)的吡啶及90mL的N-甲基吡咯啶酮。接著,將反應混合物冷卻至-10℃,一邊將溫度保持在-10±4℃一邊經10分鐘加入了16.12g(135.5毫莫耳)的SOCl 2。加入SOCl 2之期間,黏度增加。用50mL的N-甲基吡咯啶酮進行稀釋之後,在室溫下對反應混合物攪拌了2小時。接著,將在100mL的N-甲基吡咯啶酮中溶解11.08g(58.7毫莫耳)的4,4’-二胺基二苯基醚而得之溶液調整在-5~0℃的溫度範圍內,並且經20分鐘將其滴加到反應混合物。接著,在0℃下使反應混合物反應了1小時之後,加入70g的乙醇,在室溫下攪拌了1晚。接著,使聚醯亞胺前驅物在5升的水中沉澱,並將水-聚醯亞胺前驅物混合物以5,000rpm的速度攪拌了15分鐘。過濾去除聚醯亞胺前驅物,在4升的水中再次攪拌30分鐘並再次進行了過濾。接著,在減壓下,將所獲得之聚醯亞胺前驅物在45℃下乾燥了3天。該聚醯亞胺前驅物的重量平均分子量為18,000。 【化學式80】 <Synthetic Example 1> [Synthesis of a polyimide precursor (A-1: a polyimide precursor without free radical polymerizability groups) from pyromellitic dianhydride, 4,4'-diaminodiphenyl ether, and benzyl alcohol] 14.06 g (64.5 mmol) of pyromellitic dianhydride (dried at 140 °C for 12 hours) and 14.22 g (131.58 mmol) of benzyl alcohol were suspended in 50 mL of N-methylpyrrolidone and dried using a molecular sieve. The suspension was heated at 100 °C for 3 hours. The reaction mixture was cooled to room temperature, and 21.43 g (270.9 mmol) of pyridine and 90 mL of N-methylpyrrolidone were added. Next, the reaction mixture was cooled to -10°C, and 16.12 g (135.5 mmol) of SOCl₂ was added over 10 minutes while maintaining the temperature at -10 ± 4°C. The viscosity increased during the addition of SOCl₂ . After dilution with 50 mL of N-methylpyrrolidone, the reaction mixture was stirred at room temperature for 2 hours. Then, a solution obtained by dissolving 11.08 g (58.7 mmol) of 4,4'-diaminodiphenyl ether in 100 mL of N-methylpyrrolidone was adjusted to a temperature range of -5 to 0°C and added dropwise to the reaction mixture over 20 minutes. The reaction mixture was then reacted at 0°C for 1 hour, followed by the addition of 70 g of ethanol, and stirred overnight at room temperature. Next, the polyimide precursor was precipitated in 5 liters of water, and the water-polyimide precursor mixture was stirred at 5,000 rpm for 15 minutes. The polyimide precursor was removed by filtration, and the mixture was stirred again in 4 liters of water for 30 minutes and filtered again. The obtained polyimide precursor was then dried at 45°C for 3 days under reduced pressure. The weight-average molecular weight of the polyimide precursor was 18,000. [Chemical Formula 80]

<合成例2> 〔由均苯四甲酸二酐、4,4’-二胺基二苯基醚及甲基丙烯酸2-羥乙酯合成聚醯亞胺前驅物(A-2:具有自由基聚合性基之聚醯亞胺前驅物)〕 混合14.06g(64.5毫莫耳)的均苯四甲酸二酐(在140℃下乾燥了12小時)、16.8g(129毫莫耳)的甲基丙烯酸2-羥乙酯、0.05g的氫醌、20.4g(258毫莫耳)的吡啶及100g的二甘二甲醚(二乙二醇二甲醚),在60℃的溫度下攪拌18小時,製造了均苯四酸與甲基丙烯酸2-羥乙酯的二酯。接著,藉由SOCl 2氯化了所獲得之二酯之後,藉由與合成例1相同的方法用4,4’-二胺基二苯基醚轉換成聚醯亞胺前驅物,藉由與合成例1相同的方法獲得了聚醯亞胺前驅物。該聚醯亞胺前驅物的重量平均分子量為19,000。 【化學式81】 <Synthetic Example 2> [Synthesis of a polyimide precursor (A-2: a polyimide precursor with free radical polymerizability group) from pyromellitic dianhydride, 4,4'-diaminodiphenyl ether and 2-hydroxyethyl methacrylate] 14.06 g (64.5 mmol) of pyromellitic dianhydride (dried at 140°C for 12 hours), 16.8 g (129 mmol) of 2-hydroxyethyl methacrylate, 0.05 g of hydroquinone, 20.4 g (258 mmol) of pyridine and 100 g of diethylene glycol dimethyl ether were mixed and stirred at 60°C for 18 hours to produce a diester of pyromellitic dianhydride and 2-hydroxyethyl methacrylate. Next, the obtained diester was chlorinated with SOCl2 and then converted to a polyimide precursor using 4,4'-diaminodiphenyl ether in the same manner as in Synthesis Example 1. The polyimide precursor had a weight-average molecular weight of 19,000. [Chemical Formula 81]

<合成例3> 〔由4,4’-氧基二鄰苯二甲酸酐、4,4’-二胺基二苯基醚及甲基丙烯酸2-羥乙酯合成聚醯亞胺前驅物(A-3:具有自由基聚合性基之聚醯亞胺前驅物)〕 混合20.0g(64.5毫莫耳)的4,4’-氧基二鄰苯二甲酸酐(在140℃下乾燥了12小時)、16.8g(129毫莫耳)的甲基丙烯酸2-羥乙酯、0.05g的氫醌、20.4g(258毫莫耳)的吡啶及100g的二甘二甲醚,在60℃的溫度下攪拌18小時,製造了4,4’-氧基二鄰苯二甲酸與甲基丙烯酸2-羥乙酯的二酯。接著,藉由SOCl 2氯化了所獲得之二酯之後,藉由與合成例1相同的方法用4,4’-二胺基二苯基醚轉換成聚醯亞胺前驅物,藉由與合成例1相同的方法獲得了聚醯亞胺前驅物。該聚醯亞胺前驅物的重量平均分子量為18,000。 【化學式82】 <Synthetic Example 3> [Synthesis of a polyimide precursor (A-3: a polyimide precursor with free radical polymerizability group) from 4,4'-oxydiphthalic anhydride, 4,4'-diaminodiphenyl ether and 2-hydroxyethyl methacrylate] 20.0 g (64.5 mmol) of 4,4'-oxydiphthalic anhydride (dried at 140°C for 12 hours), 16.8 g (129 mmol) of 2-hydroxyethyl methacrylate, 0.05 g of hydroquinone, 20.4 g (258 mmol) of pyridine and 100 g of dimethyl methacrylate were mixed and stirred at 60°C for 18 hours to produce a diester of 4,4'-oxydiphthalic acid and 2-hydroxyethyl methacrylate. Next, the obtained diester was chlorinated with SOCl2 and then converted to a polyimide precursor using 4,4'-diaminodiphenyl ether in the same manner as in Synthesis Example 1. The polyimide precursor had a weight-average molecular weight of 18,000. [Chemical Formula 82]

<合成例4> 〔由4,4’-氧基二鄰苯二甲酸酐、4,4’-二胺基-2,2’-二甲基聯苯(聯鄰甲苯胺)及甲基丙烯酸2-羥乙酯合成聚醯亞胺前驅物(A-4:具有自由基聚合性基之聚醯亞胺前驅物)〕 混合20.0g(64.5毫莫耳)的4,4’-氧基二鄰苯二甲酸酐(在140℃下乾燥了12小時)、16.8g(129毫莫耳)的甲基丙烯酸2-羥乙酯、0.05g的氫醌、20.4g(258毫莫耳)的吡啶及100g的二甘二甲醚,在60℃的溫度下攪拌18小時,製造了4,4’-氧基二鄰苯二甲酸與甲基丙烯酸2-羥乙酯的二酯。接著,藉由SOCl 2氯化了所獲得之二酯之後,藉由與合成例1相同的方法用4,4’-二胺基-2,2’-二甲基聯苯轉換成聚醯亞胺前驅物,藉由與合成例1相同的方法獲得了聚醯亞胺前驅物。該聚醯亞胺前驅物的重量平均分子量為19,000。 【化學式83】 <Synthetic Example 4> [Synthesis of a polyimide precursor (A-4: a polyimide precursor with free radical polymerizable groups) from 4,4'-oxydiphthalic anhydride, 4,4'-diamino-2,2'-dimethylbiphenyl (bi-toluidine) and 2-hydroxyethyl methacrylate] A diester of 4,4'-oxydiphthalic anhydride (dried at 140°C for 12 hours), 16.8 g (129 mmol) of 2-hydroxyethyl methacrylate, 0.05 g of hydroquinone, 20.4 g (258 mmol) of pyridine, and 100 g of dimethyl ether were mixed and stirred at 60°C for 18 hours to produce a diester of 4,4'-oxydiphthalic acid and 2-hydroxyethyl methacrylate. Next, the obtained diester was chlorinated with SOCl2 and then converted to a polyimide precursor using 4,4'-diamino-2,2'-dimethylbiphenyl in the same manner as in Synthesis Example 1. The polyimide precursor had a weight-average molecular weight of 19,000. [Chemical Formula 83]

<合成例5> 〔由2,2'-雙(3-胺基-4-羥基苯基)六氟丙烷及4,4'-氧基二苯甲醯氯合成聚苯并噁唑前驅物(A-5)〕 向100mL的N-甲基-2-吡咯啶酮添加13.92g的2,2'-雙(3-胺基-4-羥基苯基)六氟丙烷,進行了攪拌並使其溶解。繼而,一邊將溫度保持在0~5℃,一邊經10分鐘滴加了11.21g的4,4'-氧基二苯甲醯氯之後,繼續攪拌了60分鐘。接著,使聚苯并噁唑前驅物在6升的水中沉澱,並將水-聚苯并噁唑前驅物混合物以5000rpm的速度攪拌了15分鐘。過濾去除聚苯并噁唑前驅物,在6升的水中再次攪拌30分鐘並再次進行了過濾。接著,在減壓下,將所獲得之聚苯并噁唑前驅物在45℃下乾燥了3天。該聚苯并噁唑前驅物的重量平均分子量為15,000。 【化學式84】 <Synthetic Example 5> [Synthesis of polybenzoxazole precursor (A-5) from 2,2'-bis(3-amino-4-hydroxyphenyl)hexafluoropropane and 4,4'-oxydibenzoyl chloride] 13.92 g of 2,2'-bis(3-amino-4-hydroxyphenyl)hexafluoropropane was added to 100 mL of N-methyl-2-pyrrolidone and stirred until dissolved. Then, while maintaining the temperature at 0–5 °C, 11.21 g of 4,4'-oxydibenzoyl chloride was added dropwise over 10 minutes, followed by stirring for another 60 minutes. Next, the polybenzoxazole precursor was precipitated in 6 liters of water, and the water-polybenzoxazole precursor mixture was stirred at 5000 rpm for 15 minutes. The polybenzoxazole precursor was removed by filtration, and the mixture was stirred again in 6 liters of water for 30 minutes and filtered again. Then, the obtained polybenzoxazole precursor was dried at 45°C for 3 days under reduced pressure. The weight-average molecular weight of the polybenzoxazole precursor was 15,000. [Chemical Formula 84]

<合成例6> 〔由4,4’-氧基二鄰苯二甲酸二酐、4,4’-二胺基二苯基醚及甲基丙烯酸2-羥乙酯合成聚醯亞胺前驅物(A-6:具有自由基聚合性基之聚醯亞胺前驅物)〕 將155.1g的4,4’-氧基二鄰苯二甲酸二酐(ODPA)加入到可分離燒瓶中,並且加入了134.0g的甲基丙烯酸2-羥乙酯(HEMA)及400ml的γ-丁內酯。一邊在室溫下攪拌一邊加入79.1g的吡啶,藉此獲得了反應混合物。基於反應之放熱結束之後,放冷至室溫,進而靜置了16小時。 <Synthesis Example 6> [Synthesis of a polyimide precursor (A-6: a polyimide precursor with free radical polymerizability groups) from 4,4'-oxydiphthalic dianhydride, 4,4'-diaminodiphenyl ether, and 2-hydroxyethyl methacrylate] 155.1 g of 4,4'-oxydiphthalic dianhydride (ODPA) was added to a separable flask, along with 134.0 g of 2-hydroxyethyl methacrylate (HEMA) and 400 ml of γ-butyrolactone. While stirring at room temperature, 79.1 g of pyridine was added to obtain the reaction mixture. After the exothermic reaction concluded, the mixture was cooled to room temperature and then allowed to stand for 16 hours.

接著,在冰冷下,向反應混合物中一邊攪拌一邊經40分鐘加入了藉由將206.3g的二環己基碳二亞胺(DCC)溶解於180ml的γ-丁內酯而得之溶液。繼而,一邊攪拌一邊經60分鐘加入了藉由將93.0g的4,4’-二胺基二苯基醚懸浮於350ml的γ-丁內酯而得之懸浮液。進而在室溫下攪拌2小時之後,加入30ml的乙醇攪拌了1小時。之後,加入了400ml的γ-丁內酯。藉由過濾去除了反應混合物中所生成之沉澱物,從而獲得了反應液。Next, while stirring, a solution obtained by dissolving 206.3 g of dicyclohexylcarbodiimide (DCC) in 180 ml of γ-butyrolactone was added to the reaction mixture over 40 minutes while still chilled. Then, while stirring, a suspension obtained by suspending 93.0 g of 4,4'-diaminodiphenyl ether in 350 ml of γ-butyrolactone was added over 60 minutes. After stirring at room temperature for 2 hours, 30 ml of ethanol was added and the mixture was stirred for 1 hour. Finally, 400 ml of γ-butyrolactone was added. The precipitate formed in the reaction mixture was removed by filtration, thus obtaining the reaction solution.

將所獲得之反應液加入到3升的乙醇中而生成了由粗聚合物構成之沉澱物。濾取所生成之粗聚合物,將其溶解於1.5升的四氫呋喃中獲得了粗聚合物溶液。將所獲得之粗聚合物溶液滴加到28升的水中並使聚合物沉澱,濾取所獲得之沉澱物之後進行真空乾燥,藉此獲得了粉末狀的聚合物A-6。測量該聚合物A-6的重量平均分子量(Mw)之結果為20,000。The obtained reaction solution was added to 3 liters of ethanol to generate a precipitate composed of crude polymer. The crude polymer was filtered and dissolved in 1.5 liters of tetrahydrofuran to obtain a crude polymer solution. The obtained crude polymer solution was added dropwise to 28 liters of water to precipitate the polymer. The precipitate was filtered and then vacuum dried to obtain polymer A-6 in powder form. The weight average molecular weight (Mw) of polymer A-6 was measured to be 20,000.

<合成例7> 〔由3,3’,4,4’-聯苯四羧酸二酐、4,4’-二胺基二苯基醚及甲基丙烯酸2-羥乙酯合成聚醯亞胺前驅物(A-7:具有自由基聚合性基之聚醯亞胺前驅物)〕 在合成例7中,代替4,4’-氧基二鄰苯二甲酸二酐155.1g,使用了3,3’4,4’-聯苯四羧酸二酐147.1g,除此以外,以與合成例6中所記載之方法相同的方式進行反應,藉此獲得了聚合物A-7。測量該聚合物A-7的重量平均分子量(Mw)之結果為22,000。 <合成例8(A-8:聚醯亞胺的合成)> 將4,4’-(六氟亞異丙基)雙(鄰苯二甲酸酐)(2.370kg、5.33莫耳)投入到25℃的1-(4-胺基苯基)-1,3,3-三甲基茚烷-5-胺(亦作為4,4’-[1,4-伸苯基-雙(1-甲基伸乙基)]雙苯胺(DAPI)已知)(1.465kg、5.51莫耳)的NMP(9.86kg)溶液中。使反應混合物的溫度上升至40℃,進行了6小時的反應。接著,添加乙酸酐(1.125kg)及吡啶(0.219kg),使反應混合物的溫度上升至100℃,進行了12小時的反應。 將上述反應混合物冷卻至室溫,轉移到比具備機械式攪拌器之大型的容器中。用乙酸乙酯稀釋反應溶液,用水清洗了1小時(第1次)。停止攪拌之後,靜置了混合物。產生相分離之後,去除了水相。用乙酸乙酯及丙酮的組合稀釋有機相,用水清洗了2次(第2次、第3次)。分別將上述第1次~第3次的清洗中所使用之有機溶劑(乙酸乙酯及丙酮)及水的量示於表1中。 【表1】    第1次 第2次 第3次 乙酸乙酯(kg) 20.5 4.1 4.1 丙酮(kg) - 2.3 2.3 水(kg) 22.0 26.0 26.0 <Synthesis Example 7> [Synthesis of a polyimide precursor (A-7: a polyimide precursor with free radical polymerizability groups) from 3,3',4,4'-biphenyltetracarboxylic dianhydride, 4,4'-diaminodiphenyl ether, and 2-hydroxyethyl methacrylate] In Synthesis Example 7, 147.1 g of 3,3',4,4'-biphenyltetracarboxylic dianhydride was used instead of 155.1 g of 4,4'-oxydiphthalic dianhydride. Otherwise, the reaction was carried out in the same manner as described in Synthesis Example 6, thereby obtaining polymer A-7. The weight-average molecular weight (Mw) of polymer A-7 was measured to be 22,000. <Synthetic Example 8 (A-8: Synthesis of Polyimide)> 2.370 kg (5.33 moles) of 4,4'-(hexafluoroisopropylidene)bis(phthalic anhydride) was added to a solution of 1-(4-aminophenyl)-1,3,3-trimethylindane-5-amine (also known as 4,4'-[1,4-epenylphenyl-bis(1-methylepenylethyl)]bisphenylamine (DAPI)) in 9.86 kg of NMP at 25 °C. The reaction mixture was heated to 40 °C and reacted for 6 hours. Then, acetic anhydride (1.125 kg) and pyridine (0.219 kg) were added, and the reaction mixture was heated to 100 °C and reacted for 12 hours. The reaction mixture was cooled to room temperature and transferred to a larger container equipped with a mechanical stirrer. The reaction solution was diluted with ethyl acetate and washed with water for 1 hour (first wash). After stirring was stopped, the mixture was allowed to stand. After phase separation, the aqueous phase was removed. The organic phase was diluted with a combination of ethyl acetate and acetone and washed twice with water (second and third washes). The amounts of organic solvent (ethyl acetate and acetone) and water used in the first to third washes are shown in Table 1. [Table 1] 1st time 2nd time 3rd Ethyl acetate (kg) 20.5 4.1 4.1 Acetone (kg) - 2.3 2.3 Water (kg) 22.0 26.0 26.0

向清洗之有機相加入GBL(γ-丁內酯、10kg),在減壓蒸餾下濃縮溶液,獲得了聚合物溶液。使用真空乾燥器乾燥上述聚合物溶液,獲得了聚醯亞胺(A-8)。GBL (γ-butyrolactone, 10 kg) was added to the cleaned organic phase, and the solution was concentrated under reduced pressure distillation to obtain a polymer solution. The polymer solution was dried using a vacuum dryer to obtain polyimide (A-8).

<實施例及比較例> 在各實施例中,分別混合下述表中所記載之成分,從而獲得了各樹脂組成物。又,在各比較例中,分別混合下述表中所記載之成分,從而獲得了各比較用組成物。 具體而言,將表的“溶劑”以外的欄中所記載之成分的含量設為表的“質量份”中所記載之量,將表的“溶劑”一欄中所記載之成分的含量設為組成物的固體成分濃度成為表中所記載之值之量。 又,例如表的“溶劑”的“I-1/I-2”“80/20”的記載表示I-1與I-2的含量之比以質量比計為I-1:I-2=80:20。 將所獲得之樹脂組成物及比較用組成物通過細孔的寬度為0.8μm的聚四氟乙烯製過濾器來進行了加壓過濾。 又,在表中,“-”的記載表示組成物不含有對應之成分。 <Examples and Comparative Examples> In each embodiment, the components listed in the following tables were mixed to obtain various resin compositions. Similarly, in each comparative example, the components listed in the following tables were mixed to obtain comparative compositions. Specifically, the content of components listed in columns other than "Soluble" in the tables is set to the amount listed in "Parts by Mass" in the tables, and the content of components listed in the "Soluble" column of the tables is set to the amount of solid content of the composition as listed in the tables. Furthermore, for example, the "I-1/I-2" "80/20" designation in the "Soluble" column of the tables indicates that the mass ratio of I-1 to I-2 is I-1:I-2=80:20. The obtained resin compositions and comparative compositions were pressure filtered through a polytetrafluoroethylene filter with a pore width of 0.8 μm. Furthermore, in the table, a "-" indicates that the composition does not contain the corresponding component.

【表2】    實施例 1 2 3 4 5 6 7 8 9 10 11 12 13 14 固體成分濃度(質量%) 42 42 42 42 42 42 42 42 42 42 42 42 42 42 環化樹脂或其前驅物 種類 A-3 A-3 A-3 A-3 A-3 A-3 A-3 A-3 A-1 A-2 A-4 A-5 A-3 A-3 質量份 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 化合物A 種類 B-1 B-2 B-3 B-4 B-5 B-6 B-7 B-8 B-1 B-1 B-1 B-1 B-1 B-1 質量份 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 聚合性化合物 種類 - - - - - - - - - - - - - - 質量份 - - - - - - - - - - - - - - 聚合起始劑 種類 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-2 D-1 質量份 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 鹼產生劑 種類 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-2 質量份 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 聚合抑制劑 種類 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 質量份 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 遷移抑制劑 種類 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 質量份 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 金屬接著性改良劑 種類 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 質量份 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 溶劑 種類 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 質量份 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 添加劑 種類 - - - - - - - - - - - - - -- 質量份 - - - - - - - - - - - - -    評價結果 解析性 B B B B B B B B B B B B B B 耐藥品性 A A A A B A A B B B B B A A Table 2 Implementation Examples 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Solid content (mass %) 42 42 42 42 42 42 42 42 42 42 42 42 42 42 Cyclic resins or their precursors Kind A-3 A-3 A-3 A-3 A-3 A-3 A-3 A-3 A-1 A-2 A-4 A-5 A-3 A-3 mass 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 80.74 Compound A Kind B-1 B-2 B-3 B-4 B-5 B-6 B-7 B-8 B-1 B-1 B-1 B-1 B-1 B-1 mass 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 12.12 polymeric compounds Kind - - - - - - - - - - - - - - mass - - - - - - - - - - - - - - Polymerization initiator Kind D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-2 D-1 mass 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 2.83 Alkali-producing agents Kind E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-1 E-2 mass 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 2.26 Polymerization inhibitors Kind F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 F-1 mass 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 Migration inhibitors Kind G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 G-1 mass 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 0.28 Metal adhesion modifier Kind H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 H-1 mass 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 1.61 solvent Kind I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 mass 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 Additives Kind - - - - - - - - - - - - - -- mass - - - - - - - - - - - - - Evaluation results Analytical B B B B B B B B B B B B B B Drug resistance A A A A B A A B B B B B A A

【表3】    實施例 比較例 15 16 17 18 19 20 21 1 2 3 固體成分濃度(質量%) 42 42 42 42 42 42 40 40 40 40 環化樹脂或其前驅物 種類 A-3 A-3 A-3 A-3 A-3 A-8 A-6 /A-7 A-6 /A-7 A-6 /A-7 A-6 /A-7 質量份 80.74 80.74 80.74 80.74 80.74 80.74 40 /40 40 /40 40 /40 40 /40 化合物A 種類 B-1 B-1 B-1 B-1 B-1 B-1 B-1 - - - 質量份 12.12 12.12 12.12 6.06 6.06 6.06 3.75 - - - 聚合性化合物 種類 - - - C-1 C-1 C-1 C-1 C-1 C-1 C-2 質量份 - - - 6.06 6.06 6.06 3 7.8 7.8 7.8 聚合起始劑 種類 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 質量份 2.83 2.83 2.83 2.83 2.83 2.83 3.1 3.1 3.1 3.1 鹼產生劑 種類 E-1 E-1 E-1 E-1 E-1 E-2 - - - - 質量份 2.26 2.26 2.26 2.26 2.26 2.26 - - - - 聚合抑制劑 種類 F-2 F-1 F-1 F-1 F-1 F-1 F-3 F-3 F-3 F-3 質量份 0.16 0.16 0.16 0.16 0.16 0.16 0.05 0.05 0.05 0.05 遷移抑制劑 種類 G-1 G-2 G-1 G-1 G-1 G-1 G-2 /G-3 G-2 /G-3 G-2 /G-3 G-2 /G-3 質量份 0.28 0.28 0.28 0.28 0.28 0.28 0.15 /0.15 0.15 /0.15 0.15 /0.15 0.15 /0.15 金屬接著性改良劑 種類 H-1 H-1 H-2 H-1 H-1 H-1 H-2 H-2 H-2 H-2 質量份 1.61 1.61 1.61 1.61 1.61 1.61 0.5 0.5 0.5 0.5 溶劑 種類 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-3 /I-4 I-3 /I-4 I-3 /I-4 I-3 /I-4 質量份 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 添加劑 種類 - - - - J-1 /J-2 J-1 /J-2 J-1 /J-2 - J-1 /J-2 J-1 /J-2 質量份 - - - - 5.5 /1 5.5 /1 5.5 /1 - 5.5 /1 5.5 /1 評價結果 解析性 B B B A A A A C D D 耐藥品性 A A A B B B B D D D Table 3 Implementation Examples Comparative example 15 16 17 18 19 20 twenty one 1 2 3 Solid content (mass %) 42 42 42 42 42 42 40 40 40 40 Cyclic resins or their precursors Kind A-3 A-3 A-3 A-3 A-3 A-8 A-6 /A-7 A-6 /A-7 A-6 /A-7 A-6 /A-7 mass 80.74 80.74 80.74 80.74 80.74 80.74 40/40 40/40 40/40 40/40 Compound A Kind B-1 B-1 B-1 B-1 B-1 B-1 B-1 - - - mass 12.12 12.12 12.12 6.06 6.06 6.06 3.75 - - - polymeric compounds Kind - - - C-1 C-1 C-1 C-1 C-1 C-1 C-2 mass - - - 6.06 6.06 6.06 3 7.8 7.8 7.8 Polymerization initiator Kind D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 D-1 mass 2.83 2.83 2.83 2.83 2.83 2.83 3.1 3.1 3.1 3.1 Alkali-producing agents Kind E-1 E-1 E-1 E-1 E-1 E-2 - - - - mass 2.26 2.26 2.26 2.26 2.26 2.26 - - - - Polymerization inhibitors Kind F-2 F-1 F-1 F-1 F-1 F-1 F-3 F-3 F-3 F-3 mass 0.16 0.16 0.16 0.16 0.16 0.16 0.05 0.05 0.05 0.05 Migration inhibitors Kind G-1 G-2 G-1 G-1 G-1 G-1 G-2 /G-3 G-2 /G-3 G-2 /G-3 G-2 /G-3 mass 0.28 0.28 0.28 0.28 0.28 0.28 0.15 / 0.15 0.15 / 0.15 0.15 / 0.15 0.15 / 0.15 Metal adhesion modifier Kind H-1 H-1 H-2 H-1 H-1 H-1 H-2 H-2 H-2 H-2 mass 1.61 1.61 1.61 1.61 1.61 1.61 0.5 0.5 0.5 0.5 solvent Kind I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-1 /I-2 I-3 / I-4 I-3 / I-4 I-3 / I-4 I-3 / I-4 mass 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 80/20 Additives Kind - - - - J-1 /J-2 J-1 /J-2 J-1 /J-2 - J-1 /J-2 J-1 /J-2 mass - - - - 5.5 /1 5.5 /1 5.5 /1 - 5.5 /1 5.5 /1 Evaluation results Analytical B B B A A A A C D D Drug resistance A A A B B B B D D D

表中所記載之各成分的詳細內容如下。The detailed information of each component recorded in the table is as follows.

〔環化樹脂或其前驅物〕 ・A-1~A-8:在上述中合成之A-1~A-8 [Cycated resins or their precursors] ・A-1~A-8: A-1~A-8 synthesized in the above manner

〔化合物A〕 ・B-1~B-8:在上述中合成之B-1~B-8 [Compound A] ·B-1~B-8: B-1~B-8 synthesized in the above manner

〔聚合性化合物〕 ・C-1:下述結構的化合物 ・C-2:M-327(TOAGOSEI CO.,LTD.製三聚異氰酸環氧乙烷改質三丙烯酸酯的己內酯3莫耳改質品 【化學式85】 [Polymerizable Compounds] • C-1: Compounds with the following structure • C-2: M-327 (TOAGOSEI CO.,LTD., a 3-molar modified caprolactone product of ethylene oxide-modified triacrylate triisocyanate [Chemical Formula 85])

〔添加劑〕 ・J-1:N-苯基二乙醇胺(Tokyo Chemical Industry Co.,Ltd.製) ・J-2:下述結構的化合物 【化學式86】 [Additives] • J-1: N-Phenylonamine (manufactured by Tokyo Chemical Industry Co., Ltd.) • J-2: Compounds with the following structure [Chemical Formula 86]

〔光聚合起始劑〕 ・D-1及D-2:下述結構的化合物 【化學式87】 [Photopolymerization initiators] ・D-1 and D-2: Compounds with the following structure [Chemical Formula 87]

〔鹼產生劑〕 ・E-1~E-2:下述結構的化合物 【化學式88】 [Alkali generators] ・E-1~E-2: Compounds with the following structures [Chemical Formula 88]

〔聚合抑制劑〕 ・F-1~F-3:下述結構的化合物 ・F-3:2-亞硝基-1-萘酚(Tokyo Chemical Industry Co.,Ltd.製) 【化學式89】 [Polymerization Inhibitors] • F-1 to F-3: Compounds with the following structure • F-3: 2-Nitrosino-1-naphthol (manufactured by Tokyo Chemical Industry Co., Ltd.) [Chemical Formula 89]

〔遷移抑制劑〕 ・G-1~G-3:下述結構的化合物。 【化學式90】 [Migration Inhibitors] G-1 to G-3: Compounds with the following structures. [Chemical Formula 90]

〔金屬接著性改良劑〕 ・H-1~H-3:下述結構的化合物 【化學式91】 [Metal adhesion modifier] ・H-1~H-3: Compounds with the following structure [Chemical Formula 91]

〔溶劑〕 I-1:γ-丁內酯(SANWAYUKA INDUSTRY CORPORATION製) I-2:二甲基亞碸(FUJIFILM Wako Pure Chemical Corporation製) I-3:N-甲基-2-吡咯啶酮(Ashland公司製) I-4:乳酸乙酯(Tokyo Chemical Industry Co.,Ltd.製) [Solubilizers] I-1: γ-Butyrolactone (manufactured by SANWAYUKA INDUSTRY CORPORATION) I-2: Dimethyl sulfoxide (manufactured by FUJIFILM Wako Pure Chemical Corporation) I-3: N-Methyl-2-pyrrolidone (manufactured by Ashland) I-4: Ethyl lactate (manufactured by Tokyo Chemical Industry Co., Ltd.)

<評價> 〔硬化物的製造〕 各實施例及比較例中,藉由旋塗法分別將樹脂組成物或比較用組成物適用於矽晶圓上,形成了樹脂組成物層。將形成有上述樹脂層之矽晶圓在加熱板上在100℃下乾燥4分鐘,在矽晶圓上形成了具有20μm的均勻的厚度的樹脂組成物層。 使用寬頻曝光機(USHIO INC.製:UX-1000SN-EH01),以400mJ/cm 2的曝光能量曝光矽晶圓上的樹脂組成物層,在氮氣環境下,以5℃/分鐘的升溫速度升溫經曝光之樹脂組成物層,到達180℃之後,在該溫度下加熱了2小時。將上述加熱後的樹脂組成物層及矽晶圓浸漬於3質量%氫氟酸水溶液中,從矽晶圓剝離了加熱後的樹脂組成物層。將上述剝離之加熱後的樹脂組成物層作為硬化物。 <Evaluation> [Preparation of the Cured Material] In each embodiment and comparative example, a resin composition or a comparative composition was applied to a silicon wafer by spin coating to form a resin composition layer. The silicon wafer with the above-mentioned resin layer was dried on a heating plate at 100°C for 4 minutes, forming a resin composition layer with a uniform thickness of 20 μm on the silicon wafer. A broadband exposure machine (USHIO INC., UX-1000SN-EH01) was used to expose the resin composition layer on a silicon wafer at an exposure energy of 400 mJ/ cm² . Under a nitrogen atmosphere, the exposed resin composition layer was heated at a rate of 5°C/min until it reached 180°C, where it was held for 2 hours. The heated resin composition layer and the silicon wafer were then immersed in a 3% (w/w) hydrofluoric acid aqueous solution, and the heated resin composition layer was peeled off from the silicon wafer. This peeled-off heated resin composition layer was used as a cured material.

〔耐藥品性〕 在下述條件下將所獲得之硬化物浸漬於下述藥液中,計算溶解速度。 藥液:二甲基亞碸(DMSO)與25質量%的氫氧化四甲基銨(TMAH)水溶液的90:10(質量比)的混合物 評價條件:在75℃下將硬化物浸漬於藥液中15分鐘,比較了浸漬前後的膜厚,並計算了溶解速度(nm/分鐘)。測量膜厚時,用橢圓偏光計(Foothill公司製造之KT-22)在塗佈面10點實施膜厚測定,將該平均值作為算術平均值而求出了膜厚。 按照下述評價標準進行評價,評價結果記載於表的“耐藥品性”一欄中。溶解速度的值愈小,硬化物的耐藥品性愈優異。 -評價標準- A:溶解速度小於200nm/分鐘。 B:溶解速度為200nm/分鐘以上且小於350nm/分鐘。 C:溶解速度為350nm/分鐘以上且小於500nm/分鐘。 D:溶解速度為500nm/分鐘以上。 [Chemical Resistance] The obtained hardened material was immersed in the following solution under the following conditions, and the dissolution rate was calculated. Solution: A mixture of dimethyl sulfoxide (DMSO) and 25% by mass tetramethylammonium hydroxide (TMAH) aqueous solution in a 90:10 (mass ratio) ratio. Evaluation Conditions: The hardened material was immersed in the solution at 75°C for 15 minutes. The film thickness before and after immersion was compared, and the dissolution rate (nm/min) was calculated. For film thickness measurement, an elliptical polarimeter (Foothill KT-22) was used to measure the film thickness at 10 points on the coating surface, and the average value was used as the arithmetic mean to determine the film thickness. Evaluation was conducted according to the following criteria, and the evaluation results are recorded in the "Chemical Resistance" column of the table. The lower the dissolution rate value, the better the chemical resistance of the hardened material. -Evaluation Criteria- A: Dissolution rate less than 200 nm/min. B: Dissolution rate greater than 200 nm/min but less than 350 nm/min. C: Dissolution rate greater than 350 nm/min but less than 500 nm/min. D: Dissolution rate greater than 500 nm/min.

〔微影性(解析性)評價〕 各實施例及比較例中,分別將樹脂組成物或比較用組成物旋塗於矽晶圓上,形成了樹脂組成物層。將形成有上述樹脂層之矽晶圓在加熱板上在100℃下乾燥4分鐘,在矽晶圓上形成了20μm的均勻的厚度的樹脂組成物層。使用步進機(Nikon NSR 2005 i9C)曝光矽晶圓上的樹脂組成物層,獲得了曝光後的樹脂組成物層。使用i射線進行曝光,將波長365nm中的曝光量設為400mJ/cm 2。又,使用從5μm至25μm形成有1μm刻度的線與空間圖案之光罩進行了曝光。使用環戊酮對上述曝光後的樹脂組成物層進行了60秒鐘的顯影。 使用掃描型電子顯微鏡(SEM)觀察上述顯影後的樹脂組成物層(線圖案),確定了最小線寬。 按照下述評價標準進行評價,評價結果記載於表的“解析性”一欄中。可以說上述最小線寬愈小,微影性(解析性)愈優異。 -評價標準- A:最小線寬小於10μm。 B:最小線寬為10μm以上且小於15μm。 C:最小線寬為15μm以上且小於20μm。 D:最小線寬為20μm以上或無法獲得具備具有邊緣的銳度之線寬之圖案。 [Lithography (Resolution) Evaluation] In each embodiment and comparative example, a resin composition or a comparative composition was spin-coated onto a silicon wafer to form a resin composition layer. The silicon wafer with the resin layer formed was dried on a heated plate at 100°C for 4 minutes, forming a uniform resin composition layer with a thickness of 20 μm on the silicon wafer. The resin composition layer on the silicon wafer was exposed using a stepper (Nikon NSR 2005 i9C) to obtain the exposed resin composition layer. Exposure was performed using i-rays, with the exposure dose set to 400 mJ/ cm² at a wavelength of 365 nm. Furthermore, exposure was performed using a mask with lines and spatial patterns ranging from 5μm to 25μm, each marked with a 1μm scale. The exposed resin composition layer was developed using cyclopentanone for 60 seconds. The developed resin composition layer (line pattern) was observed using a scanning electron microscope (SEM) to determine the minimum linewidth. Evaluation was conducted according to the following criteria, and the results are recorded in the "Resolution" column of the table. Generally, a smaller minimum linewidth indicates better lithography (resolution). -Evaluation Criteria- A: Minimum linewidth less than 10μm. B: Minimum linewidth 10μm or more but less than 15μm. C: Minimum linewidth 15μm or more but less than 20μm. D: Patterns with a minimum line width of 20μm or more, or where it is impossible to obtain a line width with edge sharpness.

由以上的結果可知,本發明之含有樹脂及化合物A之樹脂組成物的解析性優異。 比較例1~2之樹脂組成物不含有化合物A。可知該比較例1~2之樹脂組成物的解析性較差。 又,由以上的結果可知,本發明之含有樹脂及化合物A之樹脂組成物對硬化物的耐藥品性優異。 比較例1~2之樹脂組成物不含有化合物A。可知該比較例1~2之樹脂組成物對硬化物的耐藥品性較差。 The results above show that the resin composition of this invention, containing resin and compound A, exhibits excellent resolution. The resin compositions of Comparative Examples 1 and 2 do not contain compound A. Therefore, the resolution of these Comparative Examples 1 and 2 is relatively poor. Furthermore, the results above show that the resin composition of this invention, containing resin and compound A, exhibits excellent drug resistance to the cured material. The resin compositions of Comparative Examples 1 and 2 do not contain compound A. Therefore, the drug resistance of these Comparative Examples 1 and 2 to the cured material is relatively poor.

<實施例101> 藉由旋塗法將在實施例1中所使用之樹脂組成物以層狀適用於在表面上形成有銅薄層之樹脂基材的銅薄層的表面上,並在100℃下乾燥4分鐘而形成膜厚20μm的感光膜之後,使用步進機(Nikon Co.,Ltd.製造,NSR1505 i6)進行了曝光。關於曝光,隔著遮罩(圖案為1:1線與空間、線寬為10μm的二元遮罩)在波長365nm下進行。曝光後,在100℃下加熱了4分鐘。上述加熱後,用環己酮顯影2分鐘,並用PGMEA沖洗30秒鐘,從而獲得了層的圖案。 接著,在氮氣環境下,以10℃/分鐘的升溫速度進行升溫,在達到230℃之後,在230℃下維持120分鐘,從而形成了再配線層用層間絕緣膜。該再配線層用層間絕緣膜的絕緣性優異。 又,使用該等再配線層用層間絕緣膜製造出半導體元件,其結果,確認到正常動作。 <Example 101> The resin composition used in Example 1 was applied in a layered manner to the surface of a copper thin layer on a resin substrate having a copper thin layer formed thereon by spin coating. After drying at 100°C for 4 minutes to form a photosensitive film with a thickness of 20 μm, exposure was performed using a stepper (manufactured by Nikon Co., Ltd., NSR1505 i6). Exposure was performed at a wavelength of 365 nm through a mask (a binary mask with a 1:1 line-space pattern and a linewidth of 10 μm). After exposure, heating at 100°C for 4 minutes was performed. Following heating, development with cyclohexanone for 2 minutes and washing with PGMEA for 30 seconds were performed to obtain the layer pattern. Next, under a nitrogen atmosphere, the temperature was increased at a rate of 10°C/min, reaching 230°C, and then maintained at 230°C for 120 minutes, thereby forming an interlayer insulating film for the redistribution layer. This interlayer insulating film for the redistribution layer exhibits excellent insulation properties. Furthermore, semiconductor devices were fabricated using these interlayer insulating films for the redistribution layer, and normal operation was confirmed.

Claims (11)

一種樹脂組成物,其含有:化合物A,其為由下述式(1-1)表示之化合物並且分子量小於1000;以及選自聚醯亞胺、聚醯亞胺前驅物、聚苯并噁唑、聚苯并噁唑前驅物、聚醯胺醯亞胺及聚醯胺醯亞胺前驅物之群組中之至少1種樹脂,前述聚醯亞胺前驅物包含由下述式(2)表示之重複單元,前述聚苯并噁唑前驅物包含由下述式(3)表示之重複單元,且前述聚醯胺醯亞胺前驅物包含由下述式(PAI-2)表示之重複單元: 式(1-1)中,R1、R2及R3分別獨立地表示具有(甲基)丙烯醯氧基、(甲基)丙烯醯胺基、乙烯基苯基、烷氧基甲基、羥甲基、醯氧基甲基、環氧基、氧雜環丁基、苯并噁唑基、嵌段異氰酸酯基或胺基之1價的有機基, 式(2)中,A1及A2分別獨立地表示氧原子或-NH-,R111表示2價的有機基,R115表示4價的有機基,R113及R114分別獨立地表示氫原子或1價的 有機基, 式(3)中,R121表示2價的有機基,R122表示4價的有機基,R123及R124分別獨立地表示氫原子或1價的有機基, 式(PAI-2)中,R117表示3價的有機基,R111表示2價的有機基,A2表示氧原子或-NH-,R113表示氫原子或1價的有機基,前述化合物A的含量相對於前述樹脂組成物的總固體成分為0質量%以上且60質量%以下,前述樹脂的含量相對於前述樹脂組成物的總固體成分為20質量%以上且99.5質量%以下。 A resin composition comprising: compound A, which is a compound represented by formula (1-1) and has a molecular weight of less than 1000; and at least one resin selected from the group consisting of polyimide, polyimide precursor, polybenzoxazole, polybenzoxazole precursor, polyamideimide, and polyamideimide precursor, wherein the polyimide precursor comprises a repeating unit represented by formula (2), the polybenzoxazole precursor comprises a repeating unit represented by formula (3), and the polyamideimide precursor comprises a repeating unit represented by formula (PAI-2): In formula (1-1), R1 , R2 , and R3 independently represent organic groups having a monovalent oxidation state of (meth)acryloxy, (meth)acrylamino, vinylphenyl, alkoxymethyl, hydroxymethyl, acetoxymethyl, epoxy, oxacyclobutyl, benzoxazolyl, block isocyanate, or amino. In formula (2), A1 and A2 independently represent oxygen atoms or -NH-, R111 represents a divalent organic group, R115 represents a tetravalent organic group, and R113 and R114 independently represent hydrogen atoms or monovalent organic groups. In equation (3), R121 represents a divalent organic group, R122 represents a tetravalent organic group, and R123 and R124 independently represent a hydrogen atom or a monovalent organic group, respectively. In formula (PAI-2), R 117 represents a trivalent organic group, R 111 represents a divalent organic group, A2 represents an oxygen atom or -NH-, and R 113 represents a hydrogen atom or a monovalent organic group. The content of the aforementioned compound A is 0% by mass or more and 60% by mass or less relative to the total solid content of the aforementioned resin composition, and the content of the aforementioned resin is 20% by mass or more and 99.5% by mass or less relative to the total solid content of the aforementioned resin composition. 如請求項1所述之樹脂組成物,其進一步含有自由基聚合起始劑。 The resin composition as described in claim 1 further contains a free radical polymerization initiator. 如請求項1所述之樹脂組成物,其中作為前述樹脂,含有前述聚醯亞胺前驅物。 The resin composition as described in claim 1, wherein the aforementioned resin contains the aforementioned polyimide precursor. 如請求項1所述之樹脂組成物,其中 前述式(2)中的R113及R114中的至少一者含有自由基聚合性基。 The resin composition as described in claim 1, wherein at least one of R 113 and R 114 in the aforementioned formula (2) contains a free radical polymerizable group. 如請求項1所述之樹脂組成物,其用於形成再配線層用層間絕緣膜。 The resin composition as described in claim 1 is used to form an interlayer insulating film for a redistribution layer. 一種硬化物,其為硬化請求項1至請求項5之任一項所述之樹脂組成物而成。 A hardened material comprising a resin composition as described in any one of claims 1 to 5. 一種積層體,其包含2層以上的由請求項6所述之硬化物構成之層,在前述硬化物層之間的任一層之間包含金屬層。 A laminate comprising two or more layers of a hardened material as described in claim 6, wherein a metal layer is included between any of the aforementioned hardened material layers. 一種硬化物的製造方法,其包括將請求項1至請求項5之任一項所述之樹脂組成物適用於基材上以形成膜之膜形成步驟。 A method for manufacturing a cured material, comprising a film forming step of adapting a resin composition described in any one of claims 1 to 5 onto a substrate to form a film. 如請求項8所述之硬化物的製造方法,其包括選擇性地曝光前述膜之曝光步驟及使用顯影液顯影前述膜來形成圖案之顯影步驟。 The method for manufacturing a cured material as described in claim 8 includes an exposure step of selectively exposing the aforementioned film and a developing step of developing the aforementioned film using a developing solution to form a pattern. 如請求項8所述之硬化物的製造方法,其包括在50~450℃下加熱前述膜之加熱步驟。 The method for manufacturing the cured material as described in claim 8 includes a heating step of heating the aforementioned film at a temperature of 50-450°C. 一種半導體元件,其含有請求項6所述之硬化物。A semiconductor device comprising the hardened material described in claim 6.
TW110134956A 2020-09-25 2021-09-17 Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device TWI904243B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020160985 2020-09-25
JP2020-160985 2020-09-25

Publications (2)

Publication Number Publication Date
TW202219161A TW202219161A (en) 2022-05-16
TWI904243B true TWI904243B (en) 2025-11-11

Family

ID=80845428

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110134956A TWI904243B (en) 2020-09-25 2021-09-17 Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device

Country Status (4)

Country Link
JP (1) JPWO2022065338A1 (en)
KR (1) KR20230054708A (en)
TW (1) TWI904243B (en)
WO (1) WO2022065338A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023181982A (en) * 2022-06-13 2023-12-25 旭化成株式会社 Resin composition, polyimide manufacturing method, cured relief pattern manufacturing method, and semiconductor device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009145158A1 (en) * 2008-05-29 2009-12-03 旭化成イーマテリアルズ株式会社 Photosensitive resin composition, process for producing cured relief pattern, and semiconductor device
JP2020154205A (en) * 2019-03-22 2020-09-24 富士フイルム株式会社 Pattern formation method, curable resin composition, film, cured film, laminate, and semiconductor device

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4789657B2 (en) 2006-03-13 2011-10-12 旭化成イーマテリアルズ株式会社 Photosensitive resin composition
KR101249568B1 (en) * 2008-07-03 2013-04-01 아사히 가세이 이-매터리얼즈 가부시키가이샤 Heat-resistant resin precursor and photosensitive resin composition comprising the same
KR101443293B1 (en) * 2009-10-15 2014-09-19 주식회사 엘지화학 Alkali developable photosensitive resin composition and dry film manufactured by the same
JP5755544B2 (en) 2011-09-30 2015-07-29 三洋化成工業株式会社 Photosensitive resin composition
JP6572770B2 (en) * 2013-10-09 2019-09-11 日立化成デュポンマイクロシステムズ株式会社 Resin composition containing polyimide precursor and method for producing cured film using the same
JP7042353B2 (en) * 2018-09-10 2022-03-25 富士フイルム株式会社 Photosensitive resin compositions, cured films, laminates, methods for manufacturing cured films, and semiconductor devices.
JP7086882B2 (en) * 2019-03-22 2022-06-20 富士フイルム株式会社 Curable resin composition, cured film, laminate, method for manufacturing cured film, and semiconductor device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009145158A1 (en) * 2008-05-29 2009-12-03 旭化成イーマテリアルズ株式会社 Photosensitive resin composition, process for producing cured relief pattern, and semiconductor device
JP2020154205A (en) * 2019-03-22 2020-09-24 富士フイルム株式会社 Pattern formation method, curable resin composition, film, cured film, laminate, and semiconductor device

Also Published As

Publication number Publication date
TW202219161A (en) 2022-05-16
JPWO2022065338A1 (en) 2022-03-31
WO2022065338A1 (en) 2022-03-31
KR20230054708A (en) 2023-04-25

Similar Documents

Publication Publication Date Title
TWI894339B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI890907B (en) Resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI890798B (en) Curable resin composition, cured film, laminate, method for producing cured film, and semiconductor device
TWI888627B (en) Method for producing hardened product, method for producing laminate, and method for producing semiconductor element
TWI890841B (en) Curable resin composition, cured product, laminate, method for producing cured product, semiconductor device, polyimide precursor and method for producing the same
TWI898039B (en) Method for producing a cured product, method for producing a laminate, and method for producing a semiconductor device
CN114341731A (en) Method for producing cured film, photocurable resin composition, method for producing laminate, and method for producing semiconductor device
CN114981360B (en) Curable resin composition, cured film, laminate, method for producing cured film, and semiconductor device
TW202219080A (en) Curable resin composition, cured object, layered product, method for producing cured object, semiconductor device, and polyimide precursor and production method therefor
TWI904246B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TW202138469A (en) Curable resin composition, resin film, cured film, laminate, method for producing cured film, and semiconductor device
TWI896742B (en) Photosensitive resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TW202248289A (en) Resin composition, cured product, multilayer body, method for producing cured product, and semiconductor device
TW202219092A (en) Curable resin composition, cured product, laminate, and method for producing cured product, semiconductor element, and photobase generator
TWI882163B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI893199B (en) Composite pattern manufacturing method, resin composition, laminate manufacturing method, and semiconductor device manufacturing method
TW202244639A (en) Method for producing permanent film, method for producing multilayer body, and method for producing semiconductor device
TW202234156A (en) Resin composition, cured product, laminate, production method for cured product, semiconductor device, and compound
TWI904243B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI894341B (en) Curable resin composition, cured product, laminate, method for manufacturing cured product, and semiconductor device
TWI902904B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI912484B (en) Resin composition, cured material, laminate, method for manufacturing cured material and semiconductor device
TWI912365B (en) Resin compositions, cured materials, laminates, manufacturing methods of cured materials, and semiconductor devices
TW202219118A (en) Method for producing polyimide precursor and method for producing curable resin composition
TWI901645B (en) Photosensitive resin composition, pattern manufacturing method, photosensitive film, cured product, laminate and device